text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"FISH VENTILATORY BEHAVIOR AS A TOXIC'S MONITORING TOOL The long term objective is to develop a fish monitoring tool capable of rapidly screening chemicals for toxicity, protecting public drinking water supplies and wastewater receiving systems, and identifying the causative toxic agent(s).  Non-invasive electrode techniques receive signals from fish generated bioelectric fields.  Electronic components filter the signals generated from independently monitored fish such that the ventilatory components may be amplified and interfaced to a microcomputer. This and other laboratories have demonstrated that, upon exposure to acutely toxic chemical concentrations, several changes occur in the ventilatory components of fish, such as, frequency, amplitude, and gill purge or cough, including three major and eleven subcategories of the types of gill purge.  It is anticipated that the Phase I research will demonstrate that, upon exposure to chronically toxic chemical concentrations, the combinations of ventilatory components occurring will be unique to a given category of the chemical (e.g., concepts of structural activity relationships, heavy metal vs. pesticide, etc.).  Many chemicals that are toxic to humans and other mammilian systems are toxic to aquatic organisms.  If the long term objective is successful, this inexpensive monitoring tool would have commercal applications for the chemical manufacturing, drinking water and wastewater treatment industries, municipalities, and regulatory agencies, as well as the academic research community.  ",FISH VENTILATORY BEHAVIOR AS A TOXIC'S MONITORING TOOL,3496463,R43ES003808,"['water supply ', ' water sampling /testing ', ' water pollution control ', ' water pollution ', ' fresh water environment ', ' aquatic biology ', ' toxicant screening ', ' environmental toxicology ', ' gills ', ' pesticide biological effect ', ' cinematography ', ' metal poisoning ', ' zinc ', ' trichloroethylene ', ' chlorohydrocarbon ', ' environmental contamination ', ' computer graphics /printing ', ' artificial intelligence ', ' chemical structure function ', ' monitoring device ', ' bioassay ', ' ']",NIEHS,"BIOLOGICAL MONITORING, INC.",R43,1985,50000,0.12893018657862784
"PRIMATE CHEMICAL COMMUNICATION INTERDISCIPLINARY STUDIES This research will provide new, fundamental information concerning chemical communication in a primate species.  The overall, long range objectives are to define the chemical nature and behavioral significance of the scent marks utilized by the South American tamarin, Saguinus fuscicollis, a member of the marmoset family (Callitrichidae), in social and sexual communication.  The scent marks of these primates encode messages on identify of species, subspecies, and individual as well as information relating to sexual and social status.  Scent mark material, a mixture of gland secretion, some urine and possibly genital discharge, is chemically complex and includes esters, acids, alcohols, aldehydes and hydrocarbons.  To date our analytical studies using high resolution capillary gas chromatography have not revealed any qualitative differences in the scent marks of animals which differ in their sex, subspecies or species.  Therefore, we have embarked on a study to evaluate quantitative differences in the scent mark constituents.  Studies are proposed to identify the concentration profiles of the components which define gender, subspecies and species.  Analysis by computerized pattern recognition techniques will target those components which are correlated with gender, subspecies and species.  Sophisticated GC/MS/DS instrumentation will then be employed as the major tool for identification and quantitation of the targeted components.  Their role in chemical communication will be tested by behavioral assay.  Bacterial studies will also be undertaken to establish the role of microbial action in the production of some of the highly volatile components.  Finally, studies aimed at the identification of previously unknown components of lower volatility will be carried out.  We anticipate that this research will eventually lead to a deciphering of the chemical code such that in the end it will be possible to reconstruct with synthetic formulations the wide variety of communicatory signals employed by the tamarins.  To accomplish this goal a unique interdisciplinary research team consisting of two organic chemists, a primatologist and a bacteriologist has been assembled at the Monell Chemical Senses Center.  These studies follow logically from prior work of our laboratory.  To the best of our knowledge this research program, involving the very close collaboration of chemists, primatologists and bacteriologists to explore and define a chemical communication system in a primate species, is unique in the United States.  ",PRIMATE CHEMICAL COMMUNICATION INTERDISCIPLINARY STUDIES,3403396,R01NS021790,"['sex ', ' olfactory stimulus ', ' ethology ', ' gas chromatography ', ' microorganism classification ', ' animal communication behavior ', ' pheromone ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' analytical chemistry ', ' species difference ', ' bioassay ', ' bacteria ', ' Lepidoptera ', ' ']",NINDS,MONELL CHEMICAL SENSES CENTER,R01,1985,72512,0.11828666597937514
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures.  A general problem-solving program, LHASA II (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective data base.  The program will be applied to key problems involving biologically important substances and eventually will be made available for general use.   ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS,3269297,R01GM018519,"['computer graphics /printing ', ' computer data analysis ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1985,244475,0.08326966439153606
"CHROMOSOMAL PROTEINS DURING CHEMICAL CARCINOGENESIS Administration of many chemical agents results in induction of malignant tumors in target tissues.  These malignancies are characterized by alterations in control of cellular function, suggesting that genomic alteration (mutation) and/or alterations in gene modulation have occurred. While a substantial body of evidence indicates that altered DNA plays a major role in this process, the role of non-DNA factors has also been demonstrated.  In this continuation, we will extend our two-dimensional gel electrophoretic study of potentially critical alterations occurring in nonhistone chromosomal proteins (NHCP) and cytosolic proteins during carcinogenesis induced by diverse acting carcinogens acetylaminofluorene (AAF) and diethylnitrosamine (DEN), and in the cancers that result.  We have demonstrated that the gel system provides a highly consistent pattern of protein separation, with extreme resolution, over long periods of time. Silver and in vitro radiolabeling techniques have been developed to permit visualization of nanogram amounts of protein(s) with applicability to computer technology.  Using these techniques, we have identified induction of tumor-associated proteins (TAP) in the total NHCP fraction as well as in the phenol-soluble fraction (phosphoproteins) of rat hepatic chromatins during AAF and DEN carcinogenesis and resulting hepatocellular carcinomas. Additionally, cytosolic AAF and DEN-TAPs have been similarly demonstrated. We will determine to what extent these changes in NHCP and cytosolic proteins characterize the general process of carcinogenesis by examining spontaneous and chemically-induced hepatic and thymus tumors in a variety of mouse inbred strains.  We will further determine the time of appearance, sub-fraction location, and in the case of NHCP, genomic distribution of TAP during chemical carcinogenesis; isolate these proteins, and produce monoclonal antibodies for use in their study, as well as determining their functional significance.  Lastly, we will continue our technological developments to assure maximum detection, and computer-assisted image-processing of the complex protein patterns that characterize normal and malignant cells in order to confirm and further detect potential hallmark proteins, whose occurrence mark malignant induction.  ",CHROMOSOMAL PROTEINS DURING CHEMICAL CARCINOGENESIS,3168056,R01CA028263,"['radiotracer ', ' autoradiography ', ' gel electrophoresis ', ' electrofocusing ', ' chemical carcinogenesis ', ' thymus neoplasms ', ' liver neoplasms ', ' neoplasm /cancer genetics ', ' neoplasm /cancer classification /staging ', ' monoclonal antibody ', ' chromatin ', ' chromosomes ', ' genetic markers ', ' acetylaminofluorene ', ' artificial intelligence ', ' nitrosamines ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,1985,93047,0.02249527336321809
"PRIMATE CHEMICAL COMMUNICATION INTERDISCIPLINARY STUDIES This research will provide new, fundamental information concerning chemical communication in a primate species.  The overall, long range objectives are to define the chemical nature and behavioral significance of the scent marks utilized by the South American tamarin, Saguinus fuscicollis, a member of the marmoset family (Callitrichidae), in social and sexual communication.  The scent marks of these primates encode messages on identify of species, subspecies, and individual as well as information relating to sexual and social status.  Scent mark material, a mixture of gland secretion, some urine and possibly genital discharge, is chemically complex and includes esters, acids, alcohols, aldehydes and hydrocarbons.  To date our analytical studies using high resolution capillary gas chromatography have not revealed any qualitative differences in the scent marks of animals which differ in their sex, subspecies or species.  Therefore, we have embarked on a study to evaluate quantitative differences in the scent mark constituents.  Studies are proposed to identify the concentration profiles of the components which define gender, subspecies and species.  Analysis by computerized pattern recognition techniques will target those components which are correlated with gender, subspecies and species.  Sophisticated GC/MS/DS instrumentation will then be employed as the major tool for identification and quantitation of the targeted components.  Their role in chemical communication will be tested by behavioral assay.  Bacterial studies will also be undertaken to establish the role of microbial action in the production of some of the highly volatile components.  Finally, studies aimed at the identification of previously unknown components of lower volatility will be carried out.  We anticipate that this research will eventually lead to a deciphering of the chemical code such that in the end it will be possible to reconstruct with synthetic formulations the wide variety of communicatory signals employed by the tamarins.  To accomplish this goal a unique interdisciplinary research team consisting of two organic chemists, a primatologist and a bacteriologist has been assembled at the Monell Chemical Senses Center.  These studies follow logically from prior work of our laboratory.  To the best of our knowledge this research program, involving the very close collaboration of chemists, primatologists and bacteriologists to explore and define a chemical communication system in a primate species, is unique in the United States.  ",PRIMATE CHEMICAL COMMUNICATION INTERDISCIPLINARY STUDIES,3403399,R01NS021790,"['sex ', ' olfactory stimulus ', ' ethology ', ' gas chromatography ', ' microorganism classification ', ' animal communication behavior ', ' pheromone ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' analytical chemistry ', ' species difference ', ' bioassay ', ' bacteria ', ' Lepidoptera ', ' ']",NINDS,MONELL CHEMICAL SENSES CENTER,R01,1986,76440,0.11828666597937514
"CHROMOSOMAL PROTEINS DURING CHEMICAL CARCINOGENESIS Administration of many chemical agents results in induction of malignant tumors in target tissues.  These malignancies are characterized by alterations in control of cellular function, suggesting that genomic alteration (mutation) and/or alterations in gene modulation have occurred. While a substantial body of evidence indicates that altered DNA plays a major role in this process, the role of non-DNA factors has also been demonstrated.  In this continuation, we will extend our two-dimensional gel electrophoretic study of potentially critical alterations occurring in nonhistone chromosomal proteins (NHCP) and cytosolic proteins during carcinogenesis induced by diverse acting carcinogens acetylaminofluorene (AAF) and diethylnitrosamine (DEN), and in the cancers that result.  We have demonstrated that the gel system provides a highly consistent pattern of protein separation, with extreme resolution, over long periods of time. Silver and in vitro radiolabeling techniques have been developed to permit visualization of nanogram amounts of protein(s) with applicability to computer technology.  Using these techniques, we have identified induction of tumor-associated proteins (TAP) in the total NHCP fraction as well as in the phenol-soluble fraction (phosphoproteins) of rat hepatic chromatins during AAF and DEN carcinogenesis and resulting hepatocellular carcinomas. Additionally, cytosolic AAF and DEN-TAPs have been similarly demonstrated. We will determine to what extent these changes in NHCP and cytosolic proteins characterize the general process of carcinogenesis by examining spontaneous and chemically-induced hepatic and thymus tumors in a variety of mouse inbred strains.  We will further determine the time of appearance, sub-fraction location, and in the case of NHCP, genomic distribution of TAP during chemical carcinogenesis; isolate these proteins, and produce monoclonal antibodies for use in their study, as well as determining their functional significance.  Lastly, we will continue our technological developments to assure maximum detection, and computer-assisted image-processing of the complex protein patterns that characterize normal and malignant cells in order to confirm and further detect potential hallmark proteins, whose occurrence mark malignant induction.  ",CHROMOSOMAL PROTEINS DURING CHEMICAL CARCINOGENESIS,3168057,R01CA028263,"['radiotracer ', ' autoradiography ', ' gel electrophoresis ', ' electrofocusing ', ' chemical carcinogenesis ', ' thymus neoplasms ', ' liver neoplasms ', ' neoplasm /cancer genetics ', ' neoplasm /cancer classification /staging ', ' monoclonal antibody ', ' chromatin ', ' chromosomes ', ' genetic markers ', ' acetylaminofluorene ', ' artificial intelligence ', ' nitrosamines ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,1986,108862,0.02249527336321809
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL  SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures.  A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective database.  The program can be applied to problems involving biologically important substances and is being made available for general use.  ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL  SYNTHESIS,3269295,R01GM018519,"['mathematical model ', ' computer graphics /printing ', ' computer data analysis ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1986,213738,0.10432626711669132
"CHEMICAL COMMUNICATION INTERDISCIPLINARY STUDIES This research will provide new, fundamental information concerning chemical communication in a primate species.  The overall, long range objectives are to define the chemical nature and behavioral significance of the scent marks utilized by the South American tamarin, Saguinus fuscicollis, a member of the marmoset family (Callitrichidae), in social and sexual communication.  The scent marks of these primates encode messages on identify of species, subspecies, and individual as well as information relating to sexual and social status.  Scent mark material, a mixture of gland secretion, some urine and possibly genital discharge, is chemically complex and includes esters, acids, alcohols, aldehydes and hydrocarbons.  To date our analytical studies using high resolution capillary gas chromatography have not revealed any qualitative differences in the scent marks of animals which differ in their sex, subspecies or species.  Therefore, we have embarked on a study to evaluate quantitative differences in the scent mark constituents.  Studies are proposed to identify the concentration profiles of the components which define gender, subspecies and species.  Analysis by computerized pattern recognition techniques will target those components which are correlated with gender, subspecies and species.  Sophisticated GC/MS/DS instrumentation will then be employed as the major tool for identification and quantitation of the targeted components.  Their role in chemical communication will be tested by behavioral assay.  Bacterial studies will also be undertaken to establish the role of microbial action in the production of some of the highly volatile components.  Finally, studies aimed at the identification of previously unknown components of lower volatility will be carried out.  We anticipate that this research will eventually lead to a deciphering of the chemical code such that in the end it will be possible to reconstruct with synthetic formulations the wide variety of communicatory signals employed by the tamarins.  To accomplish this goal a unique interdisciplinary research team consisting of two organic chemists, a primatologist and a bacteriologist has been assembled at the Monell Chemical Senses Center.  These studies follow logically from prior work of our laboratory.  To the best of our knowledge this research program, involving the very close collaboration of chemists, primatologists and bacteriologists to explore and define a chemical communication system in a primate species, is unique in the United States.  ",CHEMICAL COMMUNICATION INTERDISCIPLINARY STUDIES,3403400,R01NS021790,"['sex ', ' olfactory stimulus ', ' ethology ', ' gas chromatography ', ' microorganism classification ', ' animal communication behavior ', ' pheromone ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' analytical chemistry ', ' species difference ', ' bioassay ', ' bacteria ', ' Lepidoptera ', ' ']",NINDS,MONELL CHEMICAL SENSES CENTER,R01,1987,89424,0.11828666597937514
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL  SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures.  A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective database.  The program can be applied to problems involving biologically important substances and is being made available for general use.  ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL  SYNTHESIS,3269298,R01GM018519,"['mathematical model ', ' computer graphics /printing ', ' computer data analysis ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1987,253178,0.10432626711669132
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL  SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures.  A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective database.  The program can be applied to problems involving biologically important substances and is being made available for general use.  ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL  SYNTHESIS,3269299,R01GM018519,"['mathematical model ', ' computer graphics /printing ', ' computer data analysis ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1988,225132,0.10432626711669132
"ARTIFICIAL INTELLIGENCE IN PROCESS PLANT SAFETY The major goal of this proposal is to research and demonstrate new approaches based on Artificial Intelligence (AI) towards the design of chemical process hazard detection, prevention, and control systems.  Such systems are extremely important for improving the occupational safety of chemical plants owing to the complexity of modern process plants.  Industrial statistics show that even though major catastrophies and disasters from chemical plant failures are infrequent, minor accidents are very common, occurring on a day to day basis, resulting in many occupational injuries and illnesses, costing the society billions of dollars every year.  The proposed project is aimed at the prevention and control of such frequent, day to day, accidental events in the industry. Past approaches in fault diagnostic systems did not properly include the human expert's reasoning strategies and experience and hence were not adequate in efficient and correct trouble- shooting.  We propose to improve this status by designing systems that would have better modeling of the problem-solving process through an appropriate representation of the domain knowledge through the use of causal modeling and reasoning from first principles, similar to human experts, by exploiting some of the recent advances in Artificial Intelligence.  We propose a methodology that aids the development of expert systems which are process-independent, transparent in their reasoning, resilient under unforeseen fault combinations, and capable of diagnosing a wide diversity of faults.  The domain knowledge of the system is based on a library of fault and causal models of process equipments as well as on the physical interconnections between equipment units and causal relationships among process state variables.  The inference strategy uses model-based reasoning for analyzing the plant behavior.  We describe a prototype expert system, called MODEX, based on our methodology.  The system has performed successfully on test cases of prototypical chemical process plants and looks promising.  However, before a successful transfer of this methodology to the industry can be initiated a number of research issues outlined in the proposal need to be resolved by experimenting with larger prototypical chemical plants.  ",ARTIFICIAL INTELLIGENCE IN PROCESS PLANT SAFETY,3420588,R01OH002352,"['occupational psychology ', ' industry ', ' occupational hazard ', ' occupational disease /disorder ', ' safety equipment ', ' disease /disorder prevention /control ', ' computer simulation ', ' computer system design /evaluation ', ' artificial intelligence ', ' ']",NIOSH,PURDUE UNIVERSITY,R01,1988,81910,0.1009004753346452
"SYSTEM FOR MACHINE READING OF CHEMICAL SYMBOLS This project will lead to the development of a proof-of-principle system for machine reading and understanding of hardcopy, graphical chemical structures.  This research will provide a basis for developing intelligent input devices for entry of chemical structure data into existing and future chemical information analysis and classification systems.  Such systems have applications for chemical patent searches, chemical design and analysis, and education.  Development of the proof-of-principle chemical structure reader will require a unique blend of current technologies, including electronic imaging, pattern recognition and analysis, and computer handling of chemical information.  The reader will be a microcomputer-based system using a CCD camera to capture page images consisting of chemical structure diagrams.  These images will be digitized and transmitted to the computer where the image data will be preprocessed into a format understandable by pattern recognition algorithms.  The algorithms will transform the data from a collection of graphic elements into chemical structure indices characterizing the chemical.  The specific goal of the Phase I effort will be to develop a system capable of automatically reading chemical structure diagrams from a limited set and correctly identifying the chemical.  ",SYSTEM FOR MACHINE READING OF CHEMICAL SYMBOLS,3497984,R43GM039007,"['image processing ', ' mathematical model ', ' computer system design /evaluation ', ' artificial intelligence ', ' chemical structure ', ' chemical information system ', ' biomedical equipment development ', ' ']",NIGMS,"WESTERN RESEARCH COMPANY, INC.",R43,1988,50000,0.19950697791965846
"2D NMR SPECTRA, IMAG. RECONSTRUCTION AND PATTERN RECOG. The long term objectives of this project are:  (1) to develop an entirely new computer software approach for making unambiguous spectral assignments in 2-dimensional FT NMR of small to middle-sized proteins and other biomolecules, and (2) to use the same software approach for enhancement of MR images and for automated feature recognition.  These two apparently different project areas are actually closely related technically, as the combined multivariate analysis/logic programming approach to be used is essentially identical (with different rules).  The two project goals each have important biomedical ramifications:  (1) Recognition and isolation of each spin system in a complex 2D NMR spectrum from a small potein will greatly enhance structure studies of these molecules; (2) Application to MRI will improve quality of these experiments, obviate some of many experimental difficulties, and significantly enhance image interpretation where ambiguities are present.  This project has an excellent chance to give rise to a family of software products of major commercial importance in both the biomedical and chemical marketplaces.  ","2D NMR SPECTRA, IMAG. RECONSTRUCTION AND PATTERN RECOG.",3497996,R43GM039626,"['protein structure ', ' magnetic resonance imaging ', ' image processing ', ' statistics /biometry ', ' artificial intelligence ', ' computers ', ' nuclear magnetic resonance spectroscopy ', ' ']",NIGMS,"NEW METHODS RESEARCH, INC.",R43,1988,35975,0.03883854846346543
"QUANTIFYING NITROARENE GENOTOXICITY IN COMPLEX MIXTURES The biological activity of nitrated polycyclic aromatic hydrocarbons (nitroarenes) has ben the subject of extensive study primarily because of the potent mutagenicity and carcinogenicity of some nitroarenes as well as their widespread occurrence in the environment, principally as the result of incomplete combustion processes.  However, most of us are not exposed primarily to individual compounds but rather to complex mixtures both outdoors (emissions from automobiles, power plants, etc.) and indoors (cigarette smoke, heaters, stoves, ovens etc).  The objective of the work proposed in this application is to relate the genotoxic and carcinogenic activities of individual nitroarenes to activities of artificial mixtures and extracts of emission particulates in order to use data for single chemicals to evaluate the risk of exposure to complex mixtures.  The proposed project, which employs both computerized and experimental methodologies, will involve professionals with expertise in chemistry, biochemistry, microbiology, artificial intelligence and risk assessment, and with extensive experience in the study of nitroarenes.  Two computerized techniques will be used.  First, Computer Automated Structure Evaluation (CASE), an artificial intelligence program which was developed to predict the mutagenicity of nitroarenes, will be used to identify structural determinants of mutagenicity, genotoxicity and carcinogenicity. Second, the Carcinogenicity Prediction and Battery Selection (CPBS) method will used to identify appropriate batteries of short-term tests for screening individual nitroarenes and mixtures and to predict potential carcinogenicity, including carcinogenic potency.  Experimental studies will be directed towards assessing the activities of compounds in mixtures.  Artificial mixtures of pairs of nitroarenes or related compounds, as well as extracts of combustion emissions combined with individual chemicals, will be tested for mutagenicity, metabolic activation and deactivation of mutagenicity, mammalian genotoxicity and metabolic biotransformation.  Three issues will be addressed:  whether activities are additive or are influenced by competition for enzymatic activation, whether inactivating structures identified by CASE represent alternative biotransformation or competition and how the presence of a complex mixture influences the metabolism, mutagenicity and genotoxicity of individual chemicals.  Resolving these questions about the extrapolation from individual components to mixtures would allow data for individual chemicals concerning bioavailability, metabolism, genotoxicity, detoxification and excretion to be used to reduce uncertainty in the assessment of human risk from exposure in incomplete combustion products and other complex mixtures.  ",QUANTIFYING NITROARENE GENOTOXICITY IN COMPLEX MIXTURES,3252781,R01ES004659,"['toxicant screening ', ' neoplastic cell culture for noncancer research ', ' tissue /cell culture ', ' nitrogenous heterocyclic compound ', ' chemical carcinogen ', ' chemical carcinogenesis ', ' cancer risk ', ' environment related neoplasm /cancer ', ' biotransformation ', ' mutagen testing ', ' enzyme induction /repression ', ' artificial intelligence ', ' chemical structure function ', ' bioassay ', ' Salmonella ', ' laboratory rat ', ' hamsters ', ' engine exhaust ', ' ']",NIEHS,CASE WESTERN RESERVE UNIVERSITY,R01,1988,98366,0.10058975605616419
"CHEMICAL COMMUNICATION-INTERDISCIPLINARY STUDIES This research will provide new, fundamental information concerning chemical communication in a primate species.  The overall long-range objective is to define the chemical nature and behavioral significance of the scent marks utilized by the South American tamarin, Saguinus fuscicollis, a member of the family Callitrichidae, in social and sexual communication.  Studies are proposed to elucidate in detail those chemical patterns which encode gender and species.  A combination of analytical techniques, pattern recognition methods and behavioral assays will identify those components or patterns of compounds, both volatile and non-volatile, which are associated with the commmunicatory information.  Bacteriological studies will determine which of the active components are of bacterial origin. In addition, a pilot study will assess the possible role of the fatty acids in encoding individual differences in the scent marks.  We anticipate that this research will lead to a much more complete understanding of the nature of the chemical code in this primate species, and in the end that it will be possible to reconstruct with synthetic formulations a variety of the communicatory signals employed by the tamarins.  To accomplish this goal, a unique interdisciplinary research team consisting of two organic chemists, a primatologist and two bacteriologists, as well as a pattern recognition expert has been assembled at the Monell Chemical Senses Center.  The proposed studies follow logically from prior work of our laboratory.  To the best of our knowledge, this program involving the very close collaboration of scientists in all these areas of expertise (organic and analytical chemistry, statistics, behavioral biology, primatology and microbiology) to explore and define a chemical communication system in a primate species is unique in the scientific world.  ",CHEMICAL COMMUNICATION-INTERDISCIPLINARY STUDIES,3403397,R01NS021790,"['sex ', ' olfactory stimulus ', ' ethology ', ' gas chromatography ', ' microorganism classification ', ' animal communication behavior ', ' fatty acids ', ' pheromone ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' analytical chemistry ', ' species difference ', ' bioassay ', ' bacteria ', ' Ceboidea ', ' ']",NINDS,MONELL CHEMICAL SENSES CENTER,R01,1988,235100,0.16804734245916975
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures.  A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective database.  The program can be applied to problems involving biologically important substances and is being made available for general use.  ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS,3269300,R01GM018519,"['mathematical model ', ' computer graphics /printing ', ' computer data analysis ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1989,185740,0.10432626711669132
"CHEMICAL COMMUNICATION-INTERDISCIPLINARY STUDIES This research will provide new, fundamental information concerning chemical communication in a primate species.  The overall long-range objective is to define the chemical nature and behavioral significance of the scent marks utilized by the South American tamarin, Saguinus fuscicollis, a member of the family Callitrichidae, in social and sexual communication.  Studies are proposed to elucidate in detail those chemical patterns which encode gender and species.  A combination of analytical techniques, pattern recognition methods and behavioral assays will identify those components or patterns of compounds, both volatile and non-volatile, which are associated with the commmunicatory information.  Bacteriological studies will determine which of the active components are of bacterial origin. In addition, a pilot study will assess the possible role of the fatty acids in encoding individual differences in the scent marks.  We anticipate that this research will lead to a much more complete understanding of the nature of the chemical code in this primate species, and in the end that it will be possible to reconstruct with synthetic formulations a variety of the communicatory signals employed by the tamarins.  To accomplish this goal, a unique interdisciplinary research team consisting of two organic chemists, a primatologist and two bacteriologists, as well as a pattern recognition expert has been assembled at the Monell Chemical Senses Center.  The proposed studies follow logically from prior work of our laboratory.  To the best of our knowledge, this program involving the very close collaboration of scientists in all these areas of expertise (organic and analytical chemistry, statistics, behavioral biology, primatology and microbiology) to explore and define a chemical communication system in a primate species is unique in the scientific world.  ",CHEMICAL COMMUNICATION-INTERDISCIPLINARY STUDIES,3216443,R01DC000289,"['sex ', ' olfactory stimulus ', ' ethology ', ' gas chromatography ', ' microorganism classification ', ' animal communication behavior ', ' fatty acids ', ' pheromone ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' analytical chemistry ', ' species difference ', ' bioassay ', ' bacteria ', ' Ceboidea ', ' ']",NIDCD,MONELL CHEMICAL SENSES CENTER,R01,1989,212124,0.16804734245916975
"INTELLIGENT SOFTWARE FOR WORKING WITH CHEMICAL DIAGRAMS The proposed efforts initiates research into an integrated tool for research documentation designed around the unique needs and communication language of biochemical researchers.  A computer system called ChemWriter will be implemented in Phase II from the Phase I design.  ChemWriter addresses the need of many health scientists to work with text, quantitative data, and chemical structure diagrams in an integrated fashion.  Existing tools offer only piece-meal and non-integratable solutions.  ChemWriter would enhance the research documentation process, increase researcher productivity, and speed dissemination of important research results.  The design for Chemwriter is developed through a methodology for human-computer interface design originated and successfully applied by the proposed principal investigator.  The methodology focuses on analyzing the functional needs of the specialist in the application domain (i.e., the biochemical researcher), and designing the user interface to fit these needs.  Software 'form' is then designed to the use-oriented function of the interface.  ChemWriter will incorporate elements of chemical intelligence to support and streamline the chemical structure diagram drawing process, and will be largely machine independent through use of the emerging technology of display description languages.  The chief innovation offered is applying a new design methodology to the fundamental information processing problems of biochemical professionals.  ",INTELLIGENT SOFTWARE FOR WORKING WITH CHEMICAL DIAGRAMS,3498348,R43GM042331,"['computer system design /evaluation ', ' artificial intelligence ', ' chemical information system ', ' biomedical equipment resource ', ' ']",NIGMS,"CHI SYSTEMS, INC.",R43,1989,46154,0.0679495254980085
"QUANTIFYING NITROARENE GENOTOXICITY IN COMPLEX MIXTURES The biological activity of nitrated polycyclic aromatic hydrocarbons (nitroarenes) has ben the subject of extensive study primarily because of the potent mutagenicity and carcinogenicity of some nitroarenes as well as their widespread occurrence in the environment, principally as the result of incomplete combustion processes.  However, most of us are not exposed primarily to individual compounds but rather to complex mixtures both outdoors (emissions from automobiles, power plants, etc.) and indoors (cigarette smoke, heaters, stoves, ovens etc).  The objective of the work proposed in this application is to relate the genotoxic and carcinogenic activities of individual nitroarenes to activities of artificial mixtures and extracts of emission particulates in order to use data for single chemicals to evaluate the risk of exposure to complex mixtures.  The proposed project, which employs both computerized and experimental methodologies, will involve professionals with expertise in chemistry, biochemistry, microbiology, artificial intelligence and risk assessment, and with extensive experience in the study of nitroarenes.  Two computerized techniques will be used.  First, Computer Automated Structure Evaluation (CASE), an artificial intelligence program which was developed to predict the mutagenicity of nitroarenes, will be used to identify structural determinants of mutagenicity, genotoxicity and carcinogenicity. Second, the Carcinogenicity Prediction and Battery Selection (CPBS) method will used to identify appropriate batteries of short-term tests for screening individual nitroarenes and mixtures and to predict potential carcinogenicity, including carcinogenic potency.  Experimental studies will be directed towards assessing the activities of compounds in mixtures.  Artificial mixtures of pairs of nitroarenes or related compounds, as well as extracts of combustion emissions combined with individual chemicals, will be tested for mutagenicity, metabolic activation and deactivation of mutagenicity, mammalian genotoxicity and metabolic biotransformation.  Three issues will be addressed:  whether activities are additive or are influenced by competition for enzymatic activation, whether inactivating structures identified by CASE represent alternative biotransformation or competition and how the presence of a complex mixture influences the metabolism, mutagenicity and genotoxicity of individual chemicals.  Resolving these questions about the extrapolation from individual components to mixtures would allow data for individual chemicals concerning bioavailability, metabolism, genotoxicity, detoxification and excretion to be used to reduce uncertainty in the assessment of human risk from exposure in incomplete combustion products and other complex mixtures.  ",QUANTIFYING NITROARENE GENOTOXICITY IN COMPLEX MIXTURES,3252785,R01ES004659,"['toxicant screening ', ' neoplastic cell culture for noncancer research ', ' tissue /cell culture ', ' nitrogenous heterocyclic compound ', ' chemical carcinogen ', ' chemical carcinogenesis ', ' cancer risk ', ' environment related neoplasm /cancer ', ' biotransformation ', ' mutagen testing ', ' enzyme induction /repression ', ' artificial intelligence ', ' chemical structure function ', ' bioassay ', ' Salmonella ', ' laboratory rat ', ' hamsters ', ' engine exhaust ', ' ']",NIEHS,CASE WESTERN RESERVE UNIVERSITY,R01,1989,96915,0.10058975605616419
"ARTIFICIAL INTELLIGENCE IN PROCESS PLANT SAFETY The major goal of this proposal is to research and demonstrate new approaches based on Artificial Intelligence (AI) towards the design of chemical process hazard detection, prevention, and control systems.  Such systems are extremely important for improving the occupational safety of chemical plants owing to the complexity of modern process plants.  Industrial statistics show that even though major catastrophies and disasters from chemical plant failures are infrequent, minor accidents are very common, occurring on a day to day basis, resulting in many occupational injuries and illnesses, costing the society billions of dollars every year.  The proposed project is aimed at the prevention and control of such frequent, day to day, accidental events in the industry. Past approaches in fault diagnostic systems did not properly include the human expert's reasoning strategies and experience and hence were not adequate in efficient and correct trouble- shooting.  We propose to improve this status by designing systems that would have better modeling of the problem-solving process through an appropriate representation of the domain knowledge through the use of causal modeling and reasoning from first principles, similar to human experts, by exploiting some of the recent advances in Artificial Intelligence.  We propose a methodology that aids the development of expert systems which are process-independent, transparent in their reasoning, resilient under unforeseen fault combinations, and capable of diagnosing a wide diversity of faults.  The domain knowledge of the system is based on a library of fault and causal models of process equipments as well as on the physical interconnections between equipment units and causal relationships among process state variables.  The inference strategy uses model-based reasoning for analyzing the plant behavior.  We describe a prototype expert system, called MODEX, based on our methodology.  The system has performed successfully on test cases of prototypical chemical process plants and looks promising.  However, before a successful transfer of this methodology to the industry can be initiated a number of research issues outlined in the proposal need to be resolved by experimenting with larger prototypical chemical plants.  ",ARTIFICIAL INTELLIGENCE IN PROCESS PLANT SAFETY,3420587,R01OH002352,"['occupational psychology ', ' industry ', ' occupational hazard ', ' occupational disease /disorder ', ' safety equipment ', ' disease /disorder prevention /control ', ' computer simulation ', ' computer system design /evaluation ', ' artificial intelligence ', ' ']",NIOSH,PURDUE UNIVERSITY,R01,1989,59219,0.1009004753346452
"INTELLIGENT SOFTWARE FOR CHEMICAL DIAGRAMS (Adapted from applicant's abstract):  The project continues research into an integrated tool for documentation designed around the unique needs and communication language of biochemical researchers.  A software tool called ChemWriter will be implemented based on the Phase I research results. ChemWriter addresses the need of many health scientists to work with text, instrument data, and chemical structure diagrams in an integrated fashion. The software incorporates chemical intelligence to support and streamline the chemical structure diagramming process.  Structure diagram development and manipulation is enhanced by allowing users to work at differing conceptual levels--functional group, structural skeleton and molecular-- including the atomic level.  Libraries of each kind of structure are provided and the capability to create user-libraries.  Chemical intelligence is incorporated into each chemical structure or partial structure regardless of level, giving it knowledge of how and where bonds may form.  ChemWriter also supports importation of diagrams from chemical structure databases, and laboratory instrument data directly into documents.  The software is made machine independent through use of a common software architecture and a common interface, coded in the X- Windows display description language.  ChemWriter should increase researcher productivity, and speed dissemination of important research results.  ",INTELLIGENT SOFTWARE FOR CHEMICAL DIAGRAMS,3507967,R44GM042331,"['computer program /software ', ' computer graphics /printing ', ' computer system design /evaluation ', ' artificial intelligence ', ' chemical structure ', ' chemical information system ', ' biomedical equipment resource ', ' ']",NIGMS,"COMPUTER HUMAN INTERFACE, INC.",R44,1990,264814,0.15145152973925075
"CHEMICAL COMMUNICATION-INTERDISCIPLINARY STUDIES This research will provide new, fundamental information concerning chemical communication in a primate species.  The overall long-range objective is to define the chemical nature and behavioral significance of the scent marks utilized by the South American tamarin, Saguinus fuscicollis, a member of the family Callitrichidae, in social and sexual communication.  Studies are proposed to elucidate in detail those chemical patterns which encode gender and species.  A combination of analytical techniques, pattern recognition methods and behavioral assays will identify those components or patterns of compounds, both volatile and non-volatile, which are associated with the commmunicatory information.  Bacteriological studies will determine which of the active components are of bacterial origin. In addition, a pilot study will assess the possible role of the fatty acids in encoding individual differences in the scent marks.  We anticipate that this research will lead to a much more complete understanding of the nature of the chemical code in this primate species, and in the end that it will be possible to reconstruct with synthetic formulations a variety of the communicatory signals employed by the tamarins.  To accomplish this goal, a unique interdisciplinary research team consisting of two organic chemists, a primatologist and two bacteriologists, as well as a pattern recognition expert has been assembled at the Monell Chemical Senses Center.  The proposed studies follow logically from prior work of our laboratory.  To the best of our knowledge, this program involving the very close collaboration of scientists in all these areas of expertise (organic and analytical chemistry, statistics, behavioral biology, primatology and microbiology) to explore and define a chemical communication system in a primate species is unique in the scientific world.  ",CHEMICAL COMMUNICATION-INTERDISCIPLINARY STUDIES,3216442,R01DC000289,"['sex ', ' olfactory stimulus ', ' ethology ', ' gas chromatography ', ' microorganism classification ', ' animal communication behavior ', ' fatty acids ', ' pheromone ', ' artificial intelligence ', ' gas chromatography mass spectrometry ', ' analytical chemistry ', ' species difference ', ' bioassay ', ' bacteria ', ' Ceboidea ', ' ']",NIDCD,MONELL CHEMICAL SENSES CENTER,R01,1990,218932,0.16804734245916975
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures.  A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective database.  The program can be applied to problems involving biologically important substances and is being made available for general use.  ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS,3269301,R01GM018519,"['mathematical model ', ' computer graphics /printing ', ' computer data analysis ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1990,241553,0.10432626711669132
"QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS The long-term objective of this work is the development of general computational and theoretical techniques which, based on sophisticated information-processing, insights from basic physical sciences, biological regularities, and specific observations, can determine the mechanisms and behavior of the system, consistent with prior knowledge, and guide the experiments by testing and eliminating alternative hypotheses.  As a short-term objective, proposed here is the investigation of the metabolism of small molecules (as opposed to macromolecules), carried out by enzyme-catalyzed bioreactions.  The metabolism is not uncoupled from other biological phenomena; for example, the regulation of the expression of a gene determines the conditions under which the corresponding biochemical reaction is active.  Conversely, a specific function at the bioreaction level, achieved by concerted action of several enzymes, can suggest patterns of gene expression.  The work will contribute to better understanding of defects in human metabolism and how they can be diagnosed and treated.  The extent to which different intermediates in the defective route will actually accumulate depends on the equilibrium constants of the bioreactions.  This has implications in the development of diagnostic tests of the disease based on detection of intermediates, as well as the development of means for catabolizing or simply deactivating the intermediate.  Thus, it would be very useful to have theoretical means of predicting the equilibria of bioreactions.  A second important aspect that comes into play in both diagnosis and treatment is the influence of the metabolism that surrounds the defective pathway.  It is important to know whether the surrounding metabolism can provide routes that bypass the defective step, or simply drain off the accumulating intermediates.  The identification of pathways that can fulfill such functions is another thrust of the proposed research.  The first specific question to be addressed is the determination of whether a given biochemical reaction or biotransformation is thermodynamically feasible.  Since many biochemical reactions are reversible, even if they have not been observed to proceed in the reverse direction, the derivation of the thermodynamic reversibility and feasibility of a transformation is important in the identification of feasible pathways.  One of the difficulties encountered in the thermodynamic analysis is that many biochemical compounds are resonance hybrids.  To overcome this difficulty, a method will be developed incorporating into the estimation all possible formal electronic arrangements of a hybrid compound.  The method will calculate Gibbs energies from the chemical structures of metabolites.  In order to reason about metabolic functions and the pathways that can fulfill them, an algorithm is needed for construction of pathways that can accomplish a given metabolic function, i.e., the transformation of a given set of metabolic intermediates to target products.  Computationally intensive portions of the algorithm will be enhanced by a Connection Machine -- a data-parallel computer with 16,000 processors, which will be used for preprocessing of the bioreaction database.  The role of individual enzymes and intermediates for the metabolism can often be understood in terms of the pathways in which they participate and the metabolic functions these pathways fulfill.  For example, if an enzyme occurs in all pathways then it is essential for the transformation, but if it can be bypassed through a small set of other enzymes it might not be essential.  While the work includes the creation and integration of databases, the emphasis is placed on the development of techniques which use commonly available raw information from the database to draw significant qualitative conclusions.  ",QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS,3474512,R29LM005278,"['biotransformation ', ' metabolism disorder diagnosis ', ' information retrieval ', ' information systems ', ' enzyme mechanism ', ' diagnosis design /evaluation ', ' computer program /software ', ' artificial intelligence ', ' thermodynamics ', ' computer assisted diagnosis ', ' ']",NLM,"UNIV OF MARYLAND, COLLEGE PARK",R29,1991,89783,0.06703677724381775
"COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures. A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective knowledge base.  The program can be applied to problems involving biologically important substances and is available to other scientists.  The LHASA project pioneered the field of computer-assisted synthetic analysis.  LHASA has been and continues to be the most sophisticated and powerful computer program for synthetic analysis.  Our goal is to increase greatly the capabilities of LHASA so that it becomes a valuable and widely used tool in science.  ",COMPUTER-ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS,3269296,R01GM018519,"['mathematical model ', ' computer program /software ', ' computer graphics /printing ', ' computer data analysis ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1991,304174,0.07557545271205625
"NEURAL NETWORKS FOR PROCESS FAULT DIAGNOSIS AND SAFETY The major goal of this proposal is to research and demonstrate a new approach based on the emerging technology of Neural Networks in the discipline of Artificial Intelligence (AI) towards the design of chemical process hazard detection, prevention, and control systems. Such systems are extremely important for improving the occupational safety of chemical plants owing to the complexity of modern process plants.  The proposed project is aimed at the prevention and control of such frequent, day to day, accidental events in the industry.  Past approaches in fault diagnostic systems did not properly include the human expert's reasoning strategies and experience and hence were not adequate in efficient and correct trouble-shooting.  In this project, we propose a novel methodology using Neural Networks that address the important issues which are central to the development of knowledge-based systems for process fault diagnosis and hazard control.  Our methodology for developing knowledge-based systems rests on the important characteristics of neural networks, namely, their ability to automatically classify and learn associations between input and output data and to be able to handle noisy data.  We have already successfully tested our approach on a prototypical case study based on real-plant data, that of fluidized catalytic cracking unit (FCCU) in operation in an Exxon refinery.  We plan to investigate this approach further by experimenting with larger prototypes of chemical process plants with more realistic, complex, models for the various units such as reactors, heat exchangers, distillation columns etc.  We also plan to explore the robustness of such systems for incomplete and uncertain data.  ",NEURAL NETWORKS FOR PROCESS FAULT DIAGNOSIS AND SAFETY,3420857,R01OH002740,"['chemicals ', ' industry ', ' occupational hazard ', ' occupational health /safety ', ' injury prevention ', ' artificial intelligence ', ' ']",NIOSH,PURDUE UNIVERSITY,R01,1992,78805,0.08709474765413833
"QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS The long-term objective of this work is the development of general computational and theoretical techniques which, based on sophisticated information-processing, insights from basic physical sciences, biological regularities, and specific observations, can determine the mechanisms and behavior of the system, consistent with prior knowledge, and guide the experiments by testing and eliminating alternative hypotheses.  As a short-term objective, proposed here is the investigation of the metabolism of small molecules (as opposed to macromolecules), carried out by enzyme-catalyzed bioreactions.  The metabolism is not uncoupled from other biological phenomena; for example, the regulation of the expression of a gene determines the conditions under which the corresponding biochemical reaction is active.  Conversely, a specific function at the bioreaction level, achieved by concerted action of several enzymes, can suggest patterns of gene expression.  The work will contribute to better understanding of defects in human metabolism and how they can be diagnosed and treated.  The extent to which different intermediates in the defective route will actually accumulate depends on the equilibrium constants of the bioreactions.  This has implications in the development of diagnostic tests of the disease based on detection of intermediates, as well as the development of means for catabolizing or simply deactivating the intermediate.  Thus, it would be very useful to have theoretical means of predicting the equilibria of bioreactions.  A second important aspect that comes into play in both diagnosis and treatment is the influence of the metabolism that surrounds the defective pathway.  It is important to know whether the surrounding metabolism can provide routes that bypass the defective step, or simply drain off the accumulating intermediates.  The identification of pathways that can fulfill such functions is another thrust of the proposed research.  The first specific question to be addressed is the determination of whether a given biochemical reaction or biotransformation is thermodynamically feasible.  Since many biochemical reactions are reversible, even if they have not been observed to proceed in the reverse direction, the derivation of the thermodynamic reversibility and feasibility of a transformation is important in the identification of feasible pathways.  One of the difficulties encountered in the thermodynamic analysis is that many biochemical compounds are resonance hybrids.  To overcome this difficulty, a method will be developed incorporating into the estimation all possible formal electronic arrangements of a hybrid compound.  The method will calculate Gibbs energies from the chemical structures of metabolites.  In order to reason about metabolic functions and the pathways that can fulfill them, an algorithm is needed for construction of pathways that can accomplish a given metabolic function, i.e., the transformation of a given set of metabolic intermediates to target products.  Computationally intensive portions of the algorithm will be enhanced by a Connection Machine -- a data-parallel computer with 16,000 processors, which will be used for preprocessing of the bioreaction database.  The role of individual enzymes and intermediates for the metabolism can often be understood in terms of the pathways in which they participate and the metabolic functions these pathways fulfill.  For example, if an enzyme occurs in all pathways then it is essential for the transformation, but if it can be bypassed through a small set of other enzymes it might not be essential.  While the work includes the creation and integration of databases, the emphasis is placed on the development of techniques which use commonly available raw information from the database to draw significant qualitative conclusions.  ",QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS,3474513,R29LM005278,"['parallel processing ', ' biotransformation ', ' metabolism disorder diagnosis ', ' information retrieval ', ' information systems ', ' enzyme mechanism ', ' diagnosis design /evaluation ', ' computer program /software ', ' artificial intelligence ', ' thermodynamics ', ' computer assisted diagnosis ', ' ']",NLM,"UNIV OF MARYLAND, COLLEGE PARK",R29,1992,93246,0.06703677724381775
"COMPUTER ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures. A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective knowledge base.  The program can be applied to problems involving biologically important substances and is available to other scientists.  The LHASA project pioneered the field of computer-assisted synthetic analysis.  LHASA has been and continues to be the most sophisticated and powerful computer program for synthetic analysis.  Our goal is to increase greatly the capabilities of LHASA so that it becomes a valuable and widely used tool in science.  ",COMPUTER ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS,3269302,R01GM018519,"['mathematical model ', ' computer program /software ', ' computer graphics /printing ', ' computer data analysis ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1992,273707,0.07557545271205625
"QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS The long-term objective of this work is the development of general computational and theoretical techniques which, based on sophisticated information-processing, insights from basic physical sciences, biological regularities, and specific observations, can determine the mechanisms and behavior of the system, consistent with prior knowledge, and guide the experiments by testing and eliminating alternative hypotheses.  As a short-term objective, proposed here is the investigation of the metabolism of small molecules (as opposed to macromolecules), carried out by enzyme-catalyzed bioreactions.  The metabolism is not uncoupled from other biological phenomena; for example, the regulation of the expression of a gene determines the conditions under which the corresponding biochemical reaction is active.  Conversely, a specific function at the bioreaction level, achieved by concerted action of several enzymes, can suggest patterns of gene expression.  The work will contribute to better understanding of defects in human metabolism and how they can be diagnosed and treated.  The extent to which different intermediates in the defective route will actually accumulate depends on the equilibrium constants of the bioreactions.  This has implications in the development of diagnostic tests of the disease based on detection of intermediates, as well as the development of means for catabolizing or simply deactivating the intermediate.  Thus, it would be very useful to have theoretical means of predicting the equilibria of bioreactions.  A second important aspect that comes into play in both diagnosis and treatment is the influence of the metabolism that surrounds the defective pathway.  It is important to know whether the surrounding metabolism can provide routes that bypass the defective step, or simply drain off the accumulating intermediates.  The identification of pathways that can fulfill such functions is another thrust of the proposed research.  The first specific question to be addressed is the determination of whether a given biochemical reaction or biotransformation is thermodynamically feasible.  Since many biochemical reactions are reversible, even if they have not been observed to proceed in the reverse direction, the derivation of the thermodynamic reversibility and feasibility of a transformation is important in the identification of feasible pathways.  One of the difficulties encountered in the thermodynamic analysis is that many biochemical compounds are resonance hybrids.  To overcome this difficulty, a method will be developed incorporating into the estimation all possible formal electronic arrangements of a hybrid compound.  The method will calculate Gibbs energies from the chemical structures of metabolites.  In order to reason about metabolic functions and the pathways that can fulfill them, an algorithm is needed for construction of pathways that can accomplish a given metabolic function, i.e., the transformation of a given set of metabolic intermediates to target products.  Computationally intensive portions of the algorithm will be enhanced by a Connection Machine -- a data-parallel computer with 16,000 processors, which will be used for preprocessing of the bioreaction database.  The role of individual enzymes and intermediates for the metabolism can often be understood in terms of the pathways in which they participate and the metabolic functions these pathways fulfill.  For example, if an enzyme occurs in all pathways then it is essential for the transformation, but if it can be bypassed through a small set of other enzymes it might not be essential.  While the work includes the creation and integration of databases, the emphasis is placed on the development of techniques which use commonly available raw information from the database to draw significant qualitative conclusions.  ",QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS,3474514,R29LM005278,"['parallel processing ', ' biotransformation ', ' metabolism disorder diagnosis ', ' information retrieval ', ' information systems ', ' enzyme mechanism ', ' diagnosis design /evaluation ', ' computer program /software ', ' artificial intelligence ', ' thermodynamics ', ' computer assisted diagnosis ', ' ']",NLM,NORTHWESTERN UNIVERSITY,R29,1993,97774,0.06703677724381775
"COLOR-BASED AUTOMATED MICRONUCLEUS SYSTEM The overall objective of this Phase II application is the completion and validation of a color-based Micronuclei Assay System.  Current federal plans include extensive use of the MNA to determine the potential genetic toxicity of various chemicals and drugs.  The automation of MNA, based on color separation of polychromatic erythrocytes and normochromatic erythrocytes in bone marrow and peripheral blood preparations, employs innovative neural network techniques.  A new 160-slide changer has been developed which allows total experiment operation without manual interruption, allowing a system to operate within and outside of normal working hours.  Automation produces significantly improved statistics with significantly reduced manpower requirements.  there is a large and building commercial requirement for these systems both in the US and Japan.  ",COLOR-BASED AUTOMATED MICRONUCLEUS SYSTEM,2154740,R44ES005872,"['micronucleus ', ' method development ', ' colorimetry ', ' mutagen testing ', ' cytogenetics ', ' computer data analysis ', ' artificial intelligence ', ' erythrocytes ', ' bone marrow ', ' blood ', ' biomedical automation ', ' bioassay ', ' ']",NIEHS,"LOATS ASSOCIATES, INC.",R44,1993,253695,0.060473809051456946
"NEURAL NETWORKS FOR PROCESS FAULT DIAGNOSIS AND SAFETY The major goal of this proposal is to research and demonstrate a new approach based on the emerging technology of Neural Networks in the discipline of Artificial Intelligence (AI) towards the design of chemical process hazard detection, prevention, and control systems. Such systems are extremely important for improving the occupational safety of chemical plants owing to the complexity of modern process plants.  The proposed project is aimed at the prevention and control of such frequent, day to day, accidental events in the industry.  Past approaches in fault diagnostic systems did not properly include the human expert's reasoning strategies and experience and hence were not adequate in efficient and correct trouble-shooting.  In this project, we propose a novel methodology using Neural Networks that address the important issues which are central to the development of knowledge-based systems for process fault diagnosis and hazard control.  Our methodology for developing knowledge-based systems rests on the important characteristics of neural networks, namely, their ability to automatically classify and learn associations between input and output data and to be able to handle noisy data.  We have already successfully tested our approach on a prototypical case study based on real-plant data, that of fluidized catalytic cracking unit (FCCU) in operation in an Exxon refinery.  We plan to investigate this approach further by experimenting with larger prototypes of chemical process plants with more realistic, complex, models for the various units such as reactors, heat exchangers, distillation columns etc.  We also plan to explore the robustness of such systems for incomplete and uncertain data.  ",NEURAL NETWORKS FOR PROCESS FAULT DIAGNOSIS AND SAFETY,2277594,R01OH002740,"['chemicals ', ' industry ', ' occupational hazard ', ' occupational health /safety ', ' injury prevention ', ' artificial intelligence ', ' ']",NIOSH,PURDUE UNIVERSITY,R01,1993,82901,0.08709474765413833
"COMPUTER ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS The major objective of this work is the application of digital computers to the derivation of synthetic pathways to complex organic structures. A general problem-solving program, LHASA (Logic and Heuristics Applied to Synthetic Analysis), is being developed which can be used interactively by a chemist with simple graphical input-output of structural formulas.  The principles and strategies of organic synthesis are being formalized for use by the program.  A variety of strategies including long-range search capabilities are being employed in the program.  In addition, the vast range of information on synthetic chemistry is being organized and rationalized to provide a rich and effective knowledge base.  The program can be applied to problems involving biologically important substances and is available to other scientists.  The LHASA project pioneered the field of computer-assisted synthetic analysis.  LHASA has been and continues to be the most sophisticated and powerful computer program for synthetic analysis.  Our goal is to increase greatly the capabilities of LHASA so that it becomes a valuable and widely used tool in science.  ",COMPUTER ASSISTED ANALYSIS OF CHEMICAL SYNTHESIS,2173334,R01GM018519,"['mathematical model ', ' computer program /software ', ' computer graphics /printing ', ' computer data analysis ', ' computer human interaction ', ' computer system design /evaluation ', ' artificial intelligence ', ' organic chemicals ', ' chemical synthesis ', ' stereochemistry ', ' chemical structure ', ' ']",NIGMS,HARVARD UNIVERSITY,R01,1993,273707,0.07557545271205625
"KNOWLEDGE-BASED FRAMEWORK TO AUTOMATE HAZOP ANALYSIS Hazard and operability (Hazop) analysis is the study of systematically identifying every conceivable deviation, all the possible abnormal causes for such deviation, and the adverse hazardous consequences of that deviation in a chemical plant. Modern chemical plants are extremely complex and hence are difficult to analyze and assess from this Hazop perspective, thus raising serious occupational safety related concerns. Because of this complexity, they are also more vulnerable to equipment failures, as witnessed by the recent chemical plant accidents. The major goal of this proposal is to develop a knowledge-based system framework for automating Hazop analysis of process plants. Such automated systems are extremely important for improving the occupational safety of chemical plants. Hazop analysis is often carried out by a group of experts poring over the process flowsheets for weeks or months. Thus, Hazop analysis is a very difficult, labor-intensive, and time-consuming process. In our proposed knowledge-based framework, we recognize and exploit two important features of the Hazop analysis: (i) even though each Hazop analysis is unique-to a process, it is systematic and logical; and (ii) many aspects of the analysis are the same for different process flow sheets. Thus, Hazop analysis can be automated through the use of knowledge-based systems. In this project, we propose a knowledge-based systems approach which introduces several novel techniques in a model-based framework to attack this problem. These are: (i) decomposing the knowledge-base into process specific and process general knowledge, (ii) developing generic cause-and-effect models of various processes and process equipments, and (iii) an object-oriented implementation framework. We have successfully tested the proposed approach on a small prototypical case study. Encouraged by the preliminary results, we propose to investigate this approach further by developing more comprehensive generic models library of complex process equipments, process interactions, process materials, and by testing on complex industrial scale Hazop case studies. We also propose to develop efficient search techniques for managing the complexity, handle recycle and feedback loops, and develop an intelligent object-oriented graphical interface for this system.  ",KNOWLEDGE-BASED FRAMEWORK TO AUTOMATE HAZOP ANALYSIS,3421087,R01OH003056,"['industry ', ' occupational hazard ', ' occupational health /safety ', ' artificial intelligence ', ' chemical synthesis ', ' ']",NIOSH,PURDUE UNIVERSITY,R01,1993,213908,0.13269466055122228
"KNOWLEDGE-BASED CHEMICAL SYMBOL RECOGNITION SYSTEM The ultimate goal of this project is to develop and commercialize a functional, low-cost system for machine reading and recognition of chemical structure diagrams.  The specific Phase I goal is to demonstrate the feasibility of developing such a system using a knowledge-based approach which provides a logical method for expanding the chemical symbol recognition domain and for handling exceptions to recognition rules.  Prior work on system design, algorithm development and literature research supports our contention that developing a useable chemical reader is feasible.  the chemical reader will find application as an intelligent input device for entry of chemical structure data into chemical information systems.  Yearly, thousands of structures must be entered into large databases by specially trained persons.  In addition, searches of these databases by chemistry researchers often require input of structural information.  The chemical reader will enable entry of structural information via universally recognized diagrams instead of using system specific codes.  In this proposal we describe a knowledge- based approach to developing the chemical reader.  This approach has been successfully used by others in systems designed to recognize line drawings.  In the chemical reader system a knowledge base will be built which contains rules incorporating knowledge of chemistry and diagramming conventions.  The rules will use facts obtained from feature extractors operating on pattern primitives derived from 2D gray level images of structure diagrams.  the images can be acquired using either optical scanners or CCD camera/frame grabber devices.  The result of processing the structure diagram will be a connection table, the standard representation for chemical structures.  ",KNOWLEDGE-BASED CHEMICAL SYMBOL RECOGNITION SYSTEM,3498720,R43GM047173,"['information retrieval ', ' computer program /software ', ' computer graphics /printing ', ' computer system design /evaluation ', ' artificial intelligence ', ' chemical structure ', ' chemical information system ', ' ']",NIGMS,"WESTERN RESEARCH COMPANY, INC.",R43,1993,50000,0.1831701719760319
"KNOWLEDGE-BASED FRAMEWORK TO AUTOMATE HAZOP ANALYSIS Hazard and operability (Hazop) analysis is the study of systematically identifying every conceivable deviation, all the possible abnormal causes for such deviation, and the adverse hazardous consequences of that deviation in a chemical plant. Modern chemical plants are extremely complex and hence are difficult to analyze and assess from this Hazop perspective, thus raising serious occupational safety related concerns. Because of this complexity, they are also more vulnerable to equipment failures, as witnessed by the recent chemical plant accidents. The major goal of this proposal is to develop a knowledge-based system framework for automating Hazop analysis of process plants. Such automated systems are extremely important for improving the occupational safety of chemical plants. Hazop analysis is often carried out by a group of experts poring over the process flowsheets for weeks or months. Thus, Hazop analysis is a very difficult, labor-intensive, and time-consuming process. In our proposed knowledge-based framework, we recognize and exploit two important features of the Hazop analysis: (i) even though each Hazop analysis is unique-to a process, it is systematic and logical; and (ii) many aspects of the analysis are the same for different process flow sheets. Thus, Hazop analysis can be automated through the use of knowledge-based systems. In this project, we propose a knowledge-based systems approach which introduces several novel techniques in a model-based framework to attack this problem. These are: (i) decomposing the knowledge-base into process specific and process general knowledge, (ii) developing generic cause-and-effect models of various processes and process equipments, and (iii) an object-oriented implementation framework. We have successfully tested the proposed approach on a small prototypical case study. Encouraged by the preliminary results, we propose to investigate this approach further by developing more comprehensive generic models library of complex process equipments, process interactions, process materials, and by testing on complex industrial scale Hazop case studies. We also propose to develop efficient search techniques for managing the complexity, handle recycle and feedback loops, and develop an intelligent object-oriented graphical interface for this system.  ",KNOWLEDGE-BASED FRAMEWORK TO AUTOMATE HAZOP ANALYSIS,2277684,R01OH003056,"['industry ', ' occupational hazard ', ' occupational health /safety ', ' artificial intelligence ', ' chemical synthesis ', ' ']",NIOSH,PURDUE UNIVERSITY,R01,1994,152600,0.13269466055122228
"QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS The long-term objective of this work is the development of general computational and theoretical techniques which, based on sophisticated information-processing, insights from basic physical sciences, biological regularities, and specific observations, can determine the mechanisms and behavior of the system, consistent with prior knowledge, and guide the experiments by testing and eliminating alternative hypotheses.  As a short-term objective, proposed here is the investigation of the metabolism of small molecules (as opposed to macromolecules), carried out by enzyme-catalyzed bioreactions.  The metabolism is not uncoupled from other biological phenomena; for example, the regulation of the expression of a gene determines the conditions under which the corresponding biochemical reaction is active.  Conversely, a specific function at the bioreaction level, achieved by concerted action of several enzymes, can suggest patterns of gene expression.  The work will contribute to better understanding of defects in human metabolism and how they can be diagnosed and treated.  The extent to which different intermediates in the defective route will actually accumulate depends on the equilibrium constants of the bioreactions.  This has implications in the development of diagnostic tests of the disease based on detection of intermediates, as well as the development of means for catabolizing or simply deactivating the intermediate.  Thus, it would be very useful to have theoretical means of predicting the equilibria of bioreactions.  A second important aspect that comes into play in both diagnosis and treatment is the influence of the metabolism that surrounds the defective pathway.  It is important to know whether the surrounding metabolism can provide routes that bypass the defective step, or simply drain off the accumulating intermediates.  The identification of pathways that can fulfill such functions is another thrust of the proposed research.  The first specific question to be addressed is the determination of whether a given biochemical reaction or biotransformation is thermodynamically feasible.  Since many biochemical reactions are reversible, even if they have not been observed to proceed in the reverse direction, the derivation of the thermodynamic reversibility and feasibility of a transformation is important in the identification of feasible pathways.  One of the difficulties encountered in the thermodynamic analysis is that many biochemical compounds are resonance hybrids.  To overcome this difficulty, a method will be developed incorporating into the estimation all possible formal electronic arrangements of a hybrid compound.  The method will calculate Gibbs energies from the chemical structures of metabolites.  In order to reason about metabolic functions and the pathways that can fulfill them, an algorithm is needed for construction of pathways that can accomplish a given metabolic function, i.e., the transformation of a given set of metabolic intermediates to target products.  Computationally intensive portions of the algorithm will be enhanced by a Connection Machine -- a data-parallel computer with 16,000 processors, which will be used for preprocessing of the bioreaction database.  The role of individual enzymes and intermediates for the metabolism can often be understood in terms of the pathways in which they participate and the metabolic functions these pathways fulfill.  For example, if an enzyme occurs in all pathways then it is essential for the transformation, but if it can be bypassed through a small set of other enzymes it might not be essential.  While the work includes the creation and integration of databases, the emphasis is placed on the development of techniques which use commonly available raw information from the database to draw significant qualitative conclusions.  ",QUALITATIVE ANALYSIS OF METABOLIC PATHWAYS,2237730,R29LM005278,"['parallel processing ', ' biotransformation ', ' metabolism disorder diagnosis ', ' information retrieval ', ' information systems ', ' enzyme mechanism ', ' diagnosis design /evaluation ', ' computer program /software ', ' artificial intelligence ', ' thermodynamics ', ' computer assisted diagnosis ', ' ']",NLM,NORTHWESTERN UNIVERSITY,R29,1994,102032,0.06703677724381775
"COLOR-BASED AUTOMATED MICRONUCLEUS SYSTEM The overall objective of this Phase II application is the completion and validation of a color-based Micronuclei Assay System.  Current federal plans include extensive use of the MNA to determine the potential genetic toxicity of various chemicals and drugs.  The automation of MNA, based on color separation of polychromatic erythrocytes and normochromatic erythrocytes in bone marrow and peripheral blood preparations, employs innovative neural network techniques.  A new 160-slide changer has been developed which allows total experiment operation without manual interruption, allowing a system to operate within and outside of normal working hours.  Automation produces significantly improved statistics with significantly reduced manpower requirements.  there is a large and building commercial requirement for these systems both in the US and Japan.  ",COLOR-BASED AUTOMATED MICRONUCLEUS SYSTEM,2154741,R44ES005872,"['micronucleus ', ' method development ', ' colorimetry ', ' mutagen testing ', ' cytogenetics ', ' computer data analysis ', ' artificial intelligence ', ' erythrocytes ', ' bone marrow ', ' blood ', ' biomedical automation ', ' bioassay ', ' ']",NIEHS,"LOATS ASSOCIATES, INC.",R44,1994,245437,0.060473809051456946
"NEURAL SYSTEMS THAT EXTRACT INFORMATION FROM DATABASES The intent of this project is to develop a method of automatically programming neural-networks to extract needed information from databases of biological and chemical information.  The specific application example we will pursue in Phase I will be the creation of a framework for training a neural network to predict the toxic and carcinogenic properties of chemicals using data stored in the Organ Toxicity Database.  The neural network will be trained to recognize patterns and correlations between chemical structure/substructures, physiochemical properties, and toxicologic/carcinogenic findings stored in the electronic compilation of a large subset of NTP TR and NTP TOX documents.  A system which automatically selects the pertinent data fields for accurately predicting toxicity and then trains a neural network will be developed.  The ability of the resulting neural network to predict the carcinogenic and toxic properties of known liver and kidney toxicants and carcinogens will be evaluated during Phase I. If accurate prediction is achieved, we will build a generalized framework for extending our techniques to other types of biological and chemical databases during Phase II.  The value of many databases will be greatly increased by the availability of methods to automatically create neural networks which extract needed information for various applications.  For example, our toxicity prediction system would reduce the exposure of the general public to possibly hazardous chemicals, would allow chemical manufacturers to quickly determine the hazards of new and existing products, and would same enormous amounts of time and money currently spent on animal testing.  Each application developed using our framework could offer similar benefits.  ",NEURAL SYSTEMS THAT EXTRACT INFORMATION FROM DATABASES,2104250,R43CA062795,"['method development ', ' toxicology information system ', ' chemical carcinogen ', ' information retrieval ', ' information system analysis ', ' computer system design /evaluation ', ' artificial intelligence ', ' chemical structure function ', ' chemical information system ', ' ']",NCI,NOVEL PHARMACEUTICALS,R43,1994,74785,0.13248573227759938
"CRYPTOCOCCUS NEOFORMANS--EPITOPE ANTIBODIES & STRUCTURE Cryptococcus neoformans in a pathogenic yeast that causes life-                  threatening meningoencephalitis in immunocompromised patients.                   The incidence of crytococcosis has increased dramatically in                     recent years as a consequence of the AIDS epidemic. The major                    capsular polysaccharide, glucuronoxylomannan (GXM), is                           serotype determinant of these organisms.  The capsular                           polysaccharides are important contributors to the virulence of C.                Neoformans. GXM is antiphagocytic and poorly immunogenic.  In                    vitro, GNX inhibits leukocyte migration, enhances HIV infection                  in human lymphocytes, and promotes L-selectin shedding from                      neutrophils. The sensitivity and resolution of the analysis of GXM               structure have improved due to the introduction of 1H Nuclear                    Magnetic Resonance Spectroscopy (NMR) in one and two                             dimensions.  A database of 1H NMR chemical shifts has been                       established for the structural triad based on three  -(1-3)-D-                   mannosyl residues.  The chemical shifts of the mannosyl residues                 of the various triads serve as reporter groups for the identification            and quantitation of seven structural triads as they occur in any                 GXM. The data-chemical shifts relative intensities, and peak areas               of the reporter groups-are being placed in a relational database                 program.  The specific aims for the next period are: (1) To use                  the data to create a chemotyping scheme based on the quantitative                distribution of the mannosyl triads in GXMS; (2) To use the data                 in aim one to develop a computer based neural network for the                    rapid chemotyping of C. Neoformans; (3) To determine the                         solution conformation of GXMs by high fields, multiple                           dimensional NMR since the immune response to C. Neoformans is                    intimately related to the three dimensional structure of GXM; (4)                To determine the exact linkage dispositions of the 0-acetyl                      substituent, and indispensable component of the conformational                   epitope recognized by antibodies; (5) To characterize the                        individual Factor Specific antibodies obtained by tandem-column                  affinity chromatography using-GXM-affinity matrices; (6) To                      determine the fine structures of the mannoproteins from C.                       Neoformans Cap67: (7) To determine if polysaccharide is                          covalently linked to the cell wall of C. Neoformans.  This                       information will be used to foster more precise investigations of                the pathology, treatment, mechanisms of virulence, and prevention                of cryptococcosis.                                                                ",CRYPTOCOCCUS NEOFORMANS--EPITOPE ANTIBODIES & STRUCTURE,2330365,R01AI031769,"['polysaccharides ', ' microorganism classification ', ' information systems ', ' AIDS ', ' fungal antigens ', ' antibody specificity ', ' antifungal antibody ', ' epitope mapping ', ' Cryptococcus neoformans ', ' artificial intelligence ', ' opportunistic infections ', ' nuclear magnetic resonance spectroscopy ', ' cell wall ', ' carbohydrate structure ', ' ']",NIAID,GEORGIA STATE UNIVERSITY,R01,1997,244811,0.005851577595067778
"CRYPTOCOCCUS NEOFORMANS--EPITOPE ANTIBODIES & STRUCTURE Cryptococcus neoformans in a pathogenic yeast that causes life-                  threatening meningoencephalitis in immunocompromised patients.                   The incidence of crytococcosis has increased dramatically in                     recent years as a consequence of the AIDS epidemic. The major                    capsular polysaccharide, glucuronoxylomannan (GXM), is                           serotype determinant of these organisms.  The capsular                           polysaccharides are important contributors to the virulence of C.                Neoformans. GXM is antiphagocytic and poorly immunogenic.  In                    vitro, GNX inhibits leukocyte migration, enhances HIV infection                  in human lymphocytes, and promotes L-selectin shedding from                      neutrophils. The sensitivity and resolution of the analysis of GXM               structure have improved due to the introduction of 1H Nuclear                    Magnetic Resonance Spectroscopy (NMR) in one and two                             dimensions.  A database of 1H NMR chemical shifts has been                       established for the structural triad based on three  -(1-3)-D-                   mannosyl residues.  The chemical shifts of the mannosyl residues                 of the various triads serve as reporter groups for the identification            and quantitation of seven structural triads as they occur in any                 GXM. The data-chemical shifts relative intensities, and peak areas               of the reporter groups-are being placed in a relational database                 program.  The specific aims for the next period are: (1) To use                  the data to create a chemotyping scheme based on the quantitative                distribution of the mannosyl triads in GXMS; (2) To use the data                 in aim one to develop a computer based neural network for the                    rapid chemotyping of C. Neoformans; (3) To determine the                         solution conformation of GXMs by high fields, multiple                           dimensional NMR since the immune response to C. Neoformans is                    intimately related to the three dimensional structure of GXM; (4)                To determine the exact linkage dispositions of the 0-acetyl                      substituent, and indispensable component of the conformational                   epitope recognized by antibodies; (5) To characterize the                        individual Factor Specific antibodies obtained by tandem-column                  affinity chromatography using-GXM-affinity matrices; (6) To                      determine the fine structures of the mannoproteins from C.                       Neoformans Cap67: (7) To determine if polysaccharide is                          covalently linked to the cell wall of C. Neoformans.  This                       information will be used to foster more precise investigations of                the pathology, treatment, mechanisms of virulence, and prevention                of cryptococcosis.                                                                ",CRYPTOCOCCUS NEOFORMANS--EPITOPE ANTIBODIES & STRUCTURE,2667723,R01AI031769,"['polysaccharides ', ' microorganism classification ', ' information systems ', ' AIDS ', ' fungal antigens ', ' antibody specificity ', ' antifungal antibody ', ' epitope mapping ', ' Cryptococcus neoformans ', ' artificial intelligence ', ' opportunistic infections ', ' nuclear magnetic resonance spectroscopy ', ' cell wall ', ' carbohydrate structure ', ' ']",NIAID,GEORGIA STATE UNIVERSITY,R01,1998,225752,0.005851577595067778
"CRYPTOCOCCUS NEOFORMANS--EPITOPE ANTIBODIES & STRUCTURE Cryptococcus neoformans in a pathogenic yeast that causes life-                  threatening meningoencephalitis in immunocompromised patients.                   The incidence of crytococcosis has increased dramatically in                     recent years as a consequence of the AIDS epidemic. The major                    capsular polysaccharide, glucuronoxylomannan (GXM), is                           serotype determinant of these organisms.  The capsular                           polysaccharides are important contributors to the virulence of C.                Neoformans. GXM is antiphagocytic and poorly immunogenic.  In                    vitro, GNX inhibits leukocyte migration, enhances HIV infection                  in human lymphocytes, and promotes L-selectin shedding from                      neutrophils. The sensitivity and resolution of the analysis of GXM               structure have improved due to the introduction of 1H Nuclear                    Magnetic Resonance Spectroscopy (NMR) in one and two                             dimensions.  A database of 1H NMR chemical shifts has been                       established for the structural triad based on three  -(1-3)-D-                   mannosyl residues.  The chemical shifts of the mannosyl residues                 of the various triads serve as reporter groups for the identification            and quantitation of seven structural triads as they occur in any                 GXM. The data-chemical shifts relative intensities, and peak areas               of the reporter groups-are being placed in a relational database                 program.  The specific aims for the next period are: (1) To use                  the data to create a chemotyping scheme based on the quantitative                distribution of the mannosyl triads in GXMS; (2) To use the data                 in aim one to develop a computer based neural network for the                    rapid chemotyping of C. Neoformans; (3) To determine the                         solution conformation of GXMs by high fields, multiple                           dimensional NMR since the immune response to C. Neoformans is                    intimately related to the three dimensional structure of GXM; (4)                To determine the exact linkage dispositions of the 0-acetyl                      substituent, and indispensable component of the conformational                   epitope recognized by antibodies; (5) To characterize the                        individual Factor Specific antibodies obtained by tandem-column                  affinity chromatography using-GXM-affinity matrices; (6) To                      determine the fine structures of the mannoproteins from C.                       Neoformans Cap67: (7) To determine if polysaccharide is                          covalently linked to the cell wall of C. Neoformans.  This                       information will be used to foster more precise investigations of                the pathology, treatment, mechanisms of virulence, and prevention                of cryptococcosis.                                                                ",CRYPTOCOCCUS NEOFORMANS--EPITOPE ANTIBODIES & STRUCTURE,2882173,R01AI031769,"['carbohydrate structure ', ' cell wall ', ' nuclear magnetic resonance spectroscopy ', ' opportunistic infection ', ' artificial intelligence ', ' Cryptococcus neoformans ', ' epitope mapping ', ' antifungal antibody ', ' antibody specificity ', ' fungal antigen ', ' AIDS ', ' information system ', ' microorganism classification ', ' polysaccharide ', ' ']",NIAID,GEORGIA STATE UNIVERSITY,R01,1999,233431,0.005851577595067778
"Improving Quantum Chemistry Calculations DESCRIPTION (provided by applicant): We propose to extend the functionality of our commercial quantum chemistry program, Q-Chem, to effectively treat molecules containing transition metals. This enhanced capability will provide Q-Chem's end-users with the ability to accurately model complex molecules such as proteins, enzymes, and catalysts of industrial importance. While remarkable progress has been made over the last several years in the accurate modeling of systems containing transition metals, current numerical methods for achieving SCF convergence in these systems are problematic at best, resulting in long execution times or, in some cases, complete failure to find a solution. However, a novel computational technique developed at Q-Chem has been shown to dramatically improve convergence for organic molecules with known SCF convergence problems. We propose to adapt this method for use with transition metals. Our goal is to achieve the same robust SCF convergence that is realized for most organic molecules, thereby greatly increasing productivity and extending the capability of scientists to study molecules such as enzymes and industrial catalysts. During Phase (I, our efforts will be to further extend Q-Chem's capability in the molecular biology arena. This proposal seeks to improve the quantum chemical treatment of molecular systems containing transition metals. Transition metal elements are essential to natural biological processes. The technology developed in this research will enable the computer modeling of those systems that are difficult to handle with the current methodologies and therefore increase of the applications of computational modeling. PROPOSED COMMERCIAL APPLICATION: Transition-metal elements play a vital role in biological systems.  The success of this project will improve the performance of modeling of transition-metal complexes and making the modelings possible for the systems that current algorithms fail.  The resulting work will be made available to researchers in health industry and universities through our commercial software Q-Chem. ",Improving Quantum Chemistry Calculations,6484828,R43GM065617,"['quantum chemistry ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' computer simulation ', ' mathematics ', ' heavy metal ', ' model design /development ', ' mathematical model ', ' ']",NIGMS,"Q-CHEM, INC.",R43,2002,105425,0.0640709173398022
"MCASE QSAR Expert System for Salmonella Mutagenicity   DESCRIPTION (provided by applicant): Computational expert systems provide an         inexpensive and fast alternative to short term genotoxicity assays such as the       Ames test. Validation studies show the predictive capability of the MCASE            system is about 85 percent. That is, 85 percent concordance is expected between      experiment and computational genotoxicity predictions for new chemicals. The         strong correlation between chemical structure and genotoxicity is particularly       useful for 'in silico' prescreening of new drugs in the pharmaceutical               industry.                                                                                                                                                                 The new Salmonella database modules being developed in this work will be made        available online to the public through the InfoTox web site                          (http://www.l-tox.com). Additionally, NIH grantees will be allowed unlimited         access to the Salmonella modules through InfoTox at no cost.                                                                                                              Collaboration will be sought with large drug companies, with mutual exchange of      data. Thus the databases will evolve and improve over time as new data are           submitted to form a centralized pool of mutagenicity data, that will provide a       resource for avoiding unneeded testing of chemicals structurally similarly to        those that are already thoroughly understood. Our collaborators at the FDA/CDER      will lead the effort to build this industrial consortium.                            PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE                                                                                                                   ",MCASE QSAR Expert System for Salmonella Mutagenicity,6481789,R44CA090178,"['Salmonella typhimurium ', ' chemical information system ', ' chemical structure function ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' computer simulation ', ' mutagen ', ' mutagen testing ', ' gene mutation ', ' alternatives to animals in research ', ' informatics ', ' data collection ', ' statistics /biometry ', ' mathematical model ', ' physical property ', ' toxicology ', ' chemical property ', ' high throughput technology ', ' ']",NCI,"MULTICASE, INC.",R44,2002,359495,0.14332820275949762
"Community Deposit and Review of Biochemical Databases DESCRIPTION (provided by applicant):    Understanding how the phenotype of an organism is produced by its genotype and environment is fundamental to modern biomedicine. Cellular biochemistry forms the best-characterized complex biochemical system available, and provides a unique opportunity to better understand the structure-function relationships that produce phenotypes. Understood mathematically, cells are a biochemical network whose topology, function, and possible behaviors are only still only dimly understood.      Our previous work has resulted in the development of several databases (END, BND, Klotho) and software systems (The Agora, Glossa) to provide, accumulate, and use data on biochemical networks by users worldwide. In this application for competitive renewal, we propose to embark on a systematic study of structure-function relationships in biochemical networks, focusing on the discovery of patterns of biochemical function --- functional motives. We will identify these motives and their distribution over all enzymatic reactions by comparing changes in reactants' structures and enzymes' specificities, rather than just examine keywords. This systematic examination will allow us to determine, at much greater resolution than ever before, what functions each molecule and reaction have. To do this we must significantly extend the functionalities of our current systems in three major ways. First, we will add significant new data on the structure of small molecules of biochemical interest, enzymatic reactions, the mechanisms of gene expression, and dementia. Second, we will further develop and test methods that produce semantic interoperability among independent, disparate databases. Third, we will develop algorithms to detect and catalogue patterns of biochemical function among thousands of reactions and molecules; to more speedily enumerate paths among molecules and subnets in the biochemical network; to determine the extent of convergent evolution among enzymes; to trace atoms through a sequence of reactions such as a metabolic pathway; and to suggest novel biochemical reactions. We will use these capabilities to define and search for functional motives among enzymatic reactions, testing their correlation with network topology and dynamics, and to estimate the extent to which functional similarities arise from convergent evolution of enzymes. ",Community Deposit and Review of Biochemical Databases,6694513,R01GM056529,"['biochemistry ', ' dementia ', ' molecular dynamics ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' enzyme mechanism ', ' information system analysis ', ' mathematical model ', ' physiology ', ' protein structure function ', ' molecular biology information system ', ' functional /structural genomics ', ' ']",NIGMS,UNIVERSITY OF MISSOURI-COLUMBIA,R01,2003,556670,0.06514590434232673
"MCASE QSAR Expert System for Salmonella Mutagenicity   DESCRIPTION (provided by applicant): Computational expert systems provide an         inexpensive and fast alternative to short term genotoxicity assays such as the       Ames test. Validation studies show the predictive capability of the MCASE            system is about 85 percent. That is, 85 percent concordance is expected between      experiment and computational genotoxicity predictions for new chemicals. The         strong correlation between chemical structure and genotoxicity is particularly       useful for 'in silico' prescreening of new drugs in the pharmaceutical               industry.                                                                                                                                                                 The new Salmonella database modules being developed in this work will be made        available online to the public through the InfoTox web site                          (http://www.l-tox.com). Additionally, NIH grantees will be allowed unlimited         access to the Salmonella modules through InfoTox at no cost.                                                                                                              Collaboration will be sought with large drug companies, with mutual exchange of      data. Thus the databases will evolve and improve over time as new data are           submitted to form a centralized pool of mutagenicity data, that will provide a       resource for avoiding unneeded testing of chemicals structurally similarly to        those that are already thoroughly understood. Our collaborators at the FDA/CDER      will lead the effort to build this industrial consortium.                            PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE                                                                                                                   ",MCASE QSAR Expert System for Salmonella Mutagenicity,6625981,R44CA090178,"['Salmonella typhimurium ', ' chemical information system ', ' chemical structure function ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' computer simulation ', ' mutagen ', ' mutagen testing ', ' gene mutation ', ' alternatives to animals in research ', ' informatics ', ' data collection ', ' statistics /biometry ', ' mathematical model ', ' physical property ', ' toxicology ', ' chemical property ', ' high throughput technology ', ' ']",NCI,"MULTICASE, INC.",R44,2003,278750,0.14332820275949762
"Ab-Initio Geometry Optimization of Large Molecules    DESCRIPTION (provided by applicant):  While density-functional calculations of the energy are now feasible for biomolecules, the use of density-functional geometry optimizers is still confined to relatively small molecules containing no more than thirty atoms. The key limitation of conventional density-functional geometry optimizers is that the cost of the geometry optimization scales at least quadratically with the number of atoms in the molecule. In contrast the energy at a fixed geometry can be evaluated for a cost which scales linearly with molecule size, enabling very large molecules to be treated. This proposal is based on a radical change in the algorithm for density-functional geometry optimization, potentially reducing the total cost from quadratic to linear in molecule size and enabling a quantum leap in the size of molecules that can be optimized. The proposed algorithm resembles a conventional self-consistent calculation of the energy at a fixed geometry but at convergence the proposed algorithm yields not only the density but also the optimized geometry. This is achieved by simultaneous optimization of the wavefunction and the geometry via a modified self-consistent-field procedure. The proposed algorithm will be implemented in the QChem software package and, if successful, widely distributed through QChem Inc. and Spartan Inc.           ",Ab-Initio Geometry Optimization of Large Molecules,6583907,R43GM067335,"['molecular dynamics ', ' quantum chemistry ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' computer simulation ', ' mathematics ', ' chemical model ', ' molecular size ', ' ']",NIGMS,"Q-CHEM, INC.",R43,2003,93121,0.07571570072053305
"AI Software for Science Education Related to Drug Abuse DESCRIPTION (provided by applicant): This Phase I SBIR proposal is aimed at advancing the state of the art in chemistry education software in a critically important respect demanded by students, teachers, administrators and Quantum Simulations, Inc. customers. The focus of this innovation is the development of meaningful interactive tutoring and assessment capabilities for chemistry problem solving. Empowerment of students to make the proper decisions about drugs through experiencing the scientific process requires a solid education in basic chemistry. Chemical formulas comprise much of the fundamental ""language"" of chemistry in which students must be fluent in order to succeed. The topic of writing and understanding chemical formulas, a cornerstone of all general chemistry classes, is a reasonable starting point for the development of an AI assessment system for student learning in chemistry. A solid understanding of chemical formulas is a prerequisite to success in chemistry required not only for literacy to make informed decisions about drugs from a scientific standpoint, but also to enable and prepare students to pursue careers in research related to drug abuse. Quantum has already successfully developed and commercialized an ITS for writing chemical formulas which will be used as the starting point for the present work. The proposed technology will benefit all students; however, it is specifically targeted to help those who have the greatest need, such as students of average or marginal performance and students from historically underserved groups, by lowering barriers to accessing high-quality science instructional software.  Quantum customers include textbook publishers, software providers, hardware vendors and distance learning companies. A prominent textbook publisher, Holt, Rinehart and Winston, has entered into two long-term contracts with Quantum, resulting in rapid dissemination to an established end user base. Quantum intends to employ an identical business model to commercialize the results of this project. ",AI Software for Science Education Related to Drug Abuse,6831228,R43DA018455,"['adolescence (12-20) ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' drug abuse education ', ' human subject ', ' science education ', ' clinical research ', ' educational resource design /development ', ' ']",NIDA,"QUANTUM SIMULATIONS, INC.",R43,2004,61750,0.052832733688866367
"Community Deposit and Review of Biochemical Databases DESCRIPTION (provided by applicant):    Understanding how the phenotype of an organism is produced by its genotype and environment is fundamental to modern biomedicine. Cellular biochemistry forms the best-characterized complex biochemical system available, and provides a unique opportunity to better understand the structure-function relationships that produce phenotypes. Understood mathematically, cells are a biochemical network whose topology, function, and possible behaviors are only still only dimly understood.      Our previous work has resulted in the development of several databases (END, BND, Klotho) and software systems (The Agora, Glossa) to provide, accumulate, and use data on biochemical networks by users worldwide. In this application for competitive renewal, we propose to embark on a systematic study of structure-function relationships in biochemical networks, focusing on the discovery of patterns of biochemical function --- functional motives. We will identify these motives and their distribution over all enzymatic reactions by comparing changes in reactants' structures and enzymes' specificities, rather than just examine keywords. This systematic examination will allow us to determine, at much greater resolution than ever before, what functions each molecule and reaction have. To do this we must significantly extend the functionalities of our current systems in three major ways. First, we will add significant new data on the structure of small molecules of biochemical interest, enzymatic reactions, the mechanisms of gene expression, and dementia. Second, we will further develop and test methods that produce semantic interoperability among independent, disparate databases. Third, we will develop algorithms to detect and catalogue patterns of biochemical function among thousands of reactions and molecules; to more speedily enumerate paths among molecules and subnets in the biochemical network; to determine the extent of convergent evolution among enzymes; to trace atoms through a sequence of reactions such as a metabolic pathway; and to suggest novel biochemical reactions. We will use these capabilities to define and search for functional motives among enzymatic reactions, testing their correlation with network topology and dynamics, and to estimate the extent to which functional similarities arise from convergent evolution of enzymes. ",Community Deposit and Review of Biochemical Databases,6784554,R01GM056529,"['biochemistry ', ' dementia ', ' molecular dynamics ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' enzyme mechanism ', ' information system analysis ', ' mathematical model ', ' physiology ', ' protein structure function ', ' molecular biology information system ', ' functional /structural genomics ', ' ']",NIGMS,UNIVERSITY OF MISSOURI-COLUMBIA,R01,2004,522252,0.06514590434232673
"Machine Learning in Chemistry and Biology    DESCRIPTION (provided by applicant): Machine learning has broad applicability in the fields of chemistry and biology. This research effort is focused on empirical derivation of functions that are useful in the context of predicting aspects of molecular interaction between proteins and ligands. The characteristics of this problem offer unique challenges when approached from the perspective of machine learning, key among them being that the configuration in which molecules interact is not generally known. In the case of small molecule protein interactions, where it is possible to represent molecules as 3D objects, this is manifested in terms of hidden variables in the relative conformation and alignment of protein and ligand. Most machine learning tasks do not embed hidden variables in this fashion, but the problem is not insurmountable. We have implemented a number of methods which demonstrate that the problem of hidden variables is tractable, both methodologically in model induction and scoring function optimization as well as from the perspective of computational complexity in search. In this work, we will develop novel methods and refine existing methods in 3 problem areas: 1) Developing scoring functions for small molecule protein interactions with a known protein structure (the docking problem); 2) Developing quantitative models of small molecule activity against proteins with no known structure (the 3D QSAR problem); and 3) Developing methods for search and optimization that improve both model and scoring function induction and high-throughput application to large libraries of small molecules. The goal is to address the problem of prediction in a quantifiable way, which will allow both practical improvements in applications of the methods, and will also provide insight into the mechanistic aspects of the underlying physical molecular interactions.    All methods and data will be made widely available to both academic and industrial investigators.             ",Machine Learning in Chemistry and Biology,6965574,R01GM070481,"['molecular dynamics ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' ligand ', ' intermolecular interaction ', ' protein structure ', ' problem solving ', ' method development ', ' protein protein interaction ', ' high throughput technology ', ' computational biology ', ' small molecule ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2005,279983,0.08583807134574122
"Community Deposit and Review of Biochemical Databases DESCRIPTION (provided by applicant):    Understanding how the phenotype of an organism is produced by its genotype and environment is fundamental to modern biomedicine. Cellular biochemistry forms the best-characterized complex biochemical system available, and provides a unique opportunity to better understand the structure-function relationships that produce phenotypes. Understood mathematically, cells are a biochemical network whose topology, function, and possible behaviors are only still only dimly understood.      Our previous work has resulted in the development of several databases (END, BND, Klotho) and software systems (The Agora, Glossa) to provide, accumulate, and use data on biochemical networks by users worldwide. In this application for competitive renewal, we propose to embark on a systematic study of structure-function relationships in biochemical networks, focusing on the discovery of patterns of biochemical function --- functional motives. We will identify these motives and their distribution over all enzymatic reactions by comparing changes in reactants' structures and enzymes' specificities, rather than just examine keywords. This systematic examination will allow us to determine, at much greater resolution than ever before, what functions each molecule and reaction have. To do this we must significantly extend the functionalities of our current systems in three major ways. First, we will add significant new data on the structure of small molecules of biochemical interest, enzymatic reactions, the mechanisms of gene expression, and dementia. Second, we will further develop and test methods that produce semantic interoperability among independent, disparate databases. Third, we will develop algorithms to detect and catalogue patterns of biochemical function among thousands of reactions and molecules; to more speedily enumerate paths among molecules and subnets in the biochemical network; to determine the extent of convergent evolution among enzymes; to trace atoms through a sequence of reactions such as a metabolic pathway; and to suggest novel biochemical reactions. We will use these capabilities to define and search for functional motives among enzymatic reactions, testing their correlation with network topology and dynamics, and to estimate the extent to which functional similarities arise from convergent evolution of enzymes. ",Community Deposit and Review of Biochemical Databases,6944266,R01GM056529,"['biochemistry ', ' dementia ', ' molecular dynamics ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' enzyme mechanism ', ' information system analysis ', ' mathematical model ', ' physiology ', ' protein structure function ', ' molecular biology information system ', ' functional /structural genomics ', ' ']",NIGMS,UNIVERSITY OF MISSOURI-COLUMBIA,R01,2005,523667,0.06514590434232673
"Classification Algorithms for Chemical Compounds Computational techniques that build models to correctly assign chemical compounds to various classes of interests have extensive applications in pharmaceutical research and are used extensively at various phases during the drug development process. These techniques are used to solve a number of classification problems such as predicting whether or not a chemical compound has the desired biological activity, is toxic or non-toxic, and filtering out drug-like compounds from large compound libraries. The overall goal of this proposal is to develop substructure-based classification algorithms for chemical compound datasets. The key elements of these algorithms are that they (i) utilize highly efficient substructure discovery algorithms to mine the chemical compounds and discover all substructures that can be critical for the classification task, (ii) use multiple criteria to generate a set of substructure-based features that simultaneously simplify the compounds' representation while retaining and exposing the features that are responsible for the specific classification problem, and (iii) build predictive models by employing kernel-based methods that take into account the relationships between these substructures at different levels of granularity and complexity, as well as information provided by traditional descriptors. ",Classification Algorithms for Chemical Compounds,6965348,R01LM008713,"['bioengineering /biomedical engineering ', ' chemical structure ', ' conformation ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' drug classification ', ' mathematics ', ' mathematical model ', ' bioinformatics ', ' computational biology ', ' ']",NLM,UNIVERSITY OF MINNESOTA,R01,2005,283196,0.12769227719785742
"Machine Learning in Chemistry and Biology    DESCRIPTION (provided by applicant): Machine learning has broad applicability in the fields of chemistry and biology. This research effort is focused on empirical derivation of functions that are useful in the context of predicting aspects of molecular interaction between proteins and ligands. The characteristics of this problem offer unique challenges when approached from the perspective of machine learning, key among them being that the configuration in which molecules interact is not generally known. In the case of small molecule protein interactions, where it is possible to represent molecules as 3D objects, this is manifested in terms of hidden variables in the relative conformation and alignment of protein and ligand. Most machine learning tasks do not embed hidden variables in this fashion, but the problem is not insurmountable. We have implemented a number of methods which demonstrate that the problem of hidden variables is tractable, both methodologically in model induction and scoring function optimization as well as from the perspective of computational complexity in search. In this work, we will develop novel methods and refine existing methods in 3 problem areas: 1) Developing scoring functions for small molecule protein interactions with a known protein structure (the docking problem); 2) Developing quantitative models of small molecule activity against proteins with no known structure (the 3D QSAR problem); and 3) Developing methods for search and optimization that improve both model and scoring function induction and high-throughput application to large libraries of small molecules. The goal is to address the problem of prediction in a quantifiable way, which will allow both practical improvements in applications of the methods, and will also provide insight into the mechanistic aspects of the underlying physical molecular interactions.    All methods and data will be made widely available to both academic and industrial investigators.             ",Machine Learning in Chemistry and Biology,7087989,R01GM070481,"['molecular dynamics ', ' artificial intelligence ', ' computer system design /evaluation ', ' computer program /software ', ' ligand ', ' intermolecular interaction ', ' protein structure ', ' problem solving ', ' method development ', ' protein protein interaction ', ' high throughput technology ', ' computational biology ', ' small molecule ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2006,273403,0.08583807134574122
"Community Deposit and Review of Biochemical Databases DESCRIPTION (provided by applicant):    Understanding how the phenotype of an organism is produced by its genotype and environment is fundamental to modern biomedicine. Cellular biochemistry forms the best-characterized complex biochemical system available, and provides a unique opportunity to better understand the structure-function relationships that produce phenotypes. Understood mathematically, cells are a biochemical network whose topology, function, and possible behaviors are only still only dimly understood.      Our previous work has resulted in the development of several databases (END, BND, Klotho) and software systems (The Agora, Glossa) to provide, accumulate, and use data on biochemical networks by users worldwide. In this application for competitive renewal, we propose to embark on a systematic study of structure-function relationships in biochemical networks, focusing on the discovery of patterns of biochemical function --- functional motives. We will identify these motives and their distribution over all enzymatic reactions by comparing changes in reactants' structures and enzymes' specificities, rather than just examine keywords. This systematic examination will allow us to determine, at much greater resolution than ever before, what functions each molecule and reaction have. To do this we must significantly extend the functionalities of our current systems in three major ways. First, we will add significant new data on the structure of small molecules of biochemical interest, enzymatic reactions, the mechanisms of gene expression, and dementia. Second, we will further develop and test methods that produce semantic interoperability among independent, disparate databases. Third, we will develop algorithms to detect and catalogue patterns of biochemical function among thousands of reactions and molecules; to more speedily enumerate paths among molecules and subnets in the biochemical network; to determine the extent of convergent evolution among enzymes; to trace atoms through a sequence of reactions such as a metabolic pathway; and to suggest novel biochemical reactions. We will use these capabilities to define and search for functional motives among enzymatic reactions, testing their correlation with network topology and dynamics, and to estimate the extent to which functional similarities arise from convergent evolution of enzymes. ",Community Deposit and Review of Biochemical Databases,7107923,R01GM056529,"['functional /structural genomics ', ' molecular biology information system ', ' protein structure function ', ' physiology ', ' mathematical model ', ' information system analysis ', ' enzyme mechanism ', ' computer program /software ', ' computer system design /evaluation ', ' artificial intelligence ', ' molecular dynamics ', ' dementia ', ' biochemistry ', ' ']",NIGMS,UNIVERSITY OF MISSOURI-COLUMBIA,R01,2006,509027,0.06514590434232673
"Classification Algorithms for Chemical Compounds Computational techniques that build models to correctly assign chemical compounds to various classes of interests have extensive applications in pharmaceutical research and are used extensively at various phases during the drug development process. These techniques are used to solve a number of classification problems such as predicting whether or not a chemical compound has the desired biological activity, is toxic or non-toxic, and filtering out drug-like compounds from large compound libraries. The overall goal of this proposal is to develop substructure-based classification algorithms for chemical compound datasets. The key elements of these algorithms are that they (i) utilize highly efficient substructure discovery algorithms to mine the chemical compounds and discover all substructures that can be critical for the classification task, (ii) use multiple criteria to generate a set of substructure-based features that simultaneously simplify the compounds' representation while retaining and exposing the features that are responsible for the specific classification problem, and (iii) build predictive models by employing kernel-based methods that take into account the relationships between these substructures at different levels of granularity and complexity, as well as information provided by traditional descriptors. ",Classification Algorithms for Chemical Compounds,7127208,R01LM008713,"['computational biology ', ' bioinformatics ', ' mathematical model ', ' mathematics ', ' drug classification ', ' computer program /software ', ' computer system design /evaluation ', ' artificial intelligence ', ' conformation ', ' chemical structure ', ' bioengineering /biomedical engineering ', ' ']",NLM,UNIVERSITY OF MINNESOTA,R01,2006,276362,0.12769227719785742
"Robust computational framework for predictive ADME-Tox modeling    DESCRIPTION (provided by applicant):    This proposal seeks to establish a universally applicable and robust predictive ADME-Tox modeling framework based on rigorous Quantitative Structure Activity/Property Relationships (QSAR/QSPR) modeling. The framework has been refined in the course of many years of our research in the areas of QSPR methodology development and application to experimental datasets that led to novel analytical approaches, descriptors, model validation schemes, overall QSPR workflow design, and multiple end-point studies. This proposal focuses on the design of optimized QSPR protocols for the development of reliable predictors of critically important ADME-Tox properties. The ADME properties will include, but not limited to, water solubility, membrane permeability, P450 metabolism inhibition and induction, metabolic stability, human intestinal absorption, bioavailability, transporters and PK data; a variety of toxicological end-points vital to human health will be explored; they are available from recent initiatives on development and standardization of toxicity data, such as the US FDA, NIEHS, and EPA DSS-Tox and other database projects. The ultimate goal of this project is sharing both modeling software and specialized predictors with the research community via a web-based Predictive ADME-Tox Portal. The project objectives will be achieved via concurrent development of QSPR methodology (Specific Aim 1), building highly predictive, robust QSPR models of known ADME-Tox properties (Specific Aim 2), and the deployment of both modeling software and individual predictors via a specialized web-portal (Specific Aim 3). To achieve the goals of this project focusing on the development and delivery of specialized tools and rigorous predictors, we have assembled a research team of mostly senior investigators with complimentary skills and track records of accomplishment in the areas of computational drug discovery, experimental toxicology, statistical modeling, and software development and integration; two of the team members have had recent industrial experience before transitioning to academia. To the best of our knowledge, the results of this proposal will lead to the first publicly available in silico ADME-Tox modeling framework and predictors that can be used by the research community to analyze any set of chemicals (i.e., virtual and real compound sets). The framework will have a significant impact on compound prioritization, chemical library design, and candidate selection for preclinical and clinical development.            ",Robust computational framework for predictive ADME-Tox modeling,7244058,R21GM076059,"['Ensure ', ' Intestinal Absorption ', ' gastrointestinal absorption ', ' Chemicals ', ' Screening procedure ', ' screenings ', ' screening ', ' Training ', ' knowledge of results ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Hepatotoxicity ', ' hepatoxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Individual ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Statistical Models ', ' Probabilistic Models ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Cytochrome P450 ', ' P450 ', ' Cytochrome P-450 Enzyme System ', ' Cytochrome P-450 ', ' Data Collection ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' data mining ', ' datamining ', ' Environment ', ' Address ', ' Data Set ', ' Dataset ', ' End Point ', ' Academia ', ' Data ', ' Research Infrastructure ', ' Infrastructure ', ' Statistically Significant ', ' Scheme ', ' Validation ', ' Development ', ' developmental ', ' pre-clinical ', ' preclinical ', ' Standards of Weights and Measures ', ' base ', ' career ', ' method development ', ' Organ ', ' Goals ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Area ', ' Acute ', ' Chronic ', ' Clinical ', ' Collaborations ', ' Descriptor ', ' Letters ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Metabolic ', ' Drug Kinetics ', ' Pharmacokinetics ', ' tool ', ' Records ', ' Recruitment Activity ', ' recruit ', ' Nature ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Knowledge ', ' programs ', ' Standardization ', ' Students ', ' Technology ', ' Testing ', ' Scientist ', ' Toxicology ', ' United States Environmental Protection Agency ', ' Environmental Protection Agency ', ' United States Food and Drug Administration ', ' USFDA ', ' Food and Drug Administration ', ' Protocols documentation ', ' Protocol ', ' Source ', ' Techniques ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' experience ', ' water solubility ', ' small molecule libraries ', ' chemical library ', ' genotoxicity ', ' Toxic effect ', ' Toxicities ', ' Secure ', ' Structure ', ' skills ', ' novel ', ' member ', ' reproductive ', ' Cell Membrane Permeability ', ' membrane permeability ', ' carcinogenicity ', ' Modeling ', ' Specialist ', ' Property ', ' LOINC Axis 2 Property ', ' protocol development ', ' software development ', ' developing computer software ', ' develop software ', ' Cardiotoxicity ', ' Cardiac Toxicity ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' drug discovery ', ' Communities ', ' computer framework ', ' computational framework ', ' virtual ', ' cluster computing ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' combinatorial ', ' neurotoxicity ', ' neuronal toxicity ', ' neuron toxicity ', ' open source ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computers ', ' ']",NIGMS,UNIV OF NORTH CAROLINA CHAPEL HILL,R21,2007,328325,0.07034753315245093
"Machine Learning in Chemistry and Biology    DESCRIPTION (provided by applicant): Machine learning has broad applicability in the fields of chemistry and biology. This research effort is focused on empirical derivation of functions that are useful in the context of predicting aspects of molecular interaction between proteins and ligands. The characteristics of this problem offer unique challenges when approached from the perspective of machine learning, key among them being that the configuration in which molecules interact is not generally known. In the case of small molecule protein interactions, where it is possible to represent molecules as 3D objects, this is manifested in terms of hidden variables in the relative conformation and alignment of protein and ligand. Most machine learning tasks do not embed hidden variables in this fashion, but the problem is not insurmountable. We have implemented a number of methods which demonstrate that the problem of hidden variables is tractable, both methodologically in model induction and scoring function optimization as well as from the perspective of computational complexity in search. In this work, we will develop novel methods and refine existing methods in 3 problem areas: 1) Developing scoring functions for small molecule protein interactions with a known protein structure (the docking problem); 2) Developing quantitative models of small molecule activity against proteins with no known structure (the 3D QSAR problem); and 3) Developing methods for search and optimization that improve both model and scoring function induction and high-throughput application to large libraries of small molecules. The goal is to address the problem of prediction in a quantifiable way, which will allow both practical improvements in applications of the methods, and will also provide insight into the mechanistic aspects of the underlying physical molecular interactions.    All methods and data will be made widely available to both academic and industrial investigators.             ",Machine Learning in Chemistry and Biology,7257023,R01GM070481,"['Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' small molecule ', ' Address ', ' protein structure ', ' Covalent Interaction ', ' Data ', ' Characteristics ', ' Molecular ', ' Docking ', ' Derivation procedure ', ' Derivation ', ' Development ', ' developmental ', ' Facility Construction Funding Category ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Area ', ' Surface ', ' Active Sites ', ' Chemicals ', ' insight ', ' Ligands ', ' Numbers ', ' Literature ', ' Pliability ', ' pliable ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Proteins ', ' gene product ', ' scaffold ', ' scaffolding ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Work ', ' Source ', ' Score ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Benchmarking ', ' Best Practice Analysis ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biology ', ' heuristics ', ' small molecule libraries ', ' chemical library ', ' physical model ', ' Speed (motion) ', ' Speed ', ' Structure ', ' novel ', ' Categories ', ' Cations ', ' Chemistry ', ' Relative (related person) ', ' Relative ', ' abstracting ', ' Modeling ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' predictive modeling ', ' computer based prediction ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2007,265474,0.08583807134574122
"Comparative Visualization and Analysis for GCxGC    DESCRIPTION (provided by applicant): Project Summary. This project will investigate and develop effective information technologies for comparative analysis and visualization of complex data generated by comprehensive two-dimensional gas chromatography (GCxGC). GCxGC is an emerging technology that provides an order-of-magnitude greater separation capacity, significantly better signal-to-noise ratio, and higher dimensional retention-structure relations than traditional GC. The principal challenge for utilization of GCxGC, in a wide range of public-health and other applications, is the difficulty of analyzing and interpreting the large, complex data it generates. The quantity and complexity of GCxGC data necessitates the investigation and development of new information technologies. This project will develop and demonstrate innovative methods and tools for comparative analysis of GCxGC datasets. The expected results of this research and development include a PCA-based method for chemical fingerprinting, decision trees with chemical constraints for sample classification, genetic programming for template and constraint-based matching and classification, and visualization methods for comparative GCxGC analyses. These methods will be implemented in commercial software that will support researchers and laboratory analysts in a wide range of commercial applications, including health care, environmental monitoring, and chemical processing. The power of GCxGC, supported by effective information technologies, will enable better understanding of chemical compositions and processes, a foundation for future scientific advances and discoveries. Relevance to Public Health. Today, a few advanced laboratories are pioneering GCxGC for a variety of applications such as environmental monitoring of exposure profiles in air, soil, food, and water; identification and quantification of toxic products in blood, urine, milk, and breath samples; and qualitative and quantitative metabolomics to provide a holistic view of the biochemical status or biochemical phenotype of an organism. Many analyses in these applications require detailed chemical comparisons of samples, e.g..monitoring changes, comparison to reference standards, chemical matching or ""fingerprinting"", and classification. GCxGC is a powerful new technology for such comparative analyses. This proposal will provide innovative information technologies to support users in these applications.           ",Comparative Visualization and Analysis for GCxGC,7270029,R44RR020256,"['Decision Trees ', ' metabolomics ', ' metabolism measurement ', ' Environmental Monitoring ', ' environmental testing ', ' Ecological Monitoring ', ' Ecologic Monitoring ', ' Data Set ', ' Dataset ', ' Data ', ' Range ', ' Emerging Technologies ', ' Emergent Technologies ', ' Genetic Programming ', ' Genetic Algorithm ', ' Scientific Advances and Accomplishments ', ' scientific advances ', ' scientific accomplishments ', ' Monitor ', ' Process ', ' Development ', ' developmental ', ' Fingerprint ', ' Food ', ' Foundations ', ' Future ', ' Image ', ' imaging ', ' Imagery ', ' Visualization ', ' base ', ' Goals ', ' Air ', ' Phase ', ' Biochemical ', ' Chemicals ', ' Laboratories ', ' Language ', ' Marketing ', ' Methods ', ' Milk ', ' Trademark ', ' Noise ', ' Organism ', ' living system ', ' Phenotype ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' instrument ', ' Reference Standards ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Sales ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Archives ', ' Computer software ', ' computer program/software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Soil ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Technology ', ' Urine ', ' Urine Urinary System ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Investigation ', ' Water ', ' Hydrogen Oxide ', ' Complex ', ' Pattern ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Blood ', ' Blood Reticuloendothelial System ', ' innovative technologies ', ' chemical fingerprinting ', ' Structure ', ' new technology ', ' novel technologies ', ' Reporting ', ' Today ', ' Statistical Methods ', ' Gas Chromatography ', ' vapor phase chromatography ', ' Healthcare ', ' health care ', ' Schedule ', ' Sampling ', ' Classification ', ' Systematics ', ' Information Technology ', ' innovation ', ' innovative ', ' innovate ', ' two-dimensional ', ' 2-dimensional ', ' comparative ', ' commercial application ', ' Computers ', ' ']",NCRR,"GC IMAGE, LLC",R44,2007,223713,0.10753723452012048
"Robust computational framework for predictive ADME-Tox modeling    DESCRIPTION (provided by applicant):    This proposal seeks to establish a universally applicable and robust predictive ADME-Tox modeling framework based on rigorous Quantitative Structure Activity/Property Relationships (QSAR/QSPR) modeling. The framework has been refined in the course of many years of our research in the areas of QSPR methodology development and application to experimental datasets that led to novel analytical approaches, descriptors, model validation schemes, overall QSPR workflow design, and multiple end-point studies. This proposal focuses on the design of optimized QSPR protocols for the development of reliable predictors of critically important ADME-Tox properties. The ADME properties will include, but not limited to, water solubility, membrane permeability, P450 metabolism inhibition and induction, metabolic stability, human intestinal absorption, bioavailability, transporters and PK data; a variety of toxicological end-points vital to human health will be explored; they are available from recent initiatives on development and standardization of toxicity data, such as the US FDA, NIEHS, and EPA DSS-Tox and other database projects. The ultimate goal of this project is sharing both modeling software and specialized predictors with the research community via a web-based Predictive ADME-Tox Portal. The project objectives will be achieved via concurrent development of QSPR methodology (Specific Aim 1), building highly predictive, robust QSPR models of known ADME-Tox properties (Specific Aim 2), and the deployment of both modeling software and individual predictors via a specialized web-portal (Specific Aim 3). To achieve the goals of this project focusing on the development and delivery of specialized tools and rigorous predictors, we have assembled a research team of mostly senior investigators with complimentary skills and track records of accomplishment in the areas of computational drug discovery, experimental toxicology, statistical modeling, and software development and integration; two of the team members have had recent industrial experience before transitioning to academia. To the best of our knowledge, the results of this proposal will lead to the first publicly available in silico ADME-Tox modeling framework and predictors that can be used by the research community to analyze any set of chemicals (i.e., virtual and real compound sets). The framework will have a significant impact on compound prioritization, chemical library design, and candidate selection for preclinical and clinical development.            ",Robust computational framework for predictive ADME-Tox modeling,7433931,R21GM076059,"['Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computers ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' drug discovery ', ' Communities ', ' computer framework ', ' computational framework ', ' virtual ', ' cluster computing ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' combinatorial ', ' neurotoxicity ', ' neuronal toxicity ', ' neuron toxicity ', ' open source ', ' Cytochrome P450 ', ' P450 ', ' Cytochrome P-450 Enzyme System ', ' Cytochrome P-450 ', ' Data Collection ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' data mining ', ' datamining ', ' Environment ', ' Address ', ' Data Set ', ' Dataset ', ' End Point ', ' Academia ', ' Data ', ' Research Infrastructure ', ' Infrastructure ', ' Statistically Significant ', ' Scheme ', ' Validation ', ' Development ', ' developmental ', ' pre-clinical ', ' preclinical ', ' Standards of Weights and Measures ', ' base ', ' career ', ' method development ', ' Organ ', ' Goals ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Area ', ' Acute ', ' Chronic ', ' Clinical ', ' Ensure ', ' Intestinal Absorption ', ' gastrointestinal absorption ', ' Chemicals ', ' Screening procedure ', ' screenings ', ' screening ', ' Training ', ' knowledge of results ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Hepatotoxicity ', ' hepatoxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Individual ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Statistical Models ', ' Probabilistic Models ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Collaborations ', ' Descriptor ', ' Letters ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Metabolic ', ' Drug Kinetics ', ' Pharmacokinetics ', ' tool ', ' Records ', ' Recruitment Activity ', ' recruit ', ' Nature ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Knowledge ', ' programs ', ' Standardization ', ' Students ', ' Technology ', ' Testing ', ' Scientist ', ' Toxicology ', ' United States Environmental Protection Agency ', ' Environmental Protection Agency ', ' United States Food and Drug Administration ', ' USFDA ', ' Food and Drug Administration ', ' Protocols documentation ', ' Protocol ', ' Source ', ' Techniques ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Postdoctoral Fellow ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' experience ', ' water solubility ', ' small molecule libraries ', ' chemical library ', ' genotoxicity ', ' Toxic effect ', ' Toxicities ', ' Secure ', ' Structure ', ' skills ', ' novel ', ' member ', ' reproductive ', ' Cell Membrane Permeability ', ' membrane permeability ', ' carcinogenicity ', ' Modeling ', ' Specialist ', ' Property ', ' LOINC Axis 2 Property ', ' protocol development ', ' software development ', ' developing computer software ', ' develop software ', ' Cardiotoxicity ', ' Cardiac Toxicity ', ' ']",NIGMS,UNIV OF NORTH CAROLINA CHAPEL HILL,R21,2008,322087,0.07034753315245093
"Machine Learning in Chemistry and Biology    DESCRIPTION (provided by applicant): Machine learning has broad applicability in the fields of chemistry and biology. This research effort is focused on empirical derivation of functions that are useful in the context of predicting aspects of molecular interaction between proteins and ligands. The characteristics of this problem offer unique challenges when approached from the perspective of machine learning, key among them being that the configuration in which molecules interact is not generally known. In the case of small molecule protein interactions, where it is possible to represent molecules as 3D objects, this is manifested in terms of hidden variables in the relative conformation and alignment of protein and ligand. Most machine learning tasks do not embed hidden variables in this fashion, but the problem is not insurmountable. We have implemented a number of methods which demonstrate that the problem of hidden variables is tractable, both methodologically in model induction and scoring function optimization as well as from the perspective of computational complexity in search. In this work, we will develop novel methods and refine existing methods in 3 problem areas: 1) Developing scoring functions for small molecule protein interactions with a known protein structure (the docking problem); 2) Developing quantitative models of small molecule activity against proteins with no known structure (the 3D QSAR problem); and 3) Developing methods for search and optimization that improve both model and scoring function induction and high-throughput application to large libraries of small molecules. The goal is to address the problem of prediction in a quantifiable way, which will allow both practical improvements in applications of the methods, and will also provide insight into the mechanistic aspects of the underlying physical molecular interactions.    All methods and data will be made widely available to both academic and industrial investigators.             ",Machine Learning in Chemistry and Biology,7448703,R01GM070481,"['Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' small molecule ', ' Address ', ' protein structure ', ' Covalent Interaction ', ' Data ', ' Characteristics ', ' Molecular ', ' Docking ', ' Derivation procedure ', ' Derivation ', ' Development ', ' developmental ', ' Facility Construction Funding Category ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Area ', ' Surface ', ' Active Sites ', ' Chemicals ', ' insight ', ' Ligands ', ' Numbers ', ' Literature ', ' Pliability ', ' pliable ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Proteins ', ' gene product ', ' scaffold ', ' scaffolding ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Work ', ' Source ', ' Score ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Benchmarking ', ' Best Practice Analysis ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biology ', ' heuristics ', ' small molecule libraries ', ' chemical library ', ' physical model ', ' Speed (motion) ', ' Speed ', ' Structure ', ' novel ', ' Categories ', ' Cations ', ' Chemistry ', ' Relative (related person) ', ' Relative ', ' abstracting ', ' Modeling ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' predictive modeling ', ' computer based prediction ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2008,265474,0.08583807134574122
"Novel Schizophrenia Therapeutics By Virtual High-Throughput Screening    DESCRIPTION (provided by applicant): Selective potentiators of the metabotropic glutamate receptor subtype mGluR5 have exciting potential for development of novel treatment strategies for schizophrenia and other disorders that disrupt cognitive function. The latest generation of selective mGluR5 potentiators is based on the lead compound CDPPB and features systemically active compounds with long half-lives that cross the blood-brain barrier.      A high-throughput screen (HTS) for mGluR5 potentiators at Vanderbilts NIH-funded molecular libraries screening center network facility revealed a large and diverse set of about 1400 substances whose activity was validated in independent experiments. The present ChemInformatics proposal targets utilizing the power of recent machine learning techniques such as Artificial Neural Networks (ANNs) and Support Vector Machines (SVMs) to model the complex relationship between chemical structure and biological activity of mGluR5 potentiators reflected in the HTS results. An innovative encoding scheme is developed that allows mapping of the diverse chemical space into a single mathematical model. The resulting Quantitative Structure Activity Relation (QSAR) models will serve a three-fold purpose: (a) a comprehensive binding site pharmacophore will be obtained to facilitate understanding of the SAR and rationalize further experiments; (b) the models will be used to virtually screen libraries of millions of compounds which are known but not physically available for HTS at Vanderbilt to gain a priority list for acquisition or synthesis; and (c) in combination with an existing Genetic Algorithm (GA) structure generator existing lead compounds will be optimized and new structures will be designed to identify potential new targets for synthesis.      Overall we hope to not only identify novel allosteric potentiators of mGluR5 and understand their activity as potential treatment of schizophrenia and other disorders that disrupt cognitive function, but also to build an innovative ChemInformatics software and database tool which can be adopted for research in other NIH molecular libraries screening centers. The developed applications will be made freely and readily accessible for academic research using a WWW interface deeply integrated in the drug development pipeline. The employed QSAR models require no crystal structure of the target protein. Hence the method can be readily applied to membrane proteins-such as GPCRs-which are target of 40-50% of modern medicinal drugs.      The PI of the proposal has extensive experience in the usage of ANNs and SVMs to predict properties of organic molecules and proteins (1-9), solve protein structures (10-15), and predict activity of therapeutics (16). He implemented GAs for the design and optimization of chemical structures (17,18). For the tasks at hand he teams up with Jeff Conn, a renowned expert for researching mGluRs (19) and potential therapeutics targeting these systems (20-22).          ",Novel Schizophrenia Therapeutics By Virtual High-Throughput Screening,7361172,R21MH082254,"['Disease ', ' disease/disorder ', ' Disorder ', ' Purpose ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' cheminformatics ', ' chemical informatics ', ' small molecule ', ' Educational aspects ', ' Education ', ' protein structure ', ' Molecular Bank ', ' molecular library ', ' Cognitive ', ' Genetic Programming ', ' Genetic Algorithm ', ' Scheme ', ' Screening Result ', ' Principal Investigator ', ' Development ', ' developmental ', ' base ', ' Half-Life ', ' Hand ', ' Algorithms ', ' Biological ', ' Metabotropic Glutamate Receptors ', ' Investments ', ' Chemicals ', ' Chemical Structure ', ' Screening procedure ', ' screenings ', ' screening ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Libraries ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Funding ', ' Maps ', ' Membrane Proteins ', ' Surface Proteins ', ' Membrane-Associated Proteins ', ' Methods ', ' Mining ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' tool ', ' Proteins ', ' gene product ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Schizophrenia ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' cognitive function ', ' Adopted ', ' Work ', ' Complex ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Blood - brain barrier anatomy ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' experience ', ' Membrane ', ' membrane structure ', ' Biological Neural Networks ', ' neural network ', ' pharmacophore ', ' Structure ', ' novel ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Generations ', ' chemical synthesis ', ' Modeling ', ' Property ', ' LOINC Axis 2 Property ', ' drug development ', ' high throughput screening ', ' High Throughput Assay ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' virtual ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' therapeutic target ', ' ']",NIMH,VANDERBILT UNIVERSITY,R21,2008,199280,0.11393996183337295
"Low-Cost Electronic Nose for Groundwater Contaminants    DESCRIPTION (provided by applicant): Several US agencies and regulators require low-cost chemical sensors for detecting and monitoring environmental clean-up, remediation, and decommissioning processes where groundwater may be contaminated. The sensors must be capable of detecting contaminants in the sub-surface groundwater and must be compatible with use in a range of environments. Most significantly, these customers require a low-cost alternative to its current expensive and labor intensive methods, namely using mobile laboratories. The project will result in the innovative use of low-cost sensor systems that will be capable of detecting and monitoring for dense non-aqueous phase liquids in the subsurface and groundwater, unattended, and in real- time from within a push-probe, using a chemicapacitor array and miniature preconcentrator. Seacoast's Phase I research will focus on developing the sensor array, demonstrating sensitivity to chlorinated hydrocarbons at relevant concentrations, and field tests in actual contaminated sites. The ultimate goal is to provide the DOD, DOE, NIEHS and other agencies with a method to map and track subsurface contamination plumes in real-time without requiring an operator. The systems will have MEMS microcapacitor sensor arrays that can monitor for leaks of toxic chemicals, contaminants from wastes, and changes in groundwater streams. A preconcentrator collects the contaminants and releases them to a microsensor array. The sensor arrays are filled with several chemoselective polymers whose dielectric permittivity changes when exposed to different vapors, creating a fingerprint response for each chemical. An array of differently responding sensors and pattern recognition can thereby compensate for changes in humidity, temperature, and composition. These low-power systems can be left unattended and transmit data wirelessly or through USB to a central location. The most important application to public health and safety is unattended monitoring of drinking water, water treatment processes, and water sources. The potential commercial markets include building chemical process monitoring and control, toxic vapor leak detection, industrial process control, and industrial health and safety. Transitioning the developed prototype to other markets where worker and public health, environmental health and regulatory compliance will be investigated to reduce the financial risks and broaden the acceptance of the technology. PUBLIC HEALTH RELEVANCE: This proposal will describe a potential method to specifically address the need for detecting groundwater contaminants and long-term monitoring of contaminated sites, by providing an unattended sensor system that tracks contamination in real-time and transmits contaminant concentrations. Such a system would be used in tandem with other methods, to provide comprehensive contamination management at DOE, DOD, and Superfund sites where ground and water clean-up projects are already underway. The proposed work will focus on detection of chlorinated hydrocarbons, which are described as among the most common pollutants in groundwater and soils at DOE sites.          ",Low-Cost Electronic Nose for Groundwater Contaminants,7537117,R43ES016941,"['cost effectiveness ', ' Data Collection ', ' computerized data processing ', ' signal processing ', ' data processing ', ' Electronics ', ' Engineering ', ' Environment ', ' Environmental Health ', ' Environmental Health Science ', ' Environmental Monitoring ', ' environmental testing ', ' Ecological Monitoring ', ' Ecologic Monitoring ', ' Address ', ' Data ', ' Detection ', ' Range ', ' Collection ', ' Pattern Recognition ', ' Monitor ', ' Rate ', ' Characteristics ', ' Process ', ' Modification ', ' Compatible ', ' Feedback ', ' Fingerprint ', ' Fluorescence ', ' Standards of Weights and Measures ', ' base ', ' Goals ', ' detector ', ' Pump ', ' sensor ', ' Humidity ', ' Chlorinated Hydrocarbons ', ' chlorohydrocarbon ', ' Organochlorines ', ' Organochlorine Compounds ', ' Algorithms ', ' Left ', ' Site ', ' Surface ', ' Phase ', ' Chemicals ', ' Laboratories ', ' Lasers ', ' Laser Radiation ', ' Laser Electromagnetic ', ' wasting ', ' Numbers ', ' Maps ', ' Marketing ', ' Methods ', ' Nose ', ' Respiratory System, Nose, Nasal Passages ', ' Nasal Passages Nose ', ' Nasal ', ' Simulate ', ' Liquid substance ', ' liquid ', ' fluid ', ' Poisons ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Polymers ', ' public health medicine (field) ', ' Public Health ', ' Condition ', ' Recommendation ', ' Research ', ' Risk ', ' ROC Curve ', ' ROC Analyses ', ' Safety ', ' Science ', ' Soil ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Technology ', ' Temperature ', ' Testing ', ' Time ', ' Trichloroethylene ', ' trichloro-ethene ', ' Trichloroethene ', ' Ethinyl Trichloride ', ' Water ', ' Hydrogen Oxide ', ' Work ', ' Stream ', ' Source ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' ground water ', ' vapor ', ' water treatment ', ' membrane assembly ', ' drinking water ', ' pollutant ', ' aqueous ', ' Industrial Health ', ' Industrial Hygiene ', ' Measures ', ' Sampling ', ' response ', ' Classification ', ' Systematics ', ' superfund site ', ' cold temperature ', ' low temperature ', ' cost ', ' design ', ' designing ', ' remediation ', ' innovation ', ' innovative ', ' innovate ', ' prototype ', ' ']",NIEHS,"SEACOAST SCIENCE, INC.",R43,2008,91299,0.05135446870795642
"Predicting Reactions of Xenobiotic Compounds in Mammals    DESCRIPTION (provided by applicant): In pursuit of novel therapeutics, drug developers are scanning more compounds and covering more chemical space than ever before. The time required to bring a new drug into the market has not decreased, though the cost for drug discovery is steadily increasing. The root causes of this problem are related to efficacy, toxicity, and inappropriate absorption, distribution, metabolism and excretion, as shown by recent rigorous analyses. To focus on the ADMET(Absorption, Distribution, Metabolism, Elimination and Toxicity) issues, pharmaceutical research groups have, since the late 1990s, moved various physicochemical property screens earlier in the drug discovery process. The metabolic transformations of pharmaceuticals profoundly impact their bioavailability, efficacy, chronic toxicity, metabolic idiosyncrasies, excretion rates and routes. Metabolism is one of the major hurdles to overcome. In silico tools enable fast and virtual screening of large numbers of compounds before compounds are synthesized. Such tools enable researchers to recognize complicated metabolic processes, to eliminate poor candidates, and then to use the knowledge gained to discern possible deficiencies in compounds. Still poorly understood, metabolism is the most difficult to predict. The overall goal of this proposal is to develop a system to predict xenobiotic metabolism in mammals, and to gain insights into metabolism mechanisms (aim 1), and to study the differences in metabolism between humans and model animals (aim 2). We will use MDL's Metabolite database as a source of information about drug metabolism reactions. For aim 1, we will develop both global metabolism prediction systems, which can be applied to diverse substrate without prior knowledge of enzymes, and local models for particular enzymes, when prior knowledge of the enzymes involved in reactions is available. Global metabolism prediction systems will comprise many individual models, each of which will focus on an animal species (e.g., humans), an enzyme (e.g., CYP3A4) and a specific biotransformation (e.g., hydroxylation). Machine learning techniques will be used to build each individual model using various features to characterize the chemical environments of functional groups within molecules. For local models for an enzyme, we assume that the tight binding of ligands and enzymes is not required, but rather that reactions occur at sites where enzymes can easily attack. We will design ways to model the probability that a particular site will be attacked by enzymes. In Aim 1, both the global metabolism prediction system and the local models are trained on human reactions, so the models are animal specific. In Aim 2, we will build models for rat, which is a model animal in drug development. Using rat reactions listed in MDL's Metabolite database, we will establish a global metabolism system for rats and local models for rats using the same methods outlined in Aim 1. Though the methods are the same, the training sets are different, and it is expected that the models will make different predictions. By using drugs that are known to be metabolized differently in humans and rats, we will study differences in the human and rat models. PUBLIC HEALTH RELEVANCE: In pursuit of novel therapeutics, drug developers are scanning more compounds and covering more chemical space than ever before. ADMET(Absorption, Distribution, Metabolism, Elimination and Toxicity) has assumed center stage in the drug discovery process. Predicting metabolism is one of the major challenges to be met, and metabolism is the most poorly understood of the ADMET processes, and the most difficult to predict. We propose a machine learning approach for improving metabolism prediction, and for gaining insights into metabolism mechanisms, as well as studying differences in metabolism between humans and model animals.             ",Predicting Reactions of Xenobiotic Compounds in Mammals,7531715,R21ES016920,"['novel ', ' drug metabolism ', ' Drug Interactions ', ' absorption ', ' Modeling ', ' Property ', ' LOINC Axis 2 Property ', ' drug development ', ' drug discovery ', ' cost ', ' virtual ', ' Xenobiotic Metabolism ', ' CYP3A4 gene ', ' P450PCN1 ', ' P450C3 ', ' P450-PCN1 ', ' NF-25 ', ' CYPIIIA4 ', ' CYP3A4 ', ' CYP3A3 ', ' CYP3A13 ', ' CYP3A ', ' CYP3 ', ' CP34 ', ' CP33 ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Drug toxicity ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' small molecule ', ' Environment ', ' Enzymes ', ' in vivo ', ' Ligand Binding ', ' Rate ', ' Process ', ' Goals ', ' improved ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Hydroxylation ', ' Site ', ' Chronic ', ' Biological ', ' In Vitro ', ' Chemicals ', ' Screening procedure ', ' screenings ', ' screening ', ' Training ', ' Excretory function ', ' excretion ', ' Failure (biologic function) ', ' failure ', ' FLR ', ' insight ', ' Individual ', ' Numbers ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Mammals ', ' Mammalia ', ' Marketing ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' metabolic abnormality assessment ', ' Metabolism Studies ', ' Metabolic Studies ', ' Abnormal Assessment of Metabolism ', ' Organism ', ' living system ', ' Animals ', ' Metabolic ', ' Probability ', ' Staging ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Testing ', ' Time ', ' Xenobiotics ', ' Scanning ', ' Reaction ', ' Source ', ' Route ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Metabolic Biotransformation ', ' Biotransformation ', ' enzyme model ', ' functional group ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' Toxic effect ', ' Toxicities ', ' Speed (motion) ', ' Speed ', ' design ', ' designing ', ' novel therapeutics ', ' next generation therapeutics ', ' new therapeutics ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' ']",NIEHS,LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB,R21,2008,267896,0.08382085676933307
"Classification Algorithms for Chemical Compounds Computational techniques that build models to correctly assign chemical compounds to various classes of interests have extensive applications in pharmaceutical research and are used extensively at various phases during the drug development process. These techniques are used to solve a number of classification problems such as predicting whether or not a chemical compound has the desired biological activity, is toxic or non-toxic, and filtering out drug-like compounds from large compound libraries. The overall goal of this proposal is to develop substructure-based classification algorithms for chemical compound datasets. The key elements of these algorithms are that they (i) utilize highly efficient substructure discovery algorithms to mine the chemical compounds and discover all substructures that can be critical for the classification task, (ii) use multiple criteria to generate a set of substructure-based features that simultaneously simplify the compounds' representation while retaining and exposing the features that are responsible for the specific classification problem, and (iii) build predictive models by employing kernel-based methods that take into account the relationships between these substructures at different levels of granularity and complexity, as well as information provided by traditional descriptors. ",Classification Algorithms for Chemical Compounds,7495003,R01LM008713,"['Figs - dietary ', ' Figs ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' programs ', ' Technology ', ' Frequencies (time pattern) ', ' Frequency ', ' Techniques ', ' Location ', ' Class ', ' interest ', ' Structure ', ' Graph ', ' Generations ', ' Relative (related person) ', ' Relative ', ' Modeling ', ' desire ', ' drug development ', ' Classification ', ' Systematics ', ' Accounting ', ' vector ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Dependency (Psychology) ', ' emotional dependency ', ' Dependency ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Effectiveness ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Elements ', ' Data Set ', ' Dataset ', ' Computational Technique ', ' Process ', ' Facility Construction Funding Category ', ' base ', ' Goals ', ' Hybrids ', ' Algorithms ', ' Phase ', ' Biological ', ' Chemicals ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Libraries ', ' Numbers ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Mining ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Descriptor ', ' ']",NLM,UNIVERSITY OF MINNESOTA,R01,2008,270892,0.12769227719785742
"Predicting Reactions of Xenobiotic Compounds in Mammals    DESCRIPTION (provided by applicant): In pursuit of novel therapeutics, drug developers are scanning more compounds and covering more chemical space than ever before. The time required to bring a new drug into the market has not decreased, though the cost for drug discovery is steadily increasing. The root causes of this problem are related to efficacy, toxicity, and inappropriate absorption, distribution, metabolism and excretion, as shown by recent rigorous analyses. To focus on the ADMET(Absorption, Distribution, Metabolism, Elimination and Toxicity) issues, pharmaceutical research groups have, since the late 1990s, moved various physicochemical property screens earlier in the drug discovery process. The metabolic transformations of pharmaceuticals profoundly impact their bioavailability, efficacy, chronic toxicity, metabolic idiosyncrasies, excretion rates and routes. Metabolism is one of the major hurdles to overcome. In silico tools enable fast and virtual screening of large numbers of compounds before compounds are synthesized. Such tools enable researchers to recognize complicated metabolic processes, to eliminate poor candidates, and then to use the knowledge gained to discern possible deficiencies in compounds. Still poorly understood, metabolism is the most difficult to predict. The overall goal of this proposal is to develop a system to predict xenobiotic metabolism in mammals, and to gain insights into metabolism mechanisms (aim 1), and to study the differences in metabolism between humans and model animals (aim 2). We will use MDL's Metabolite database as a source of information about drug metabolism reactions. For aim 1, we will develop both global metabolism prediction systems, which can be applied to diverse substrate without prior knowledge of enzymes, and local models for particular enzymes, when prior knowledge of the enzymes involved in reactions is available. Global metabolism prediction systems will comprise many individual models, each of which will focus on an animal species (e.g., humans), an enzyme (e.g., CYP3A4) and a specific biotransformation (e.g., hydroxylation). Machine learning techniques will be used to build each individual model using various features to characterize the chemical environments of functional groups within molecules. For local models for an enzyme, we assume that the tight binding of ligands and enzymes is not required, but rather that reactions occur at sites where enzymes can easily attack. We will design ways to model the probability that a particular site will be attacked by enzymes. In Aim 1, both the global metabolism prediction system and the local models are trained on human reactions, so the models are animal specific. In Aim 2, we will build models for rat, which is a model animal in drug development. Using rat reactions listed in MDL's Metabolite database, we will establish a global metabolism system for rats and local models for rats using the same methods outlined in Aim 1. Though the methods are the same, the training sets are different, and it is expected that the models will make different predictions. By using drugs that are known to be metabolized differently in humans and rats, we will study differences in the human and rat models. PUBLIC HEALTH RELEVANCE: In pursuit of novel therapeutics, drug developers are scanning more compounds and covering more chemical space than ever before. ADMET(Absorption, Distribution, Metabolism, Elimination and Toxicity) has assumed center stage in the drug discovery process. Predicting metabolism is one of the major challenges to be met, and metabolism is the most poorly understood of the ADMET processes, and the most difficult to predict. We propose a machine learning approach for improving metabolism prediction, and for gaining insights into metabolism mechanisms, as well as studying differences in metabolism between humans and model animals.             ",Predicting Reactions of Xenobiotic Compounds in Mammals,7684034,R21ES016920,"['Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Testing ', ' Time ', ' Xenobiotics ', ' Scanning ', ' Reaction ', ' Source ', ' Route ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' meetings ', ' Metabolic Biotransformation ', ' Biotransformation ', ' enzyme model ', ' functional group ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' Toxic effect ', ' Toxicities ', ' Speed (motion) ', ' Speed ', ' novel ', ' drug metabolism ', ' Drug Interactions ', ' absorption ', ' Modeling ', ' Property ', ' LOINC Axis 2 Property ', ' drug development ', ' drug discovery ', ' cost ', ' virtual ', ' design ', ' designing ', ' novel therapeutics ', ' next generation therapeutics ', ' new therapeutics ', ' public health relevance ', ' drug candidate ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Xenobiotic Metabolism ', ' CYP3A4 gene ', ' P450PCN1 ', ' P450C3 ', ' P450-PCN1 ', ' NF-25 ', ' CYPIIIA4 ', ' CYP3A4 ', ' CYP3A3 ', ' CYP3A13 ', ' CYP3A ', ' CYP3 ', ' CP34 ', ' CP33 ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Drug toxicity ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' small molecule ', ' Environment ', ' Enzymes ', ' in vivo ', ' Ligand Binding ', ' Process ', ' Goals ', ' improved ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Hydroxylation ', ' Site ', ' Chronic ', ' Biological ', ' In Vitro ', ' Chemicals ', ' Screening procedure ', ' screenings ', ' screening ', ' Training ', ' Excretory function ', ' excretion ', ' Failure (biologic function) ', ' failure ', ' FLR ', ' insight ', ' Individual ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Drug usage ', ' drug use ', ' Plant Roots ', ' root ', ' Mammals ', ' Mammalia ', ' Marketing ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' metabolic abnormality assessment ', ' Metabolism Studies ', ' Metabolic Studies ', ' Abnormal Assessment of Metabolism ', ' Organism ', ' living system ', ' Animals ', ' Metabolic ', ' Probability ', ' Staging ', ' tool ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Research ', ' ']",NIEHS,LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB,R21,2009,306310,0.08382085676933307
"Low-Cost Electronic Nose for Groundwater Contaminants    DESCRIPTION (provided by applicant): Several US agencies and regulators require low-cost chemical sensors for detecting and monitoring environmental clean-up, remediation, and decommissioning processes where groundwater may be contaminated. The sensors must be capable of detecting contaminants in the sub-surface groundwater and must be compatible with use in a range of environments. Most significantly, these customers require a low-cost alternative to its current expensive and labor intensive methods, namely using mobile laboratories. The project will result in the innovative use of low-cost sensor systems that will be capable of detecting and monitoring for dense non-aqueous phase liquids in the subsurface and groundwater, unattended, and in real- time from within a push-probe, using a chemicapacitor array and miniature preconcentrator. Seacoast's Phase I research will focus on developing the sensor array, demonstrating sensitivity to chlorinated hydrocarbons at relevant concentrations, and field tests in actual contaminated sites. The ultimate goal is to provide the DOD, DOE, NIEHS and other agencies with a method to map and track subsurface contamination plumes in real-time without requiring an operator. The systems will have MEMS microcapacitor sensor arrays that can monitor for leaks of toxic chemicals, contaminants from wastes, and changes in groundwater streams. A preconcentrator collects the contaminants and releases them to a microsensor array. The sensor arrays are filled with several chemoselective polymers whose dielectric permittivity changes when exposed to different vapors, creating a fingerprint response for each chemical. An array of differently responding sensors and pattern recognition can thereby compensate for changes in humidity, temperature, and composition. These low-power systems can be left unattended and transmit data wirelessly or through USB to a central location. The most important application to public health and safety is unattended monitoring of drinking water, water treatment processes, and water sources. The potential commercial markets include building chemical process monitoring and control, toxic vapor leak detection, industrial process control, and industrial health and safety. Transitioning the developed prototype to other markets where worker and public health, environmental health and regulatory compliance will be investigated to reduce the financial risks and broaden the acceptance of the technology. PUBLIC HEALTH RELEVANCE: This proposal will describe a potential method to specifically address the need for detecting groundwater contaminants and long-term monitoring of contaminated sites, by providing an unattended sensor system that tracks contamination in real-time and transmits contaminant concentrations. Such a system would be used in tandem with other methods, to provide comprehensive contamination management at DOE, DOD, and Superfund sites where ground and water clean-up projects are already underway. The proposed work will focus on detection of chlorinated hydrocarbons, which are described as among the most common pollutants in groundwater and soils at DOE sites.          ",Low-Cost Electronic Nose for Groundwater Contaminants,7847964,R43ES016941,"['cost effectiveness ', ' Data Collection ', ' computerized data processing ', ' signal processing ', ' data processing ', ' Electronics ', ' Engineering ', ' Environment ', ' Environmental Health ', ' Environmental Health Science ', ' Environmental Monitoring ', ' environmental testing ', ' Ecological Monitoring ', ' Ecologic Monitoring ', ' Address ', ' Data ', ' Detection ', ' Collection ', ' Pattern Recognition ', ' Monitor ', ' Characteristics ', ' Process ', ' Modification ', ' Feedback ', ' Fingerprint ', ' Fluorescence ', ' base ', ' Goals ', ' detector ', ' Pump ', ' sensor ', ' National Institute of Environmental Health Sciences ', ' NIEHS ', ' Humidity ', ' Chlorinated Hydrocarbons ', ' chlorohydrocarbon ', ' Organochlorines ', ' Organochlorine Compounds ', ' Algorithms ', ' Left ', ' Site ', ' Surface ', ' Phase ', ' Chemicals ', ' Laboratories ', ' Lasers ', ' Laser Radiation ', ' Laser Electromagnetic ', ' wasting ', ' Maps ', ' Marketing ', ' Methods ', ' Nose ', ' Respiratory System, Nose, Nasal Passages ', ' Nasal Passages Nose ', ' Nasal ', ' Simulate ', ' Liquid substance ', ' liquid ', ' fluid ', ' Poisons ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Polymers ', ' public health medicine (field) ', ' Public Health ', ' Recommendation ', ' Research ', ' Risk ', ' ROC Curve ', ' ROC Analyses ', ' Safety ', ' Science ', ' Soil ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Technology ', ' Temperature ', ' Testing ', ' Time ', ' Trichloroethylene ', ' trichloro-ethene ', ' Trichloroethene ', ' Ethinyl Trichloride ', ' Water ', ' Hydrogen Oxide ', ' Work ', ' Stream ', ' Source ', ' System ', ' LOINC Axis 4 System ', ' Location ', ' ground water ', ' vapor ', ' water treatment ', ' membrane assembly ', ' drinking water ', ' pollutant ', ' aqueous ', ' Industrial Health ', ' Industrial Hygiene ', ' Measures ', ' Sampling ', ' response ', ' Classification ', ' Systematics ', ' superfund site ', ' cold temperature ', ' low temperature ', ' cost ', ' design ', ' designing ', ' remediation ', ' innovation ', ' innovative ', ' innovate ', ' prototype ', ' public health relevance ', ' ']",NIEHS,"SEACOAST SCIENCE, INC.",R43,2009,11376,0.05135446870795642
"Novel Schizophrenia Therapeutics By Virtual High-Throughput Screening    DESCRIPTION (provided by applicant): Selective potentiators of the metabotropic glutamate receptor subtype mGluR5 have exciting potential for development of novel treatment strategies for schizophrenia and other disorders that disrupt cognitive function. The latest generation of selective mGluR5 potentiators is based on the lead compound CDPPB and features systemically active compounds with long half-lives that cross the blood-brain barrier.      A high-throughput screen (HTS) for mGluR5 potentiators at Vanderbilts NIH-funded molecular libraries screening center network facility revealed a large and diverse set of about 1400 substances whose activity was validated in independent experiments. The present ChemInformatics proposal targets utilizing the power of recent machine learning techniques such as Artificial Neural Networks (ANNs) and Support Vector Machines (SVMs) to model the complex relationship between chemical structure and biological activity of mGluR5 potentiators reflected in the HTS results. An innovative encoding scheme is developed that allows mapping of the diverse chemical space into a single mathematical model. The resulting Quantitative Structure Activity Relation (QSAR) models will serve a three-fold purpose: (a) a comprehensive binding site pharmacophore will be obtained to facilitate understanding of the SAR and rationalize further experiments; (b) the models will be used to virtually screen libraries of millions of compounds which are known but not physically available for HTS at Vanderbilt to gain a priority list for acquisition or synthesis; and (c) in combination with an existing Genetic Algorithm (GA) structure generator existing lead compounds will be optimized and new structures will be designed to identify potential new targets for synthesis.      Overall we hope to not only identify novel allosteric potentiators of mGluR5 and understand their activity as potential treatment of schizophrenia and other disorders that disrupt cognitive function, but also to build an innovative ChemInformatics software and database tool which can be adopted for research in other NIH molecular libraries screening centers. The developed applications will be made freely and readily accessible for academic research using a WWW interface deeply integrated in the drug development pipeline. The employed QSAR models require no crystal structure of the target protein. Hence the method can be readily applied to membrane proteins-such as GPCRs-which are target of 40-50% of modern medicinal drugs.      The PI of the proposal has extensive experience in the usage of ANNs and SVMs to predict properties of organic molecules and proteins (1-9), solve protein structures (10-15), and predict activity of therapeutics (16). He implemented GAs for the design and optimization of chemical structures (17,18). For the tasks at hand he teams up with Jeff Conn, a renowned expert for researching mGluRs (19) and potential therapeutics targeting these systems (20-22).          ",Novel Schizophrenia Therapeutics By Virtual High-Throughput Screening,7544499,R21MH082254,"['Disease ', ' disease/disorder ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' cheminformatics ', ' chemical informatics ', ' small molecule ', ' Educational aspects ', ' Education ', ' protein structure ', ' Molecular Bank ', ' molecular library ', ' Cognitive ', ' Genetic Programming ', ' Genetic Algorithm ', ' Scheme ', ' Screening Result ', ' Principal Investigator ', ' Development ', ' developmental ', ' base ', ' Half-Life ', ' Hand ', ' Algorithms ', ' Biological ', ' Metabotropic Glutamate Receptors ', ' Investments ', ' Chemicals ', ' Chemical Structure ', ' Screening procedure ', ' screenings ', ' screening ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Libraries ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Funding ', ' Maps ', ' Membrane Proteins ', ' Surface Proteins ', ' Membrane-Associated Proteins ', ' Methods ', ' Mining ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' tool ', ' Proteins ', ' gene product ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Schizophrenia ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' cognitive function ', ' Adopted ', ' Work ', ' Complex ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Blood - brain barrier anatomy ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' experience ', ' Membrane ', ' membrane structure ', ' Biological Neural Networks ', ' neural network ', ' pharmacophore ', ' Structure ', ' novel ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Generations ', ' chemical synthesis ', ' Modeling ', ' Property ', ' LOINC Axis 2 Property ', ' drug development ', ' high throughput screening ', ' High Throughput Assay ', ' mathematical model ', ' mathematical modeling ', ' Math Models ', ' virtual ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' therapeutic target ', ' treatment strategy ', ' ']",NIMH,VANDERBILT UNIVERSITY,R21,2009,164425,0.11393996183337295
"Machine Learning in Chemistry and Biology    DESCRIPTION (provided by applicant): Machine learning has broad applicability in the fields of chemistry and biology. This research effort is focused on empirical derivation of functions that are useful in the context of predicting aspects of molecular interaction between proteins and ligands. The characteristics of this problem offer unique challenges when approached from the perspective of machine learning, key among them being that the configuration in which molecules interact is not generally known. In the case of small molecule protein interactions, where it is possible to represent molecules as 3D objects, this is manifested in terms of hidden variables in the relative conformation and alignment of protein and ligand. Most machine learning tasks do not embed hidden variables in this fashion, but the problem is not insurmountable. We have implemented a number of methods which demonstrate that the problem of hidden variables is tractable, both methodologically in model induction and scoring function optimization as well as from the perspective of computational complexity in search. In this work, we will develop novel methods and refine existing methods in 3 problem areas: 1) Developing scoring functions for small molecule protein interactions with a known protein structure (the docking problem); 2) Developing quantitative models of small molecule activity against proteins with no known structure (the 3D QSAR problem); and 3) Developing methods for search and optimization that improve both model and scoring function induction and high-throughput application to large libraries of small molecules. The goal is to address the problem of prediction in a quantifiable way, which will allow both practical improvements in applications of the methods, and will also provide insight into the mechanistic aspects of the underlying physical molecular interactions.    All methods and data will be made widely available to both academic and industrial investigators.             ",Machine Learning in Chemistry and Biology,7931152,R01GM070481,"['Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' small molecule ', ' Address ', ' protein structure ', ' Covalent Interaction ', ' Data ', ' Characteristics ', ' Molecular ', ' Docking ', ' Derivation procedure ', ' Derivation ', ' Development ', ' developmental ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Area ', ' Surface ', ' Active Sites ', ' Chemicals ', ' insight ', ' Ligands ', ' Literature ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Proteins ', ' gene product ', ' scaffold ', ' scaffolding ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Work ', ' Source ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' Benchmarking ', ' Best Practice Analysis ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biology ', ' heuristics ', ' small molecule libraries ', ' chemical library ', ' physical model ', ' Speed (motion) ', ' Speed ', ' Structure ', ' novel ', ' Categories ', ' Cations ', ' Chemistry ', ' Relative (related person) ', ' Relative ', ' abstracting ', ' Modeling ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' predictive modeling ', ' computer based prediction ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' flexibility ', ' flexible ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2009,235562,0.08583807134574122
"Technology to Identify and Assay Chemical Genomic Probes    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and deploy cutting edge technologies and chemical genomic tools and to understand the effects of small molecule inhibitors in vivo, and to characterize the model organism Saccharomyces cerevisiae on a systems level. Over the course of the past 3.5 years, as part of an NHGRI-funded project, we have applied three unique genome-wide screens to ~2,000 chemical inhibitors of growth. These data have led to several notable findings, including: 1) novel drug/target interactions, 2) a chemical phenotype for nearly all yeast genes, 3) a systems-level characterization of yeast, and 4) a better understanding of chemical structure-activity relationships as they manifest in vivo. These data have also guided the design of the next-generation chemical genomic assays proposed herein. Using our established bioinformatics and robotics infrastructure, we will design the next generation of assays to interrogate the genome's interaction with small molecules to unprecedented levels of scrutiny, while decreasing cost per chemical. PUBLIC HEALTH RELEVANCE: Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.           Narrative Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.",Technology to Identify and Assay Chemical Genomic Probes,7580032,R01HG003317,"['Bioinformatics ', ' Bio-Informatics ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Drug Industry ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' chemical genetics ', ' small molecule ', ' Address ', ' Data ', ' Mammalian Cell ', ' Research Infrastructure ', ' Infrastructure ', ' in vivo ', ' Collection ', ' Ligand Binding ', ' Molecular ', ' Knock-out ', ' Knockout ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genome ', ' base ', ' dosage ', ' Goals ', ' Growth Inhibitors ', ' Cell Growth Inhibitors ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Phase ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Ligands ', ' Individual ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Funding ', ' Letters ', ' inhibitor/antagonist ', ' inhibitor ', ' Phenotype ', ' Genetic ', ' Productivity ', ' tool ', ' Proteins ', ' gene product ', ' Robotics ', ' Role ', ' social role ', ' Running ', ' Saccharomyces ', ' Saccharomyces cerevisiae ', ' S. cerevisiae ', ' S. Cerevisiae [{C0036025}] ', ' S cerevisiae ', "" Brewer's Yeast "", "" Baker's Yeast "", ' Skiing ', ' Snow Skiing ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Structure-Activity Relationship ', ' structure function relationship ', ' chemical structure function ', ' Technology ', ' Translating ', ' Yeasts ', ' Complex ', ' System ', ' LOINC Axis 4 System ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' experience ', ' mutant ', ' particle ', ' Surface Plasmon Resonance ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' technology development ', ' cellular targeting ', ' Toxic effect ', ' Toxicities ', ' skills ', ' novel ', ' Drug Interactions ', ' Open Reading Frames ', ' Protein Coding Region ', ' ORFs ', ' Drug Delivery Systems ', ' Drug Targeting ', ' Drug Delivery ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' digital ', ' design ', ' designing ', ' next generation ', ' Resistance ', ' resistant ', ' small hairpin RNA ', ' short hairpin RNA ', ' shRNA ', ' loss of function ', ' gain of function ', ' overexpression ', ' overexpress ', ' public health relevance ', ' FDA approved ', ' genome-wide ', ' genomewide ', ' drug candidate ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NHGRI,STANFORD UNIVERSITY,R01,2009,1154710,0.19873363494347862
"Technology to Identify and Assay Chemical Genomic Probes    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and deploy cutting edge technologies and chemical genomic tools and to understand the effects of small molecule inhibitors in vivo, and to characterize the model organism Saccharomyces cerevisiae on a systems level. Over the course of the past 3.5 years, as part of an NHGRI-funded project, we have applied three unique genome-wide screens to ~2,000 chemical inhibitors of growth. These data have led to several notable findings, including: 1) novel drug/target interactions, 2) a chemical phenotype for nearly all yeast genes, 3) a systems-level characterization of yeast, and 4) a better understanding of chemical structure-activity relationships as they manifest in vivo. These data have also guided the design of the next-generation chemical genomic assays proposed herein. Using our established bioinformatics and robotics infrastructure, we will design the next generation of assays to interrogate the genome's interaction with small molecules to unprecedented levels of scrutiny, while decreasing cost per chemical. PUBLIC HEALTH RELEVANCE: Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.           Narrative Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.",Technology to Identify and Assay Chemical Genomic Probes,7768509,R01HG003317,"['Bioinformatics ', ' Bio-Informatics ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Drug Industry ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' chemical genetics ', ' small molecule ', ' Address ', ' Data ', ' Mammalian Cell ', ' Research Infrastructure ', ' Infrastructure ', ' in vivo ', ' Collection ', ' Ligand Binding ', ' Molecular ', ' Knock-out ', ' Knockout ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genome ', ' base ', ' dosage ', ' Goals ', ' Growth Inhibitors ', ' Cell Growth Inhibitors ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Phase ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Ligands ', ' Individual ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Funding ', ' Letters ', ' inhibitor/antagonist ', ' inhibitor ', ' Phenotype ', ' Genetic ', ' Productivity ', ' tool ', ' Proteins ', ' gene product ', ' Robotics ', ' Role ', ' social role ', ' Running ', ' Saccharomyces ', ' Saccharomyces cerevisiae ', ' S. cerevisiae ', ' S. Cerevisiae [{C0036025}] ', ' S cerevisiae ', "" Brewer's Yeast "", "" Baker's Yeast "", ' Skiing ', ' Snow Skiing ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Structure-Activity Relationship ', ' structure function relationship ', ' chemical structure function ', ' Technology ', ' Translating ', ' Yeasts ', ' Complex ', ' System ', ' LOINC Axis 4 System ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' experience ', ' mutant ', ' particle ', ' Surface Plasmon Resonance ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' technology development ', ' cellular targeting ', ' Toxic effect ', ' Toxicities ', ' skills ', ' novel ', ' Drug Interactions ', ' Open Reading Frames ', ' Protein Coding Region ', ' ORFs ', ' Drug Delivery Systems ', ' Drug Targeting ', ' Drug Delivery ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' digital ', ' design ', ' designing ', ' next generation ', ' Resistance ', ' resistant ', ' small hairpin RNA ', ' short hairpin RNA ', ' shRNA ', ' loss of function ', ' gain of function ', ' overexpression ', ' overexpress ', ' public health relevance ', ' FDA approved ', ' genome-wide ', ' genomewide ', ' drug candidate ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NHGRI,STANFORD UNIVERSITY,R01,2010,1128314,0.19873363494347862
"Technology to Identify and Assay Chemical Genomic Probes    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and deploy cutting edge technologies and chemical genomic tools and to understand the effects of small molecule inhibitors in vivo, and to characterize the model organism Saccharomyces cerevisiae on a systems level. Over the course of the past 3.5 years, as part of an NHGRI-funded project, we have applied three unique genome-wide screens to ~2,000 chemical inhibitors of growth. These data have led to several notable findings, including: 1) novel drug/target interactions, 2) a chemical phenotype for nearly all yeast genes, 3) a systems-level characterization of yeast, and 4) a better understanding of chemical structure-activity relationships as they manifest in vivo. These data have also guided the design of the next-generation chemical genomic assays proposed herein. Using our established bioinformatics and robotics infrastructure, we will design the next generation of assays to interrogate the genome's interaction with small molecules to unprecedented levels of scrutiny, while decreasing cost per chemical. PUBLIC HEALTH RELEVANCE: Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.           Narrative Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.",Technology to Identify and Assay Chemical Genomic Probes,8057799,R01HG003317,"['Bioinformatics ', ' Bio-Informatics ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Drug Industry ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' chemical genetics ', ' small molecule ', ' Address ', ' Data ', ' Mammalian Cell ', ' Research Infrastructure ', ' Infrastructure ', ' in vivo ', ' Collection ', ' Ligand Binding ', ' Molecular ', ' Knock-out ', ' Knockout ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genome ', ' base ', ' dosage ', ' Goals ', ' Growth Inhibitors ', ' Cell Growth Inhibitors ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Phase ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Ligands ', ' Individual ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Funding ', ' Letters ', ' inhibitor/antagonist ', ' inhibitor ', ' Phenotype ', ' Genetic ', ' Productivity ', ' tool ', ' Proteins ', ' gene product ', ' Robotics ', ' Role ', ' social role ', ' Running ', ' Saccharomyces ', ' Saccharomyces cerevisiae ', ' S. cerevisiae ', ' S. Cerevisiae [{C0036025}] ', ' S cerevisiae ', "" Brewer's Yeast "", "" Baker's Yeast "", ' Skiing ', ' Snow Skiing ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Structure-Activity Relationship ', ' structure function relationship ', ' chemical structure function ', ' Technology ', ' Translating ', ' Yeasts ', ' Complex ', ' System ', ' LOINC Axis 4 System ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' experience ', ' mutant ', ' particle ', ' Surface Plasmon Resonance ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' technology development ', ' cellular targeting ', ' Toxic effect ', ' Toxicities ', ' skills ', ' novel ', ' Drug Interactions ', ' Open Reading Frames ', ' Protein Coding Region ', ' ORFs ', ' Drug Delivery Systems ', ' Drug Targeting ', ' Drug Delivery ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Genomics ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' digital ', ' design ', ' designing ', ' next generation ', ' Resistance ', ' resistant ', ' small hairpin RNA ', ' short hairpin RNA ', ' shRNA ', ' loss of function ', ' gain of function ', ' overexpression ', ' overexpress ', ' public health relevance ', ' FDA approved ', ' genome-wide ', ' genomewide ', ' drug candidate ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NHGRI,STANFORD UNIVERSITY,R01,2010,361760,0.19873363494347862
"High Throughput Screen for Myotonic Dystrophy Type 1    DESCRIPTION (provided by applicant): Myotonic dystrophy (DM1) is the most common adult onset muscular dystrophy in humans. Currently, there is no cure or an FDA approved drug for DM1 and related diseases. The molecular basis of DM1 is the expansion of a CTG-repeat sequence in the 3' untranslated region of the protein kinase gene, DMPK. This defect results in the expression of mutant DMPK RNAs encoding expanded CUG repeats (CUGexp) that form large intra nuclear RNA-protein complexes or foci. Expression of CUGexp RNAs leads to abnormal RNA splicing, which in turn has been linked to the development of key features of DM1 pathology. We hypothesize that small molecules that degrade or disperse CUGexp RNAs in DM1 cells can re-establish normal splice patterns and reverse DM1 pathology. To test this hypothesis, we developed a primary HTS and a secondary hit validation assay to identify small-molecules that alter the biology of CUGexp RNAs without affecting the normal transcript. Our in house library was developed using a robust machine learning chemoinformatics platform and consists of 40,000 highly diverse small-molecules representing a library of over a million compounds. An initial screen of 2,500 small molecules from this library resulted in the identification of a potent lead compound, MDI16, which reverses aberrant RNA splice patterns in both DM1 patient myoblasts and in the HSALR mouse model for DM1. In a concerted effort to identify other potent lead compounds we propose the following: Aim 1. Implement primary HTS and the secondary hit validation assay in the MLPCN center. Aim 2. Test hits in tertiary cell-based assays to identify highly potent molecules that reverse four key cellular DM1 phenotypes. Aim 3. Characterize the selectivity and toxicity of lead compounds and identify their mechanism of action at the cellular level using a set of cell-based assays developed in the lab. Aim 4. In conjunction with the MLPCN center, we will refine the chemical structure of lead compounds reiteratively to optimize pharmacological properties and establish structure-activity relationships.      PUBLIC HEALTH RELEVANCE: Lay Summary Myotonic dystrophy type 1 is a neuromuscular disorder for which there is no treatment or cure. Over the past few years exciting strides in our understanding of the mechanistic basis of this disorder have been made. Thus the field is poised to make a major breakthrough and develop a drug for this disorder. We have developed a sensitive high throughput screen (HTS) to identify compounds that cure or ameliorate pathologies associated with myotonic dystrophy. Currently we have discovered potent molecules, which rescue DM1 pathology in both DM1 patient myoblasts and in DM1 mouse models. As our screens have been proven to identify potent molecules that rescue DM1 pathology, in this application we propose to identify other lead compounds by screening the MLPCN chemical library with our HTS. Identification of multiple leads will greatly improve the probability of a small molecule therapy for DM1.           Lay Summary Myotonic dystrophy type 1 is a neuromuscular disorder for which there is no treatment or cure. Over the past few years exciting strides in our understanding of the mechanistic basis of this disorder have been made. Thus the field is poised to make a major breakthrough and develop a drug for this disorder. We have developed a sensitive high throughput screen (HTS) to identify compounds that cure or ameliorate pathologies associated with myotonic dystrophy. Currently we have discovered potent molecules, which rescue DM1 pathology in both DM1 patient myoblasts and in DM1 mouse models. As our screens have been proven to identify potent molecules that rescue DM1 pathology, in this application we propose to identify other lead compounds by screening the MLPCN chemical library with our HTS. Identification of multiple leads will greatly improve the probability of a small molecule therapy for DM1.         ",High Throughput Screen for Myotonic Dystrophy Type 1,8209483,R03MH095544,"['Precursor Muscle Cells ', ' Embryonic Muscle Cells ', ' Myoblasts ', ' Ectopic Expression ', ' Chemical Structure ', ' Protein Family ', ' Steinert Disease ', ' Myotonia Dystrophica ', ' Myotonia Atrophica ', ' Dystrophia Myotonica ', ' Myotonic Dystrophy ', "" 3'UTR "", "" 3' Untranslated Regions "", ' neuromuscular disorder ', ' myoneural disorder ', ' Neuromuscular Diseases ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' muscle dystrophy ', ' Myodystrophy ', ' Myodystrophica ', ' Muscular Dystrophies ', ' chemical library ', ' small molecule libraries ', ' Gene Expression Inhibitor ', ' Antisense Agent ', ' Anti-Sense Oligonucleotides ', ' Antisense Oligonucleotides ', ' phosphorylase b kinase kinase ', ' hydroxyalkyl protein kinase ', ' glycogen synthase a kinase ', ' ATP-protein phosphotransferase ', ' Protein Kinase ', ' Series ', ' transcription factor ', ' Housing ', ' FDA approved ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' Link ', ' Therapeutic ', ' Toxicities ', ' Toxic effect ', ' LOINC Axis 2 Property ', ' Property ', ' developmental ', ' Development ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' therapeutic target ', ' improved ', ' Testing ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Cells ', ' Phenotype ', ' Affect ', ' mutant ', ' High Throughput Assay ', ' high throughput screening ', ' In Vitro ', ' Genes ', ' in vivo ', ' Patients ', ' Libraries ', ' base ', ' Defect ', ' Mediating ', ' Screening procedure ', ' Pattern ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Data ', ' small molecule ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' Molecular ', ' LOINC Axis 4 System ', ' System ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' mouse model ', ' Biology ', ' Validation ', ' Pathology ', ' Splicing ', ' RNA Splicing ', ' protein complex ', ' Probability ', ' Consult ', ' structure function relationship ', ' chemical structure function ', ' Structure-Activity Relationship ', ' Transcript ', ' Protein Kinase Calpha ', ' PKC(alpha) ', ' Protein Kinase C Alpha ', ' Nuclear RNA ', ' ']",NIMH,UNIVERSITY OF SOUTHERN CALIFORNIA,R03,2011,40750,0.054977794222403654
"Technology to Identify and Assay Chemical Genomic Probes    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and deploy cutting edge technologies and chemical genomic tools and to understand the effects of small molecule inhibitors in vivo, and to characterize the model organism Saccharomyces cerevisiae on a systems level. Over the course of the past 3.5 years, as part of an NHGRI-funded project, we have applied three unique genome-wide screens to ~2,000 chemical inhibitors of growth. These data have led to several notable findings, including: 1) novel drug/target interactions, 2) a chemical phenotype for nearly all yeast genes, 3) a systems-level characterization of yeast, and 4) a better understanding of chemical structure-activity relationships as they manifest in vivo. These data have also guided the design of the next-generation chemical genomic assays proposed herein. Using our established bioinformatics and robotics infrastructure, we will design the next generation of assays to interrogate the genome's interaction with small molecules to unprecedented levels of scrutiny, while decreasing cost per chemical. PUBLIC HEALTH RELEVANCE: Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.           Narrative Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.",Technology to Identify and Assay Chemical Genomic Probes,8004073,R01HG003317,"['cellular targeting ', ' Structure-Activity Relationship ', ' structure function relationship ', ' chemical structure function ', ' technology development ', ' Drug Industry ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' gain of function ', ' chemical genetics ', ' loss of function ', ' National Human Genome Research Institute ', ' National Center for Human Genome Research ', ' NHGRI ', ' Letters ', ' Knock-out ', ' Knockout ', ' particle ', ' Saccharomyces ', ' next generation ', ' Translating ', ' Research Infrastructure ', ' Infrastructure ', ' Mammalian Cell ', ' Saccharomyces cerevisiae ', ' S. cerevisiae ', ' S. Cerevisiae [{C0036025}] ', ' S cerevisiae ', "" Brewer's Yeast "", "" Baker's Yeast "", ' Running ', ' Technology ', ' small hairpin RNA ', ' short hairpin RNA ', ' shRNA ', ' drug candidate ', ' dosage ', ' Toxic effect ', ' Toxicities ', ' skills ', ' cost ', ' experience ', ' Ligands ', ' Individual ', ' Pathway interactions ', ' pathway ', ' Binding Proteins ', ' Ligand Binding Protein ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Open Reading Frames ', ' Protein Coding Region ', ' ORFs ', ' Chemical Structure ', ' Phenotype ', ' Funding ', ' Surface Plasmon Resonance ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' tool ', ' mutant ', ' Genes ', ' small molecule ', ' Phase ', ' Role ', ' social role ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' overexpression ', ' overexpress ', ' Collection ', ' Genome ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Proteins ', ' gene product ', ' Molecular ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Bioinformatics ', ' Bio-Informatics ', ' inhibitor/antagonist ', ' inhibitor ', ' Goals ', ' base ', ' Growth Inhibitors ', ' Cell Growth Inhibitors ', ' novel ', ' Address ', ' Drug Delivery Systems ', ' Drug Targeting ', ' Drug Delivery ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Ensure ', ' Resistance ', ' resistant ', ' Data ', ' design ', ' designing ', ' Genomics ', ' Animal Model ', ' model organism ', ' Animal Models and Related Studies ', ' Yeasts ', ' Chemicals ', ' Complex ', ' Genetic ', ' FDA approved ', ' digital ', ' System ', ' LOINC Axis 4 System ', ' in vivo ', ' Experimental Designs ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Robotics ', ' Drug Interactions ', ' genome-wide ', ' genomewide ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Ligand Binding ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Productivity ', ' ']",NHGRI,STANFORD UNIVERSITY,R01,2011,1117031,0.19873363494347862
"Low-Cost Electronic Nose for Groundwater Contaminants    DESCRIPTION (provided by applicant): Several US agencies and regulators require low-cost chemical sensors for detecting and monitoring environmental clean-up, remediation, and decommissioning processes where groundwater may be contaminated. The sensors must be capable of detecting contaminants in the sub-surface groundwater and must be compatible with use in a range of environments. Most significantly, these customers require a low-cost alternative to its current expensive and labor intensive methods, namely using mobile laboratories. The project will result in the innovative use of low-cost sensor systems that will be capable of detecting and monitoring for dense non-aqueous phase liquids in the subsurface and groundwater, unattended, and in real- time from within a push-probe, using a chemicapacitor array and miniature preconcentrator.  The ultimate goal of this SBIR project is to provide the DOD, DOE, and other agencies with a method to map and track subsurface contamination plumes in real-time without requiring an operator. In Phase I, Seacoast successfully demonstrated the feasibility of using a microsensor array with a proprietary trap-and- purge preconcentrator to detect chlorinated solvents, specifically TCE, and TCA, at levels low enough to meet EPA mandated levels for drinking water. In Phase II Seacoast proposes to improve the selectivity and sensitivity of the system to better meet the needs identified by the Phase I consultant. The systems have MEMS microcapacitor sensor arrays that can monitor for leaks of toxic chemicals, contaminants from wastes, and changes in groundwater streams. A preconcentrator traps the contaminants and releases them to a microsensor array. These sensor arrays are filled with several chemoselective polymers whose dielectric permittivity changes when exposed to different vapors, creating a fingerprint response for each chemical.  In Phase II Seacoast will specifically develop new materials to improve the sensor array selectivity, 1) by using impedance spectroscopy to study the mechanisms by which the polymer-based sensors sorb the target chemicals, 2) by implementing pattern recognition algorithms to identify chemicals for the sensor responses, and 3) by designing new preconcentrator materials that can bind these chemicals more strongly.  The most important application to public health and safety is unattended monitoring of drinking water, water treatment processes, and water sources. Potential markets include building chemical process monitoring and control, toxic vapor leak detection, industrial process control, and industrial health and safety. Transitioning the developed prototype to other markets where worker and public health, environmental health and regulatory compliance will be investigated to reduce the financial risks and broaden the acceptance of the technology.      PUBLIC HEALTH RELEVANCE: This proposal describes a novel technology that specifically addresses the need for detecting groundwater contaminants and long-term monitoring of contaminated sites, by providing an unattended sensor system that tracks contamination in real-time and transmits contaminant concentrations. Such a system would be used in tandem with other methods, to provide comprehensive contamination management at DOE, DOD, and Superfund sites where ground and water clean-up projects are already underway. The proposed work will focus on detection of chlorinated hydrocarbons, which are described as among the most common pollutants in groundwater and soils at DOE sites.           This proposal describes a novel technology that specifically addresses the need for detecting groundwater contaminants and long-term monitoring of contaminated sites, by providing an unattended sensor system that tracks contamination in real-time and transmits contaminant concentrations. Such a system would be used in tandem with other methods, to provide comprehensive contamination management at DOE, DOD, and Superfund sites where ground and water clean-up projects are already underway. The proposed work will focus on detection of chlorinated hydrocarbons, which are described as among the most common pollutants in groundwater and soils at DOE sites.         ",Low-Cost Electronic Nose for Groundwater Contaminants,8059710,R44ES016941,"['ground water ', ' NIEHS ', ' National Institute of Environmental Health Sciences ', ' Impedance ', ' Electrical Impedance ', ' electric impedance ', ' Industrial Hygiene ', ' Industrial Health ', ' drinking water ', ' pollutant ', ' water treatment ', ' Fingerprint ', ' Pesticides ', ' Cyclohexatriene ', ' Benzole ', ' Benzol ', ' Benzene ', ' purging ', ' purge ', ' Cost Analyses ', ' Cost Analysis ', ' analytical method ', ' superfund site ', ' Hazardous Waste ', ' trichloro-ethene ', ' Trichloroethene ', ' Ethinyl Trichloride ', ' Trichloroethylene ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' oncogenic agent ', ' Oncogens ', ' Cancer Causing Agents ', ' Carcinogens ', ' vapor ', ' Respiratory System, Nose, Nasal Passages ', ' Nasal Passages Nose ', ' Nasal ', ' Nose ', ' method development ', ' Environmental Health Science ', ' Environmental Health ', ' Solvents ', ' Pattern Recognition ', ' Pollution ', ' Cost Savings ', ' Route ', ' Source ', ' response ', ' Goals ', ' Data Collection ', ' Stream ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lasers ', ' Monitor ', ' success ', ' Data ', ' novel technologies ', ' new technology ', ' Metals ', ' Plants ', ' sensor ', ' innovative ', ' innovate ', ' innovation ', ' Address ', ' Work ', ' Science ', ' operation ', ' Small Business Innovation Research ', ' SBIRS (R43/44) ', ' SBIR ', ' Small Business Innovation Research Grant ', ' novel ', ' Safety ', ' Maps ', ' developmental ', ' Development ', ' LOINC Axis 4 System ', ' System ', ' Algorithms ', ' Equipment ', ' Recommendation ', ' knowledgebase ', ' knowledge base ', ' Marketing ', ' Environment ', ' Area ', ' Process ', ' liquid ', ' fluid ', ' Liquid substance ', ' Engineering ', ' Left ', ' improved ', ' meetings ', ' base ', ' detector ', ' Laboratories ', ' Phase ', ' Technology ', ' Public Health ', ' public health medicine (field) ', ' Time ', ' designing ', ' design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Fluorescence ', ' Guidelines ', ' Hydrogen Oxide ', ' Water ', ' Detection ', ' Collection ', ' Sampling ', ' Temperature ', ' Best Practice Analysis ', ' Benchmarking ', ' cost ', ' Evaluation ', ' Chemicals ', ' Research ', ' Polymers ', ' Electronics ', ' Methods ', ' instrument ', ' computer program/software ', ' Software ', ' Computer software ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' prototype ', ' Site ', ' Measures ', ' Risk ', ' Surface ', ' programs ', ' chlorohydrocarbon ', ' Organochlorines ', ' Organochlorine Compounds ', ' Chlorinated Hydrocarbons ', ' Soil ', ' Systematics ', ' Classification ', ' wasting ', ' Equation ', ' Gases ', ' Spectrum Analyses ', ' Spectroscopy ', ' Spectrum Analysis ', ' scientific advances ', ' scientific accomplishments ', ' Scientific Advances and Accomplishments ', ' chemical binding ', ' environmental testing ', ' Ecological Monitoring ', ' Ecologic Monitoring ', ' Environmental Monitoring ', ' remediation ', ' wireless ', ' Wireless Technology ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Poisons ', ' ']",NIEHS,"SEACOAST SCIENCE, INC.",R44,2011,497388,0.07782508162460253
"Image analysis for high-throughput C. elegans infection and metabolism assays    DESCRIPTION (provided by applicant): High-throughput screening (HTS) is a technique for searching large libraries of chemical or genetic perturbants, to find new treatments for a disease or to better understand disease pathways. As automated image analysis for cultured cells has improved, microscopy has emerged as one of the most powerful and informative ways to analyze screening samples. However, many diseases and biological pathways can be better studied in whole animals-particularly diseases that involve organ systems and multicellular interactions, such as metabolism and infection. The worm Caenorhabditis elegans is a well-established and effective model organism, used by thousands of researchers worldwide to study complex biological processes. Samples of C. elegans can be robotically prepared and imaged by high-throughput microscopy, but existing image-analysis methods are insuf- ficient for most assays. In this project, image-analysis algorithms that are capable of scoring high-throughput assays of C. elegans will be developed.  The algorithms will be tested and refined in three high-throughput screens, which will uncover chemical and genetic regulators of fat metabolism and infection: (1) A C. elegans viability assay to identify modulators of infection. The proposed algorithms use a probabilistic shape model of C. elegans in order to identify and mea- sure individual worms even when the animals touch or cross. These methods are the basis for quantifying many other phenotypes, including body morphology and subtle variations in reporter signal levels. (2) A C. elegans lipid assay to identify genes that regulate fat metabolism. The algorithms proposed for illumination correction, level-set-based foreground segmentation, well-edge detection, and artifact removal will result in improved or- business in high-throughput experiments. (3) A fluorescence gene expression assay to identify regulators of the response of the C. elegans host to Staphylococcus aureus infection. The proposed techniques for constructing anatomical maps of C. elegans will make it possible to quantify a variety of changes in fluorescent localization patterns in a biologically relevant way.  In addition to discovering new metabolism- and infection-related drugs and genetic regulators through these specific screens, this work will provide the C. elegans community with (a) a new framework for extracting mor- phological features from C. elegans for quantitative analysis of this organism, and (b) a versatile, modular, open-source toolbox of algorithms enabling the discovery of genetic pathways, chemical probes, and drug can- didates in whole organism high-throughput screens relevant to a variety of diseases.  This work is a close collaboration with C. elegans experts Fred Ausubel and Gary Ruvkun at Massachusetts General Hospital/Harvard Medical School, with Polina Golland and Tammy Riklin-Raviv, experts in model-based segmentation and statistical image analysis at MIT's Computer Science and Artificial Intelligence Laboratory, and with Anne Carpenter, developer of open-source image analysis software at the Broad Institute.      PUBLIC HEALTH RELEVANCE: Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.           Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.         ",Image analysis for high-throughput C. elegans infection and metabolism assays,8022635,R01GM095672,"['biomedical scientist ', ' chemical genetics ', ' 2-dimensional ', ' two-dimensional ', ' Microscopy ', ' Whole Organism ', ' Computer Software Engineering ', ' Computer Software Development ', ' Software Engineering ', ' high throughput analysis ', ' General Hospitals ', ' Businesses ', ' computer science ', ' drug candidate ', ' Descriptor ', ' Microsporidia ', ' Microspora ', ' Microsporidia (protozoa) ', ' computational tools ', ' computerized tools ', ' Illumination ', ' Lighting ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Maps ', ' Phenotype ', ' Biological ', ' Genes ', ' Learning ', ' Sampling ', ' Techniques ', ' Collaborations ', ' imaging ', ' Image ', ' Detection ', ' human disease ', ' Measurement ', ' Communities ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' base ', ' Research ', ' Testing ', ' improved ', ' Methods ', ' High Throughput Assay ', ' high throughput screening ', ' Work ', ' pathway ', ' Pathway interactions ', ' developmental ', ' Development ', ' Process ', ' Measures ', ' pathogen ', ' Stainings ', ' Staining method ', ' Screening procedure ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' designing ', ' design ', ' Address ', ' Fluorescence ', ' Infection ', ' resistant ', ' Resistance ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Cells ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Laboratories ', ' Gene Expression ', ' novel ', ' Modeling ', ' Chemicals ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' Population ', ' Complex ', ' Genetic ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' interest ', ' response ', ' Morphology ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Life ', ' Variation ', ' Variant ', ' Animals ', ' Individual ', ' Pattern ', ' Institutes ', ' Goals ', ' school of medicine ', ' medical college ', ' medical schools ', ' Biological Function ', ' Biological Process ', ' Reporter ', ' Lipids ', ' Algorithms ', ' Preparation ', ' Bacteria ', ' immunoresponse ', ' host response ', ' Immune response ', ' Disease Pathway ', ' Drug Delivery Systems ', ' Drug Delivery ', ' Shapes ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Atlases ', ' living system ', ' Organism ', ' S.aureus ', ' S. aureus ', ' Staphylococcus aureus ', ' communicable disease control agent ', ' Antiinfective Agents ', ' AntiInfectives ', ' AntiInfective Drugs ', ' Anti-infective Preparation ', ' Anti-Infectives ', ' Anti-Infective Drugs ', ' Anti-Infective Agents ', ' fat metabolism ', ' lipid metabolism ', ' Organ System ', ' body system ', ' Stains ', ' C.elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' Massachusetts ', ' Cultured Cells ', ' Touch ', ' Touch sensation ', ' Data Quality ', ' chemical library ', ' small molecule libraries ', ' image processing ', ' Morphologic artifacts ', ' Artifacts ', ' open source ', ' computer program/software ', ' Software ', ' Computer software ', ' imaging Segmentation ', ' ']",NIGMS,"BROAD INSTITUTE, INC.",R01,2011,304318,0.08563464040509781
"Discovery of A-beta Oligomer Antagonists via 3D Pharmacophore Space Analysis The goal of this proposal is to discover drug-like retinoid X receptor (RXR) agonists that can halt and reverse the progression of Alzheimer's disease (AD). The research strategy is to target ApoE gene expression through RXR agonists; this has recently been shown to improve A turnover, reduction in A plaque area, and the reversal of cognitive, social and olfactory deficits. The research plan consists of two steps. The first step is computer-aided prediction of agonistic RXR binding, blood brain barrier permeability, and absence of side effects. This step relies on a novel method for pharmacophore analysis by examining the joint space of chemical compounds, targets, and chemical/biological properties. This joint space is defined using machine learning on the 3D geometry of spatial arrangement of pharmacophoric points, using attributes such as donors, acceptors, aromatic rings, and charged fragments. The second step consists of biochemical assays including competitive binding with bexarotene, and ApoE level determination in cultured mouse brain cells. A small number of drug-like compounds will be obtained through multiple iterations of the two steps of in-silico prediction and assays at the end of Phase 1. The outcome of this study will be new drug leads to potentially treat and prevent AD at different stages of cognitive decline and neurodegeneration. Interleaving of computer-aided screening of large chemical databases through novel machine learning based models with biochemical assays will identify drug-like compounds that can clear toxic chemicals responsible for Alzheimer's Disease from brain cells with minimal side-effects. These compounds will form the starting point for the first true cure of Alzheimer's Disease by slowing and reversing its effects.",Discovery of A-beta Oligomer Antagonists via 3D Pharmacophore Space Analysis,8253357,R43GM100664,"['Affect ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Amyloid Substance ', ' Amyloid ', ' ApoE ', ' Apo-E ', ' APOE [{C0003595}] ', ' Apolipoprotein E ', ' Astroglia ', ' Astrocytus ', ' Astrocytes ', ' Competitive Binding ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' Blood - brain barrier anatomy ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' California ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Charge ', ' Cholest-5-en-3-ol (3beta)- ', ' Cholesterol ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Diarrhea ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Family ', ' Gene Expression ', ' Goals ', ' Half-Life ', ' head ache ', ' Head Pain ', ' Cranial Pain ', ' Cephalodynia ', ' Cephalgia ', ' Cephalalgia ', ' Headache ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Hippocampus (Brain) ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' H-bond ', ' Hydrogen Bonding ', ' Hypothyroidism ', ' Articulation ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Ligands ', ' Literature ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mining ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Nausea and Vomiting ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Permeability ', ' Play ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Poisons ', ' gene product ', ' Proteins ', ' Publishing ', ' Research ', ' Research Institute ', ' Science ', ' Sensitivity and Specificity ', ' Sleep ', ' Technology ', ' Testing ', ' Triacylglycerol ', ' Triglycerides ', ' Universities ', ' Work ', ' soluble amyloid precursor protein ', ' beta amyloid fibril ', ' amyloid-b protein ', ' amyloid beta ', ' abeta ', ' a beta peptide ', ' Amyloid Protein A4 ', "" Amyloid Fibril Protein (Alzheimer's) "", ' Amyloid Beta-Peptide ', "" Amyloid Alzeheimer's Dementia Amyloid Protein "", "" Alzheimer's amyloid "", "" Alzheimer's Amyloid beta-Protein "", ' Alzheimer beta-Protein ', ' Amyloid beta-Protein ', ' Measures ', ' Retinoid X Receptors ', ' Retinoic Acid Receptor RXR ', ' RXR Protein ', ' 9-cis-Retinoic Acid Receptor ', ' RXR ', ' base ', ' improved ', ' Area ', ' Phase ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Chemicals ', ' screenings ', ' screening ', ' Screening procedure ', ' Training ', ' Blood Serum ', ' Serum ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Disease Progression ', ' Agonist ', ' Space Models ', ' Therapeutic ', ' Hops ', ' Humulus ', ' Staging ', ' Deposit ', ' Deposition ', ' scaffolding ', ' scaffold ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Oral ', ' LOINC Axis 4 System ', ' System ', ' neurodegenerative illness ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Neurodegenerative Disorders ', ' Outcome Study ', ' Services ', ' American ', ' brain cell ', ' Receptor Protein ', ' receptor ', ' receptor binding ', ' chemical library ', ' small molecule libraries ', ' pharmacophore ', ' Cognitive deficits ', ' novel ', ' social ', ' Targretin ', ' 3-methyl TTNEB ', ' Bexarotene ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Skin ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' preventing ', ' prevent ', ' small molecule ', ' Symptoms ', ' Cognitive ', ' Ligand Binding ', ' Neurosciences Research ', ' Molecular ', ' preclinical trial ', ' pre-clinical trial ', ' pre-clinical study ', ' preclinical study ', ' Behavioral Assay ', ' virtual ', ' computer aided ', ' Computer Assisted ', ' mouse model ', ' drug candidate ', ' flexible ', ' flexibility ', ' ']",NIGMS,"ACELOT, INC.",R43,2012,171028,-0.029242468040500777
"Technology to Identify and Assay Chemical Genomic Probes    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and deploy cutting edge technologies and chemical genomic tools and to understand the effects of small molecule inhibitors in vivo, and to characterize the model organism Saccharomyces cerevisiae on a systems level. Over the course of the past 3.5 years, as part of an NHGRI-funded project, we have applied three unique genome-wide screens to ~2,000 chemical inhibitors of growth. These data have led to several notable findings, including: 1) novel drug/target interactions, 2) a chemical phenotype for nearly all yeast genes, 3) a systems-level characterization of yeast, and 4) a better understanding of chemical structure-activity relationships as they manifest in vivo. These data have also guided the design of the next-generation chemical genomic assays proposed herein. Using our established bioinformatics and robotics infrastructure, we will design the next generation of assays to interrogate the genome's interaction with small molecules to unprecedented levels of scrutiny, while decreasing cost per chemical. PUBLIC HEALTH RELEVANCE: Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.           Narrative Small molecules, the central focus of this proposal, make up the majority of FDA approved drugs. Unfortunately, the pharmaceutical industry is currently experiencing sky-rocketing costs (~800 million dollars per new drug) in addition to steadily decreasing productivity. These struggles are attributed in part to unforeseen side-effects of promising drug candidates and by a lack of validated cellular ""targets"" to which a drug can bind and elicit a medicinal effect. The specific aims of this proposal address both of these problems.",Technology to Identify and Assay Chemical Genomic Probes,8206671,R01HG003317,"['inhibitor ', ' inhibitor/antagonist ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Drug Industry ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Experimental Designs ', ' Genes ', ' Genome ', ' Goals ', ' Cell Growth Inhibitors ', ' Growth Inhibitors ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Ligands ', ' Phenotype ', ' Productivity ', ' gene product ', ' Proteins ', ' Robotics ', ' social role ', ' Role ', ' Running ', ' Saccharomyces ', ' S. cerevisiae ', ' S. Cerevisiae [{C0036025}] ', ' S cerevisiae ', "" Brewer's Yeast "", "" Baker's Yeast "", ' Saccharomyces cerevisiae ', ' structure function relationship ', ' chemical structure function ', ' Structure-Activity Relationship ', ' Technology ', ' Translating ', ' Yeasts ', ' Protein Coding Region ', ' ORFs ', ' Open Reading Frames ', ' Drug Targeting ', ' Drug Delivery ', ' Drug Delivery Systems ', ' base ', ' dosage ', ' Phase ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Individual ', ' Ligand Binding Protein ', ' Binding Proteins ', ' Funding ', ' Letters ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' experience ', ' mutant ', ' particle ', ' Surface Plasmon Resonance ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' technology development ', ' cellular targeting ', ' Toxicities ', ' Toxic effect ', ' skills ', ' novel ', ' Drug Interactions ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Genomics ', ' Bio-Informatics ', ' Bioinformatics ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' chemical genetics ', ' small molecule ', ' Address ', ' Data ', ' Mammalian Cell ', ' Infrastructure ', ' Research Infrastructure ', ' in vivo ', ' Collection ', ' Ligand Binding ', ' Molecular ', ' Knockout ', ' Knock-out ', ' pathway ', ' Pathway interactions ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' cost ', ' digital ', ' designing ', ' design ', ' next generation ', ' resistant ', ' Resistance ', ' short hairpin RNA ', ' shRNA ', ' small hairpin RNA ', ' loss of function ', ' gain of function ', ' overexpress ', ' overexpression ', ' FDA approved ', ' genomewide ', ' genome-wide ', ' drug candidate ', ' ']",NHGRI,STANFORD UNIVERSITY,R01,2012,1117030,0.19873363494347862
"Low-Cost Electronic Nose for Groundwater Contaminants    DESCRIPTION (provided by applicant): Several US agencies and regulators require low-cost chemical sensors for detecting and monitoring environmental clean-up, remediation, and decommissioning processes where groundwater may be contaminated. The sensors must be capable of detecting contaminants in the sub-surface groundwater and must be compatible with use in a range of environments. Most significantly, these customers require a low-cost alternative to its current expensive and labor intensive methods, namely using mobile laboratories. The project will result in the innovative use of low-cost sensor systems that will be capable of detecting and monitoring for dense non-aqueous phase liquids in the subsurface and groundwater, unattended, and in real- time from within a push-probe, using a chemicapacitor array and miniature preconcentrator.  The ultimate goal of this SBIR project is to provide the DOD, DOE, and other agencies with a method to map and track subsurface contamination plumes in real-time without requiring an operator. In Phase I, Seacoast successfully demonstrated the feasibility of using a microsensor array with a proprietary trap-and- purge preconcentrator to detect chlorinated solvents, specifically TCE, and TCA, at levels low enough to meet EPA mandated levels for drinking water. In Phase II Seacoast proposes to improve the selectivity and sensitivity of the system to better meet the needs identified by the Phase I consultant. The systems have MEMS microcapacitor sensor arrays that can monitor for leaks of toxic chemicals, contaminants from wastes, and changes in groundwater streams. A preconcentrator traps the contaminants and releases them to a microsensor array. These sensor arrays are filled with several chemoselective polymers whose dielectric permittivity changes when exposed to different vapors, creating a fingerprint response for each chemical.  In Phase II Seacoast will specifically develop new materials to improve the sensor array selectivity, 1) by using impedance spectroscopy to study the mechanisms by which the polymer-based sensors sorb the target chemicals, 2) by implementing pattern recognition algorithms to identify chemicals for the sensor responses, and 3) by designing new preconcentrator materials that can bind these chemicals more strongly.  The most important application to public health and safety is unattended monitoring of drinking water, water treatment processes, and water sources. Potential markets include building chemical process monitoring and control, toxic vapor leak detection, industrial process control, and industrial health and safety. Transitioning the developed prototype to other markets where worker and public health, environmental health and regulatory compliance will be investigated to reduce the financial risks and broaden the acceptance of the technology.      PUBLIC HEALTH RELEVANCE: This proposal describes a novel technology that specifically addresses the need for detecting groundwater contaminants and long-term monitoring of contaminated sites, by providing an unattended sensor system that tracks contamination in real-time and transmits contaminant concentrations. Such a system would be used in tandem with other methods, to provide comprehensive contamination management at DOE, DOD, and Superfund sites where ground and water clean-up projects are already underway. The proposed work will focus on detection of chlorinated hydrocarbons, which are described as among the most common pollutants in groundwater and soils at DOE sites.           PROJECT NARRATIVE This proposal describes a novel technology that specifically addresses the need for detecting groundwater contaminants and long-term monitoring of contaminated sites, by providing an unattended sensor system that tracks contamination in real-time and transmits contaminant concentrations. Such a system would be used in tandem with other methods, to provide comprehensive contamination management at DOE, DOD, and Superfund sites where ground and water clean-up projects are already underway. The proposed work will focus on detection of chlorinated hydrocarbons, which are described as among the most common pollutants in groundwater and soils at DOE sites.",Low-Cost Electronic Nose for Groundwater Contaminants,8260510,R44ES016941,"['Algorithms ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Cyclohexatriene ', ' Benzole ', ' Benzol ', ' Benzene ', ' oncogenic agent ', ' Oncogens ', ' Cancer Causing Agents ', ' Carcinogens ', ' Systematics ', ' Classification ', ' Cost Analyses ', ' Cost Analysis ', ' Data Collection ', ' Electronics ', ' Engineering ', ' Environment ', ' Environmental Health Science ', ' Environmental Health ', ' environmental testing ', ' Ecological Monitoring ', ' Ecologic Monitoring ', ' Environmental Monitoring ', ' Equipment ', ' Fingerprint ', ' Fluorescence ', ' Gases ', ' Goals ', ' Hazardous Waste ', ' chlorohydrocarbon ', ' Organochlorines ', ' Organochlorine Compounds ', ' Chlorinated Hydrocarbons ', ' Laboratories ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lasers ', ' Maps ', ' Marketing ', ' Metals ', ' Methods ', ' Respiratory System, Nose, Nasal Passages ', ' Nasal Passages Nose ', ' Nasal ', ' Nose ', ' Pesticides ', ' Plants ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Poisons ', ' Polymers ', ' Public Health ', ' public health medicine (field) ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Safety ', ' Science ', ' computer program/software ', ' Software ', ' Computer software ', ' Soil ', ' Solvents ', ' Spectrum Analyses ', ' Spectroscopy ', ' Spectrum Analysis ', ' Technology ', ' Temperature ', ' Time ', ' trichloro-ethene ', ' Trichloroethene ', ' Ethinyl Trichloride ', ' Trichloroethylene ', ' Hydrogen Oxide ', ' Water ', ' Work ', ' Industrial Hygiene ', ' Industrial Health ', ' Measures ', ' Cost Savings ', ' Impedance ', ' Electrical Impedance ', ' electric impedance ', ' Guidelines ', ' analytical method ', ' base ', ' chemical binding ', ' method development ', ' detector ', ' sensor ', ' improved ', ' Left ', ' Site ', ' Area ', ' Surface ', ' Phase ', ' Chemicals ', ' Evaluation ', ' wasting ', ' liquid ', ' fluid ', ' Liquid substance ', ' instrument ', ' programs ', ' Pollution ', ' Stream ', ' Source ', ' Route ', ' LOINC Axis 4 System ', ' System ', ' Best Practice Analysis ', ' Benchmarking ', ' Equation ', ' meetings ', ' ground water ', ' success ', ' vapor ', ' water treatment ', ' drinking water ', ' pollutant ', ' knowledgebase ', ' knowledge base ', ' novel ', ' novel technologies ', ' new technology ', ' purging ', ' purge ', ' Sampling ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' superfund site ', ' Address ', ' Data ', ' Detection ', ' Collection ', ' Pattern Recognition ', ' scientific advances ', ' scientific accomplishments ', ' Scientific Advances and Accomplishments ', ' Small Business Innovation Research ', ' SBIRS (R43/44) ', ' SBIR ', ' Small Business Innovation Research Grant ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' NIEHS ', ' National Institute of Environmental Health Sciences ', ' cost ', ' designing ', ' design ', ' remediation ', ' innovative ', ' innovate ', ' innovation ', ' prototype ', ' public health relevance ', ' operation ', ' ']",NIEHS,"SEACOAST SCIENCE, INC.",R44,2012,429413,0.07782508162460253
"Image analysis for high-throughput C. elegans infection and metabolism assays    DESCRIPTION (provided by applicant): High-throughput screening (HTS) is a technique for searching large libraries of chemical or genetic perturbants, to find new treatments for a disease or to better understand disease pathways. As automated image analysis for cultured cells has improved, microscopy has emerged as one of the most powerful and informative ways to analyze screening samples. However, many diseases and biological pathways can be better studied in whole animals-particularly diseases that involve organ systems and multicellular interactions, such as metabolism and infection. The worm Caenorhabditis elegans is a well-established and effective model organism, used by thousands of researchers worldwide to study complex biological processes. Samples of C. elegans can be robotically prepared and imaged by high-throughput microscopy, but existing image-analysis methods are insuf- ficient for most assays. In this project, image-analysis algorithms that are capable of scoring high-throughput assays of C. elegans will be developed.  The algorithms will be tested and refined in three high-throughput screens, which will uncover chemical and genetic regulators of fat metabolism and infection: (1) A C. elegans viability assay to identify modulators of infection. The proposed algorithms use a probabilistic shape model of C. elegans in order to identify and mea- sure individual worms even when the animals touch or cross. These methods are the basis for quantifying many other phenotypes, including body morphology and subtle variations in reporter signal levels. (2) A C. elegans lipid assay to identify genes that regulate fat metabolism. The algorithms proposed for illumination correction, level-set-based foreground segmentation, well-edge detection, and artifact removal will result in improved or- business in high-throughput experiments. (3) A fluorescence gene expression assay to identify regulators of the response of the C. elegans host to Staphylococcus aureus infection. The proposed techniques for constructing anatomical maps of C. elegans will make it possible to quantify a variety of changes in fluorescent localization patterns in a biologically relevant way.  In addition to discovering new metabolism- and infection-related drugs and genetic regulators through these specific screens, this work will provide the C. elegans community with (a) a new framework for extracting mor- phological features from C. elegans for quantitative analysis of this organism, and (b) a versatile, modular, open-source toolbox of algorithms enabling the discovery of genetic pathways, chemical probes, and drug can- didates in whole organism high-throughput screens relevant to a variety of diseases.  This work is a close collaboration with C. elegans experts Fred Ausubel and Gary Ruvkun at Massachusetts General Hospital/Harvard Medical School, with Polina Golland and Tammy Riklin-Raviv, experts in model-based segmentation and statistical image analysis at MIT's Computer Science and Artificial Intelligence Laboratory, and with Anne Carpenter, developer of open-source image analysis software at the Broad Institute.      PUBLIC HEALTH RELEVANCE: Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.           Public Health Relevance/Narrative Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.",Image analysis for high-throughput C. elegans infection and metabolism assays,8208036,R01GM095672,"['Algorithms ', ' Animals ', ' communicable disease control agent ', ' Antiinfective Agents ', ' AntiInfectives ', ' AntiInfective Drugs ', ' Anti-infective Preparation ', ' Anti-Infectives ', ' Anti-Infective Drugs ', ' Anti-Infective Agents ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Atlases ', ' Bacteria ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cells ', ' Cultured Cells ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Fluorescence ', ' Gene Expression ', ' Genes ', ' Goals ', ' General Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Infection ', ' Institutes ', ' Laboratories ', ' Learning ', ' Illumination ', ' Lighting ', ' Lipids ', ' Maps ', ' Massachusetts ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Microscopy ', ' living system ', ' Organism ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' school of medicine ', ' medical college ', ' medical schools ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Engineering ', ' Computer Software Development ', ' Software Engineering ', ' Stains ', ' S.aureus ', ' S. aureus ', ' Staphylococcus aureus ', ' Testing ', ' Work ', ' Measures ', ' Artifacts ', ' Morphologic artifacts ', ' Drug Targeting ', ' Drug Delivery ', ' Drug Delivery Systems ', ' Microsporidia ', ' Microspora ', ' Microsporidia (protozoa) ', ' Businesses ', ' C.elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' base ', ' image processing ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' screenings ', ' screening ', ' Screening procedure ', ' Individual ', ' Data Quality ', ' Measurement ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Descriptor ', ' immunoresponse ', ' host response ', ' Immune response ', ' Genetic ', ' Morphology ', ' Shapes ', ' Reporter ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Complex ', ' Pattern ', ' Techniques ', ' Organ System ', ' body system ', ' Stainings ', ' Staining method ', ' interest ', ' chemical library ', ' small molecule libraries ', ' biomedical scientist ', ' fat metabolism ', ' lipid metabolism ', ' computer science ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Touch ', ' Touch sensation ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' Modeling ', ' Sampling ', ' response ', ' high throughput analysis ', ' High Throughput Assay ', ' high throughput screening ', ' chemical genetics ', ' Address ', ' Detection ', ' Disease Pathway ', ' Whole Organism ', ' Preparation ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' pathogen ', ' Population ', ' resistant ', ' Resistance ', ' imaging Segmentation ', ' 2-dimensional ', ' two-dimensional ', ' open source ', ' human disease ', ' public health relevance ', ' drug candidate ', ' ']",NIGMS,"BROAD INSTITUTE, INC.",R01,2012,311786,0.08563464040509781
"Image analysis for high-throughput C. elegans infection and metabolism assays    DESCRIPTION (provided by applicant): High-throughput screening (HTS) is a technique for searching large libraries of chemical or genetic perturbants, to find new treatments for a disease or to better understand disease pathways. As automated image analysis for cultured cells has improved, microscopy has emerged as one of the most powerful and informative ways to analyze screening samples. However, many diseases and biological pathways can be better studied in whole animals-particularly diseases that involve organ systems and multicellular interactions, such as metabolism and infection. The worm Caenorhabditis elegans is a well-established and effective model organism, used by thousands of researchers worldwide to study complex biological processes. Samples of C. elegans can be robotically prepared and imaged by high-throughput microscopy, but existing image-analysis methods are insuf- ficient for most assays. In this project, image-analysis algorithms that are capable of scoring high-throughput assays of C. elegans will be developed.  The algorithms will be tested and refined in three high-throughput screens, which will uncover chemical and genetic regulators of fat metabolism and infection: (1) A C. elegans viability assay to identify modulators of infection. The proposed algorithms use a probabilistic shape model of C. elegans in order to identify and mea- sure individual worms even when the animals touch or cross. These methods are the basis for quantifying many other phenotypes, including body morphology and subtle variations in reporter signal levels. (2) A C. elegans lipid assay to identify genes that regulate fat metabolism. The algorithms proposed for illumination correction, level-set-based foreground segmentation, well-edge detection, and artifact removal will result in improved or- business in high-throughput experiments. (3) A fluorescence gene expression assay to identify regulators of the response of the C. elegans host to Staphylococcus aureus infection. The proposed techniques for constructing anatomical maps of C. elegans will make it possible to quantify a variety of changes in fluorescent localization patterns in a biologically relevant way.  In addition to discovering new metabolism- and infection-related drugs and genetic regulators through these specific screens, this work will provide the C. elegans community with (a) a new framework for extracting mor- phological features from C. elegans for quantitative analysis of this organism, and (b) a versatile, modular, open-source toolbox of algorithms enabling the discovery of genetic pathways, chemical probes, and drug can- didates in whole organism high-throughput screens relevant to a variety of diseases.  This work is a close collaboration with C. elegans experts Fred Ausubel and Gary Ruvkun at Massachusetts General Hospital/Harvard Medical School, with Polina Golland and Tammy Riklin-Raviv, experts in model-based segmentation and statistical image analysis at MIT's Computer Science and Artificial Intelligence Laboratory, and with Anne Carpenter, developer of open-source image analysis software at the Broad Institute.       PUBLIC HEALTH RELEVANCE: Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.         ",Image analysis for high-throughput C. elegans infection and metabolism assays,8402395,R01GM095672,"['Algorithms ', ' Animals ', ' communicable disease control agent ', ' Antiinfective Agents ', ' AntiInfectives ', ' AntiInfective Drugs ', ' Anti-infective Preparation ', ' Anti-Infectives ', ' Anti-Infective Drugs ', ' Anti-Infective Agents ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Atlases ', ' Bacteria ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cells ', ' Cultured Cells ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Fluorescence ', ' Gene Expression ', ' Genes ', ' Goals ', ' General Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Infection ', ' Institutes ', ' Laboratories ', ' Learning ', ' Illumination ', ' Lighting ', ' Lipids ', ' Maps ', ' Massachusetts ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Microscopy ', ' living system ', ' Organism ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' school of medicine ', ' medical college ', ' medical schools ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Engineering ', ' Computer Software Development ', ' Software Engineering ', ' Stains ', ' S.aureus ', ' S. aureus ', ' Staphylococcus aureus ', ' Testing ', ' Work ', ' Measures ', ' Artifacts ', ' Morphologic artifacts ', ' Microsporidia ', ' Microspora ', ' Microsporidia (protozoa) ', ' Businesses ', ' C.elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' base ', ' image processing ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Individual ', ' Data Quality ', ' Measurement ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Descriptor ', ' immunoresponse ', ' host response ', ' Immune response ', ' Genetic ', ' Morphology ', ' Shapes ', ' Reporter ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Complex ', ' Pattern ', ' Techniques ', ' Organ System ', ' body system ', ' Stainings ', ' Staining method ', ' interest ', ' chemical library ', ' small molecule libraries ', ' biomedical scientist ', ' fat metabolism ', ' lipid metabolism ', ' computer science ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Touch ', ' Touch sensation ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' Modeling ', ' Sampling ', ' response ', ' high throughput analysis ', ' High Throughput Assay ', ' high throughput screening ', ' chemical genetics ', ' Address ', ' Detection ', ' Disease Pathway ', ' Whole Organism ', ' Preparation ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' pathogen ', ' Population ', ' resistant ', ' Resistance ', ' imaging Segmentation ', ' 2-dimensional ', ' two-dimensional ', ' open source ', ' human disease ', ' public health relevance ', ' drug candidate ', ' screening ', ' Drug Targeting ', ' ']",NIGMS,"BROAD INSTITUTE, INC.",R01,2013,301051,0.08444612975726605
"Binding-Site Modeling with Multiple-Instance Machine-Learning     DESCRIPTION (provided by applicant): This proposal is entitled ""Binding-Site Modeling with Multiple-Instance Machine-Learning."" One of the most challenging and longest studied problems in computer-aided drug design has been affinity prediction of small molecule ligands for their cognate protein targets. Despite decades of work, quantitative structure-activity re- lationship prediction (QSAR) approaches still suffer from poor accuracy, especially when predicting outside of closely related series of molecules. Even with high-quality structures of target proteins, approaches grounded in physics are also far from robust and accurate enough for reliable use in drug lead optimization. This proposal will build upon a foundation in multiple-instance machine learning applied to computer-aided drug design problems and develop a robust, accurate, and practically applicable affinity prediction methodology. The methodology requires only ligand structures and associated activity data for training, and it induces a virtual protein binding site composed of molecular fragments. The virtual binding pocket (or ""pocketmol"") is used in conjunction with a scoring function developed originally for molecular docking. The pocketmol configuration is chosen such that the optimal conformation and alignment of a ligand (based on the docking scoring function), yields scores for training ligands that are close to the known experimental values. Feasibility has been demon- strated in papers involving both membrane-bound receptors and enzymes.  However, multiple challenges remain and are the subject of the proposed research. There are three key issues. First, there exist many pocketmols that satisfy the requirements of fitting the training data, so general solutions must be developed to address the inductive bias of the learning procedure as well as model selection after the procedure. Second, since any particular model is the product of a learning process, it will have some domain of applicability, with some new molecules likely to be predicted well and others poorly. Further, the model will be better informed by learning with certain new molecules but not others. We must develop solutions for estimating confidence of predictions for new molecules as well as for identifying particular molecules that will be highly informative. Third, the operational application of these methods involves model building, guided chemical synthesis, and iterative refinement of models. Convincing validation will require application on temporal series of molecules synthesized for multiple targets of pharmaceutical interest. The proposed work will develop novel methods to address these challenges and will establish extensive validation on multiple pharmaceutically relevant temporal series of small molecules that were the subject of real-world lead-optimization exercises.         PUBLIC HEALTH RELEVANCE: The dominant mode of therapeutic discovery involves the design ""me-too"" drugs that are very similar in structure and effect to existing drugs. In order to address the unmet medical needs of an aging population, novel therapeutics must be developed, and this will require much more creativity in the design process. The proposed research will develop a predictive computational framework to aid in active design of structurally novel drug molecules during the drug discovery lead optimization process.            ",Binding-Site Modeling with Multiple-Instance Machine-Learning,8436505,R01GM101689,"['Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' chemical synthesis ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' creativity ', ' Creativeness ', ' Drug Design ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzymes ', ' Physical Exercise ', ' Exercise ', ' Foundations ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Ligands ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Paper ', ' Physics ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' Research ', ' Solutions ', ' Testing ', ' Work ', ' Measures ', ' falls ', ' Dataset ', ' Data Set ', ' base ', ' Procedures ', ' Site ', ' Medical ', ' Series ', ' Chemicals ', ' Training ', ' Collaborations ', ' Therapeutic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' membrane structure ', ' Membrane ', ' receptor binding ', ' Structure ', ' novel ', ' design and construct ', ' design and construction ', ' Modeling ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' small molecule ', ' Address ', ' Affinity ', ' Data ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' computational framework ', ' computer framework ', ' virtual ', ' computer based prediction ', ' predictive modeling ', ' computer aided ', ' Computer Assisted ', ' designing ', ' design ', ' blind ', ' Population ', ' prospective ', ' next generation therapeutics ', ' new therapeutics ', ' novel therapeutics ', ' population aging ', ' aging population ', ' public health relevance ', ' process optimization ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2013,291402,0.07577142247097053
"Identification of novel therapeutics for tuberculosis combining cheminformatics,     DESCRIPTION (provided by applicant): We are witnessing the growing menace of both increasing cases of drug-sensitive and drug-resistant Mycobacterium tuberculosis (Mtb) strains and the challenge to produce the first new tuberculosis (TB) drug in well over 40 years. The TB community, having invested in extensive high-throughput screening efforts, is faced with the question of how to optimally leverage this data in order to move from a hit to a lead to a clinical candidate and potentially a new drug. Complementing this approach, yet conducted on a much smaller scale, cheminformatic techniques have been leveraged. We suggest these computational approaches should be more optimally integrated in a workflow with experimental approaches to accelerate TB drug discovery. This Small Business Technology Transfer Phase II project entitled ""Identification of novel therapeutics for tuberculosis combining cheminformatics, diverse databases and logic-based pathway analysis"" describes the development of software that will facilitate new drug discovery efforts for Mycobacterium tuberculosis (TB) and the progression of molecules discovered with it as mimics for substrates of enzymes and their in vivo essential genes. In phase 1 we illustrated the concept of loosely marrying the cheminformatic and pathways database that resulted in two compounds as proposed mimics of 2 D-fructose 1,6 bisphosphate with activity against Mtb (MIC 20 and 40mg/ml). In phase II via an API we will link the knowledge in CDD, SRI and other databases and tools seamlessly. A researcher will be able to investigate molecules, targets, pathways and then select metabolites or other molecules for pharmacophore analysis, scoring with TB machine learning models and ADME and drug-likeness assessment from within one interface. This tool will be used to aid the identification of novel therapeutics for tuberculosis and be useful for hypotheses testing, knowledge sharing, data archiving, data mining and drug discovery. We will make CDD into a mobile application such that the generalized workflow in this project can be performed anywhere. We present promising preliminary work which resulted in two active compounds, that suggests phase II support of the mimic strategy to identify compounds of interest for TB would be a viable strategy. This proposal balances software development, database development and drug discovery activities in order to achieve our goals. We expect this product could be quickly applied to other infectious diseases which have a great societal impact and as a stretch goal we will endeavor to demonstrate this.          We propose to develop an integrated system to facilitate new drug discovery efforts for TB using novel logical inference techniques developed by scientists at SRI International, linked with knowledge which has been assembled by the curation of diverse biological data types and computational prediction by Collaborative Drug Discovery (CDD). This tool will be used to aid the identification of novel therapeutics for tuberculosis by combining cheminformatics, diverse databases and logic-based pathway analysis. We will demonstrate the utility of the tool (available also as a mobile application) and overall workflow ourselves by discovering and developing compounds for TB and other infectious diseases.            ","Identification of novel therapeutics for tuberculosis combining cheminformatics,",8462896,R42AI088893,"['L-Isomer Alanine ', ' L-Alanine ', ' Alanine ', ' Archives ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Wall ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Clinical Study ', ' Clinical Research ', ' Infectious Disorder ', ' Infectious Diseases and Manifestations ', ' Infectious Diseases ', ' Infectious Disease Pathway ', ' Communicable Diseases ', ' Communities ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Death ', ' Cessation of life ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Developing Countries ', ' Dihydropteroate Synthetase ', ' Dihydropteroate Pyrophosphorylase ', ' Dihydropteroate Synthase ', ' disease/disorder ', ' Disorder ', ' Disease ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Drug resistance ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzymes ', ' balance function ', ' balance ', ' Equilibrium ', ' Foundations ', ' Levulose ', ' Fructose ', ' Goals ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' Logic ', ' Plasmodium Infections ', ' Paludism ', ' Malaria ', ' Mining ', ' beta lactam antibiotic ', ' Monocyclic beta-Lactams ', ' Monobactam Antibiotics ', ' Lactam Antibiotics ', ' Monobactams ', ' mtb ', ' M.tuberculosis ', ' M.tb ', ' M. tuberculosis ', ' M. tb ', ' Mycobacterium tuberculosis ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Murein ', ' Peptidoglycan ', ' Permeability ', ' Publishing ', ' Research ', ' R&D ', ' R & D ', ' Development and Research ', ' research and development ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' computer program/software ', ' Software ', ' Computer software ', ' Solubility ', ' Sulfonamides ', ' Technology ', ' Testing ', ' Time ', ' tuberculous spondyloarthropathy ', ' infection due to Mycobacterium tuberculosis ', ' disseminated tuberculosis ', ' disseminated TB ', ' Mycobacterium tuberculosis infection ', ' Mycobacterium tuberculosis (MTB) infection ', ' Mtb infection [{C0041296}] ', ' MTB infection ', ' M.tuberculosis infection ', ' M. tuberculosis infection ', ' Tuberculosis ', ' Vendor ', ' Work ', ' alkaline protease inhibitor ', ' MAPI ', ' API ', ' microbial alkaline proteinase inhibitor ', ' Relative ', ' Relative (related person) ', ' Businesses ', ' Dataset ', ' Data Set ', ' base ', ' enzyme substrate ', ' p aminobenzoate ', ' Clinical ', ' Phase ', ' Biological ', ' Link ', ' Evaluation ', ' Intuition ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Technology Transfer ', ' analog ', ' mimic 2 ', ' NT mimic 2 ', ' neurotensin mimic 2 ', ' Collaborations ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' Developed Countries ', ' Metabolic ', ' tool ', ' scaffolding ', ' scaffold ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Scientist ', ' Route ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' experience ', ' pharmacophore ', ' knowledgebase ', ' knowledge base ', ' Stretching ', ' Essential Genes ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' novel ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' developing computer software ', ' develop software ', ' software development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' drug discovery ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Metabolic Pathway ', ' chemical informatics ', ' cheminformatics ', ' datamining ', ' data mining ', ' Address ', ' Systems Biology ', ' Data ', ' International ', ' in vivo ', ' STTR ', ' Small Business Technology Transfer Research ', ' Validation ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' cost ', ' drug resistant in tuberculosis ', ' drug resistance Mycobacteria Tuberculosis ', ' drug resistance M Tuberculosis ', ' Drug resistant Mycobacteria Tuberculosis ', ' Drug resistant M Tuberculosis ', ' Drug Resistance Of Mycobacterium Tuberculosis ', ' Drug resistance in tuberculosis ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' Drug-sensitive ', ' anti-microbial ', ' antimicrobial ', ' next generation therapeutics ', ' new therapeutics ', ' novel therapeutics ', ' TB drugs ', ' tuberculosis drugs ', ' tuberculosis therapy ', ' TB treatment ', ' TB therapy ', ' tuberculosis treatment ', ' combat ', ' in vitro activity ', ' data transmission ', ' data exchange ', ' drug candidate ', ' sharing data ', ' screening ', ' Drug Targeting ', ' ']",NIAID,"COLLABORATIVE DRUG DISCOVERY, INC.",R42,2013,517573,0.05644163468072639
"Binding-Site Modeling with Multiple-Instance Machine-Learning     DESCRIPTION (provided by applicant): This proposal is entitled ""Binding-Site Modeling with Multiple-Instance Machine-Learning."" One of the most challenging and longest studied problems in computer-aided drug design has been affinity prediction of small molecule ligands for their cognate protein targets. Despite decades of work, quantitative structure-activity re- lationship prediction (QSAR) approaches still suffer from poor accuracy, especially when predicting outside of closely related series of molecules. Even with high-quality structures of target proteins, approaches grounded in physics are also far from robust and accurate enough for reliable use in drug lead optimization. This proposal will build upon a foundation in multiple-instance machine learning applied to computer-aided drug design problems and develop a robust, accurate, and practically applicable affinity prediction methodology. The methodology requires only ligand structures and associated activity data for training, and it induces a virtual protein binding site composed of molecular fragments. The virtual binding pocket (or ""pocketmol"") is used in conjunction with a scoring function developed originally for molecular docking. The pocketmol configuration is chosen such that the optimal conformation and alignment of a ligand (based on the docking scoring function), yields scores for training ligands that are close to the known experimental values. Feasibility has been demon- strated in papers involving both membrane-bound receptors and enzymes.  However, multiple challenges remain and are the subject of the proposed research. There are three key issues. First, there exist many pocketmols that satisfy the requirements of fitting the training data, so general solutions must be developed to address the inductive bias of the learning procedure as well as model selection after the procedure. Second, since any particular model is the product of a learning process, it will have some domain of applicability, with some new molecules likely to be predicted well and others poorly. Further, the model will be better informed by learning with certain new molecules but not others. We must develop solutions for estimating confidence of predictions for new molecules as well as for identifying particular molecules that will be highly informative. Third, the operational application of these methods involves model building, guided chemical synthesis, and iterative refinement of models. Convincing validation will require application on temporal series of molecules synthesized for multiple targets of pharmaceutical interest. The proposed work will develop novel methods to address these challenges and will establish extensive validation on multiple pharmaceutically relevant temporal series of small molecules that were the subject of real-world lead-optimization exercises.         PUBLIC HEALTH RELEVANCE: The dominant mode of therapeutic discovery involves the design ""me-too"" drugs that are very similar in structure and effect to existing drugs. In order to address the unmet medical needs of an aging population, novel therapeutics must be developed, and this will require much more creativity in the design process. The proposed research will develop a predictive computational framework to aid in active design of structurally novel drug molecules during the drug discovery lead optimization process.            ",Binding-Site Modeling with Multiple-Instance Machine-Learning,8598096,R01GM101689,"['Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' chemical synthesis ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' creativity ', ' Creativeness ', ' Drug Design ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzymes ', ' Physical Exercise ', ' Exercise ', ' Foundations ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Ligands ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Paper ', ' Physics ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' Research ', ' Solutions ', ' Testing ', ' Work ', ' Measures ', ' falls ', ' Dataset ', ' Data Set ', ' base ', ' Procedures ', ' Site ', ' Medical ', ' Series ', ' Chemicals ', ' Training ', ' Collaborations ', ' Therapeutic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' membrane structure ', ' Membrane ', ' receptor binding ', ' Structure ', ' novel ', ' design and construct ', ' design and construction ', ' Modeling ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' small molecule ', ' Address ', ' Affinity ', ' Data ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' computational framework ', ' computer framework ', ' virtual ', ' computer based prediction ', ' predictive modeling ', ' computer aided ', ' Computer Assisted ', ' designing ', ' design ', ' blind ', ' Population ', ' prospective ', ' next generation therapeutics ', ' new therapeutics ', ' novel therapeutics ', ' population aging ', ' aging population ', ' public health relevance ', ' process optimization ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2014,299250,0.07577142247097053
"Image analysis for high-throughput C. elegans infection and metabolism assays    DESCRIPTION (provided by applicant): High-throughput screening (HTS) is a technique for searching large libraries of chemical or genetic perturbants, to find new treatments for a disease or to better understand disease pathways. As automated image analysis for cultured cells has improved, microscopy has emerged as one of the most powerful and informative ways to analyze screening samples. However, many diseases and biological pathways can be better studied in whole animals-particularly diseases that involve organ systems and multicellular interactions, such as metabolism and infection. The worm Caenorhabditis elegans is a well-established and effective model organism, used by thousands of researchers worldwide to study complex biological processes. Samples of C. elegans can be robotically prepared and imaged by high-throughput microscopy, but existing image-analysis methods are insuf- ficient for most assays. In this project, image-analysis algorithms that are capable of scoring high-throughput assays of C. elegans will be developed.  The algorithms will be tested and refined in three high-throughput screens, which will uncover chemical and genetic regulators of fat metabolism and infection: (1) A C. elegans viability assay to identify modulators of infection. The proposed algorithms use a probabilistic shape model of C. elegans in order to identify and mea- sure individual worms even when the animals touch or cross. These methods are the basis for quantifying many other phenotypes, including body morphology and subtle variations in reporter signal levels. (2) A C. elegans lipid assay to identify genes that regulate fat metabolism. The algorithms proposed for illumination correction, level-set-based foreground segmentation, well-edge detection, and artifact removal will result in improved or- business in high-throughput experiments. (3) A fluorescence gene expression assay to identify regulators of the response of the C. elegans host to Staphylococcus aureus infection. The proposed techniques for constructing anatomical maps of C. elegans will make it possible to quantify a variety of changes in fluorescent localization patterns in a biologically relevant way.  In addition to discovering new metabolism- and infection-related drugs and genetic regulators through these specific screens, this work will provide the C. elegans community with (a) a new framework for extracting mor- phological features from C. elegans for quantitative analysis of this organism, and (b) a versatile, modular, open-source toolbox of algorithms enabling the discovery of genetic pathways, chemical probes, and drug can- didates in whole organism high-throughput screens relevant to a variety of diseases.  This work is a close collaboration with C. elegans experts Fred Ausubel and Gary Ruvkun at Massachusetts General Hospital/Harvard Medical School, with Polina Golland and Tammy Riklin-Raviv, experts in model-based segmentation and statistical image analysis at MIT's Computer Science and Artificial Intelligence Laboratory, and with Anne Carpenter, developer of open-source image analysis software at the Broad Institute.       PUBLIC HEALTH RELEVANCE: Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.         ",Image analysis for high-throughput C. elegans infection and metabolism assays,8600293,R01GM095672,"['Algorithms ', ' Animals ', ' communicable disease control agent ', ' Antiinfective Agents ', ' AntiInfectives ', ' AntiInfective Drugs ', ' Anti-infective Preparation ', ' Anti-Infectives ', ' Anti-Infective Drugs ', ' Anti-Infective Agents ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Atlases ', ' Bacteria ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cells ', ' Cultured Cells ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Fluorescence ', ' Gene Expression ', ' Genes ', ' Goals ', ' General Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Infection ', ' Institutes ', ' Laboratories ', ' Learning ', ' Illumination ', ' Lighting ', ' Lipids ', ' Maps ', ' Massachusetts ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Microscopy ', ' living system ', ' Organism ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' school of medicine ', ' medical college ', ' medical schools ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Engineering ', ' Computer Software Development ', ' Software Engineering ', ' Stains ', ' S.aureus ', ' S. aureus ', ' Staphylococcus aureus ', ' Testing ', ' Work ', ' Measures ', ' Artifacts ', ' Morphologic artifacts ', ' Microsporidia ', ' Microspora ', ' Microsporidia (protozoa) ', ' Businesses ', ' C.elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' base ', ' image processing ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Individual ', ' Data Quality ', ' Measurement ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Descriptor ', ' immunoresponse ', ' host response ', ' Immune response ', ' Genetic ', ' Morphology ', ' Shapes ', ' Reporter ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Complex ', ' Pattern ', ' Techniques ', ' Organ System ', ' body system ', ' Stainings ', ' Staining method ', ' interest ', ' chemical library ', ' small molecule libraries ', ' biomedical scientist ', ' fat metabolism ', ' lipid metabolism ', ' computer science ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Touch ', ' Touch sensation ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' Modeling ', ' Sampling ', ' response ', ' high throughput analysis ', ' High Throughput Assay ', ' high throughput screening ', ' chemical genetics ', ' Address ', ' Detection ', ' Disease Pathway ', ' Whole Organism ', ' Preparation ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' pathogen ', ' Population ', ' resistant ', ' Resistance ', ' imaging Segmentation ', ' 2-dimensional ', ' two-dimensional ', ' open source ', ' human disease ', ' public health relevance ', ' drug candidate ', ' screening ', ' Drug Targeting ', ' ']",NIGMS,"BROAD INSTITUTE, INC.",R01,2014,310129,0.08444612975726605
"HLS13-04 High-Content High-Throughput Screen for Diamond Blackfan Anemia Treatments     DESCRIPTION (provided by applicant):  There are thousands of rare genetic diseases that have no approved treatment. Recursion Pharmaceuticals has developed a drug discovery platform that seeks to re-purpose known drugs for the treatment of such diseases. The platform consists of high content immunofluorescent image analysis using machine-learning algorithms to identify relevant and on-target changes induced by both RNAi and various chemicals. This system has been used to identify a phenotype for loss of function of two related genes, RPS19 and RPS10 in multiple human cell types. Mutations in these genes are the primary cause of Diamond Blackfan Anemia, a rare genetic disease with no specific targeted therapy. In this grant, we propose to: develop RPS19 and RPS10 knockout cell lines using CRISPR/Cas9 technology; evaluate knockout cell lines for phenotypes ('phenoprints') using our drug discovery platform; conduct chemical suppressor screens of thousands of known drug candidates to identify those that  ameliorate on-target phenoprints associated with loss of RPS19 and RPS10; expand the capabilities of our drug screening platform to enable the use of non-adherent cell lines in  our workflow and use the expanded capabilities to confirm the validity of drugs identifie as candidate therapies in  CD34+ suspended cell culture models of Diamond Blackfan Anemia. Recursion Pharmaceuticals has the experience, tools, and drive to execute this Phase I SBIR proposal, and to accelerate commercial development of any compounds arising from the project. The proposed study would have significant societal and commercial implications.         PUBLIC HEALTH RELEVANCE: Diamond Blackfan Anemia (DBA) is a rare genetic disease for which no targeted therapy exists. Loss of function in RPS19 and RPS10, or other ribosomal protein genes, results in the disease. We will use chemical suppressor screens of known drugs, based on structural changes in cellular disease models, to identify potential therapeutics for treatment of DBA.            ",HLS13-04 High-Content High-Throughput Screen for Diamond Blackfan Anemia Treatments,8902889,R43HL127820,"['Accounting ', ' Algorithms ', ' Anemia ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cell culture ', ' Cell Culture Techniques ', ' necrocytosis ', ' Cell Death ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Evaluation Studies, Drug, Preclinical ', ' Evaluation Studies, Drug, Pre-Clinical ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Orphan Drugs ', ' Epithelial Cells ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Erythrocytes ', ' Erythropoiesis ', ' Genes ', ' Goals ', ' Grant ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Fetal Hydrops ', ' Fetal Edema ', ' Hydrops Fetalis ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' Life Expectancy ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Patients ', ' Phenotype ', ' Ribosomal Proteins ', ' computer program/software ', ' Software ', ' Computer software ', ' Progenitor Cells ', ' Stem cells ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Suspensions ', ' Syndrome ', ' Technology ', ' Testing ', ' Veins ', ' Yeasts ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' base ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Phase ', ' Chemicals ', ' Susceptibility ', ' Predisposition ', ' Individual ', ' cerebral ', ' Cerebrum ', ' Measurement ', ' Therapeutic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Hereditary ', ' Inherited ', ' Severities ', ' Clinic ', ' cell type ', ' LOINC Axis 4 System ', ' System ', ' experience ', ' success ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' orphan disorder ', ' Rare Disorder ', ' Orphan Disease ', ' Rare Diseases ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' novel technologies ', ' new technology ', ' disorder model ', ' Disease model ', ' Modeling ', ' High Throughput Assay ', ' high throughput screening ', ' phase I trial ', ' phase I protocol ', ' phase 1 trial ', ' Phase 1 Clinical Trials ', ' Early-Stage Clinical Trials ', ' Phase I Clinical Trials ', ' drug discovery ', ' siRNA ', ' Small Interfering RNA ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Bio-Informatics ', ' Bioinformatics ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Diamond-Blackfan anemia ', ' malignant soft tissue tumor ', ' Malignant Soft Tissue Neoplasm ', ' sarcoma ', ' HPCA1 ', ' CD34 ', ' CD34 gene ', ' suspension ', ' Suspension substance ', ' Symptoms ', ' Detection ', ' Small Business Innovation Research ', ' SBIRS (R43/44) ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Validation ', ' Preparation ', ' Knockout ', ' Knock-out ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' preclinical trial ', ' pre-clinical trial ', ' pre-clinical study ', ' preclinical study ', ' early onset ', ' working group ', ' disease phenotype ', ' erythroid differentiation ', ' knock-down ', ' Population ', ' Cavernous Malformation ', ' loss of function ', ' A549 ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' drug candidate ', ' phase II study ', ' phase 2 study ', ' screening ', ' Cas nuclease technology ', ' CRISPR/Cas system ', ' CRISPR ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' ']",NHLBI,"RECURSION PHARMACEUTICALS, LLC",R43,2015,203133,0.07958772113638635
"Expansion of an efficient drug repurposing platform for rare genetic diseases.     DESCRIPTION (provided by applicant): There are thousands of rare genetic diseases that have no approved treatment. Recursion Pharmaceuticals has developed a drug discovery platform that seeks to re-purpose known drugs for the treatment of such diseases. The platform consists of high content immunofluorescent image analysis and transcellular resistance measurements. These measurements evaluated using machine-learning algorithms to identify relevant and on- target changes induced by both RNAi and various chemicals. These assays can be simultaneously performed on thousands of rare genetic disease models. In this grant, we specifically propose to:  Model 2,000 genetic diseases in multiple human cell types using RNAi technology.  Identify and prioritize 200 of these disease models with the most compelling phenotypic changes, according to multi-parametric quantification.  Utilize these 200 disease models as the basis of chemical suppressor screens of thousands of known drug candidates.  Validate the 20 best drug/disease combinations using an orthogonal genetic manipulation technique in human cells.  Study the best five to ten validated drug/disease combinations in relevant animal models. The proposed study would have significant societal and commercial implications.         PUBLIC HEALTH RELEVANCE: There are thousands of rare genetic diseases that together affect millions of Americans. We will use chemical suppressor screens of known drugs, based on structural and functional changes in cellular disease models, to identify potential therapeutics for treatment of these diseases.            ",Expansion of an efficient drug repurposing platform for rare genetic diseases.,8834608,R44TR001197,"['Affect ', ' Algorithms ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' clinical investigation ', ' Clinical Trials ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Animal Disease Models ', ' Evaluation Studies, Drug, Preclinical ', ' Evaluation Studies, Drug, Pre-Clinical ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epithelial Cells ', ' Genes ', ' Grant ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' In Vitro ', ' Libraries ', ' Marketing ', ' Methods ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Patents ', ' Legal patent ', ' Phenotype ', ' Research ', ' Safety ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Syndrome ', ' Technology ', ' Time ', ' Immunofluorescence ', ' Immunofluorescence Immunologic ', ' base ', ' genetic manipulation ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Phase ', ' Chemicals ', ' Endothelial Cells ', ' cerebral ', ' Cerebrum ', ' Orphan ', ' Measurement ', ' Funding ', ' Collaborations ', ' phase II trial ', ' phase II protocol ', ' phase 2 trial ', ' Phase 2 Clinical Trials ', ' Phase II Clinical Trials ', ' Therapeutic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Hereditary ', ' Inherited ', ' Source ', ' cell type ', ' Techniques ', ' American ', ' success ', ' drug efficacy ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' orphan disorder ', ' Rare Disorder ', ' Orphan Disease ', ' Rare Diseases ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' disorder model ', ' Disease model ', ' Modeling ', ' drug development ', ' drug discovery ', ' siRNA ', ' Small Interfering RNA ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Data ', ' Clinical Data ', ' Small Business Innovation Research ', ' SBIRS (R43/44) ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Knockout ', ' Knock-out ', ' Process ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' cost ', ' knock-down ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Prevalence ', ' direct application ', ' loss of function mutation ', ' resistant ', ' Resistance ', ' Cellular model ', ' Cell model ', ' clinical relevance ', ' clinically relevant ', ' Cavernous Malformation ', ' human disease ', ' loss of function ', ' commercialization ', ' public health relevance ', ' drug candidate ', ' screening ', ' Cas nuclease technology ', ' CRISPR/Cas system ', ' CRISPR ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' ']",NCATS,"RECURSION PHARMACEUTICALS, LLC",R44,2015,809130,0.12778264956046523
"Binding-Site Modeling with Multiple-Instance Machine-Learning DESCRIPTION (provided by applicant): This proposal is entitled ""Binding-Site Modeling with Multiple-Instance Machine-Learning."" One of the most challenging and longest studied problems in computer-aided drug design has been affinity prediction of small molecule ligands for their cognate protein targets. Despite decades of work, quantitative structure-activity re- lationship prediction (QSAR) approaches still suffer from poor accuracy, especially when predicting outside of closely related series of molecules. Even with high-quality structures of target proteins, approaches grounded in physics are also far from robust and accurate enough for reliable use in drug lead optimization. This proposal will build upon a foundation in multiple-instance machine learning applied to computer-aided drug design problems and develop a robust, accurate, and practically applicable affinity prediction methodology. The methodology requires only ligand structures and associated activity data for training, and it induces a virtual protein binding site composed of molecular fragments. The virtual binding pocket (or ""pocketmol"") is used in conjunction with a scoring function developed originally for molecular docking. The pocketmol configuration is chosen such that the optimal conformation and alignment of a ligand (based on the docking scoring function), yields scores for training ligands that are close to the known experimental values. Feasibility has been demon- strated in papers involving both membrane-bound receptors and enzymes.  However, multiple challenges remain and are the subject of the proposed research. There are three key issues. First, there exist many pocketmols that satisfy the requirements of fitting the training data, so general solutions must be developed to address the inductive bias of the learning procedure as well as model selection after the procedure. Second, since any particular model is the product of a learning process, it will have some domain of applicability, with some new molecules likely to be predicted well and others poorly. Further, the model will be better informed by learning with certain new molecules but not others. We must develop solutions for estimating confidence of predictions for new molecules as well as for identifying particular molecules that will be highly informative. Third, the operational application of these methods involves model building, guided chemical synthesis, and iterative refinement of models. Convincing validation will require application on temporal series of molecules synthesized for multiple targets of pharmaceutical interest. The proposed work will develop novel methods to address these challenges and will establish extensive validation on multiple pharmaceutically relevant temporal series of small molecules that were the subject of real-world lead-optimization exercises. PUBLIC HEALTH RELEVANCE: The dominant mode of therapeutic discovery involves the design ""me-too"" drugs that are very similar in structure and effect to existing drugs. In order to address the unmet medical needs of an aging population, novel therapeutics must be developed, and this will require much more creativity in the design process. The proposed research will develop a predictive computational framework to aid in active design of structurally novel drug molecules during the drug discovery lead optimization process.",Binding-Site Modeling with Multiple-Instance Machine-Learning,8786087,R01GM101689,"['Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' chemical synthesis ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' creativity ', ' Creativeness ', ' Drug Design ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzymes ', ' Physical Exercise ', ' Exercise ', ' Foundations ', ' Health ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Ligands ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Paper ', ' Physics ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' Research ', ' Solutions ', ' Testing ', ' Work ', ' Measures ', ' falls ', ' Dataset ', ' Data Set ', ' base ', ' Procedures ', ' Site ', ' Medical ', ' Series ', ' Chemicals ', ' Training ', ' Collaborations ', ' Therapeutic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' membrane structure ', ' Membrane ', ' receptor binding ', ' Structure ', ' novel ', ' design and construct ', ' design and construction ', ' Modeling ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' small molecule ', ' Address ', ' Affinity ', ' Data ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' computational framework ', ' computer framework ', ' virtual ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computer aided ', ' Computer Assisted ', ' designing ', ' design ', ' blind ', ' Population ', ' prospective ', ' next generation therapeutics ', ' new therapeutics ', ' novel therapeutics ', ' population aging ', ' aging population ', ' process optimization ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2015,300675,0.07577142247097053
"Image analysis for high-throughput C. elegans infection and metabolism assays DESCRIPTION (provided by applicant): High-throughput screening (HTS) is a technique for searching large libraries of chemical or genetic perturbants, to find new treatments for a disease or to better understand disease pathways. As automated image analysis for cultured cells has improved, microscopy has emerged as one of the most powerful and informative ways to analyze screening samples. However, many diseases and biological pathways can be better studied in whole animals-particularly diseases that involve organ systems and multicellular interactions, such as metabolism and infection. The worm Caenorhabditis elegans is a well-established and effective model organism, used by thousands of researchers worldwide to study complex biological processes. Samples of C. elegans can be robotically prepared and imaged by high-throughput microscopy, but existing image-analysis methods are insuf- ficient for most assays. In this project, image-analysis algorithms that are capable of scoring high-throughput assays of C. elegans will be developed.  The algorithms will be tested and refined in three high-throughput screens, which will uncover chemical and genetic regulators of fat metabolism and infection: (1) A C. elegans viability assay to identify modulators of infection. The proposed algorithms use a probabilistic shape model of C. elegans in order to identify and mea- sure individual worms even when the animals touch or cross. These methods are the basis for quantifying many other phenotypes, including body morphology and subtle variations in reporter signal levels. (2) A C. elegans lipid assay to identify genes that regulate fat metabolism. The algorithms proposed for illumination correction, level-set-based foreground segmentation, well-edge detection, and artifact removal will result in improved or- business in high-throughput experiments. (3) A fluorescence gene expression assay to identify regulators of the response of the C. elegans host to Staphylococcus aureus infection. The proposed techniques for constructing anatomical maps of C. elegans will make it possible to quantify a variety of changes in fluorescent localization patterns in a biologically relevant way.  In addition to discovering new metabolism- and infection-related drugs and genetic regulators through these specific screens, this work will provide the C. elegans community with (a) a new framework for extracting mor- phological features from C. elegans for quantitative analysis of this organism, and (b) a versatile, modular, open-source toolbox of algorithms enabling the discovery of genetic pathways, chemical probes, and drug can- didates in whole organism high-throughput screens relevant to a variety of diseases.  This work is a close collaboration with C. elegans experts Fred Ausubel and Gary Ruvkun at Massachusetts General Hospital/Harvard Medical School, with Polina Golland and Tammy Riklin-Raviv, experts in model-based segmentation and statistical image analysis at MIT's Computer Science and Artificial Intelligence Laboratory, and with Anne Carpenter, developer of open-source image analysis software at the Broad Institute. PUBLIC HEALTH RELEVANCE: Large-scale screening experiments that test the effects of thousands of chemicals or genetic perturbants by microscopy and image analysis can discover new treatments and help biomedical scientists understand dis- ease mechanisms. Microscopy screens of cultured cells are routine, but researchers wish to study complex processes like metabolism and infection in a whole animal like the tiny worm Caenorhabditis elegans, for which existing image analysis methods are insufficient. The goal of this research is to develop open-source software to automatically identify and measure C. elegans in microscopy images, thereby making it possible for researchers worldwide to screen a wide variety of complex biological processes related to human disease.",Image analysis for high-throughput C. elegans infection and metabolism assays,8786567,R01GM095672,"['Algorithms ', ' Animals ', ' communicable disease control agent ', ' Antiinfective Agents ', ' AntiInfectives ', ' AntiInfective Drugs ', ' Anti-infective Preparation ', ' Anti-Infectives ', ' Anti-Infective Drugs ', ' Anti-Infective Agents ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Atlases ', ' Bacteria ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cells ', ' Cultured Cells ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Fluorescence ', ' Genes ', ' Goals ', ' Health ', ' General Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Infection ', ' Institutes ', ' Laboratories ', ' Learning ', ' Illumination ', ' Lighting ', ' Lipids ', ' Maps ', ' Massachusetts ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Microscopy ', ' living system ', ' Organism ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' school of medicine ', ' medical college ', ' medical schools ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Engineering ', ' Computer Software Development ', ' Software Engineering ', ' Stains ', ' S.aureus ', ' S. aureus ', ' Staphylococcus aureus ', ' Testing ', ' Work ', ' Measures ', ' Morphologic artifacts ', ' Artifacts ', ' Microsporidia ', ' Microspora ', ' Microsporidia (protozoa) ', ' Businesses ', ' C.elegans ', ' C elegans ', ' Caenorhabditis elegans ', ' base ', ' image processing ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Individual ', ' Data Quality ', ' Measurement ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Descriptor ', ' immunoresponse ', ' host response ', ' Immune response ', ' Genetic ', ' Morphology ', ' Shapes ', ' Reporter ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Complex ', ' Pattern ', ' Techniques ', ' Organ System ', ' body system ', ' Stainings ', ' Staining method ', ' interest ', ' chemical library ', ' small molecule libraries ', ' biomedical scientist ', ' fat metabolism ', ' lipid metabolism ', ' computer science ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Touch ', ' Touch sensation ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Excision ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' Gene Expression Profiling ', ' Modeling ', ' Sampling ', ' response ', ' high throughput analysis ', ' High Throughput Assay ', ' high throughput screening ', ' chemical genetics ', ' Address ', ' Detection ', ' Disease Pathway ', ' Whole Organism ', ' Preparation ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' pathogen ', ' Population ', ' resistant ', ' Resistance ', ' imaging Segmentation ', ' 2-dimensional ', ' two-dimensional ', ' open source ', ' human disease ', ' drug candidate ', ' screening ', ' Drug Targeting ', ' ']",NIGMS,"BROAD INSTITUTE, INC.",R01,2015,309263,0.08444612975726605
"Binding-Site Modeling with Multiple-Instance Machine-Learning DESCRIPTION (provided by applicant): This proposal is entitled ""Binding-Site Modeling with Multiple-Instance Machine-Learning."" One of the most challenging and longest studied problems in computer-aided drug design has been affinity prediction of small molecule ligands for their cognate protein targets. Despite decades of work, quantitative structure-activity re- lationship prediction (QSAR) approaches still suffer from poor accuracy, especially when predicting outside of closely related series of molecules. Even with high-quality structures of target proteins, approaches grounded in physics are also far from robust and accurate enough for reliable use in drug lead optimization. This proposal will build upon a foundation in multiple-instance machine learning applied to computer-aided drug design problems and develop a robust, accurate, and practically applicable affinity prediction methodology. The methodology requires only ligand structures and associated activity data for training, and it induces a virtual protein binding site composed of molecular fragments. The virtual binding pocket (or ""pocketmol"") is used in conjunction with a scoring function developed originally for molecular docking. The pocketmol configuration is chosen such that the optimal conformation and alignment of a ligand (based on the docking scoring function), yields scores for training ligands that are close to the known experimental values. Feasibility has been demon- strated in papers involving both membrane-bound receptors and enzymes.  However, multiple challenges remain and are the subject of the proposed research. There are three key issues. First, there exist many pocketmols that satisfy the requirements of fitting the training data, so general solutions must be developed to address the inductive bias of the learning procedure as well as model selection after the procedure. Second, since any particular model is the product of a learning process, it will have some domain of applicability, with some new molecules likely to be predicted well and others poorly. Further, the model will be better informed by learning with certain new molecules but not others. We must develop solutions for estimating confidence of predictions for new molecules as well as for identifying particular molecules that will be highly informative. Third, the operational application of these methods involves model building, guided chemical synthesis, and iterative refinement of models. Convincing validation will require application on temporal series of molecules synthesized for multiple targets of pharmaceutical interest. The proposed work will develop novel methods to address these challenges and will establish extensive validation on multiple pharmaceutically relevant temporal series of small molecules that were the subject of real-world lead-optimization exercises. PUBLIC HEALTH RELEVANCE: The dominant mode of therapeutic discovery involves the design ""me-too"" drugs that are very similar in structure and effect to existing drugs. In order to address the unmet medical needs of an aging population, novel therapeutics must be developed, and this will require much more creativity in the design process. The proposed research will develop a predictive computational framework to aid in active design of structurally novel drug molecules during the drug discovery lead optimization process.",Binding-Site Modeling with Multiple-Instance Machine-Learning,8987578,R01GM101689,"['Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' chemical synthesis ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' creativity ', ' Creativeness ', ' Drug Design ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Exercise ', ' Foundations ', ' Health ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Ligands ', ' Methods ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Paper ', ' Physics ', ' Proteins ', ' Publishing ', ' Research ', ' Testing ', ' Work ', ' Measures ', ' falls ', ' Data Set ', ' Dataset ', ' base ', ' Procedures ', ' Site ', ' Medical ', ' Series ', ' Chemicals ', ' Training ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' Collaborations ', ' Therapeutic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' System ', ' interest ', ' membrane structure ', ' Membrane ', ' receptor binding ', ' Structure ', ' novel ', ' design and construct ', ' design and construction ', ' Modeling ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' small molecule ', ' Address ', ' Affinity ', ' Data ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' computational framework ', ' computer framework ', ' virtual ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computer aided ', ' Computer Assisted ', ' designing ', ' design ', ' blind ', ' Population ', ' prospective ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' aging population ', ' population aging ', ' process optimization ', ' model building ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2016,301150,0.07577142247097053
"Expansion of an efficient drug repurposing platform for rare genetic diseases. DESCRIPTION (provided by applicant): There are thousands of rare genetic diseases that have no approved treatment. Recursion Pharmaceuticals has developed a drug discovery platform that seeks to re-purpose known drugs for the treatment of such diseases. The platform consists of high content immunofluorescent image analysis and transcellular resistance measurements. These measurements evaluated using machine-learning algorithms to identify relevant and on- target changes induced by both RNAi and various chemicals. These assays can be simultaneously performed on thousands of rare genetic disease models. In this grant, we specifically propose to:  Model 2,000 genetic diseases in multiple human cell types using RNAi technology.  Identify and prioritize 200 of these disease models with the most compelling phenotypic changes, according to multi-parametric quantification.  Utilize these 200 disease models as the basis of chemical suppressor screens of thousands of known drug candidates.  Validate the 20 best drug/disease combinations using an orthogonal genetic manipulation technique in human cells.  Study the best five to ten validated drug/disease combinations in relevant animal models. The proposed study would have significant societal and commercial implications. PUBLIC HEALTH RELEVANCE: There are thousands of rare genetic diseases that together affect millions of Americans. We will use chemical suppressor screens of known drugs, based on structural and functional changes in cellular disease models, to identify potential therapeutics for treatment of these diseases.",Expansion of an efficient drug repurposing platform for rare genetic diseases.,9021016,R44TR001197,"['Affect ', ' Algorithms ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Body ', ' Cells ', ' Clinical Trials ', ' Disorder ', ' Disease ', ' Animal Disease Models ', ' Pre-clinical Drug Evaluation ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epithelial Cells ', ' Genes ', ' Grant ', ' Health ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Modern Man ', ' Human ', ' In Vitro ', ' Libraries ', ' Marketing ', ' Methods ', ' Patents ', ' Legal patent ', ' Phenotype ', ' Research ', ' Safety ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' stroke ', ' Syndrome ', ' Technology ', ' Time ', ' Immunofluorescence Immunologic ', ' Immunofluorescence ', ' base ', ' genetic manipulation ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Phase ', ' Chemicals ', ' Endothelial Cells ', ' Orphan ', ' Measurement ', ' Funding ', ' Collaborations ', ' phase II protocol ', ' phase 2 trial ', ' Phase 2 Clinical Trials ', ' Phase II Clinical Trials ', ' Therapeutic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Hereditary ', ' Inherited ', ' Source ', ' cell type ', ' Techniques ', ' American ', ' success ', ' drug efficacy ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' orphan disorder ', ' Rare Disorder ', ' Orphan Disease ', ' Rare Diseases ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' disorder model ', ' Disease model ', ' Modeling ', ' drug development ', ' drug discovery ', ' siRNA ', ' Short interfering RNA ', ' Small Interfering RNA ', ' Sequence-Specific Posttranscriptional Gene Silencing ', ' RNAi ', ' RNA Silencing ', ' Quelling ', ' Posttranscriptional Gene Silencing ', ' Post-Transcriptional Gene Silencing ', ' RNA Interference ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Candidate Gene ', ' Candidate Disease Gene ', ' cerebral cavernous malformations ', ' Data ', ' Clinical Data ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Knockout ', ' Knock-out ', ' Process ', ' imaging ', ' Image ', ' preclinical ', ' pre-clinical ', ' cost ', ' knockdown ', ' knock-down ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Prevalence ', ' direct application ', ' loss of function mutation ', ' Resistance ', ' resistant ', ' Cell model ', ' Cellular model ', ' clinically relevant ', ' clinical relevance ', ' human disease ', ' mouse model ', ' murine model ', ' loss of function ', ' commercialization ', ' drug candidate ', ' screening ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' CRISPR/Cas system ', ' CRISPR ', ' Mendelian disorder ', ' single-gene disorder ', ' single-gene disease ', ' monogenic disorder ', ' monogenic disease ', ' Mendelian genetic disorder ', ' Mendelian disease ', ' ']",NCATS,"RECURSION PHARMACEUTICALS, LLC",R44,2016,650041,0.12778264956046523
"A Machine-Learning Based Software Widget for Resolving Metabolite Identities Owing to recent technological advances in measurement platforms, it is now possible to simultaneously detect and characterize a very large number of metabolites covering a substantial fraction of the small molecules present in a biological sample. This presents an exciting opportunity to develop potentially transformative approaches to study cells and organisms. One major challenge in realizing this potential lies in processing and analyzing the data. A typical dataset from an untargeted experiment contains many of thousands of features, each of which could correspond to a unique metabolite. Analyzing such datasets to obtain meaningful biological information depends on reliably and efficiently resolving the chemical identities of the detected features. Currently, in silico fragmentation methods predict candidate metabolites that are scored and ranked based on how well the fragmentation explains the observed MS/MS spectrum, and on other factors influencing fragmentation such as bond dissociation energies and ionization conditions. Deciding which candidate metabolites is the best match for a particular feature in the context of the biological sample, however, is a daunting task. Extensive testing of candidate metabolites against chemical standards library may be prohibitive in terms of cost and efforts. We seek to develop software-enabled workflows centered on resolving metabolite identities. Our approach is to exploit knowledge of the biological context of a sample to identify the metabolites. Recognizing that the metabolites present in a sample result from enzyme-catalyzed biochemical reactions active in the corresponding biological system, we employ topological analysis and inference to best map the metabolites implied by the detected features to metabolic pathways that are feasible based on the genome(s) of cells in the biological system. Aim 1 develops a computational method based on Bayesian-inference to enhance candidate metabolite rankings that are obtained via in silico fragmentation analysis. Our method utilizes all available information (database lookups, in silico fragmentation analysis, and network/pathway context) to maximally inform and adjust the rankings. Aim 2 will build software widgets to implement the metabolite identification workflow within a data-analytics framework. As the analytics framework, we will use Orange, which allows the user to create interactive data analysis pipelines through a plug-and-play graphical user interface (GUI). Aim 3 will validate the computational method and software widget implementation. Experimental validation will utilize high-purity standards to confirm (or reject) the computationally assigned metabolite identities. Widget implementation will be evaluated through a focus group discussion with the widget users in the labs directed by the PIs. As project outcomes, we anticipate both a methodological advance in analyzing mass signature data as well as a suite of easily accessible software in the form of widgets. Metabolomics is concerned with the comprehensive characterization of the small molecule metabolites in biological systems. Owing to recent technological advances in measurement platforms, it is now possible to simultaneously detect and characterize a very large number of metabolites. Prospectively, advanced computational tools and software for metabolomics data analysis can aid discovery efforts aimed at identifying novel bioactive metabolites that could be developed into diagnostic indicators or therapeutic agents.",A Machine-Learning Based Software Widget for Resolving Metabolite Identities,9223450,R03CA211839,"['Algorithms ', ' inhibitor ', ' inhibitor/antagonist ', ' Attention ', ' automated data processing ', ' Electronic Data Processing ', ' Computer Data Processing ', ' Automatic Data Processing ', ' Cell Body ', ' Cells ', ' Systematics ', ' Classification ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Environment ', ' Enzyme Gene ', ' Enzymes ', ' Feedback ', ' Focus Groups ', ' Genes ', ' Genome ', ' Goals ', ' Modern Man ', ' Human ', ' Libraries ', ' Literature ', ' Manuals ', ' Maps ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Nuclear Magnetic Resonance ', ' living system ', ' Organism ', ' Play ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Dissociation ', ' Uncertainty ', ' doubt ', ' Data Set ', ' Dataset ', ' base ', ' Biological ', ' Chemicals ', ' Visual ', ' Bayesian statistics ', ' Bayesian statistical inference ', ' Bayesian statistical analysis ', ' Bayesian spatial analysis ', ' Bayesian network analysis ', ' Bayesian inference ', ' Bayesian Analysis ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Therapeutic Agents ', ' instrument ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Complex ', ' Pattern ', ' ionization ', ' heuristics ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Network Analysis ', ' Pathway Analysis ', ' Sampling ', ' developing computer software ', ' develop software ', ' software development ', ' Oranges ', ' protein expression ', ' Metabolic Pathway ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' small molecule ', ' chemical standard ', ' Address ', ' Enzymatic Reaction ', ' Biochemical Reaction ', ' Data ', ' Reproducibility ', ' Resolution ', ' Validation ', ' Process ', ' pathway ', ' Pathway interactions ', ' cost ', ' mass spectrometer ', ' computational tools ', ' computerized tools ', ' functional outcomes ', ' Outcome ', ' graphical user interface ', ' graphic user interface ', ' Graphical interface ', ' biological systems ', ' flexibility ', ' flexible ', ' database query ', ' data base query ', ' Data Analytics ', ' ']",NCI,TUFTS UNIVERSITY MEDFORD,R03,2016,147569,0.02047683821635169
"Development of integrative models for early liver toxicity assessment     DESCRIPTION (provided by applicant): Computational toxicology has become a critical area of research due to the burgeoning need to evaluate thousands of pharmaceutical and environmental chemicals with unknown toxicity profiles, the high demand in time and resources by current experimental toxicity testing, and the growing ethical concerns over animal use in toxicity studies. Despite tremendous efforts, little success has been attained thus far in the development of predictive computational models for toxicity, primarily due to the complexity of toxicity mechanisms as well as the lack of high-quality experimental data for model development.  A critical challenge in toxicity testing of chemicals is that toxicity effects are doe-dependent: the true toxic hits may show no toxicity at all at low dose level. Therefore, traditiona high-throughput screening (HTS) that test chemicals only at a single concentration is not suitable for toxicity screening. On the contrary, the recently developed quantitative high-throughput screening (qHTS) platforms can evaluate each chemical across a broad range of concentrations, and is gaining ever-increasing popularity as a tool for in vitro toxicity profiling The concentration-response information generated by qHTS are expected to provide more accurate and comprehensive information of the toxicity effects of chemicals, offering promising data that can be mined to estimate in vivo toxicities of chemicals. However, our previous studies showed that if processed inappropriately, such concentration-response information contribute little to improve the toxicity prediction. This is especially true when multiple types of qHTS data are used together. Therefore, in this study, we will extend our previous approaches to develop novel statistical and computational tools that can curate, preprocess, and normalize the concentration-response information from multiple different qHTS databases.  Traditionally, toxicity models are based on either the chemical data (such as the quantitative structure- activity relationship analysis), or the in vitro toxicity profiling data (such as the in vitro-in vivo extrapolations). Our previous experiences suggested that integrating biological descriptors such as the in vitro cytotoxicity profiles or the short-term toxigenomic data, with chemical structural features is able to predict rodent acute liver toxicity with reasonable accuracy. Therefore, the second part of this proposal will be devoted to develop novel computational models for hepatotoxicity prediction by integrating qHTS toxicity profiles and chemical structural information In Aim 1, we will curate, preprocess, and normalize collected public liver toxicity datasets. In ths study, we will model toxicity effects using multiple large public datasets such as HTS and qHTS bioassay data (Tox21[1] and ToxCast[2]), hepatotoxicity side effect reports on marketed failed drugs[3], the Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD[4]), etc. Statistical methods for cross-study validation and quality control will be applied to the collected datasets to ensure computational compatibility and to select the appropriate datasets for analysis. In Aim 2, we will develop predictive models for chemicals' liver toxicity based on an integrative modeling workflow that will make use of both structural and in vitro toxicity profiles of a chemical. Our previous studies [5] showed that models using both in vitro toxicity profiles and chemical structural data have better accuracy for rodent acute liver toxicity than models using either data type alone. Here, we will develop a novel modeling workflow that start with defining the functional clusters of chemicals via curated qHTS toxicity profiles, and is followed by developing computational models to correlate chemical and biological data with overall toxicity risks in humans. The predictive models will be validated using independent datasets with over 800 compounds. In Aim 3, we propose to prioritize the qHTS profiling assays used in the model for future toxicity testing. We will evaluate all the in vitro assays as biological descriptors from thee perspectives, including descriptor importance in the integrative toxicity model, correlation with i vivo DILI outcomes, and level of information content estimated by a novel approach based on network analysis.    PUBLIC HEALTH RELEVANCE: In this study we aim to develop computational models that can identify potential liver toxicants. Liver toxicity is a significant contributor to the high attition rate in drug development. Moreover, toxic chemicals in food, water, and consumer products all pose serious risks for liver toxicity. As a result, there is great interest in developing high-throughput, high-content experimental and computational tools to evaluate the liver toxicity of thousands of pharmaceutical and environmental chemicals. This study focuses on developing novel informatics tools that enable the extraction and integration of chemical concentration-response information from multiple quantitative high-throughput screening databases for model development, and developing statistical models that are able to integrate this concentration-response information with chemical structural features to predict their risk of liver toxicity.  ",Development of integrative models for early liver toxicity assessment,9017336,R03ES026397,"['Algorithms ', ' Animals ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' dreaming ', ' Dreams ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethical ', ' Ethics ', ' Food or Food Product ', ' Food ', ' Future ', ' Gene Expression ', ' Goals ', ' Au element ', ' Gold ', ' Health ', ' Modern Man ', ' Human ', ' In Vitro ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Marketing ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' North Carolina ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Poisons ', ' Productivity ', ' Quality Control ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Rodents Mammals ', ' Rodentia ', ' Rodent ', ' Testing ', ' Time ', ' Toxicology ', ' United States Environmental Protection Agency ', ' Environmental Protection Agency ', ' United States Food and Drug Administration ', ' USFDA ', ' Food and Drug Administration ', ' Universities ', ' Water ', ' Hydrogen Oxide ', ' Data Set ', ' Dataset ', ' drug withdrawal ', ' base ', ' improved ', ' Area ', ' Acute ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Ensure ', ' Chemicals ', ' hepatoxicity ', ' hepatic toxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Hepatotoxicity ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Toxicity Testing ', ' Toxicity Tests ', ' Descriptor ', ' Shapes ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Scientist ', ' Complex ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' consumer product ', ' Lytotoxicity ', ' cytotoxicity ', ' experience ', ' Performance ', ' success ', ' toxicant ', ' knowledgebase ', ' knowledge base ', ' Informatics ', ' Toxicities ', ' Toxic effect ', ' novel ', ' drug market ', ' validation studies ', ' Reporting ', ' Statistical Methods ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' drug development ', ' High Throughput Assay ', ' high throughput screening ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Quantitative Structure-Activity Relationship ', ' Genomics ', ' model development ', ' Toxicology Genetics ', ' Genetic Toxicology ', ' Toxicogenetics ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Address ', ' Dose ', ' Data ', ' International ', ' in vitro Assay ', ' in vivo ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Process ', ' developmental ', ' Development ', ' pre-clinical study ', ' preclinical study ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' NIEHS ', ' National Institute of Environmental Health Sciences ', ' cost ', ' data modeling ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' post-market ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' cost effective ', ' cost-effective ', ' environmental chemical ', ' screening ', ' liver injury ', ' liver damage ', ' hepatic injury ', ' hepatic damage ', ' model building ', ' ']",NIEHS,UT SOUTHWESTERN MEDICAL CENTER,R03,2016,81000,0.18009966569362576
"Integrating cheminformatics and molecular simulations for virtual drug screening     DESCRIPTION (provided by applicant): The development of highly efficient and accurate approaches to structure-based virtual screening (VS) continues to represent a formidable challenge in the field of computational drug discovery. Outstanding and widely recognized research problems in the field include the relative computational inefficiency of most approaches, which limits the size of molecular libraries used for virtual screening; the low hit rate; and the inaccurate prediction of ligand binding affinity and pose. The proposed studies address these challenges by using innovative and computationally efficient approaches to VS that fully integrate concepts from the complementary fields of cheminformatics and molecular simulation to devise an integrated two-step VS methodology. Building upon our experience in cheminformatics and QSAR modeling, we aim to develop novel, computationally efficient cheminformatics approaches to pre-process very large (on the order of 107 compounds) chemical libraries available for biological screening, and eliminate up to 99% of improbable ligands. Only the remaining 1% of probable ligands will be evaluated by slower but accurate ensemble flexible docking approaches relying on molecular simulation techniques. The cheminformatics step will also produce important information on privileged protein-ligand interactions that will be used in a live-processing step to guide the structure-based virtual screening and avoid oversampling of ligand poses. Moreover, post- processing cheminformatics methods will be implemented to filter out decoy poses from docking calculations. The ultimate goal of our hybrid methodology is to arrive at a small set of high-affinity computational hits in receptor-bound conformations that can be validated experimentally. We will pursue this goal following three specific aims: 1) Develop novel cheminformatics-based virtual screening approaches to eliminate both improbable ligands and improbable poses, as well as generate information on preferred protein-ligand interactions; 2) Develop new, efficient flexible ensemble docking methods guided by the preferred protein- ligand interactions to select the most probable ligands and predict their binding poses; 3) Apply the developed hierarchical virtual screening workflow to several therapeutic targets and test high-confidence computational hits in experimental assays. All computational tools resulting from this project will be made publicly available. This proposal is innovative because the proposed VS platform will result from a unique marriage of disparate approaches for VS, combining their corresponding strengths. This proposal is significant because the implementation of this project will enable substantial improvement in the efficiency, accuracy, and experimentally-confirmed impact of structure-based drug discovery tools.         PUBLIC HEALTH RELEVANCE: Advances in drug discovery rely on the development of novel effective computational methodologies. This proposal advances an efficient and robust computational workflow for structure-based virtual screening of very large chemical libraries. The ultimate goal of this project is to arrive at a small number of candidate molecules with high predicted binding affinity to their biological targets, which will be tested in confirmatory experiments.        ",Integrating cheminformatics and molecular simulations for virtual drug screening,8858750,R01GM114015,"['Affect ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Pre-clinical Drug Evaluation ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Goals ', ' Hybrids ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' Ligands ', ' Marriage ', ' Methods ', ' Methodology ', ' Mining ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Phosphotransferases ', ' Planning Technic ', ' Planning Methodology ', ' Planning Techniques ', ' Proteins ', ' Research ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' sperm cell ', ' backbone ', ' Spine ', ' Spinal Column ', ' Vertebral column ', ' Technology ', ' Testing ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Biological ', ' Series ', ' Active Sites ', ' Chemicals ', ' Orphan ', ' Descriptor ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' programs ', ' Side ', ' Protocol ', ' Protocols documentation ', ' Techniques ', ' Best Practice Analysis ', ' Benchmarking ', ' experience ', ' Performance ', ' receptor binding ', ' chemical library ', ' small molecule libraries ', ' user friendly computer software ', ' user friendly software ', ' Structure ', ' simulation ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' GPCR ', ' G Protein-Coupled Receptor Genes ', ' G Protein-Complex Receptor ', ' G-Protein-Coupled Receptors ', ' Modeling ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' chemical informatics ', ' cheminformatics ', ' small molecule ', ' Address ', ' Affinity ', ' molecular library ', ' Molecular Bank ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' developmental ', ' Development ', ' virtual ', ' computational tools ', ' computerized tools ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' innovation ', ' innovative ', ' innovate ', ' therapeutic target ', ' public health relevance ', ' flexibility ', ' flexible ', ' screening ', ' Computational Geometry ', ' improved outcome ', ' ']",NIGMS,UNIV OF NORTH CAROLINA CHAPEL HILL,R01,2016,293344,0.05662815169959435
"Biomedical Data Translator Technical Feasibility Assessment and Architecture Design A fundamental challenge to translate insights between biomedical researchers, who study biological mechanisms, and clinicians, who diagnose patient symptoms, is that many links between biological processes and disease pathophysiology are poorly understood. A comprehensive Biomedical Translator must enable chains of inference across objects as diverse as genetic mutations, molecular effects, tissue-specific expression patterns, cellular processes, organ phenotypes, disease states, patient symptoms, and drug responses, a challenge beyond the scope of any one organization. Fortunately, many individual links in this chain have been made by experiments yielding statistical connections between individual data types. High-throughput perturbation screens link chemical and genetic perturbations to cellular phenotypes such as gene-expression patterns, cell survival, or changes in phosphorylation. Genetic association studies link mutations to human disease or intermediate phenotypes and biomarkers. Electronic medical records (EMR) link diseases or human phenotypes to diagnostic or current procedural terminology (CPT) codes, and clinical trials link the impact of drugs and drug candidates on disease states. In principle, incorporating these links into chains of inference could translate results between the full set of data types within them. In practice, each link is maintained by experts with domain-specific experiments, semantic terminology, and methodological standards. While a key challenge faced by a global Biomedical Translator is to establish consistent standards across these existing data types, a more important goal is to develop a principled and robust framework to (a) model biological systems and experimental approaches to investigate them; (b) organize knowledge about biological mechanism and disease; and (c) incorporate diverse datasets that serve as windows into the underlying and unknown state of nature. We propose to implement a Biomedical Translator as a probabilistic graphical model, a paradigm from artificial intelligence (AI) research. Just as separate research communities form weakly coupled parts of the translation process, graphical models allow global inferences from weakly coupled nodes. These inferences require each node to publish only probability distributions, enabling interoperability without necessarily having global entity-resolution standards, and benefit from paradigms for quality control, fault tolerance, and relevance assessment common in AI research. We hypothesize that a limited number of APIs, implemented as probability computations by communities around the world, would yield a Biomedical Translator as an emergent property of weakly coupled knowledge sources. From basic properties of graphical models, such a Translator could probabilistically translate among any data types connected within it, allowing for relatively complex query concepts. For example: What cellular processes in which tissues are impacted in a patient-based EMR? What genetic mutations sensitize cells to small-molecule treatment effects? Which small molecules mimic genetic experiments of nature that protect against disease? To illustrate the value of these resources and our architectural paradigm, we propose a demonstration project to implement a Biomedical Translator supporting queries between small molecules, biological processes, genes, and disease. The demonstration project will provide a valuable first step to confront key data-integration and organizational challenges and will enable previously impossible queries, such as identifying small molecules that perturb the same biological processes implicated by human genetics in a disease context. In this capacity, such Translator could realistically identify existing drugs for known symptoms (i.e., repurposing), but could more broadly serve as an engine for hypothesis generation and biological discovery, suggesting pre-clinical small molecules to develop based on their observed biological activity, or providing heretofore novel links between cellular protein function and disease pathophysiology. ",Biomedical Data Translator Technical Feasibility Assessment and Architecture Design,9337924,OT3TR002025,"['Architecture ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Artificial Intelligence ', ' DNA Alteration ', ' DNA mutation ', ' Genetic mutation ', ' Sequence Alteration ', ' genomic alteration ', ' preclinical ', ' Expression Signature ', ' designing ', ' Body Tissues ', ' gene expression pattern ', ' gene expression signature ', ' transcriptional signature ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Electronic Medical Record ', ' Protein Phosphorylation ', ' Modern Man ', ' Dataset ', ' Investigators ', ' Researchers ', ' Research Resources ', ' disease phenotype ', ' Link ', ' Diagnostic ', ' Nature ', ' Resolution ', ' Translation Process ', ' treatment effect ', ' interoperability ', ' DNA Sequence Alteration ', ' Data ', ' Knowledge ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' insight ', ' Individual ', ' human disease ', ' Cell Viability ', ' Cell Body ', ' research study ', ' Complex ', ' Molecular ', ' protein function ', ' Source ', ' Engineering / Architecture ', ' Modeling ', ' Pattern ', ' Property ', ' response ', ' Computer Reasoning ', ' Machine Intelligence ', ' chemical genetics ', ' small molecule ', ' genetic association ', ' Current Procedural Terminology Codes ', ' Biological Markers ', ' Genetic ', ' novel ', ' Biological Process ', ' Functional disorder ', ' Symptoms ', ' pre-clinical ', ' Coupled ', ' Gene Expression Profile ', ' biological systems ', ' drug candidate ', ' Probability ', ' Processed Genes ', ' base ', ' Data Set ', ' Human ', ' Mutation ', ' Human Genetics ', ' Organ ', ' Disorder ', ' data integration ', ' design ', ' Biological ', ' Diagnosis ', ' Terminology ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Biological Function ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Tissues ', ' Disease ', ' Pharmaceutical Preparations ', ' experiment ', ' experimental research ', ' experimental study ', ' Cell physiology ', ' Cell Survival ', ' Cells ', ' Translating ', ' Computerized Medical Record ', ' Patients ', ' Phenotype ', ' Generations ', ' Clinical Trials ', ' Phosphorylation ', ' Research ', ' Semantics ', ' CPT Codes ', ' Research Personnel ', ' Resources ', ' Communities ', ' Publishing ', ' Quality Control ', ' Goals ', ' ']",NCATS,"BROAD INSTITUTE, INC.",OT3,2016,399608,0.0059084244958927295
"Discovery of LXR Agonists via Pharmacophore Space Mining The goal of this proposal is to discover drug-like liver X receptor (LXR)  selective agonists that can halt and reverse the progression of Alzheimers disease (AD). Recent work demonstrated that activation of the LXR signaling pathways leads to improved amyloid  (A) turnover, reduction in A plaque area, and the reversal of cognitive, social and olfactory deficits. The research plan consists of two steps. The first step is computer-aided prediction of agonistic LXR selective binding, blood brain barrier permeability, and absence of side effects such as mutagenicity or binding to undesired targets. This step relies on a novel method for pharmacophore analysis by examining the joint space of chemical compounds, targets, and chemical/biological properties. This joint space is defined using machine learning on the 3D geometry of spatial arrangement of pharmacophoric points, using attributes such as donors, acceptors, aromatic rings, and charged fragments. The second step consists of biological assays to assess toxicity, brain penetration potential and the ability to induce expression of the corresponding genes. A dozen diverse compounds will have been tested through two iterations of the two steps of in silico prediction and assays at the end of Phase 1. These initial leads will be augmented with additional de novo compounds and further scrutinized via behavioral assays, dose-response studies and more detailed, sophisticated, and mechanistic assays during Phase 2. The outcome of this study will be new drug leads to potentially treat and prevent AD at different stages of cognitive decline and neurodegeneration. Interleaving of computer-aided screening of large chemical databases through novel machine learning based models with biological assays will identify drug-like LXR selective agonists with minimal side-effects. These agonists will slow and reverse Alzheimers Disease.",Discovery of LXR Agonists via Pharmacophore Space Mining,9202941,R43AG054350,"['Affect ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Amyloid Substance ', ' Amyloid ', ' Behavior ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' Blood - brain barrier anatomy ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cell culture ', ' Cell Culture Techniques ', ' Charge ', ' Clinical Trials ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Future ', ' Genes ', ' Goals ', ' Modern Man ', ' Human ', ' Articulation ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Ligands ', ' Photoradiation ', ' Light ', ' Memory ', ' Methods ', ' Methodology ', ' Mining ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Permeability ', ' Pharmacokinetics ', ' Drug Kinetics ', ' Research ', ' Signal Pathway ', ' Testing ', ' Work ', ' Mediating ', ' Retinoic Acid Receptor ', ' Thiazolidinedione Receptor ', ' Peroxisome Proliferator-Activated Receptor  ', ' Peroxisome Proliferator-Activated Receptor gamma ', ' Peroxisome Proliferative Activated Receptor Gamma ', ' PPAR ', ' PPARgamma ', ' PPAR- ', ' PPAR gamma ', ' base ', ' improved ', ' Peripheral ', ' Area ', ' Penetration ', ' Phase ', ' Biological ', ' Biochemical ', ' Series ', ' Nuclear Receptors ', ' Chemicals ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Agonist ', ' oxysterols receptor LXR-alpha ', ' orphan nuclear receptor LXR-alpha ', ' liver X receptor  ', ' liver X receptor alpha ', ' LXR ', ' LXRalpha ', ' LXRA gene product ', ' LXR-alpha protein ', ' LXRalpha protein ', ' Therapeutic ', ' Staging ', ' scaffolding ', ' scaffold ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Impaired cognition ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neuro-degenerative Disorders ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' Neurodegenerative Disorders ', ' Outcome Study ', ' American ', ' Isoforms ', ' Protein Isoforms ', ' Receptor Protein ', ' receptor ', ' fat metabolism ', ' lipid metabolism ', ' computer science ', ' pharmacophore ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' Toxicities ', ' Toxic effect ', ' novel ', ' social ', ' Modeling ', ' Property ', ' response ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Adverse effects ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' Effectiveness ', ' preventing ', ' prevent ', ' Dose ', ' Receptor Signaling ', ' in vitro Model ', ' in vivo ', ' Cognitive ', ' Molecular ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' Behavioral Assay ', ' computer aided ', ' Computer Assisted ', ' Outcome ', ' Population ', ' clinical application ', ' clinical applicability ', ' neurotoxic ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' mouse model ', ' murine model ', ' screening ', ' Drug Targeting ', ' Geometry ', ' Liver X Receptor ', ' ']",NIA,"ACELOT, INC.",R43,2016,208715,-0.034373998332514984
"DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY     DESCRIPTION (provided by applicant):         Adverse drug reactions (ADRs) are dangerous and expensive, afflicting about 1.5% of hospitalized patients with profound health and financial consequences. In Medicare patients alone, adverse drug reactions account for 19% of total spending ($339 billion), more than 1,900 deaths, and more than 77,000 extra hospital days per year. Idiosyncratic ADRs, especially rare and severe hypersensitivity-driven ADRs, are the leading cause of medicine withdrawal and termination of clinical development. At the same time, a large proportion of drugs are not associated with hypersensitivity driven ADRs, offering hope that new medicines could avoid them entirely with reliable predictors of risk. Hypersensitivity driven ADRs are caused by the formation of chemically reactive metabolites by metabolic enzymes. These reactive metabolites covalently attach to proteins to become immunogenic and provoke an ADR. Unfortunately, current computational and experimental approaches do not reliably identify drug candidates that form reactive metabolites. These approaches are limited because they inadequately model metabolism, which can both render toxic molecules safe and safe molecules toxic. To overcome this limitation, the proposed study aims to curate a public database of metabolism and reactivity and use this database to build accurate and validated mathematical models of metabolism and reactivity. The models will be constructed using machine-learning algorithms that quantitatively summarize the knowledge from thousands of published studies. The Aims are to (1) curate a database of metabolism and build models that identify rules governing the structure of reaction products during drug metabolism in the liver, (2) curate a database of reactivity and build improved reactivity models that mechanistically predict which metabolites are reactive with biological molecules, and (3) curate a database of reactive metabolites and combine these models to predict when molecules form reactive metabolites that covalently bind proteins. The computational models generated by these Aims will be validated through statistical approaches and against bench-top experiments. Taken together, this approach will substantially improve on existing approaches by more accurately modeling the properties determining whether metabolism renders drugs toxic or safe. The predictive models will make new medicines safer by helping researchers avoid molecules prone to ADRs without harming patients.         PROJECT NARRATIVE Adverse drug reactions, especially rare but severe hypersensitivity-driven reactions, have profound financial and health implications and are caused by reactive drug metabolites. As an extension of tools and data developed by our groups, we will build and test mathematical models and datasets that more accurately predict when molecules form clinically important reactive metabolites than current methodologies, such as structural alerts. We will use these models to build a tool that will better predict when drug candidates form reactive metabolites, which will make new medicines safer by enabling researchers to avoid drug candidates prone to causing adverse reactions.",DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY,9006922,R01LM012222,"['Accounting ', ' Algorithms ', ' necrocytosis ', ' Cell Death ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Death ', ' Cessation of life ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Skin Rash ', ' Rash ', ' Exanthem ', ' Exanthema ', ' Foundations ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' Allergy ', ' Hypersensitivity ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Literature ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Medicine ', ' Metabolic Activation ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' Chemical Models ', ' Macromolecular Structure ', ' Molecular Structure ', ' Patients ', ' Proteins ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' Erythema Multiforme Major ', ' Stevens-Johnson Syndrome ', ' Testing ', ' Time ', ' Mediating ', ' Data Set ', ' Dataset ', ' drug withdrawal ', ' macromolecule ', ' improved ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Series ', ' Chemicals ', ' hepatoxicity ', ' hepatic toxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Hepatotoxicity ', ' Withdrawal ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Relative Risks ', ' Biological Function ', ' Biological Process ', ' immunoresponse ', ' host response ', ' Immune response ', ' Metabolic ', ' gene function ', ' Exposure to ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Immune ', ' Event ', ' Reaction ', ' Pattern ', ' Adverse reactions ', ' adduct ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' drug metabolism ', ' Modeling ', ' Property ', ' drug development ', ' immunogenic ', ' repository ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' mathematical model ', ' hepatic metabolism ', ' liver metabolism ', ' Data ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' Molecular Profiling ', ' in vitro Assay ', ' Validation ', ' Molecular ', ' Process ', ' protein function ', ' developmental ', ' Development ', ' data modeling ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' immunogenicity ', ' quantum ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' drug candidate ', ' screening ', ' model building ', ' Assessment tool ', ' Assessment instrument ', ' online repository ', ' web-based repository ', ' web repository ', ' online archive ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2016,351101,0.07188929896491424
"DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY     DESCRIPTION (provided by applicant):         Adverse drug reactions (ADRs) are dangerous and expensive, afflicting about 1.5% of hospitalized patients with profound health and financial consequences. In Medicare patients alone, adverse drug reactions account for 19% of total spending ($339 billion), more than 1,900 deaths, and more than 77,000 extra hospital days per year. Idiosyncratic ADRs, especially rare and severe hypersensitivity-driven ADRs, are the leading cause of medicine withdrawal and termination of clinical development. At the same time, a large proportion of drugs are not associated with hypersensitivity driven ADRs, offering hope that new medicines could avoid them entirely with reliable predictors of risk. Hypersensitivity driven ADRs are caused by the formation of chemically reactive metabolites by metabolic enzymes. These reactive metabolites covalently attach to proteins to become immunogenic and provoke an ADR. Unfortunately, current computational and experimental approaches do not reliably identify drug candidates that form reactive metabolites. These approaches are limited because they inadequately model metabolism, which can both render toxic molecules safe and safe molecules toxic. To overcome this limitation, the proposed study aims to curate a public database of metabolism and reactivity and use this database to build accurate and validated mathematical models of metabolism and reactivity. The models will be constructed using machine-learning algorithms that quantitatively summarize the knowledge from thousands of published studies. The Aims are to (1) curate a database of metabolism and build models that identify rules governing the structure of reaction products during drug metabolism in the liver, (2) curate a database of reactivity and build improved reactivity models that mechanistically predict which metabolites are reactive with biological molecules, and (3) curate a database of reactive metabolites and combine these models to predict when molecules form reactive metabolites that covalently bind proteins. The computational models generated by these Aims will be validated through statistical approaches and against bench-top experiments. Taken together, this approach will substantially improve on existing approaches by more accurately modeling the properties determining whether metabolism renders drugs toxic or safe. The predictive models will make new medicines safer by helping researchers avoid molecules prone to ADRs without harming patients. PROJECT NARRATIVE Adverse drug reactions, especially rare but severe hypersensitivity-driven reactions, have profound financial and health implications and are caused by reactive drug metabolites. As an extension of tools and data developed by our groups, we will build and test mathematical models and datasets that more accurately predict when molecules form clinically important reactive metabolites than current methodologies, such as structural alerts. We will use these models to build a tool that will better predict when drug candidates form reactive metabolites, which will make new medicines safer by enabling researchers to avoid drug candidates prone to causing adverse reactions.",DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY,9265938,R01LM012222,"['Algorithms ', ' necrocytosis ', ' Cell Death ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Dangerousness ', ' Death ', ' Cessation of life ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Skin Rash ', ' Rash ', ' Exanthem ', ' Exanthema ', ' Foundations ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' Allergy ', ' Hypersensitivity ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Literature ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Medicine ', ' Metabolic Activation ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Chemical Models ', ' Molecular Structure ', ' Macromolecular Structure ', ' Patients ', ' Proteins ', ' Publishing ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Role ', ' social role ', ' Stevens-Johnson Syndrome ', ' Erythema Multiforme Major ', ' Testing ', ' Time ', ' Mediating ', ' Dataset ', ' Data Set ', ' drug withdrawal ', ' macromolecule ', ' improved ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Series ', ' Chemicals ', ' hepatoxicity ', ' hepatic toxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Hepatotoxicity ', ' Withdrawal ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Relative Risks ', ' Biological Function ', ' Biological Process ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Metabolic ', ' gene function ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Immune ', ' Immunes ', ' Event ', ' Reaction ', ' Pattern ', ' Adverse reactions ', ' adduct ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' drug metabolism ', ' Modeling ', ' Property ', ' drug development ', ' immunogenic ', ' repository ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' liver metabolism ', ' hepatic metabolism ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Profiling ', ' in vitro Assay ', ' Validation ', ' Molecular ', ' Process ', ' protein function ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' immunogenicity ', ' quantum ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' drug candidate ', ' screening ', ' model building ', ' Assessment tool ', ' Assessment instrument ', ' online repository ', ' web-based repository ', ' web repository ', ' online archive ', ' experimental study ', ' experimental research ', ' experiment ', ' clinical development ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2017,374026,0.07188929896491424
"Biomedical Data Translator Technical Feasibility Assessment and Architecture Design A fundamental challenge to translate insights between biomedical researchers, who study biological mechanisms, and clinicians, who diagnose patient symptoms, is that many links between biological processes and disease pathophysiology are poorly understood. A comprehensive Biomedical Translator must enable chains of inference across objects as diverse as genetic mutations, molecular effects, tissue-specific expression patterns, cellular processes, organ phenotypes, disease states, patient symptoms, and drug responses, a challenge beyond the scope of any one organization. Fortunately, many individual links in this chain have been made by experiments yielding statistical connections between individual data types. High-throughput perturbation screens link chemical and genetic perturbations to cellular phenotypes such as gene-expression patterns, cell survival, or changes in phosphorylation. Genetic association studies link mutations to human disease or intermediate phenotypes and biomarkers. Electronic medical records (EMR) link diseases or human phenotypes to diagnostic or current procedural terminology (CPT) codes, and clinical trials link the impact of drugs and drug candidates on disease states. In principle, incorporating these links into chains of inference could translate results between the full set of data types within them. In practice, each link is maintained by experts with domain-specific experiments, semantic terminology, and methodological standards. While a key challenge faced by a global Biomedical Translator is to establish consistent standards across these existing data types, a more important goal is to develop a principled and robust framework to (a) model biological systems and experimental approaches to investigate them; (b) organize knowledge about biological mechanism and disease; and (c) incorporate diverse datasets that serve as windows into the underlying and unknown state of nature. We propose to implement a Biomedical Translator as a probabilistic graphical model, a paradigm from artificial intelligence (AI) research. Just as separate research communities form weakly coupled parts of the translation process, graphical models allow global inferences from weakly coupled nodes. These inferences require each node to publish only probability distributions, enabling interoperability without necessarily having global entity-resolution standards, and benefit from paradigms for quality control, fault tolerance, and relevance assessment common in AI research. We hypothesize that a limited number of APIs, implemented as probability computations by communities around the world, would yield a Biomedical Translator as an emergent property of weakly coupled knowledge sources. From basic properties of graphical models, such a Translator could probabilistically translate among any data types connected within it, allowing for relatively complex query concepts. For example: What cellular processes in which tissues are impacted in a patient-based EMR? What genetic mutations sensitize cells to small-molecule treatment effects? Which small molecules mimic genetic experiments of nature that protect against disease? To illustrate the value of these resources and our architectural paradigm, we propose a demonstration project to implement a Biomedical Translator supporting queries between small molecules, biological processes, genes, and disease. The demonstration project will provide a valuable first step to confront key data-integration and organizational challenges and will enable previously impossible queries, such as identifying small molecules that perturb the same biological processes implicated by human genetics in a disease context. In this capacity, such Translator could realistically identify existing drugs for known symptoms (i.e., repurposing), but could more broadly serve as an engine for hypothesis generation and biological discovery, suggesting pre-clinical small molecules to develop based on their observed biological activity, or providing heretofore novel links between cellular protein function and disease pathophysiology. ",Biomedical Data Translator Technical Feasibility Assessment and Architecture Design,9540181,OT3TR002025,"['Engineering / Architecture ', ' Architecture ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Viability ', ' Cell Survival ', ' Cell Body ', ' Cells ', ' Clinical Trials ', ' Communities ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Goals ', ' Modern Man ', ' Human ', ' Human Genetics ', ' Methodology ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Terminology ', ' Patients ', ' Phenotype ', ' Phosphorylation ', ' Protein Phosphorylation ', ' Probability ', ' Processed Genes ', ' Publishing ', ' Quality Control ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Semantics ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Generations ', ' Dataset ', ' Data Set ', ' base ', ' Organ ', ' Biological ', ' Link ', ' insight ', ' Individual ', ' Biological Function ', ' Biological Process ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Genetic ', ' Diagnostic ', ' Nature ', ' Knowledge ', ' Complex ', ' Source ', ' Pattern ', ' novel ', ' Modeling ', ' Property ', ' response ', ' Current Procedural Terminology Codes ', ' CPT Codes ', ' chemical genetics ', ' small molecule ', ' genetic association ', ' Symptoms ', ' DNA Sequence Alteration ', ' genomic alteration ', ' Sequence Alteration ', ' Genetic mutation ', ' DNA mutation ', ' DNA Alteration ', ' Data ', ' Resolution ', ' Translation Process ', ' Molecular ', ' protein function ', ' preclinical ', ' pre-clinical ', ' transcriptional signature ', ' gene expression signature ', ' gene expression pattern ', ' Expression Signature ', ' Gene Expression Profile ', ' data integration ', ' designing ', ' design ', ' Coupled ', ' treatment effect ', ' interoperability ', ' human disease ', ' biological systems ', ' drug candidate ', ' phenotypic biomarker ', ' phenotypic marker ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NCATS,"BROAD INSTITUTE, INC.",OT3,2017,651119,0.0059084244958927295
"Development of integrative models for early liver toxicity assessment     DESCRIPTION (provided by applicant): Computational toxicology has become a critical area of research due to the burgeoning need to evaluate thousands of pharmaceutical and environmental chemicals with unknown toxicity profiles, the high demand in time and resources by current experimental toxicity testing, and the growing ethical concerns over animal use in toxicity studies. Despite tremendous efforts, little success has been attained thus far in the development of predictive computational models for toxicity, primarily due to the complexity of toxicity mechanisms as well as the lack of high-quality experimental data for model development.  A critical challenge in toxicity testing of chemicals is that toxicity effects are doe-dependent: the true toxic hits may show no toxicity at all at low dose level. Therefore, traditiona high-throughput screening (HTS) that test chemicals only at a single concentration is not suitable for toxicity screening. On the contrary, the recently developed quantitative high-throughput screening (qHTS) platforms can evaluate each chemical across a broad range of concentrations, and is gaining ever-increasing popularity as a tool for in vitro toxicity profiling The concentration-response information generated by qHTS are expected to provide more accurate and comprehensive information of the toxicity effects of chemicals, offering promising data that can be mined to estimate in vivo toxicities of chemicals. However, our previous studies showed that if processed inappropriately, such concentration-response information contribute little to improve the toxicity prediction. This is especially true when multiple types of qHTS data are used together. Therefore, in this study, we will extend our previous approaches to develop novel statistical and computational tools that can curate, preprocess, and normalize the concentration-response information from multiple different qHTS databases.  Traditionally, toxicity models are based on either the chemical data (such as the quantitative structure- activity relationship analysis), or the in vitro toxicity profiling data (such as the in vitro-in vivo extrapolations). Our previous experiences suggested that integrating biological descriptors such as the in vitro cytotoxicity profiles or the short-term toxigenomic data, with chemical structural features is able to predict rodent acute liver toxicity with reasonable accuracy. Therefore, the second part of this proposal will be devoted to develop novel computational models for hepatotoxicity prediction by integrating qHTS toxicity profiles and chemical structural information In Aim 1, we will curate, preprocess, and normalize collected public liver toxicity datasets. In ths study, we will model toxicity effects using multiple large public datasets such as HTS and qHTS bioassay data (Tox21[1] and ToxCast[2]), hepatotoxicity side effect reports on marketed failed drugs[3], the Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD[4]), etc. Statistical methods for cross-study validation and quality control will be applied to the collected datasets to ensure computational compatibility and to select the appropriate datasets for analysis. In Aim 2, we will develop predictive models for chemicals' liver toxicity based on an integrative modeling workflow that will make use of both structural and in vitro toxicity profiles of a chemical. Our previous studies [5] showed that models using both in vitro toxicity profiles and chemical structural data have better accuracy for rodent acute liver toxicity than models using either data type alone. Here, we will develop a novel modeling workflow that start with defining the functional clusters of chemicals via curated qHTS toxicity profiles, and is followed by developing computational models to correlate chemical and biological data with overall toxicity risks in humans. The predictive models will be validated using independent datasets with over 800 compounds. In Aim 3, we propose to prioritize the qHTS profiling assays used in the model for future toxicity testing. We will evaluate all the in vitro assays as biological descriptors from thee perspectives, including descriptor importance in the integrative toxicity model, correlation with i vivo DILI outcomes, and level of information content estimated by a novel approach based on network analysis. PUBLIC HEALTH RELEVANCE: In this study we aim to develop computational models that can identify potential liver toxicants. Liver toxicity is a significant contributor to the high attition rate in drug development. Moreover, toxic chemicals in food, water, and consumer products all pose serious risks for liver toxicity. As a result, there is great interest in developing high-throughput, high-content experimental and computational tools to evaluate the liver toxicity of thousands of pharmaceutical and environmental chemicals. This study focuses on developing novel informatics tools that enable the extraction and integration of chemical concentration-response information from multiple quantitative high-throughput screening databases for model development, and developing statistical models that are able to integrate this concentration-response information with chemical structural features to predict their risk of liver toxicity.  ",Development of integrative models for early liver toxicity assessment,9333370,R03ES026397,"['Algorithms ', ' Animals ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' dreaming ', ' Dreams ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' ethical ', ' Ethics ', ' Food or Food Product ', ' Food ', ' Future ', ' Gene Expression ', ' Goals ', ' Gold ', ' Modern Man ', ' Human ', ' In Vitro ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Marketing ', ' Chemical Models ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' North Carolina ', ' Poisons ', ' toxic compound ', ' poison ', ' Toxic Substance ', ' Toxic Chemical ', ' Productivity ', ' Quality Control ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Rodent ', ' Rodents Mammals ', ' Rodentia ', ' Testing ', ' Time ', ' Toxicology ', ' Environmental Protection Agency ', ' United States Environmental Protection Agency ', ' USFDA ', ' Food and Drug Administration ', ' United States Food and Drug Administration ', ' Universities ', ' Hydrogen Oxide ', ' Water ', ' Dataset ', ' Data Set ', ' drug withdrawal ', ' base ', ' improved ', ' Area ', ' Acute ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Ensure ', ' Chemicals ', ' hepatoxicity ', ' hepatic toxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Hepatotoxicity ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Toxicity Testing ', ' Toxicity Tests ', ' Descriptor ', ' Shapes ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' Complex ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' consumer product ', ' cytotoxicity ', ' Lytotoxicity ', ' experience ', ' Performance ', ' success ', ' toxicant ', ' knowledge base ', ' knowledgebase ', ' Informatics ', ' Toxic effect ', ' Toxicities ', ' novel ', ' drug market ', ' validation studies ', ' Reporting ', ' Statistical Methods ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' response ', ' drug development ', ' high throughput screening ', ' High Throughput Assay ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' Genomics ', ' model development ', ' Toxicogenetics ', ' Toxicology Genetics ', ' Genetic Toxicology ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Address ', ' Dose ', ' Data ', ' International ', ' in vitro Assay ', ' in vivo ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Process ', ' developmental ', ' Development ', ' pre-clinical study ', ' preclinical study ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' NIEHS ', ' National Institute of Environmental Health Sciences ', ' cost ', ' data modeling ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' cost effective ', ' cost-effective ', ' Network-based ', ' environmental chemical ', ' public health relevance ', ' screening ', ' liver injury ', ' liver damage ', ' hepatic injury ', ' hepatic damage ', ' computational toxicology ', ' ']",NIEHS,UT SOUTHWESTERN MEDICAL CENTER,R03,2017,81000,0.18009966569362576
"Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC PROJECT SUMMARY The Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC (CMP-GA) is a cross-cutting team with advanced high-throughput chemical analytics and big data capabilities to develop a comprehensive map of molecular transducers of physical activity. The investigative team excels in ultrasensitive, precise and spatially resolved analyses of small molecules, lipids, and proteins. The team members have strong academic records as innovative, independent scientists, core laboratory directors and effective collaborators in complex research initiatives. Instrumentation includes state-of-the-art ultra-high resolution accurate mass high-field Orbitrap tandem mass spectrometry (MS) and ultraperformance liquid chromatography (UPLC); three- dimensional (3-D) molecular imaging via high throughput multi-modal MS at 5 m resolution; unique ion mobility-mass spectrometry machine-learning approaches for chemical identifications; and other such as GC- Orbitrap, 1D and 2D high field (800 MHz) NMR spectroscopy, ICP-MS, immunoassays, chemical and enzymatic assays, etc. The analytical laboratories are integrated through the NIH-supported Atlanta Clinical and Translational Sciences Institute, and operate within the outstanding research environment of Emory University and the Georgia Institute of Technology (GA Tech). CMP-GA has six elements organized to provide 1) leadership in the design and implementation of MoTrPAC goals; 2) bioinformatics, computational support and data delivery to the MoTrPAC Data Coordinating Center; 3) global, targeted and spatially resolved metabolomics; 4) metabolite forensics for unequivocal chemical identification of novel molecular transducers; 5) innovative proteomic and chemoproteomic technologies to define transducers within the redox proteome, ubiquitinome, acetylome, kinome and nuclear proteome; and 6) identification and quantification of lipid transducers. Through the successful completion of these aims and collaboration with the MoTrPAC consortium, investigators of CMP-GA will deliver a publically-available data resource and molecular transducer map that will enhance and accelerate mechanistic research on diseases and conditions affected by physical activity. PROJECT NARRATIVE This is a comprehensive metabolomics and proteomics chemical analysis site to support the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Advanced analytical methods, including mass spectrometry, bioinformatics and chemical forensics are used to provide targeted and global analysis of small molecules, lipids, proteins to develop a molecular transducer map for physical activity.",Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC,9246760,U24DK112341,"['Affect ', ' Aging ', ' Animal Research ', ' Animal Experimental Use ', ' Animal Experimentation ', ' Animals ', ' driving ', ' Automobile Driving ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Liquid Chromatography ', ' Clinical Study ', ' Clinical Research ', ' Communication ', ' Complement Proteins ', ' Complement ', ' Disorder ', ' Disease ', ' Elements ', ' Environment ', ' Exercise ', ' Forensics ', ' Forensic Medicine ', ' Goals ', ' Health ', ' Immunoassay ', ' Institutes ', ' instrumentation ', ' Isotopes ', ' Laboratories ', ' Leadership ', ' Lipids ', ' Maps ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Muscle ', ' muscular ', ' Muscle Tissue ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oxidation-Reduction ', ' oxidation reduction reaction ', ' Redox ', ' Particle Size ', ' Peptide Mapping ', ' Peptide Fingerprinting ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Time ', ' Transducers ', ' Universities ', ' cytokine ', ' Measures ', ' Health Benefit ', ' Mediating ', ' Custom ', ' analytical method ', ' Label ', ' Procedures ', ' Site ', ' Clinical ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Link ', ' Chemicals ', ' Training ', ' Physical activity ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Oxidative Stress ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' lectures ', ' Scientist ', ' Dimensions ', ' Complex ', ' Oral ', ' Protocols documentation ', ' Protocol ', ' Reaction ', ' System ', ' 3-Dimensional ', ' 3-D ', ' Nuclear ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neuro-degenerative Disorders ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' oxidized lipid ', ' tandem mass spectrometry ', ' novel ', ' member ', ' Modality ', ' Proteome ', ' Sampling ', ' response ', ' Proteomics ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Bioinformatics ', ' Bio-Informatics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Systems Biology ', ' Data ', ' Molecular Target ', ' Resolution ', ' Clinical Sciences ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Validation ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' ion mobility ', ' Data Coordination Center ', ' Data Coordinating Center ', ' designing ', ' design ', ' innovation ', ' innovative ', ' innovate ', ' advanced system ', ' ultra high resolution ', ' Big Data ', ' BigData ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' phenotypic biomarker ', ' phenotypic marker ', ' chemoproteomics ', ' data resource ', ' ']",NIDDK,EMORY UNIVERSITY,U24,2017,84511,0.07436405813847966
"Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC PROJECT SUMMARY The Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC (CMP-GA) is a cross-cutting team with advanced high-throughput chemical analytics and big data capabilities to develop a comprehensive map of molecular transducers of physical activity. The investigative team excels in ultrasensitive, precise and spatially resolved analyses of small molecules, lipids, and proteins. The team members have strong academic records as innovative, independent scientists, core laboratory directors and effective collaborators in complex research initiatives. Instrumentation includes state-of-the-art ultra-high resolution accurate mass high-field Orbitrap tandem mass spectrometry (MS) and ultraperformance liquid chromatography (UPLC); three- dimensional (3-D) molecular imaging via high throughput multi-modal MS at 5 m resolution; unique ion mobility-mass spectrometry machine-learning approaches for chemical identifications; and other such as GC- Orbitrap, 1D and 2D high field (800 MHz) NMR spectroscopy, ICP-MS, immunoassays, chemical and enzymatic assays, etc. The analytical laboratories are integrated through the NIH-supported Atlanta Clinical and Translational Sciences Institute, and operate within the outstanding research environment of Emory University and the Georgia Institute of Technology (GA Tech). CMP-GA has six elements organized to provide 1) leadership in the design and implementation of MoTrPAC goals; 2) bioinformatics, computational support and data delivery to the MoTrPAC Data Coordinating Center; 3) global, targeted and spatially resolved metabolomics; 4) metabolite forensics for unequivocal chemical identification of novel molecular transducers; 5) innovative proteomic and chemoproteomic technologies to define transducers within the redox proteome, ubiquitinome, acetylome, kinome and nuclear proteome; and 6) identification and quantification of lipid transducers. Through the successful completion of these aims and collaboration with the MoTrPAC consortium, investigators of CMP-GA will deliver a publically-available data resource and molecular transducer map that will enhance and accelerate mechanistic research on diseases and conditions affected by physical activity. PROJECT NARRATIVE This is a comprehensive metabolomics and proteomics chemical analysis site to support the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Advanced analytical methods, including mass spectrometry, bioinformatics and chemical forensics are used to provide targeted and global analysis of small molecules, lipids, proteins to develop a molecular transducer map for physical activity.",Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC,9516960,U24DK112341,"['Affect ', ' Aging ', ' Animal Research ', ' Animal Experimental Use ', ' Animal Experimentation ', ' Animals ', ' driving ', ' Automobile Driving ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Liquid Chromatography ', ' Clinical Study ', ' Clinical Research ', ' Communication ', ' Complement Proteins ', ' Complement ', ' Disorder ', ' Disease ', ' Elements ', ' Environment ', ' Exercise ', ' Forensics ', ' Forensic Medicine ', ' Goals ', ' Health ', ' Immunoassay ', ' Institutes ', ' instrumentation ', ' Isotopes ', ' Laboratories ', ' Leadership ', ' Lipids ', ' Maps ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Muscle ', ' muscular ', ' Muscle Tissue ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oxidation-Reduction ', ' oxidation reduction reaction ', ' Redox ', ' Particle Size ', ' Peptide Mapping ', ' Peptide Fingerprinting ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Time ', ' Transducers ', ' Universities ', ' cytokine ', ' Measures ', ' Health Benefit ', ' Mediating ', ' Custom ', ' analytical method ', ' Label ', ' Procedures ', ' Site ', ' Clinical ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Link ', ' Chemicals ', ' Training ', ' Physical activity ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Oxidative Stress ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' lectures ', ' Scientist ', ' Dimensions ', ' Complex ', ' Oral ', ' Protocols documentation ', ' Protocol ', ' Reaction ', ' System ', ' 3-Dimensional ', ' 3-D ', ' Nuclear ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neuro-degenerative Disorders ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' oxidized lipid ', ' tandem mass spectrometry ', ' novel ', ' member ', ' Modality ', ' Proteome ', ' Sampling ', ' response ', ' Proteomics ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Bioinformatics ', ' Bio-Informatics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Systems Biology ', ' Data ', ' Molecular Target ', ' Resolution ', ' Clinical Sciences ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Validation ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' ion mobility ', ' Data Coordination Center ', ' Data Coordinating Center ', ' designing ', ' design ', ' innovation ', ' innovative ', ' innovate ', ' advanced system ', ' ultra high resolution ', ' Big Data ', ' BigData ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' phenotypic biomarker ', ' phenotypic marker ', ' chemoproteomics ', ' data resource ', ' ']",NIDDK,EMORY UNIVERSITY,U24,2017,149094,0.07436405813847966
"Integrating cheminformatics and molecular simulations for virtual drug screening     DESCRIPTION (provided by applicant): The development of highly efficient and accurate approaches to structure-based virtual screening (VS) continues to represent a formidable challenge in the field of computational drug discovery. Outstanding and widely recognized research problems in the field include the relative computational inefficiency of most approaches, which limits the size of molecular libraries used for virtual screening; the low hit rate; and the inaccurate prediction of ligand binding affinity and pose. The proposed studies address these challenges by using innovative and computationally efficient approaches to VS that fully integrate concepts from the complementary fields of cheminformatics and molecular simulation to devise an integrated two-step VS methodology. Building upon our experience in cheminformatics and QSAR modeling, we aim to develop novel, computationally efficient cheminformatics approaches to pre-process very large (on the order of 107 compounds) chemical libraries available for biological screening, and eliminate up to 99% of improbable ligands. Only the remaining 1% of probable ligands will be evaluated by slower but accurate ensemble flexible docking approaches relying on molecular simulation techniques. The cheminformatics step will also produce important information on privileged protein-ligand interactions that will be used in a live-processing step to guide the structure-based virtual screening and avoid oversampling of ligand poses. Moreover, post- processing cheminformatics methods will be implemented to filter out decoy poses from docking calculations. The ultimate goal of our hybrid methodology is to arrive at a small set of high-affinity computational hits in receptor-bound conformations that can be validated experimentally. We will pursue this goal following three specific aims: 1) Develop novel cheminformatics-based virtual screening approaches to eliminate both improbable ligands and improbable poses, as well as generate information on preferred protein-ligand interactions; 2) Develop new, efficient flexible ensemble docking methods guided by the preferred protein- ligand interactions to select the most probable ligands and predict their binding poses; 3) Apply the developed hierarchical virtual screening workflow to several therapeutic targets and test high-confidence computational hits in experimental assays. All computational tools resulting from this project will be made publicly available. This proposal is innovative because the proposed VS platform will result from a unique marriage of disparate approaches for VS, combining their corresponding strengths. This proposal is significant because the implementation of this project will enable substantial improvement in the efficiency, accuracy, and experimentally-confirmed impact of structure-based drug discovery tools. PUBLIC HEALTH RELEVANCE: Advances in drug discovery rely on the development of novel effective computational methodologies. This proposal advances an efficient and robust computational workflow for structure-based virtual screening of very large chemical libraries. The ultimate goal of this project is to arrive at a small number of candidate molecules with high predicted binding affinity to their biological targets, which will be tested in confirmatory experiments.",Integrating cheminformatics and molecular simulations for virtual drug screening,9325031,R01GM114015,"['Affect ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Biological Availability ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Pre-clinical Drug Evaluation ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Goals ', ' Hybrids ', ' Libraries ', ' Ligands ', ' Marriage ', ' Methods ', ' Methodology ', ' Mining ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Pharmacology ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Proteins ', ' Research ', ' sperm cell ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' Vertebral column ', ' backbone ', ' Spine ', ' Spinal Column ', ' Technology ', ' Testing ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Biological ', ' Series ', ' Active Sites ', ' Chemicals ', ' Orphan ', ' Descriptor ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Side ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Benchmarking ', ' Best Practice Analysis ', ' experience ', ' molecular size ', ' Performance ', ' receptor binding ', ' receptor bound ', ' small molecule libraries ', ' chemical library ', ' user friendly software ', ' user friendly computer software ', ' Structure ', ' simulation ', ' novel ', ' G-Protein-Coupled Receptors ', ' GPCR ', ' G Protein-Coupled Receptor Genes ', ' G Protein-Complex Receptor ', ' Modeling ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' drug discovery ', ' Binding ', ' Molecular Interaction ', ' therapeutic evaluation ', ' therapeutic testing ', ' cheminformatics ', ' chemical informatics ', ' small molecule ', ' Address ', ' Affinity ', ' Molecular Bank ', ' molecular library ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' developmental ', ' Development ', ' virtual ', ' computational tools ', ' computerized tools ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' innovation ', ' innovative ', ' innovate ', ' therapeutic target ', ' public health relevance ', ' flexibility ', ' flexible ', ' screening ', ' Computational Geometry ', ' improved outcome ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NIGMS,UNIV OF NORTH CAROLINA CHAPEL HILL,R01,2017,293344,0.05662815169959435
"Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization Project Summary  The proposed work will accelerate the pace of drug discovery by developing, validating, and testing new methods, tools, and resources for structure-based drug design. Two fundamental challenges of structure-based drug design are the accurate scoring and ranking of protein-ligand structures, which identies active com- pounds, and the ability to efciently search a large number of ligands, which ensures that active compounds are sampled. This proposal will address these challenges by developing a novel approach for protein-ligand scoring and expanding the size of the chemical space that can be efciently searched during lead optimiza- tion. The methods will be validated by their prospective application toward the discovery of new anti-cancer molecules and will be made readily accessible through online resources and open-source tools.  The proposal leverages recent and signicant advances in deep learning and image recognition to develop scoring functions that accurately recognize high-afnity protein-ligand interactions. This is achieved by design- ing and training convolutional neural nets on three-dimensional representations of protein-ligand structures to discriminate between binders and non-binders. Convolutional neural net training will exploit large datasets of afnity and structural data to automatically extract the relevant features necessary to accurately prioritize compounds. Additionally, the proposal develops the rst means of fully integrating a convolutional neural net scoring function directly into an energy minimization and docking workow.  Interactive virtual screening enables the search of millions of compounds in a few seconds so that queries can be interactively optimized. Interactivity enables the synergistic unication of human expert knowledge and efcient computational algorithms. The proposed work will dramatically expand the size of chemical space ac- cessible through interactive virtual screening. Algorithms for efciently searching the chemical space of billions or trillions of compounds implicitly dened by a set of reaction schemas and fragments will be created as part of a lead optimization workow. Fragment-oriented search will be accelerated by a new data structure that combines pharmacophore and molecular shape information into a single sub-linear time index.  The scoring and lead optimization methods developed in this proposal will be released as open-source soft- ware and made immediately available through open-access online resources. As part of the prospective valida- tion of the proposed methods, these resources will be used to identify hit compounds and optimize leads for two targets related to cancer metabolism: serine hydroxymethyltransferase and kidney glutaminase isoform C. Successful completion of the objectives of this proposal will positively impact public health by reducing the cost and time-to-market of developing new drugs, particularly with respect to novel protein targets. Project Narrative  Researchers will be able to more quickly and accurately identify potential drug candidates using the new methods, tools, and resources for structure-based drug discovery created by this project. These tools will be readily accessible through open-access web sites and open-source software. As part of the project these tools will be used to identify new molecules that are relevant to the treatment of cancer.","Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization",9235506,R01GM108340,"['Algorithms ', ' Award ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Cellular Growth ', ' Cellular Expansion ', ' cell growth ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Drug Design ', ' Environment ', ' Feedback ', ' Liver Glutaminase ', ' L glutamine amidohydrolase ', ' GA Protein ', ' EC 3.5.1.2 ', ' Breast Cell Glutaminase ', ' Glutaminase ', ' Q. Levoglutamide ', ' Q Levoglutamide ', ' L-Glutamine ', ' Gln ', ' Glutamine ', ' Modern Man ', ' Human ', ' In Vitro ', ' indexing ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Libraries ', ' Ligands ', ' Methods ', ' Modernization ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Play ', ' Proteins ', ' Public Health ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Glycine Hydroxymethyltransferase ', ' Threonine Aldolase ', ' Serine Transhydroxymethylase ', ' Serine Hydroxymethyltransferase ', ' Serine Hydroxymethylase ', ' Serine Aldolase ', ' Allothreonine Aldolase ', ' Computer software ', ' Software ', ' Testing ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' Visualization ', ' Imagery ', ' base ', ' improved ', ' Biochemical ', ' Ensure ', ' Chemicals ', ' Training ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Knowledge ', ' Dimensions ', ' Dependence ', ' Reaction ', ' Cell Proliferation ', ' Cellular Proliferation ', ' Cell Multiplication ', ' Cell Growth in Number ', ' molecular shape ', ' neoplastic cell ', ' Tumor Cell ', ' Performance ', ' Protein Isoforms ', ' Isoforms ', ' success ', ' Biological Neural Networks ', ' neural network ', ' pharmacophore ', ' relating to nervous system ', ' neural ', ' resource guides ', ' Structure ', ' novel ', ' Sampling ', ' Neural Network Simulation ', ' Perceptrons ', ' Neural Network Models ', ' Connectionist Models ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' drug discovery ', ' RANK protein ', ' receptor activator of NF-kappaB ', ' TNFRSF11A gene product ', ' Effectiveness ', ' cheminformatics ', ' chemical informatics ', ' Address ', ' Affinity ', ' Data ', ' Research Infrastructure ', ' Infrastructure ', ' in vivo ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' Modification ', ' imaging ', ' Image ', ' website ', ' web site ', ' cost ', ' virtual ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' tumor xenograft ', ' blind ', ' prospective ', ' combinatorial ', ' user-friendly ', ' Computational algorithm ', ' computer algorithm ', ' data structure ', ' web interface ', ' open source ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' overexpression ', ' overexpress ', ' over-expression ', ' drug candidate ', ' tumor metabolism ', ' tumor cell metabolism ', ' cancer metabolism ', ' cancer cell metabolism ', ' screening ', ' Algorithmic Software ', ' Software Algorithm ', ' Algorithmic Tools ', ' online resource ', ' web-based resource ', ' web resource ', ' on-line resource ', ' internet resource ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2017,309750,0.12914649675204226
"Illuminating Function of the Understudied Druggable Kinome Project Summary/Abstract Kinases are among the most important drug targets and clinically significant kinase inhibitors have been developed for multiple diseases. A subset of kinases, the understudied dark kinases (DKs), have received little or no attention because foundational data on their biochemical and biological functions is not available. This proposal will collect such data by perturbing DKs genetically and with small molecules and then measuring the cellular consequences using multiplex proteomic, gene expression, metabolomic and imaging assays. A subset of DKs with potential links to human disease will be intensively studied as a means to qualify new therapeutic drug targets. Data collected in this project will be aggregated with existing information from previous NIH-funded large-scale structural and genomic projects to create a Dark Kinase Knowledgebase (DKK) that provides gene-by-gene and network-level information on the dark kinome and its interaction with other signal transduction and regulatory networks. Close coordination with the NIH LINCS project will ensure data interoperability and make efficient use of informatics tools. The DKK will be developed in collaboration with the IDG Knowledge Management Center (KMC), adhere to standards for Findable, Accessible, Interoperable and Reusable (FAIR) data, and be accessible to human users and machines (via an API). Commercially available DK reagents be validated and extended with new genetic and chemical tools provided to the Resource Dissemination Center (RDOC). The overall approach will be iterative, with simpler methods applied first (e.g. simple gene knockout) and more sophisticated methods subsequently (e.g. stable CRIPSRa/i) pursued by an interdisciplinary team of chemists, computational biologists, mass spectroscopists and pharmacologists working on five linked aims. Aim 1 will develop a computational algorithm for prioritizing DKs, develop and maintain the DKK, and perform network-level analysis on the kinome using supervised and unsupervised machine learning. Aim 2 will measure kinase abundance in normal and perturbed cells using parallel reaction monitoring with stable isotope dilution (PRM-SID) and RNASeq and data analyzed using network inference tools to provide insight into dark and light kinome in diverse cell types. Aim 3 will perturb DKs with genetic tools such as CRIPSR/Cas9-mediated gene knockout, CRIPSRa/i to induce more subtle-up and down regulation and inducible gene inaction. The impact on cell fate, morphology and signal transduction will then be determined using PRM-SID, phosphoproteomics, RNASeq, gene reporter assays, metabolomics profiling and highly multiplex single-cell imaging. Aim 4 will extend DK analysis to small molecule inhibitors by carefully profiling existing drugs against DKs and by designing and synthesizing new chemical ligands. Aim 5 will involve collaboration with other investigators to assay the expression and function of DKs in primary human cells and tissues relevant to the NIH Precision Medicine Initiative. All aims will be pursued in parallel for a progressively expanding resource of data and tools for continued study of DKs. Project Narrative/Health Relevance Advancing understanding of understudied kinases, a highly druggable class of proteins, will increase knowledge about signal transduction and control over cellular physiology and is likely to reveal a subset of proteins that should be advanced as targets for new therapeutic drugs.",Illuminating Function of the Understudied Druggable Kinome,9453342,U24DK116204,"['Algorithms ', ' joint inflammation ', ' arthritic ', ' Arthritis ', ' Attention ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' Complement Proteins ', ' Complement ', ' Mucoviscidosis ', ' Cystic Fibrosis ', ' Darkness ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Downregulation ', ' Down-Regulation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' Foundations ', ' Gene Expression ', ' Genes ', ' Goals ', ' Health ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Modern Man ', ' Human ', ' Libraries ', ' Ligands ', ' Light ', ' Photoradiation ', ' Logic ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Phenotype ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Play ', ' Production ', ' Proteins ', ' Reagent ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Supervision ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Upregulation ', ' Up-Regulation ', ' Generations ', ' Measures ', ' Mediating ', ' Signal Transduction Pathway ', ' base ', ' Site ', ' Biological ', ' Biochemical ', ' Reporter Genes ', ' Link ', ' Ensure ', ' biosynthesis ', ' Anabolism ', ' Chemicals ', ' insight ', ' Individual ', ' Measurement ', ' Funding ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Therapeutic ', ' stable isotope ', ' Genetic ', ' Morphology ', ' Reporter ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Reaction ', ' cell type ', ' Tumor Tissue ', ' knockout gene ', ' knowledge base ', ' knowledgebase ', ' Informatics ', ' novel ', ' Information Resources Management ', ' Knowledge Management ', ' Modeling ', ' protein protein interaction ', ' drug development ', ' Proteomics ', ' kinase inhibitor ', ' structural genomics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Data ', ' Mutate ', ' Resolution ', ' Collection ', ' Validation ', ' Monitor ', ' Molecular ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' meta data ', ' Metadata ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' innovation ', ' innovative ', ' innovate ', ' clinically significant ', ' clinical significance ', ' interoperability ', ' Computational algorithm ', ' computer algorithm ', ' human disease ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' therapeutic target ', ' therapeutic development ', ' therapeutic agent development ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' screening ', ' Drug Targeting ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' CRISPR/Cas system ', ' CRISPR ', ' Precision Medicine Initiative ', ' small molecule inhibitor ', ' metabolic profile ', ' phosphoproteomics ', ' phospho-proteomics ', ' FAIR principles ', ' Findable, Accessible, Interoperable, and Reusable ', ' FAIR data ', ' data resource ', ' ']",NIDDK,UNIV OF NORTH CAROLINA CHAPEL HILL,U24,2017,2308193,0.06041628026753181
"Quantifying the role of adaptation in olfactory coding through the logic of navigation  Project Narrative This project will contribute to our understanding of how the olfactory sensory periphery and neural circuitry have evolved to effectively encode our vast and varied chemical environment. The project will help reveal how odor discrimination capability is maintained in natural odor landscapes, leading to practical interventional strategies for the control of disease vectors such as tsetse flies and mosquitos, who rely critically on their sense of smell to navigate. Chemical sensing is the only shared sensation among organisms as simple as bacteria and as complex as humans, and this project will enhance our fundamental knowledge of this universal sensory modality.",Quantifying the role of adaptation in olfactory coding through the logic of navigation,9667825,F32MH118700,[''],NIMH,YALE UNIVERSITY,F32,2018,63654,0.15056336310371132
"Digital representation of chemical mixtures to aid drug discovery and formulation PROJECT SUMMARY Collaborative Drug Discovery, Inc. (CDD) proposes to develop a suite of software modules to enable scientists to unambiguously represent chemical mixtures in standard machine-readable formats, filling an urgent and widely-recognized need. Chemicals are typically formulated as mixtures. Recording and communicating information about chemical mixtures is essential for scientists and support staff in the pharmaceutical industry, in academia, in non-profit research organizations, in government, at specialty chemical vendors, and at commercial manufacturers to:  discover, develop, formulate, manufacture and regulate drugs;  manage reagent inventories; comply with laboratory safety requirements; inform first responders;  describe and reproduce biomedical experiments; and  assess and disseminate information about toxicity risks of chemical reagents and consumer products.  A working committee of the International Union of Pure and Applied Chemistry (IUPAC) is close to formalizing Mixtures InChI (or MInChI), which will extend the International Chemical Identifier (InChI) to become the first standard to encompass mixtures. MInChI will effectively index mixtures in the same way that InChI indexes individual compounds.  CDD will first develop the data structures and software necessary to enable adoption and utilization of MInChI and create the first general-purpose system for recording information about chemical mixtures that is computable and interoperable. The most innovative part of the project and the bulk of the effort will be to develop a sophisticated automated translation tool that will accurately convert legacy catalogs of chemical mixtures from plaintext descriptions or ad hoc formats so that they are properly represented in a machine readable format that can in turn be easily rendered into MInChI identifiers. The broad vision is to help industry to overcome the barriers to adoption so that MInChI can quickly deliver benefits for drug discovery, chemical safety, and toxicology. PROJECT NARRATIVE The proposed project will create novel computational tools that will help researchers to efficiently and accurately document the composition of chemical mixtures in a format that computers can easily interpret, process, and exchange. This innovative capability will help to accelerate the discovery and development of novel and improved drugs against a wide range of diseases. It will also help to advance our understanding of the toxicology of mixtures (which often differs from the toxicology of individual components) and improve laboratory safety both in industry and in educational settings. !",Digital representation of chemical mixtures to aid drug discovery and formulation,9611819,R43TR002528,"['Adoption ', ' Chemistry ', ' Computers ', ' Disease ', ' Disorder ', ' Drug Industry ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Elements ', ' Government ', ' Human ', ' Modern Man ', ' indexing ', ' Industry ', ' Equipment and supply inventories ', ' Inventory ', ' Laboratories ', ' Methods ', ' Names ', ' Reagent ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Safety ', ' Shorthand ', ' Computer software ', ' Software ', ' Solvents ', ' medical specialties ', ' Specialty ', ' Technology ', ' Toxicology ', ' Traction ', ' Translations ', ' Vendor ', ' Vision ', ' visual function ', ' Sight ', ' cofactor ', ' improved ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Visual ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' Collaborations ', ' Letters ', ' tool ', ' English Language ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Anti-HIV Agents ', ' antiAIDS agent ', ' Anti-Human Immunodeficiency Virus Agents ', ' Anti-HIV Drugs ', ' Anti-AIDS Drugs ', ' Anti-AIDS Agents ', ' AIDS Drugs ', ' Catalogs ', ' Scientist ', ' System ', ' Drug Formulations ', ' Services ', ' consumer product ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' member ', ' Code ', ' Coding System ', ' Modeling ', ' Readability ', ' drug discovery ', ' Manufacturer Name ', ' Manufacturer ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Address ', ' Academia ', ' Data ', ' International ', ' Research Infrastructure ', ' Infrastructure ', ' Process ', ' Text ', ' developmental ', ' Development ', ' first responder ', ' emergency service responder ', ' emergency service personnel ', ' Emergency responder ', ' emergency service/first responder ', ' digital ', ' computational tools ', ' computerized tools ', ' innovative ', ' innovate ', ' innovation ', ' interoperability ', ' data structure ', ' open source ', ' natural language ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NCATS,"COLLABORATIVE DRUG DISCOVERY, INC.",R43,2018,149471,0.19074195678426362
"Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery Project Summary High-throughput omics technologies allow for measuring various biomolecules comprehensively and over the past decade have become exponentially less expensive. Coupling these developing emerging technologies with automation approaches and the phenotypic-based drug discovery paradigm allows for data-driven drug discovery (D4). D4 focuses on a complete cellular readout, quantitatively measuring 100s to 100,000s of biomolecules, rather than focusing on a single protein, pathway, or physiological trait. The complexity of this data requires computational tools for proper analysis and interpretation. A pioneering project and dataset for D4 is the Broad Institutes Connectivity Map, which is a transcriptomics screening and query platform for drug characterization, discovery, and repositioning. Though with many successes, the Connectivity Map is based on only a single biomolecule type, RNA, and downstream effects caused by chemical perturbations to proteins and metabolites are ignored. In this proposal, we combine the dual strengths of experts in LC-MS/MS based metabolomics (Omix Technologies) with leaders in metabolic network modeling and metabolomics data analysis (Sinopia Biosciences) to develop a metabolomics based high-throughput compound screening platform. Our preliminary data for two major drugs (doxorubicin and rapamycin) showcases that our approach has technical validity, accuracy, and provides potential biological utility that complements transcriptomics based approaches. This Phase I proposal will assess the biological utility of a metabolomics-based screening platform. First, we will profile ~250 FDA approved small molecules from a broad range of drug classes. Second, we will develop the necessary bioinformatics pipelines, mechanistic metabolic models, and machine learning algorithms to analyze and interpret these complex datasets. Finally, we will assess whether adding metabolomics data to the Connectivity Map boosts D4 predictions including assessing compound mechanisms of actions, compound similarity, identifying biomarkers for drug efficacy and safety, and identifying drug repurposing opportunities. After the biological utility of this approach is demonstrated in Phase I, Phase II will focus on profiling of novel chemical and genetic perturbations to further demonstrate the power of the platform and identify commercial opportunities for treating rare genetic diseases. Project Narrative Data-driven drug discovery provides the potential to accelerate drug development timelines, decrease costs, and ultimately provide better care to patients. Combining Sinopia Biosciences and Omix Technologies strengths in high-throughput data generation and analysis, we will build a unique platform focused on the impact of human metabolism in disease. This proposal will test the viability of this approach and focus on several rare genetic diseases with significant unmet needs.",Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery,9621965,R43GM130268,"['Age ', ' ages ', ' Algorithms ', ' inhibitor/antagonist ', ' inhibitor ', ' Automation ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Sciences ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' cell growth ', ' Cellular Growth ', ' Cellular Expansion ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Complement ', ' Complement Proteins ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Disease ', ' Disorder ', ' Doxorubicin ', ' Hydroxyldaunorubicin ', ' Hydroxyl Daunorubicin ', ' Doxorubicina ', ' Adriamycine ', ' 14-Hydroxydaunomycin ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Evolution ', ' Gene Expression ', ' Human ', ' Modern Man ', ' In Vitro ', ' Institutes ', ' Luminescent Proteins ', ' Photoproteins ', ' Bioluminescent Proteins ', ' Maps ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methodology ', ' Patients ', ' Pharmaceutical Services ', ' Pharmacy Services ', ' Pharmaceutic Services ', ' Phenotype ', ' Physiological Processes ', ' Physiologic Processes ', ' Organismal Process ', ' Organism-Level Process ', ' Proteins ', ' Research ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Safety ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Time ', ' Sirolimus ', ' Rapamycin ', ' Rapamune ', ' Generations ', ' Measures ', ' TimeLine ', ' Data Set ', ' Dataset ', ' Caring ', ' base ', ' improved ', ' Phase ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Chemicals ', ' Data Quality ', ' Measurement ', ' Metabolic Networks ', ' Biochemical Pathway ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Dimensions ', ' Complex ', ' MCF7 cell ', ' MCF7 ', ' MCF-7WT ', ' MCF-7DR ', ' MCF-7 Cell ', ' MCF-7 ', ' success ', ' drug efficacy ', ' synergism ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' trait ', ' novel ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' drug development ', ' high throughput screening ', ' High Throughput Assay ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' drug discovery ', ' Bioinformatics ', ' Bio-Informatics ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' chemical genetics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Microarray Analysis ', ' microarray technology ', ' microarray analyses ', ' Microarray-Based Analysis ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' in vivo ', ' Emergent Technologies ', ' Emerging Technologies ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' protein metabolite ', ' cost ', ' computational tools ', ' computerized tools ', ' data integration ', ' Cancer cell line ', ' cost efficient ', ' Coupling ', ' innovative ', ' innovate ', ' innovation ', ' transcriptomics ', ' data acquisition ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' network models ', ' commercialization ', ' FDA approved ', ' molecular phenotype ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' screening ', ' multi-omics ', ' multiple omics ', ' Expression Profiling ', ' genetic disorder ', ' genetic condition ', ' Genetic Diseases ', ' ']",NIGMS,"SINOPIA BIOSCIENCES, INC.",R43,2018,413484,0.07312375889203632
"Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level Project summary: Although altered cell metabolism is becoming an established hallmark of cancer, there remains a crucial need of new tools for quantitation of metabolites at single living cell level. In particular, due to lack of specific labels for metabolites, there is an unmet need for high-resolution imaging tools capable of mapping metabolites and small molecules (fatty acids, carbohydrates, amino acids) that play essential roles in pathogenesis of cancer. Supported by a R21 grant through the IMAT program, our team partially addressed this need via developing a multiplex stimulated Raman scattering (SRS) microscope, which enabled vibrational imaging of metabolites in live tumor cells and intact biopsies at the speed of 5 microseconds per spectrum. This R33 application aims to push the hyperspectral stimulated Raman imaging technology to the next level through (i) technical simplification and validation, (ii) developing a robust hyperspectral image segmentation framework, and (iii) integrating the SRS modality with a commercial spontaneous Raman microscope towards broad use by non-experts. We have assembled an inter-disciplinary team for the proposed development. The three specific aims are: (1) Developing an easy-to-operate, highly sensitive line-by-line hyperspectral SRS microscope and validate its capacity for cancer metabolic imaging at single cell level. (2) Establishing a feature analysis framework for segmentation of hyperspectral SRS images using the non-parametric Bayesian model. (3) Integrating and validating the stimulated Raman imaging modality on a spontaneous Raman microscope. By completing the proposed development and validation activities, we will have generated a highly novel spectroscopic imaging system broadly applicable to analysis of chemical contents of cells and tissues for discovery-driven research and marker- based precision diagnosis. Project Narrative: Altered cell metabolism is becoming an established hallmark of cancer. We propose a label-free stimulated Raman spectroscopic imaging system broadly applicable to analysis of chemical contents of cells and tissues for discovery-driven cancer research and marker-based precision diagnosis.",Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level,9565020,R33CA223581,"['Amino Acids ', ' aminoacid ', ' Amplifiers ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbohydrates ', ' Cells ', ' Cell Body ', ' Color ', ' Diagnosis ', ' Dimethyl Sulfoxide ', ' Dromisol ', ' Domoso ', ' Dimethylsulphoxide ', ' Dimethylsulphinyl ', ' Demeso ', ' Demasorb ', ' DMSO ', ' Endoplasmic Reticulum ', ' Ergastoplasm ', ' Fatty Acids ', ' Flow Cytometry ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Grant ', ' Hybrids ', ' Industrialization ', ' Lipids ', ' Microscopy ', ' Electron Microscopy ', ' Fluorescence Microscopy ', ' Fluorescence Light Microscopy ', ' Patients ', ' Play ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Raman Spectrum Analysis ', ' Raman spectrometry ', ' Raman Spectroscopy ', ' IR/UV/Raman Spectroscopy ', ' Time ', ' Tissue Extracts ', ' Tissues ', ' Body Tissues ', ' Water ', ' Hydrogen Oxide ', ' Businesses ', ' Visualization ', ' Imagery ', ' base ', ' Label ', ' Microscope ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Chemicals ', ' Bayesian posterior distribution ', ' Bayesian classification procedure ', ' Bayesian classification method ', ' Bayesian approaches ', ' Bayesian Statistical Method ', ' Bayesian Methodology ', ' Bayesian Method ', ' Collaborations ', ' Metabolic ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' instrument ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' millisecond ', ' Msec ', ' Side ', ' System ', ' vibration ', ' neoplastic cell ', ' Tumor Cell ', ' particle ', ' Speed ', ' novel ', ' Modality ', ' Pathogenesis ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' imaging modality ', ' imaging method ', ' image-based method ', ' small molecule ', ' Address ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Imaging Device ', ' Imaging Tool ', ' Imaging Instrument ', ' Molecular Analysis ', ' Resolution ', ' Cancer Biology ', ' Validation ', ' Monitor ', ' Molecular ', ' cellular metabaolism ', ' cell metabolism ', ' Cellular Metabolic Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cancer research ', ' anti-cancer research ', ' anticancer research ', ' imaging spectroscopy ', ' spectroscopic imaging ', ' tumor imaging ', ' oncology imaging ', ' oncologic imaging ', ' cancer imaging ', ' malignant stem cell ', ' cancer stem cell ', ' Imaging technology ', ' imaging Segmentation ', ' commercialization ', ' endoplasmic reticulum stress ', ' tumor cell metabolism ', ' cancer metabolism ', ' cancer cell metabolism ', ' tumor metabolism ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' imaging system ', ' targeted imaging ', ' cancer markers ', ' cancer biomarkers ', ' 3D culture ', ' 3D cell culture ', ' three dimensional cell culture ', ' high resolution imaging ', ' human imaging ', ' metabolic imaging ', ' ']",NCI,BOSTON UNIVERSITY (CHARLES RIVER CAMPUS),R33,2018,390880,0.051274442657896845
"DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY     DESCRIPTION (provided by applicant):         Adverse drug reactions (ADRs) are dangerous and expensive, afflicting about 1.5% of hospitalized patients with profound health and financial consequences. In Medicare patients alone, adverse drug reactions account for 19% of total spending ($339 billion), more than 1,900 deaths, and more than 77,000 extra hospital days per year. Idiosyncratic ADRs, especially rare and severe hypersensitivity-driven ADRs, are the leading cause of medicine withdrawal and termination of clinical development. At the same time, a large proportion of drugs are not associated with hypersensitivity driven ADRs, offering hope that new medicines could avoid them entirely with reliable predictors of risk. Hypersensitivity driven ADRs are caused by the formation of chemically reactive metabolites by metabolic enzymes. These reactive metabolites covalently attach to proteins to become immunogenic and provoke an ADR. Unfortunately, current computational and experimental approaches do not reliably identify drug candidates that form reactive metabolites. These approaches are limited because they inadequately model metabolism, which can both render toxic molecules safe and safe molecules toxic. To overcome this limitation, the proposed study aims to curate a public database of metabolism and reactivity and use this database to build accurate and validated mathematical models of metabolism and reactivity. The models will be constructed using machine-learning algorithms that quantitatively summarize the knowledge from thousands of published studies. The Aims are to (1) curate a database of metabolism and build models that identify rules governing the structure of reaction products during drug metabolism in the liver, (2) curate a database of reactivity and build improved reactivity models that mechanistically predict which metabolites are reactive with biological molecules, and (3) curate a database of reactive metabolites and combine these models to predict when molecules form reactive metabolites that covalently bind proteins. The computational models generated by these Aims will be validated through statistical approaches and against bench-top experiments. Taken together, this approach will substantially improve on existing approaches by more accurately modeling the properties determining whether metabolism renders drugs toxic or safe. The predictive models will make new medicines safer by helping researchers avoid molecules prone to ADRs without harming patients. PROJECT NARRATIVE Adverse drug reactions, especially rare but severe hypersensitivity-driven reactions, have profound financial and health implications and are caused by reactive drug metabolites. As an extension of tools and data developed by our groups, we will build and test mathematical models and datasets that more accurately predict when molecules form clinically important reactive metabolites than current methodologies, such as structural alerts. We will use these models to build a tool that will better predict when drug candidates form reactive metabolites, which will make new medicines safer by enabling researchers to avoid drug candidates prone to causing adverse reactions.",DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY,9479284,R01LM012222,"['Algorithms ', ' Cell Death ', ' necrocytosis ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Dangerousness ', ' Cessation of life ', ' Death ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Enzymes ', ' Enzyme Gene ', ' Exanthema ', ' Skin Rash ', ' Rash ', ' Exanthem ', ' Foundations ', ' Health ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Hypersensitivity ', ' Allergy ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Length of Stay ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Literature ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Medicine ', ' Metabolic Activation ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Chemical Models ', ' Molecular Structure ', ' Macromolecular Structure ', ' Patients ', ' Proteins ', ' Publishing ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Role ', ' social role ', ' Stevens-Johnson Syndrome ', ' Erythema Multiforme Major ', ' Testing ', ' Time ', ' Mediating ', ' Data Set ', ' Dataset ', ' drug withdrawal ', ' macromolecule ', ' improved ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Series ', ' Chemicals ', ' hepatoxicity ', ' hepatic toxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Hepatotoxicity ', ' Withdrawal ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data base ', ' Data Bases ', ' Databases ', ' Relative Risks ', ' Biological Function ', ' Biological Process ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Metabolic ', ' gene function ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Immune ', ' Immunes ', ' Event ', ' Reaction ', ' Pattern ', ' Adverse reactions ', ' adduct ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' drug metabolism ', ' Modeling ', ' Property ', ' drug development ', ' immunogenic ', ' repository ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' liver metabolism ', ' hepatic metabolism ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' in vitro Assay ', ' Validation ', ' Molecular ', ' Process ', ' protein function ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' immunogenicity ', ' quantum ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' drug candidate ', ' screening ', ' model building ', ' Assessment instrument ', ' Assessment tool ', ' web-based repository ', ' web repository ', ' online archive ', ' online repository ', ' experimental research ', ' experiment ', ' experimental study ', ' clinical development ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2018,374026,0.07188929896491424
"Identification of Neurochemical Antecedents and Consequences of Distinct Learning Processes Relevant to Addiction Liability ABSTRACT Cues or stimuli in the environment can guide behavior in adaptive ways, bringing one in close proximity to valuable resources (i.e. food, water, mates); but they can also elicit maladaptive behavior. For example, in addicts, exposure to cues (e.g. places, paraphernalia) previously associated with drug-taking often leads to relapse, despite the desire to remain abstinent. The ability of such cues to elicit complex emotional and motivational states and gain control over one's behavior occurs via Pavlovian learning mechanisms. Using an animal model that captures individual differences in response to reward cues, we can now study the neural processes underlying aberrant forms of cue-reward learning, bringing us closer to identifying novel targets for the treatment of addiction. When rats are exposed to a Pavlovian conditioning paradigm wherein a discrete cue is repeatedly paired with presentation of a reward, some are sign-trackersthose that attribute incentive salience to the cue, and others goal-trackersthose that assign only predictive value to the cue. Thus, there is individual variation in the extent to which food cues are attributed with Pavlovian incentive motivational value (incentive salience), and this variation predicts the degree to which drug cues will attain control over behavior and the propensity to relapse. Furthermore, this animal model allows us to parse the incentive from the predictive properties of reward cues, and we have used it to demonstrate that distinct neural circuits regulate these different forms of cue-reward learning. In addition, we have shown that dopamine is critical for incentive learning (i.e. sign-tracking), but not predictive learning (i.e. goal-tracking). Most studies to-date, however, have been hampered by the inability to measure neural correlates of these phenotypes prior to learning. That is, rats must first undergo Pavlovian conditioning in order to be characterized as sign- or goal-trackers. Thus, the first Aim of the current proposal is to determine whether there are pre-existing basal differences in neurotransmitter signaling in the nucleus accumbens core that predict those individuals prone to attribute incentive salience to reward cues prior to behavioral testing. To do this, we will use a novel chemical analytical approach (stable-isotope labeling) that will allow us, for the first time, to assess true basal levels of dopamine, norepinephrine, acetylcholine, serotonin, glutamate and GABA in sign- and goal-trackers. The second Aim will use another novel, but different, chemical analytical approach to simultaneously assess up to 50 neurochemicals in the nucleus accumbens core in sign- and goal-trackers. The focus of the second Aim will be on the neurochemical profiles that emerge as a consequence of an individual's associative learning style. Advanced statistical analyses will be applied in order to identify neurochemical profiles that best predict the behavioral phenotypes and to examine the relationship between neurochemicals over the course of learning. This work will highlight specific neural systems that may render an individual more susceptible to control by reward cues and lay the foundation for future studies to identify novel neuromolecular targets for the treatment of addiction. PROJECT NARRATIVE The way an individual responds to cues associated with rewards may be a key determinant of vulnerability to addiction and relapse. We will employ novel analytical approaches to uncover neurochemical signatures associated with individual variation in response to reward cues. These studies will identify pre-existing and experience-dependent neural mechanisms that allow cues in the environment to gain inordinate control over behavior, and could lead to novel targets for the treatment of addiction.",Identification of Neurochemical Antecedents and Consequences of Distinct Learning Processes Relevant to Addiction Liability,9527977,R21DA045146,"['Acetylcholine ', ' Behavior ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Chlorides ', ' High Pressure Liquid Chromatography ', ' High Speed Liquid Chromatography ', ' High Performance Liquid Chromatography ', ' HPLC ', ' classical conditioning ', ' associative conditioning ', ' Pavlovian conditioning ', ' Associative Learning ', ' Cues ', ' Statistical Data Interpretation ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Disease ', ' Disorder ', ' Dopamine ', ' Hydroxytyramine ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Exhibits ', ' Food ', ' Food or Food Product ', ' Foundations ', ' Future ', ' gamma-Aminobutyric Acid ', ' -Aminobutyric Acid ', ' GABA ', ' Aminalone ', ' Aminalon ', ' 4-amino-butanoic acid ', ' 4-Aminobutyric Acid ', ' 4-Aminobutanoic Acid ', ' Glutamates ', ' glutamatergic ', ' L-Glutamate ', ' Goals ', ' Grant ', ' Incentives ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Methods ', ' Modernization ', ' Motivation ', ' neurochemistry ', ' neurochemical ', ' Neurotransmitters ', ' Nerve Transmitter Substances ', ' Norepinephrine ', ' Noradrenaline ', ' Levonorepinephrine ', ' Levarterenol ', ' Nucleus Accumbens ', ' Phenotype ', ' Psychopathology ', ' abnormal psychology ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Relapse ', ' Resources ', ' Research Resources ', ' Rewards ', ' Serotonin ', ' Hippophaine ', ' Enteramine ', ' 5HT ', ' 5-Hydroxytryptamine ', ' 5-HT ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Thinking ', ' thoughts ', ' Time ', ' Water ', ' Hydrogen Oxide ', ' Work ', ' Measures ', ' Outcome Measure ', ' Data Set ', ' Dataset ', ' reinforcer ', ' improved ', ' Procedures ', ' specimen collection ', ' sample collection ', ' Variation ', ' Variant ', ' Microdialysis ', ' Chemicals ', ' Stimulus ', ' Conditioned Stimulus ', ' Individual ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Techniques ', ' System ', ' Location ', ' experience ', ' tandem mass spectrometry ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' relating to nervous system ', ' neural ', ' novel ', ' Partner in relationship ', ' mate ', ' behavior test ', ' behavioral test ', ' drug seeking behavior ', ' Drug Exposure ', ' neural circuit ', ' synaptic circuitry ', ' synaptic circuit ', ' neural circuitry ', ' Impulsivity ', ' Emotional ', ' Modeling ', ' Sampling ', ' Property ', ' response ', ' executive function ', ' executive control ', ' Stable Isotope Labeling ', ' Address ', ' Predictive Value ', ' Pathologic ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' motivated behavior ', ' Individual Differences ', ' neural mechanism ', ' neuromechanism ', ' Heritability ', ' addictive disorder ', ' addiction ', ' neurobiological mechanism ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' algorithmic composition ', ' algorithm engineering ', ' Algorithmic Engineering ', ' Algorithmic Design ', ' Algorithm Design ', ' neural correlate ', ' incentive salience ', ' learning method ', ' learning activity ', ' learning strategy ', ' high dimensionality ', ' individual variability ', ' individual heterogeneity ', ' individual variation ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R21,2018,208699,0.041881690743943795
"Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling Project Summary/Abstract With the global rise in obesity-related diseases and increasing recognition of the role of fat in diseases such as fatty liver, there is growing need for a noninvasive chemical assay of in vivo lipid depots. But the rich chemistry of these molecules is often ignored in MRI, which typically treats fat as a homogeneous proton species because differences in chemical shift and relaxation are difficult to distinguish in a clinical setting. Innovation: This proposal will be the first to use nonuniform echo spacing to generate J-coupling based contrast between chemically different fats. While fat spins often give monotonically decaying signal under a uniformly spaced spin echo train, J-coupling causes nonuniformly spaced spin echo trains to generate complex fingerprints, which distinguish and even quantify fats with otherwise similar MR properties. Significance: The immediate clinical impact will be to demonstrate a novel J-coupling based contrast mechanism in vivo which will contribute to a multiparametric MRI protocol to distinguish the 25% of the population with benign steatosis from the 2-3% with nonalcoholic steatohepatitis (NASH). The broader significance of this work is that this novel contrast mechanism could revolutionize the study and clinical management of many diseases associated with bioactive lipid subtypes. Approach: The aims are designed to test the hypothesis that nonuniform echo trains (1) can create contrast between different fats, which (2) will contribute to a multiparametric noninvasive protocol to distinguish benign steatosis and NASH. Aim 1 will identify the echo spacing best suited for distinguishing benign steatosis and NASH, first using density matrix simulations based on high resolution spectra of liver fat from animals with each disease, and then using experiments on whole rat livers. In Aim 2, the sequence developed in Aim 1 will be tested in humans with biopsy proven benign steatosis or NASH, along with a suite of standard methods of liver and fat characterization. This metric, and also metrics derived from conventional images, will be tested for the ability to separate these patient groups. In addition, machine learning algorithms will be used to find a metric that combines multiecho intensities with standard MR metrics. This proposal will prove the usefulness of nonuniform echo trains as a new contrast mechanism and yield a multiparametric MRI protocol to distinguish simple steatosis and NASH. Moreover, this general approach to distinguish fats could ultimately find a broad range of biomedical applications, such as imaging lipid based therapeutics, distinguishing the 4 fatty acids that make up 90% of the adipose stores, or detecting other lipotoxic subtypes. The results of this work will justify a larger scale study to properly validate the sensitivity to different fat species in humans. Project Narrative This proposal will prove the usefulness of nonuniform echo trains both as a new J-coupling based contrast mechanism and as part of a multiparametric MRI protocol to distinguish simple steatosis (~25% of the population) from patients on the NASHfibrosiscirrhosis trajectory of metabolically induced liver disease (2- 3% of the population). Moreover, this general approach to distinguish fats could ultimately find a broad range of biomedical applications, such as imaging lipid based therapeutics, distinguishing the 4 fatty acids that make up 90% of the adipose stores, or detecting other lipotoxic subtypes. The results of this work will justify a larger scale study to properly validate the sensitivity to different fat species in humans.",Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling,9529959,R21EB023414,"['Adipose tissue ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Algorithms ', ' Animals ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Chemistry ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Fatty acid glycerol esters ', ' Fats ', ' Fatty Acids ', ' Fatty Liver ', ' hepatic steatosis ', ' Liver Steatosis ', ' Fibrosis ', ' Fingerprint ', ' Human ', ' Modern Man ', ' Lipids ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Matched Group ', ' Methods ', ' Oils ', ' Patients ', ' Protons ', ' Hydrogen Ions ', ' H+ element ', ' Rattus ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Relaxation ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Spectrum Analysis ', ' Spectrum Analyses ', ' Spectroscopy ', ' Testing ', ' Work ', ' base ', ' density ', ' liver scanning ', ' liver imaging ', ' Benign ', ' Clinical ', ' Chemicals ', ' Susceptibility ', ' Predisposition ', ' Training ', ' analog ', ' Therapeutic ', ' Metabolic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' age group ', ' simulation ', ' novel ', ' Code ', ' Coding System ', ' Property ', ' Data ', ' Resolution ', ' in vivo ', ' Clinical Management ', ' trend ', ' sex ', ' cirrhotic ', ' Cirrhosis ', ' imaging ', ' Image ', ' designing ', ' design ', ' Obesity related disease ', ' Obesity associated disease ', ' Population ', ' Coupling ', ' innovative ', ' innovate ', ' innovation ', ' nonalcoholic steato-hepatitis ', ' non-alcoholic steatohepatitis ', ' non-alcoholic steato-hepatitis ', ' non-alcohol induced steatohepatitis ', ' NASH ', ' nonalcoholic steatohepatitis ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NIBIB,YALE UNIVERSITY,R21,2018,251250,0.024074188450169107
"Integrated Instrument for non-natural aptamer generation Project Summary DNA and RNA aptamers are a useful class of synthetic affinity reagents. However, their performance can be greatly improved through the site-specific incorporation of chemically modified, non-natural nucleotides that provide a greater chemical repertoire to enable superior aptamer affinity and specificity. Because a broad spectrum of chemical functional groups can be incorporated, non-natural aptamers offer the exciting potential for targeting molecules for which the generation of monoclonal antibodies remains difficult, such as small- molecule drugs, metabolites and carbohydrates. Unfortunately, the access to non-natural aptamers is severely limited. This is because the process of generating non-natural aptamers is technically challenging and limited to a few specialized laboratories. The goal of this project is to develop an integrated instrument, the Non-Natural Aptamer Array (N2A2) that eliminates these bottlenecks and enable rapid and facile non-natural aptamer discovery at virtually any research laboratory. The N2A2 will be built on a modified version of a benchtop commercial sequencer (Illumina MiSeq), and will perform every stage of non-natural aptamer discovery including sequencing, screening and binding measurementsas part of a single work-flow. There are three main innovative aspects of our N2A2 system. First, our approach will entirely eliminate the need for polymerase engineering, and thus allows us to incorporate virtually any chemical functional group through click chemistry. Second, N2A2 will enable us to directly obtain the binding affinity (Kd) of ~10^7 aptamers directly in complex samples (e.g. cell lysate or serum), thereby resulting in aptamers with high-specificity. Finally, we will develop a machine-learning (ML) approach to identify key motifs (k-mers) and predict novel sequences with potentially higher affinity and specificity that can be tested using the N2A2 instrument. We believe this powerful combination of massively parallel, sequence-linked binding measurements with ML-based predictions will allow us to explore sequence space that is currently inaccessible to traditional in vitro selection methods, and enable us to discover aptamers with superior performance. The success of this project will produce an integrated instrument that greatly streamlines and accelerates the discovery of non-natural aptamers for a wide range of targets in complex media. The instrument is based on a commercially available sequencer and we will make all software available to the public. In this way, we believe the N2A2 instrument could broadly expand access to robust, high quality, custom affinity reagents for biomedical research and clinical diagnostics. Project Narrative We will develop an integrated instrument that simplifies the discovery of non-natural aptamer reagents for a wide range of molecules that are difficult to target using conventional antibody reagents. The access to these custom reagents will accelerate biomedical research and clinical diagnostics.",Integrated Instrument for non-natural aptamer generation,9579149,R01GM129313,"['Algorithms ', ' Antibodies ', ' Monoclonal Antibodies ', ' mAbs ', ' Clinical Treatment Moab ', ' Biomedical Research ', ' Carbohydrates ', ' Cells ', ' Cell Body ', ' Chemistry ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Engineering ', ' Goals ', ' In Vitro ', ' Laboratories ', ' Laboratory Research ', ' Methods ', ' Nucleotides ', ' Proteins ', ' Reagent ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Computer software ', ' Software ', ' Specificity ', ' Testing ', ' Tyrosine ', ' Work ', ' Generations ', ' Chinese Hamster Ovary Cell ', ' CHO Cells ', ' Custom ', ' base ', ' Label ', ' improved ', ' Site ', ' Link ', ' Chemicals ', ' Blood Serum ', ' Serum ', ' Opiates ', ' Opioid ', ' Measurement ', ' directed evolution ', ' Directed Molecular Evolution ', ' scaffold ', ' scaffolding ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' System ', ' Performance ', ' success ', ' functional group ', ' aptamer ', ' novel ', ' Graph ', ' Modeling ', ' Sampling ', ' Binding ', ' Molecular Interaction ', ' small molecule ', ' Polymerase ', ' SLEB2 gene ', ' systemic lupus erythematosus susceptibility 2 ', ' sle2 ', ' programmed death 1 ', ' programmed cell death 1 ', ' PD1 gene ', ' PD-1 ', ' Affinity ', ' Data ', ' Reproducibility ', ' Process ', ' virtual ', ' innovative ', ' innovate ', ' innovation ', ' screening ', ' clinical diagnostics ', ' ']",NIGMS,STANFORD UNIVERSITY,R01,2018,314000,0.04381482491261879
"Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding Project Summary/Abstract Human induced pluripotent stem cells (hiPSCs) are poised to transform toxicological evaluation, however new approaches to enable their functional and structural profiling are needed to improve the utility of hiPSC -based models for predictive and mechanistic toxicology screening. This need is addressed by our projects Specific Aims that encompass (1) development of a novel platform for generation of hiPSC-derived reporter cells; (2) generation of a panel of multicolor hiPSC-derived cardiomyocytes (hiPSC-CMs) with stable lineage specific fluorescent reporters; and (3) implementation and validation of a pilot machine learning-enabled predictive cardiotoxicity screen using these tools. The proposed tools are configured to be extensible to other toxicology- relevant pathways and phenotypes making it uniquely positioned to capitalize on the growing commercial need for high-throughput predictive toxicology assays. The project deliverables benefit public health by improving the ability to rapidly identify liabilities in specific cardiomyocyte lineage types, thus reducing the time and cost to pinpoint cardiotoxicity of pharmaceutical and environmental chemicals. Project Narrative The assay and reagents established in the course of this project directly address the goals of significant initiatives to improve the effectiveness of cardiotoxicity testing, such as the FDAs CiPA initiative and the work of the Cardiac Safety Research Consortium. The resulting improvements in the pace and precision of drug testing will result in public health benefit through the development of more cost-effective and safer medicines. Beyond toxicological evaluation of therapeutic compounds, our innovative technology will deliver additional benefit to public health by virtue of its utility in investigating the toxicities of environmental chemicals, in line with the focus of government agencies and initiatives such as the EPA and Tox21 in the US and EU-ToxRisk in Europe.",Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding,9623156,R44TR002572,"['Algorithms ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Drug Modelings ', ' Drug toxicity ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Europe ', ' Foundations ', ' Goals ', ' Government Agencies ', ' Heart Atrium ', ' atrium ', ' Cardiac Atrium ', ' Atrial ', ' Human ', ' Modern Man ', ' In Vitro ', ' Medicine ', ' Methods ', ' Microscopy ', ' Mitochondria ', ' mitochondrial ', ' Patients ', ' Phenotype ', ' Public Health ', ' Reagent ', ' Research ', ' Safety ', ' Sarcomeres ', ' Specificity ', ' Testing ', ' Time ', ' Toxicology ', ' Work ', ' Generations ', ' Health Benefit ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' base ', ' immortalized cell ', ' improved ', ' Site ', ' Phase ', ' Physiologic ', ' Physiological ', ' Chemicals ', ' Evaluation ', ' Training ', ' cardiomyocyte ', ' Heart myocyte ', ' Heart Muscle Cells ', ' Cardiocyte ', ' Cardiac Muscle Cells ', ' Cardiac Myocytes ', ' Withdrawal ', ' Toxicity Testing ', ' Toxicity Tests ', ' Cell Structure ', ' Cell Components ', ' Cellular Structures ', ' Cell Lineage ', ' Contracts ', ' Contracting Opportunities ', ' Reporter ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Nodal ', ' Nuclear ', ' innovative technologies ', ' success ', ' expression vector ', ' cell immortalization ', ' Toxic effect ', ' Toxicities ', ' Speed ', ' Structure ', ' novel ', ' new technology ', ' novel technologies ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' Treatment-Related Cancer ', ' Treatment-Associated Cancer ', ' Therapy-Related Cancer ', ' Therapy-Associated Cancers ', ' Therapy Related Malignant Tumor ', ' Therapy Related Malignant Neoplasm ', ' Iatrogenic Cancer ', ' response ', ' high throughput screening ', ' High Throughput Assay ', ' Cardiotoxicity ', ' Cardiotoxic ', ' Cardiac Toxicity ', ' drug discovery ', ' model development ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Effectiveness ', ' therapeutic evaluation ', ' therapeutic testing ', ' Address ', ' Data ', ' cell assay ', ' Cellular Assay ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Validation ', ' Ventricular ', ' Cardiac ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' preclinical ', ' pre-clinical ', ' cost ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' cost-effective ', ' cost effective ', ' innovative ', ' innovate ', ' innovation ', ' site-specific integration ', ' drug detection ', ' drug testing ', ' environmental chemical ', ' iPSCs ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' therapeutic agent development ', ' therapeutic development ', ' screening ', ' clinical predictors ', ' phase I trial ', ' genomic editing ', ' genome editing ', ' Industry Standard ', ' Cas nuclease technology ', ' CRISPR/Cas9 technology ', ' CRISPR/Cas9 ', ' CRISPR/Cas method ', ' CRISPR-based tool ', ' CRISPR-based technology ', ' CRISPR-based technique ', ' CRISPR-based method ', ' CRISPR-CAS-9 ', ' CRISPR technology ', ' CRISPR technique ', ' CRISPR methodology ', ' CRISPR method ', ' CRISPR/Cas technology ', ' predictive tools ', ' clinical candidate ', ' predictive assay ', ' predictive test ', ' ']",NCATS,"CAIRN BIOSCIENCES, INC.",R44,2018,1101295,0.04738830294320879
"Simulation of Proton Translocation in Biomolecules PROJECT SUMMARY  The transport of protons in biomolecular systems is a phenomenon of fundamental importance to processes such as ATP synthesis, enzyme catalysis, the maintenance of pH gradients, proton pumping, viral infection, and substrate/ion transport across membranes via protein transporters, symporters, and antiporters. Modeling biomolecular proton translocation in silico is a significant challenge due to the complex chemical reactions involved in Grotthuss proton shutting between water molecules and with protonatable amino acids, as well as the complexity of the target biomolecular systems. In most cases, it is not only important to understand the mechanism of proton binding and transport, but also its coupling to other mechanistically relevant biomolecular processes, such as protein conformational changes, substrate binding, other protonation events, and dynamic hydration.  In this project the continued development and application of a powerful multiscale computer simulation methodology is described for the study of proton transport in several key classes of proton translocating biomolecular systems, including channels (influenza A and B M2 channels), antiporters/symporters (ClC Cl-/H+ antiporter and phosphate transporter, respectively), and transporters (proton-coupled oligopeptide transporter and EmrE multidrug transporter). The overall research plan is made possible by a novel reactive molecular dynamics simulation approach integrated with quantum mechanics/molecular mechanics (QM/MM) methods that allows for the study of explicit long-length and -time scale proton transport through water molecules and ionizable molecular groups in hydrogen-bonded networks, as well as by new innovations in enhanced free energy sampling methodology, machine learning, kinetic network theory, and coarse-graining. A primary goal in the research with this methodology in hand is to reveal the mechanisms of proton transport, as well as its coupling to hydration and conformational changes, in the above mentioned biomolecular systems. All of these studies will be carried out in collaboration with leading experimentalists, while continuing to add a new dimension to the field of biomolecular computer simulation as a whole. 1 PROJECT NARRATIVE  In this project, computer simulations will be used to study proton transport in several important biomolecular systems. Proton translocation is of fundamental significance throughout biology, as demonstrated by the pH-dependence of biomolecular structure and function and the central role of transmembrane proton gradients in bioenergy conversion. Moreover, understanding proton transport is of fundamental importance and direct relevance to numerous aspects of human health, including metabolism, aging, diabetes, neurodegeneration, retinal degeneration, antivral and anti-bacterial therapeutics, and homeostasis. 1",Simulation of Proton Translocation in Biomolecules,9543037,R01GM053148,"['Achievement ', ' Achievement Attainment ', ' Aging ', ' Amino Acids ', ' aminoacid ', ' Anions ', ' Behavior ', ' Sampling Biases ', ' Biology ', ' Carrier Proteins ', ' Transporter Protein ', ' Transport Proteins ', ' Transport Protein Gene ', ' Catalysis ', ' Charge ', ' Communities ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Diabetes Mellitus ', ' diabetes ', ' Diffusion ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Elements ', ' Enzymes ', ' Enzyme Gene ', ' Future ', ' Goals ', ' Proton Pump ', ' H+ Pump ', ' H(+) Pump ', ' Hand ', ' Health ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Human ', ' Modern Man ', ' Hydrogen Bonding ', ' H-bond ', ' Influenza ', ' influenza infection ', ' flu infection ', ' Grippe ', ' Kinetics ', ' Maintenance ', ' Medicine ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Methods ', ' Methodology ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Motion ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Nerve Degeneration ', ' neuronal degeneration ', ' neurological degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Oligopeptides ', ' inorganic phosphate ', ' Phosphates ', ' Protein Conformation ', ' Proteins ', ' Protons ', ' Hydrogen Ions ', ' H+ element ', ' Publishing ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Support ', ' Retinal Degeneration ', ' retinal degenerative diseases ', ' retinal degenerative ', ' retina degeneration ', ' degenerative retina diseases ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' Specificity ', ' Time ', ' Travel ', ' Virus Diseases ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Water ', ' Hydrogen Oxide ', ' Wisconsin ', ' antiporter ', ' Ion Transport ', ' protonation ', ' Area ', ' Medical ', ' insight ', ' Progress Reports ', ' Funding ', ' antibacterial ', ' anti-bacterial ', ' Antibacterial Agents ', ' Anti-Bacterial Agents ', ' Collaborations ', ' Letters ', ' Therapeutic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Entropy ', ' Mechanics ', ' mechanical ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Reaction ', ' System ', ' Consult ', ' chemical reaction ', ' Membrane ', ' membrane structure ', ' molecular dynamics ', ' Molecular Dynamics Simulation ', ' symporter ', ' Co-Transporters ', ' Free Energy ', ' Structure ', ' simulation ', ' novel ', ' Agreement ', ' Code ', ' Coding System ', ' chemical bond ', ' Modeling ', ' Sampling ', ' theories ', ' molecular mechanics ', ' Inorganic Phosphate Transporter ', ' Phosphate Transporters ', ' Phosphate Transport Proteins ', ' Influenza A virus ', ' Orthomyxovirus Type A ', ' Influenzavirus A ', ' Influenza Viruses Type A ', ' Influenza A ', ' Influenza B Virus ', ' Orthomyxoviruses Type B ', ' Influenza Viruses Type B ', ' Influenza B ', ' pH gradient ', ' deltapH ', ' delta pH ', ' Binding ', ' Molecular Interaction ', ' Hydration status ', ' Hydration ', ' Length ', ' Defect ', ' ATP Synthesis Pathway ', ' ATP Synthesis ', ' Data ', ' Quantum Mechanics ', ' Molecular Transport ', ' Transport Process ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' antiflu drug ', ' anti-flu drug ', ' anti-influenza drug ', ' quantum ', ' Outcome ', ' migration ', ' Coupled ', ' Coupling ', ' innovative ', ' innovate ', ' innovation ', ' multidrug transporter ', ' multi drug transporter ', ' experimental research ', ' experiment ', ' experimental study ', ' Grain ', ' ']",NIGMS,UNIVERSITY OF CHICAGO,R01,2018,310328,0.0374765116784504
"Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC PROJECT SUMMARY The Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC (CMP-GA) is a cross-cutting team with advanced high-throughput chemical analytics and big data capabilities to develop a comprehensive map of molecular transducers of physical activity. The investigative team excels in ultrasensitive, precise and spatially resolved analyses of small molecules, lipids, and proteins. The team members have strong academic records as innovative, independent scientists, core laboratory directors and effective collaborators in complex research initiatives. Instrumentation includes state-of-the-art ultra-high resolution accurate mass high-field Orbitrap tandem mass spectrometry (MS) and ultraperformance liquid chromatography (UPLC); three- dimensional (3-D) molecular imaging via high throughput multi-modal MS at 5 m resolution; unique ion mobility-mass spectrometry machine-learning approaches for chemical identifications; and other such as GC- Orbitrap, 1D and 2D high field (800 MHz) NMR spectroscopy, ICP-MS, immunoassays, chemical and enzymatic assays, etc. The analytical laboratories are integrated through the NIH-supported Atlanta Clinical and Translational Sciences Institute, and operate within the outstanding research environment of Emory University and the Georgia Institute of Technology (GA Tech). CMP-GA has six elements organized to provide 1) leadership in the design and implementation of MoTrPAC goals; 2) bioinformatics, computational support and data delivery to the MoTrPAC Data Coordinating Center; 3) global, targeted and spatially resolved metabolomics; 4) metabolite forensics for unequivocal chemical identification of novel molecular transducers; 5) innovative proteomic and chemoproteomic technologies to define transducers within the redox proteome, ubiquitinome, acetylome, kinome and nuclear proteome; and 6) identification and quantification of lipid transducers. Through the successful completion of these aims and collaboration with the MoTrPAC consortium, investigators of CMP-GA will deliver a publically-available data resource and molecular transducer map that will enhance and accelerate mechanistic research on diseases and conditions affected by physical activity. PROJECT NARRATIVE This is a comprehensive metabolomics and proteomics chemical analysis site to support the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Advanced analytical methods, including mass spectrometry, bioinformatics and chemical forensics are used to provide targeted and global analysis of small molecules, lipids, proteins to develop a molecular transducer map for physical activity.",Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC,9394009,U24DK112341,"['Affect ', ' Aging ', ' Animal Experimentation ', ' Animal Research ', ' Animal Experimental Use ', ' Animals ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Liquid Chromatography ', ' Clinical Research ', ' Clinical Study ', ' Communication ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Elements ', ' Environment ', ' Exercise ', ' Forensic Medicine ', ' Forensics ', ' Goals ', ' Health ', ' Immunoassay ', ' Institutes ', ' instrumentation ', ' Isotopes ', ' Laboratories ', ' Leadership ', ' Lipids ', ' Maps ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Muscle ', ' muscular ', ' Muscle Tissue ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Oxidation-Reduction ', ' oxidation reduction reaction ', ' Redox ', ' Particle Size ', ' Peptide Mapping ', ' Peptide Fingerprinting ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Records ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Time ', ' Transducers ', ' Universities ', ' cytokine ', ' Measures ', ' Health Benefit ', ' Mediating ', ' Custom ', ' analytical method ', ' Label ', ' Procedures ', ' Site ', ' Clinical ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Adipocytes ', ' Link ', ' Chemicals ', ' Training ', ' Physical activity ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Oxidative Stress ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' lectures ', ' Scientist ', ' Dimensions ', ' Complex ', ' Oral ', ' Protocols documentation ', ' Protocol ', ' Reaction ', ' System ', ' 3-Dimensional ', ' 3-D ', ' Nuclear ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' oxidized lipid ', ' tandem mass spectrometry ', ' novel ', ' member ', ' Modality ', ' Proteome ', ' Sampling ', ' response ', ' Proteomics ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Bioinformatics ', ' Bio-Informatics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Systems Biology ', ' Data ', ' Molecular Target ', ' Resolution ', ' Clinical Sciences ', ' translation research ', ' Translational Science ', ' Translational Research ', ' Validation ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' ion mobility ', ' Data Coordination Center ', ' Data Coordinating Center ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' advanced system ', ' ultra high resolution ', ' BigData ', ' Big Data ', ' transcriptional differences ', ' differentially expressed ', ' differential expression ', ' phenotypic marker ', ' phenotypic biomarker ', ' chemoproteomics ', ' data resource ', ' ']",NIDDK,EMORY UNIVERSITY,U24,2018,1612261,0.07436405813847966
"Illuminating Function of the Understudied Druggable Kinome Project Summary/Abstract Kinases are among the most important drug targets and clinically significant kinase inhibitors have been developed for multiple diseases. A subset of kinases, the understudied dark kinases (DKs), have received little or no attention because foundational data on their biochemical and biological functions is not available. This proposal will collect such data by perturbing DKs genetically and with small molecules and then measuring the cellular consequences using multiplex proteomic, gene expression, metabolomic and imaging assays. A subset of DKs with potential links to human disease will be intensively studied as a means to qualify new therapeutic drug targets. Data collected in this project will be aggregated with existing information from previous NIH-funded large-scale structural and genomic projects to create a Dark Kinase Knowledgebase (DKK) that provides gene-by-gene and network-level information on the dark kinome and its interaction with other signal transduction and regulatory networks. Close coordination with the NIH LINCS project will ensure data interoperability and make efficient use of informatics tools. The DKK will be developed in collaboration with the IDG Knowledge Management Center (KMC), adhere to standards for Findable, Accessible, Interoperable and Reusable (FAIR) data, and be accessible to human users and machines (via an API). Commercially available DK reagents be validated and extended with new genetic and chemical tools provided to the Resource Dissemination Center (RDOC). The overall approach will be iterative, with simpler methods applied first (e.g. simple gene knockout) and more sophisticated methods subsequently (e.g. stable CRIPSRa/i) pursued by an interdisciplinary team of chemists, computational biologists, mass spectroscopists and pharmacologists working on five linked aims. Aim 1 will develop a computational algorithm for prioritizing DKs, develop and maintain the DKK, and perform network-level analysis on the kinome using supervised and unsupervised machine learning. Aim 2 will measure kinase abundance in normal and perturbed cells using parallel reaction monitoring with stable isotope dilution (PRM-SID) and RNASeq and data analyzed using network inference tools to provide insight into dark and light kinome in diverse cell types. Aim 3 will perturb DKs with genetic tools such as CRIPSR/Cas9-mediated gene knockout, CRIPSRa/i to induce more subtle-up and down regulation and inducible gene inaction. The impact on cell fate, morphology and signal transduction will then be determined using PRM-SID, phosphoproteomics, RNASeq, gene reporter assays, metabolomics profiling and highly multiplex single-cell imaging. Aim 4 will extend DK analysis to small molecule inhibitors by carefully profiling existing drugs against DKs and by designing and synthesizing new chemical ligands. Aim 5 will involve collaboration with other investigators to assay the expression and function of DKs in primary human cells and tissues relevant to the NIH Precision Medicine Initiative. All aims will be pursued in parallel for a progressively expanding resource of data and tools for continued study of DKs. Project Narrative/Health Relevance Advancing understanding of understudied kinases, a highly druggable class of proteins, will increase knowledge about signal transduction and control over cellular physiology and is likely to reveal a subset of proteins that should be advanced as targets for new therapeutic drugs.",Illuminating Function of the Understudied Druggable Kinome,9564894,U24DK116204,"['Algorithms ', ' Arthritis ', ' joint inflammation ', ' arthritic ', ' Attention ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Cell Body ', ' Complement ', ' Complement Proteins ', ' Cystic Fibrosis ', ' Mucoviscidosis ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diabetes Mellitus ', ' diabetes ', ' Disease ', ' Disorder ', ' Down-Regulation ', ' Downregulation ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Engineering ', ' Foundations ', ' Gene Expression ', ' Genes ', ' Goals ', ' Health ', ' Homeostasis ', ' Physiological Homeostasis ', ' Autoregulation ', ' Human ', ' Modern Man ', ' Libraries ', ' Ligands ', ' Light ', ' Photoradiation ', ' Logic ', ' Chronic Obstructive Airway Disease ', ' Chronic Obstructive Pulmonary Disease ', ' Chronic Obstructive Lung Disease ', ' COPD ', ' COAD ', ' Methods ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Phenotype ', ' Phosphotransferases ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Play ', ' Production ', ' Proteins ', ' Reagent ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Supervision ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Up-Regulation ', ' Upregulation ', ' Generations ', ' Measures ', ' Mediating ', ' Signal Transduction Pathway ', ' base ', ' Site ', ' Biological ', ' Biochemical ', ' Reporter Genes ', ' Link ', ' Ensure ', ' biosynthesis ', ' Anabolism ', ' Chemicals ', ' insight ', ' Individual ', ' Measurement ', ' Funding ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Therapeutic ', ' stable isotope ', ' Genetic ', ' Morphology ', ' Reporter ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Reaction ', ' cell type ', ' Tumor Tissue ', ' knockout gene ', ' knowledge base ', ' knowledgebase ', ' Informatics ', ' novel ', ' Information Resources Management ', ' Knowledge Management ', ' Modeling ', ' protein protein interaction ', ' Proteomics ', ' kinase inhibitor ', ' structural genomics ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' small molecule ', ' Data ', ' Mutate ', ' Resolution ', ' Collection ', ' Validation ', ' Monitor ', ' Molecular ', ' developmental ', ' Development ', ' cell imaging ', ' cellular imaging ', ' imaging ', ' Image ', ' meta data ', ' Metadata ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' clinical significance ', ' clinically significant ', ' interoperability ', ' computer algorithm ', ' Computational algorithm ', ' human disease ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' therapeutic target ', ' therapeutic agent development ', ' therapeutic development ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' screening ', ' Drug Targeting ', ' CRISPR/Cas system ', ' CRISPR ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' Precision Medicine Initiative ', ' small molecule inhibitor ', ' metabolic profile ', ' phospho-proteomics ', ' phosphoproteomics ', ' Findable, Accessible, Interoperable, and Reusable ', ' FAIR data ', ' FAIR principles ', ' data resource ', ' human model ', ' unsupervised machine learning ', ' unsupervised learning ', ' ']",NIDDK,UNIV OF NORTH CAROLINA CHAPEL HILL,U24,2018,2270717,0.06041628026753181
"Rules for penetrating the Gram-negative bacterial envelope The development of new antimicrobials has drastically lagged behind the fast growth of drug resistant pathogenic microbes, especially for Gram-negative (GN) bacteria. To be effective in GN bacteria, entering and staying in the cells is a challenge. Insight into the physicochemical properties that enable the entrance of compounds is critical to direct future effort in the development of effective treatment against GN pathogens. Toward this goal, we will develop methods to accurately quantify the accumulation of small molecule compounds, without requiring fluorescence or other properties for detection, and independent of their antibacterial activity. In addition, we will develop a novel computational algorithm to describe and predict physicochemical properties that favors entry and evade efflux in GN bacteria. The computer model will be validated and refined through the selection and characterization of ~1,500 of compounds. Specifically, we will pursue the following aims: Aim 1) To develop and validate LC-MS/MS based assays to quantify compound partition. We will use a panel of antibiotics as ""gold standards"" to develop and validate assays to accurately determine the accumulation of small molecule compounds in different cellular compartments. We will develop LC-MS/MS assays and experiment with the kinetics of entrance, optimizing the conditions to enable reproducible and accurate quantification. We will use a CRE strain of E. coli and a MDR strain of Acinetobacter baumannii in this study. Aim 2) To develop a computational algorithm for predicting compounds that are potentially good penetrators for GN bacteria. We will develop a new and highly accurate computational algorithm through machine learning which can systematically recognize all favorable structural factors of the compounds effective for GN bacteria. Selected compounds will be experimentally characterized in Aim 3, the knowledge from which will be incorporated back into refining the computational algorithm to generate a new round of learning/prediction. This cycle will be repeated, with the testing of ~1,500 compounds in total. Aim 3) To measure the accumulation and subcellular distribution of selected compounds and to validate rules on compound accumulation. With the assays from Aim 1, we will measure the accumulation data of compounds selected through Aim 2. Data from these analyses will be used to polish the computer model in Aim 2. Finally, the models will be evaluated through measurement of accumulation data of selected compounds and examine if the experimental data match the prediction. The knowledge gap about penetrating the cellular envelope has become the biggest hurdle to the rational design of new classes of antimicrobials against all GN pathogens. Outcome from the proposed study will help bridge the gap between a potent inhibitor and an effective antibacterial drug. The combined use of the detailed experimental assays and the new computational algorithm will empower drug discovery efforts that aim to identify promising drug candidates targeting GN bacteria. The development of new antimicrobials has drastically lagged behind the fast growth of drug resistant pathogenic microbes, especially for Gram-negative (GN) bacteria. Insight into the physicochemical properties that enable the entrance of compounds is critical to direct future effort in the development of effective treatment against GN pathogens. Outcome from the proposed study using the combination of detailed experimental assays and new computational algorithms will empower drug discovery efforts that aim to identify promising drug candidates targeting GN bacteria.",Rules for penetrating the Gram-negative bacterial envelope,9753472,R56AI137020,"['inhibitor/antagonist ', ' inhibitor ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Back ', ' Dorsum ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cells ', ' Cell Body ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Cytoplasm ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Drug resistance ', ' resistant to Drug ', ' resistance to Drug ', ' drug resistant ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Escherichia coli ', ' E. coli ', ' E coli ', ' Fluorescence ', ' Future ', ' Goals ', ' Gold ', ' Gram-Negative Bacteria ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' In Vitro ', ' Kinetics ', ' Learning ', ' Methods ', ' Obstruction ', ' Polishes ', ' Production ', ' Testing ', ' Measures ', ' Experimental Models ', ' base ', ' Chemicals ', ' insight ', ' Measurement ', ' antibacterial ', ' anti-bacterial ', ' Antibacterial Agents ', ' Anti-Bacterial Agents ', ' Acinetobacter baumannii ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' periplasm ', ' periplasmic ', ' Periplasmic Space ', ' Membrane ', ' membrane structure ', ' mutant ', ' Performance ', ' novel ', ' Modeling ', ' Property ', ' assay development ', ' drug discovery ', ' Pathogenicity ', ' small molecule ', ' Data ', ' Detection ', ' Reproducibility ', ' Collection ', ' Validation ', ' developmental ', ' Development ', ' designing ', ' design ', ' Outcome ', ' Drug-sensitive ', ' pathogen ', ' anti-microbial ', ' antimicrobial ', ' Microbe ', ' computer algorithm ', ' Computational algorithm ', ' effective treatment ', ' effective therapy ', ' drug candidate ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' experimental research ', ' experiment ', ' experimental study ', ' ']",NIAID,UNIVERSITY OF KENTUCKY,R56,2018,565371,0.0564645250461188
"Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria PROJECT SUMMARY Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria. Antibiotic-resistant Gram-negative bacterial infections are increasing in incidence and novel antibiotics are urgently needed to combat this growing threat to public health. A major roadblock to the development of novel antibiotics is our poor understanding of the structural features of small molecules that correlate with bacterial penetration and efflux. As a result, while potent biochemical inhibitors can often be identified for new targets, developing them into compounds with whole-cell antibacterial activity has proven challenging. To address this critical problem, we propose herein a comprehensive, multidisciplinary approach to develop quantitative models to predict small-molecule penetration and efflux in Gram-negative bacteria. We have pioneered a general platform for systematic, quantitative evaluation of small-molecule accumulation in bacteria, using label-free LC-MS/MS detection and multivariate cheminformatic analysis. We have also developed unique isogenic strain sets of wild-type, hyperporinated, efflux-knockout, and doubly-compromised E. coli, P. aeruginosa, and A. baumannii that allow us to dissect the individual contributions of outer/inner membrane penetration and active efflux to net accumulation, using a kinetic model that accurately recapitulates available experimental data. Moreover, we have developed machine learning and neural network approaches to QSAR (quantitative structureactivity relationship) modeling of pharmacological properties that will now be used to develop predictive cheminformatic models for Gram-negative accumulation, penetration, and efflux. This project will be carried out by a multidisciplinary SPEAR-GN Project Team (Small-molecule Penetration & Efflux in Antibiotic-Resistant Gram-Negatives, speargun) involving the labs of Derek Tan (MSK, PI), Helen Zgurskaya (OU, PI), Bradley Sherborne (Merck, Lead Collaborator), Valentin Rybenkov (OU, Co-I), Adam Duerfeldt (OU, Co-I), Carl Balibar (Merck, Collaborator), and David McLaren (Merck, Collaborator), comprising extensive combined expertise in organic and diversity-oriented synthesis, biochemistry, microbiology, high- throughput screening, mass spectrometry, biophysical modeling, cheminformatics, and medicinal chemistry. Herein, we will design and synthesize chemical libraries with diverse structural and physicochemical properties; analyze their accumulation in the isogenic strain sets in both high-throughput and high-density assay formats; extract kinetic parameters for penetration and efflux from the resulting experimental datasets; develop and validate robust QSAR models for accumulation, penetration, and efflux; and demonstrate the utility of these models in medicinal chemistry campaigns to develop novel Gram-negative antibiotics against three targets. This project will provide a major advance in the field of antibacterial drug discovery, providing powerful enabling tools to the scientific community to address this major threat to public health. PUBLIC HEALTH RELEVANCE Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria. Antibiotic-resistant Gram-negative bacteria pose a growing threat to public health in the U.S. and globally. A major obstacle to the development of new antibiotics to combat such infections is our poor understanding of the chemical requirements for small molecules to enter Gram-negative cells and to avoid ejection by efflux pumps. The proposed comprehensive, multidisciplinary research program aims to develop predictive computational tools to identify such molecules by carrying out large-scale, quantitative analyses of the accumulation of diverse small molecules in Gram-negative bacteria. These tools will then enable medicinal chemistry campaigns to develop novel antibiotics.",Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria,9486312,R01AI136795,"['Individual ', ' Interdisciplinary Study ', ' Measurement ', ' Chemicals ', ' base ', ' density ', ' Label ', ' improved ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' analog ', ' Penetration ', ' Variant ', ' Biochemical ', ' P aeruginosa ', ' P. aeruginosa ', ' P.aeruginosa ', ' Pseudomonas pyocyanea ', ' social role ', ' Effectiveness ', ' Biological Neural Networks ', ' cheminformatics ', ' small molecule ', ' Address ', ' Oral ', ' Structure ', ' novel ', ' Partner in relationship ', ' Data ', ' Detection ', ' Anti-Bacterial Agents ', ' Acinetobacter baumannii ', ' Modeling ', ' Property ', ' high throughput screening ', ' Quantitative Structure-Activity Relationship ', ' tool ', ' success ', ' Machine Learning ', ' Membrane ', ' programs ', ' drug discovery ', ' cell envelope ', ' small molecule libraries ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Pharmaceutical Chemistry ', ' Lead ', ' Libraries ', ' Pseudomonas aeruginosa ', ' Public Health ', ' inhibitor/antagonist ', ' Antibiotics ', ' Pharmaceutical Preparations ', ' Architecture ', ' Quantitative Evaluations ', ' Gram-Negative Bacterial Infections ', ' Antibiotic Resistance ', ' Escherichia coli ', ' Bacteria ', ' Resistance to antibiotics ', ' Resistant to antibiotics ', ' antibiotic drug resistance ', ' antibiotic resistant ', ' Variation ', ' Mammalian Cell ', ' Microbiology ', ' Role ', ' Biochemistry ', ' Dataset ', ' Biological Assay ', ' Biological Availability ', ' Pharmacology ', ' Measures ', ' Mass Spectrum Analysis ', ' Antibacterial Agents ', ' anti-bacterial ', ' antibacterial ', ' Gram-Negative Bacteria ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Data Set ', ' Cells ', ' kernel methods ', ' statistical learning ', ' support vector machine ', ' public health relevance ', ' neural network ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' risk prediction model ', ' computational tools ', ' Testing ', ' Algorithmic Tools ', ' Software Algorithm ', ' multidisciplinary approach ', ' efflux pump ', ' Human ', ' Communities ', ' designing ', ' biophysical modeling ', ' Algorithmic Software ', ' biophysical model ', ' High Throughput Assay ', ' Biological Chemistry ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Bioavailability ', ' Biologic Availability ', ' Physiologic Availability ', ' Incidence ', ' Infection ', ' chemical informatics ', ' QSAR ', ' Quantitiative Structure Activity Relationship ', ' interdisciplinary approach ', ' Kinetics ', ' mate ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' membrane structure ', ' chemical library ', ' drug/agent ', ' Knockout ', ' combat ', ' developmental ', ' multidisciplinary ', ' Modern Man ', ' learning network ', ' E coli ', ' E. coli ', ' predictive modeling ', ' computerized tools ', ' lead optimization ', ' inhibitor ', ' screening ', ' design ', ' prospective ', ' Knock-out ', ' Cell Body ', ' Development ', ' Medicinal Chemistry ', ' Pharmaceutic Chemistry ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Engineering / Architecture ', ' ']",NIAID,SLOAN-KETTERING INST CAN RESEARCH,R01,2018,1527746,0.0889977291708514
"Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization Project Summary  The proposed work will accelerate the pace of drug discovery by developing, validating, and testing new methods, tools, and resources for structure-based drug design. Two fundamental challenges of structure-based drug design are the accurate scoring and ranking of protein-ligand structures, which identies active com- pounds, and the ability to efciently search a large number of ligands, which ensures that active compounds are sampled. This proposal will address these challenges by developing a novel approach for protein-ligand scoring and expanding the size of the chemical space that can be efciently searched during lead optimiza- tion. The methods will be validated by their prospective application toward the discovery of new anti-cancer molecules and will be made readily accessible through online resources and open-source tools.  The proposal leverages recent and signicant advances in deep learning and image recognition to develop scoring functions that accurately recognize high-afnity protein-ligand interactions. This is achieved by design- ing and training convolutional neural nets on three-dimensional representations of protein-ligand structures to discriminate between binders and non-binders. Convolutional neural net training will exploit large datasets of afnity and structural data to automatically extract the relevant features necessary to accurately prioritize compounds. Additionally, the proposal develops the rst means of fully integrating a convolutional neural net scoring function directly into an energy minimization and docking workow.  Interactive virtual screening enables the search of millions of compounds in a few seconds so that queries can be interactively optimized. Interactivity enables the synergistic unication of human expert knowledge and efcient computational algorithms. The proposed work will dramatically expand the size of chemical space ac- cessible through interactive virtual screening. Algorithms for efciently searching the chemical space of billions or trillions of compounds implicitly dened by a set of reaction schemas and fragments will be created as part of a lead optimization workow. Fragment-oriented search will be accelerated by a new data structure that combines pharmacophore and molecular shape information into a single sub-linear time index.  The scoring and lead optimization methods developed in this proposal will be released as open-source soft- ware and made immediately available through open-access online resources. As part of the prospective valida- tion of the proposed methods, these resources will be used to identify hit compounds and optimize leads for two targets related to cancer metabolism: serine hydroxymethyltransferase and kidney glutaminase isoform C. Successful completion of the objectives of this proposal will positively impact public health by reducing the cost and time-to-market of developing new drugs, particularly with respect to novel protein targets. Project Narrative  Researchers will be able to more quickly and accurately identify potential drug candidates using the new methods, tools, and resources for structure-based drug discovery created by this project. These tools will be readily accessible through open-access web sites and open-source software. As part of the project these tools will be used to identify new molecules that are relevant to the treatment of cancer.","Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization",9419924,R01GM108340,"['Algorithms ', ' Award ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' cell growth ', ' Cellular Growth ', ' Cellular Expansion ', ' Communities ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Drug Design ', ' Environment ', ' Feedback ', ' Glutaminase ', ' Liver Glutaminase ', ' L glutamine amidohydrolase ', ' GA Protein ', ' EC 3.5.1.2 ', ' Breast Cell Glutaminase ', ' Glutamine ', ' Q. Levoglutamide ', ' Q Levoglutamide ', ' L-Glutamine ', ' Gln ', ' Human ', ' Modern Man ', ' In Vitro ', ' indexing ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Libraries ', ' Ligands ', ' Methods ', ' Modernization ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Play ', ' Proteins ', ' Public Health ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Glycine Hydroxymethyltransferase ', ' Threonine Aldolase ', ' Serine Transhydroxymethylase ', ' Serine Hydroxymethyltransferase ', ' Serine Hydroxymethylase ', ' Serine Aldolase ', ' Allothreonine Aldolase ', ' Computer software ', ' Software ', ' Testing ', ' Time ', ' Work ', ' Data Set ', ' Dataset ', ' Visualization ', ' Imagery ', ' base ', ' improved ', ' Biochemical ', ' Ensure ', ' Chemicals ', ' Training ', ' data base ', ' Data Bases ', ' Databases ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Knowledge ', ' Dimensions ', ' Dependence ', ' Reaction ', ' Cell Proliferation ', ' Cellular Proliferation ', ' Cell Multiplication ', ' Cell Growth in Number ', ' molecular shape ', ' neoplastic cell ', ' Tumor Cell ', ' Performance ', ' Protein Isoforms ', ' Isoforms ', ' success ', ' Biological Neural Networks ', ' neural network ', ' pharmacophore ', ' relating to nervous system ', ' neural ', ' resource guides ', ' Structure ', ' novel ', ' Sampling ', ' Neural Network Simulation ', ' Perceptrons ', ' Neural Network Models ', ' Connectionist Models ', ' cancer therapy ', ' anticancer therapy ', ' anti-cancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' drug discovery ', ' RANK protein ', ' receptor activator of NF-kappaB ', ' TNFRSF11A gene product ', ' Effectiveness ', ' cheminformatics ', ' chemical informatics ', ' Address ', ' Affinity ', ' Data ', ' Research Infrastructure ', ' Infrastructure ', ' in vivo ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' Modification ', ' imaging ', ' Image ', ' website ', ' web site ', ' cost ', ' virtual ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' tumor xenograft ', ' blind ', ' prospective ', ' combinatorial ', ' user-friendly ', ' computer algorithm ', ' Computational algorithm ', ' data structure ', ' web interface ', ' open source ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' overexpress ', ' over-expression ', ' overexpression ', ' drug candidate ', ' tumor cell metabolism ', ' cancer metabolism ', ' cancer cell metabolism ', ' tumor metabolism ', ' screening ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' web-based resource ', ' web resource ', ' online compendium ', ' on-line resource ', ' on-line compendium ', ' internet resource ', ' online resource ', ' lead optimization ', ' anticancer ', ' anti-cancer ', ' deep learning ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2018,312167,0.12914649675204226
"Pacific Northwest Advanced Compound Identification Core OVERALL SUMMARY The capability to chemically identify thousands of metabolites and other chemicals in clinical samples will revolutionize the search for environmental, dietary, and metabolic determinants of disease. By comparison to near-comprehensive genetic information, comparatively little is understood of the totality of the human metabolome, largely due to insufficiencies in molecular identification methods. Through innovations in computational chemistry and advanced ion mobility separations coupled with mass spectrometry, we propose to overcome a significant, long standing obstacle in the field of metabolomics: the absence of methods for accurate and comprehensive identification of metabolites without relying on data from analysis of authentic chemical standards. A paradigm shift in metabolomics, we will use gas-phase molecular properties that can be both accurately predicted computationally and consistently measured experimentally, and which can thus be used for comprehensive identification of the metabolome without the need for authentic chemical standards. The outcomes of this proposal directly advance the mission and goals of the NIH Common Fund by: (i) transforming metabolomics science by enabling consideration of the totality of the human metabolome through optimized identification of currently unidentifiable molecules, eventually reaching hundreds of thousands of molecules, and (ii) developing standardized computational tools and analytical methods to increase the national capacity for biomedical researchers to identify metabolites quickly and accurately. This work is significant because it enables comprehensive and confident chemical measurement of the metabolome. This work is innovative because it utilizes an integrated quantum-chemistry and machine learning computational pipeline to accurately predict physical-chemical properties of metabolites coupled to measurements. OVERALL NARRATIVE This project will utilize integrated quantum-chemistry and machine learning computational computational approaches coupled with advanced instrumentation to characterize the human metabolome, and identify currently unidentifiable molecules without the use of authentic chemical standards. Results from these studies will contribute to the goal of understanding diseases, and the tools and resources will be made publically available for biomedical researchers.",Pacific Northwest Advanced Compound Identification Core,9589783,U2CES030170,"['Adoption ', ' Algorithms ', ' Biomedical Research ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Communities ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Engineering ', ' Gases ', ' Goals ', ' Human ', ' Modern Man ', ' instrumentation ', ' Isotopes ', ' Libraries ', ' Methods ', ' Methodology ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Pacific Northwest ', ' Probability ', ' Reference Standards ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Science ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Toxin ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Measures ', ' Uncertainty ', ' doubt ', ' analytical method ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Phase ', ' Biological ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Blood Serum ', ' Serum ', ' Workshop ', ' Educational workshop ', ' data base ', ' Data Bases ', ' Databases ', ' Measurement ', ' Funding ', ' chemical property ', ' Liquid substance ', ' liquid ', ' fluid ', ' Metabolic ', ' Genetic ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Dependence ', ' Source ', ' Techniques ', ' experience ', ' quantum chemistry ', ' small molecule libraries ', ' chemical library ', ' High Performance Computing ', ' high-end computing ', ' stereochemistry ', ' novel ', ' Sampling ', ' Property ', ' computational chemistry ', ' drug discovery ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' chemical standard ', ' Data ', ' Resolution ', ' Supercomputing ', ' super computing ', ' Attributes of Chemicals ', ' Computer Instrumentation ', ' Advanced Instrumentation ', ' Computers and Advanced Instrumentation ', ' Molecular ', ' ion mobility ', ' computational tools ', ' computerized tools ', ' Outcome ', ' Coupled ', ' innovative ', ' innovate ', ' innovation ', ' human disease ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' comparative ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' nongenetic ', ' non-genetic ', ' drug candidate ', ' genetic information ', ' dark matter ', ' Predictive Analytics ', ' metabonome ', ' metabolome ', ' ']",NIEHS,BATTELLE PACIFIC NORTHWEST LABORATORIES,U2C,2018,1076717,0.16409630656627852
"Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts PROJECT SUMMARY Collaborative Drug Discovery, Inc. (CDD) proposes to develop a novel approach based on deep learning neural networks to encode molecules into chemically rich vectors. We will first apply this representation to build more powerful computational models that can more accurately predict properties such as bioactivity, ADME/ Tox, and pharmacokinetics across libraries of molecular structures. The ultimate goal is to leverage this repre- sentation to generate novel compounds with better combinations of properties. Both of these capabilities will help scientists to accelerate discovery of new drugs broadly across many therapeutic areas.  Scientists engaged in drug discovery research from academic laboratories to large pharmaceutical companies rely on computational QSAR models to predict pharmacologically relevant properties and obviate the need to perform expensive, time-consuming assays (many of which require animal studies) for every molecule of interest. Some properties (e.g. logP) can now be modeled with such high confidence that the models have replaced the need to perform the assays, but many other critical properties (e.g. solubility, ADME, PK, hERG) remain far from this goal. We expect that our proposed chemically rich vectors will significantly advance the state of the art beyond what can be achieved with conventional descriptors and fingerprints. Improved models will enable researchers to select lead candidate series more effectively, explore chemical space around leads to generate novel IP more efficiently, reduce failure rates for compounds advancing through the drug discovery pipeline, and accelerate the entire drug discovery process. These benefits will be realized broadly across most therapeutic areas.  Our central innovation is a novel computational strategy: first develop a deep learning (DL) model optimized to best capture the essential structural and chemical features of molecules, starting from the most natural structural representation; then validate the DL model by applying it to improve QSAR modeling of pharmacological properties; and finally extend it to generate previously unknown molecules that have superior properties  the so-called inverse QSAR problem, which is the Holy Grail of computational medicinal chemistry. Others have unsuccessfully tried to leap directly to solve the inverse QSAR problem. We propose a more patient and methodical approach that will allow the neural network to perform self-supervised training to learn about chemical structures and properties from readily available, extremely large datasets, then transfer this learning to improve modeling; only after establishing this solid foundation do we intend to apply the models to attempt inverse QSAR. Prior attempts in this area have also relied on neural network architectures designed originally for language processing. We will design a new architecture, more akin to neural network architectures that have proven most successful at image classification, and optimize it to directly process the molecular graph that represents the relationship of atoms and bonds in molecules. PROJECT NARRATIVE The proposed project will create novel computational tools that will help researchers to understand whether potential new drugs are likely to be both safe and effective, and identify similar compounds that are likely to be safer and more effective against the same target. This innovative capability will help to accelerate the discovery and development of novel and improved drugs against a wide range of diseases. !",Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts,9612249,R43TR002527,"['Animals ', ' Architecture ', ' Engineering / Architecture ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Pharmaceutical Chemistry ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Classification ', ' Systematics ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Fingerprint ', ' Foundations ', ' Goals ', ' Human ', ' Modern Man ', ' Laboratories ', ' Language ', ' Learning ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Patients ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Pharmacology ', ' Play ', ' Publishing ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Solubility ', ' Supervision ', ' Technology ', ' Testing ', ' Time ', ' Psychological Transfer ', ' training transfer ', ' learning transfer ', ' Translations ', ' Work ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Area ', ' Solid ', ' Phase ', ' Series ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Failure ', ' Intuition ', ' chemical property ', ' Descriptor ', ' Therapeutic ', ' Scientist ', ' Dimensions ', ' Techniques ', ' Benchmarking ', ' Best Practice Analysis ', ' interest ', ' experience ', ' Performance ', ' Biological Neural Networks ', ' neural network ', ' novel ', ' Graph ', ' Modeling ', ' Property ', ' computational chemistry ', ' molecular vector ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' drug discovery ', ' voice recognition ', ' Pharmacologic Substance ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Data ', ' Molecular Bank ', ' molecular library ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' vector ', ' feeding ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' innovative ', ' innovate ', ' innovation ', ' language processing ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' lead series ', ' drug candidate ', ' network architecture ', ' learning method ', ' learning activity ', ' learning strategy ', ' lead candidate ', ' deep learning ', ' ']",NCATS,"COLLABORATIVE DRUG DISCOVERY, INC.",R43,2018,149830,0.10285995354158214
"Simulation of Proton Translocation in Biomolecules PROJECT SUMMARY  The transport of protons in biomolecular systems is a phenomenon of fundamental importance to processes such as ATP synthesis, enzyme catalysis, the maintenance of pH gradients, proton pumping, viral infection, and substrate/ion transport across membranes via protein transporters, symporters, and antiporters. Modeling biomolecular proton translocation in silico is a significant challenge due to the complex chemical reactions involved in Grotthuss proton shutting between water molecules and with protonatable amino acids, as well as the complexity of the target biomolecular systems. In most cases, it is not only important to understand the mechanism of proton binding and transport, but also its coupling to other mechanistically relevant biomolecular processes, such as protein conformational changes, substrate binding, other protonation events, and dynamic hydration.  In this project the continued development and application of a powerful multiscale computer simulation methodology is described for the study of proton transport in several key classes of proton translocating biomolecular systems, including channels (influenza A and B M2 channels), antiporters/symporters (ClC Cl-/H+ antiporter and phosphate transporter, respectively), and transporters (proton-coupled oligopeptide transporter and EmrE multidrug transporter). The overall research plan is made possible by a novel reactive molecular dynamics simulation approach integrated with quantum mechanics/molecular mechanics (QM/MM) methods that allows for the study of explicit long-length and -time scale proton transport through water molecules and ionizable molecular groups in hydrogen-bonded networks, as well as by new innovations in enhanced free energy sampling methodology, machine learning, kinetic network theory, and coarse-graining. A primary goal in the research with this methodology in hand is to reveal the mechanisms of proton transport, as well as its coupling to hydration and conformational changes, in the above mentioned biomolecular systems. All of these studies will be carried out in collaboration with leading experimentalists, while continuing to add a new dimension to the field of biomolecular computer simulation as a whole. 1 PROJECT NARRATIVE  In this project, computer simulations will be used to study proton transport in several important biomolecular systems. Proton translocation is of fundamental significance throughout biology, as demonstrated by the pH-dependence of biomolecular structure and function and the central role of transmembrane proton gradients in bioenergy conversion. Moreover, understanding proton transport is of fundamental importance and direct relevance to numerous aspects of human health, including metabolism, aging, diabetes, neurodegeneration, retinal degeneration, antivral and anti-bacterial therapeutics, and homeostasis. 1",Simulation of Proton Translocation in Biomolecules,9770887,R01GM053148,"['Achievement ', ' Achievement Attainment ', ' Aging ', ' Amino Acids ', ' aminoacid ', ' Anions ', ' Behavior ', ' Sampling Biases ', ' Biology ', ' Transporter Protein ', ' Transport Proteins ', ' Transport Protein Gene ', ' Carrier Proteins ', ' Catalysis ', ' Charge ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' diabetes ', ' Diabetes Mellitus ', ' Diffusion ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Enzyme Gene ', ' Enzymes ', ' Future ', ' Goals ', ' H+ Pump ', ' H(+) Pump ', ' Proton Pump ', ' Hand ', ' Health ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Modern Man ', ' Human ', ' H-bond ', ' Hydrogen Bonding ', ' influenza infection ', ' flu infection ', ' Grippe ', ' Influenza ', ' Kinetics ', ' Maintenance ', ' Medicine ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Motion ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' neuronal degeneration ', ' neurological degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Oligopeptides ', ' Phosphates ', ' inorganic phosphate ', ' Protein Conformation ', ' Proteins ', ' Hydrogen Ions ', ' H+ element ', ' Protons ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' retinal degenerative diseases ', ' retinal degenerative ', ' retina degeneration ', ' degenerative retina diseases ', ' Retinal Degeneration ', ' social role ', ' Role ', ' Software ', ' Computer software ', ' Specificity ', ' Time ', ' Travel ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' Hydrogen Oxide ', ' Water ', ' Wisconsin ', ' antiporter ', ' Ion Transport ', ' protonation ', ' Area ', ' Medical ', ' insight ', ' Progress Reports ', ' Funding ', ' Anti-Bacterial Agents ', ' antibacterial ', ' anti-bacterial ', ' Antibacterial Agents ', ' Collaborations ', ' Letters ', ' Therapeutic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Entropy ', ' Mechanics ', ' mechanical ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Reaction ', ' System ', ' Consult ', ' chemical reaction ', ' Membrane ', ' membrane structure ', ' molecular dynamics ', ' Molecular Dynamics Simulation ', ' symporter ', ' Co-Transporters ', ' Free Energy ', ' Structure ', ' simulation ', ' novel ', ' Agreement ', ' Code ', ' Coding System ', ' chemical bond ', ' Modeling ', ' Sampling ', ' theories ', ' molecular mechanics ', ' Inorganic Phosphate Transporter ', ' Phosphate Transporters ', ' Phosphate Transport Proteins ', ' Influenza A virus ', ' Type A Influenza ', ' Orthomyxovirus Type A ', ' Influenzavirus A ', ' Influenza Viruses Type A ', ' Influenza A ', ' Influenza B Virus ', ' Orthomyxoviruses Type B ', ' Influenza Viruses Type B ', ' Influenza B ', ' pH gradient ', ' deltapH ', ' delta pH ', ' Molecular Interaction ', ' Binding ', ' Hydration ', ' Hydration status ', ' Length ', ' Defect ', ' ATP Synthesis Pathway ', ' ATP Synthesis ', ' Data ', ' Quantum Mechanics ', ' Transport Process ', ' Molecular Transport ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' anti-influenza drug ', ' antiflu drug ', ' anti-flu drug ', ' quantum ', ' Outcome ', ' migration ', ' Coupled ', ' Coupling ', ' innovation ', ' innovative ', ' innovate ', ' multi drug transporter ', ' multidrug transporter ', ' experimental study ', ' experimental research ', ' experiment ', ' Grain ', ' ']",NIGMS,UNIVERSITY OF CHICAGO,R01,2019,310328,0.0374765116784504
"Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level Project summary: Although altered cell metabolism is becoming an established hallmark of cancer, there remains a crucial need of new tools for quantitation of metabolites at single living cell level. In particular, due to lack of specific labels for metabolites, there is an unmet need for high-resolution imaging tools capable of mapping metabolites and small molecules (fatty acids, carbohydrates, amino acids) that play essential roles in pathogenesis of cancer. Supported by a R21 grant through the IMAT program, our team partially addressed this need via developing a multiplex stimulated Raman scattering (SRS) microscope, which enabled vibrational imaging of metabolites in live tumor cells and intact biopsies at the speed of 5 microseconds per spectrum. This R33 application aims to push the hyperspectral stimulated Raman imaging technology to the next level through (i) technical simplification and validation, (ii) developing a robust hyperspectral image segmentation framework, and (iii) integrating the SRS modality with a commercial spontaneous Raman microscope towards broad use by non-experts. We have assembled an inter-disciplinary team for the proposed development. The three specific aims are: (1) Developing an easy-to-operate, highly sensitive line-by-line hyperspectral SRS microscope and validate its capacity for cancer metabolic imaging at single cell level. (2) Establishing a feature analysis framework for segmentation of hyperspectral SRS images using the non-parametric Bayesian model. (3) Integrating and validating the stimulated Raman imaging modality on a spontaneous Raman microscope. By completing the proposed development and validation activities, we will have generated a highly novel spectroscopic imaging system broadly applicable to analysis of chemical contents of cells and tissues for discovery-driven research and marker- based precision diagnosis. Project Narrative: Altered cell metabolism is becoming an established hallmark of cancer. We propose a label-free stimulated Raman spectroscopic imaging system broadly applicable to analysis of chemical contents of cells and tissues for discovery-driven cancer research and marker-based precision diagnosis.",Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level,9789229,R33CA223581,"['Amino Acids ', ' aminoacid ', ' Amplifiers ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Carbohydrates ', ' Cell Body ', ' Cells ', ' Color ', ' Diagnosis ', ' Dromisol ', ' Domoso ', ' Dimethylsulphoxide ', ' Dimethylsulphinyl ', ' Demeso ', ' Demasorb ', ' DMSO ', ' Dimethyl Sulfoxide ', ' Ergastoplasm ', ' Endoplasmic Reticulum ', ' Fatty Acids ', ' flow cytophotometry ', ' Flow Microfluorometry ', ' Flow Microfluorimetry ', ' Flow Cytofluorometry ', ' Flow Cytofluorometries ', ' Flow Cytometry ', ' Grant ', ' Hybrids ', ' Industrialization ', ' Lipids ', ' Microscopy ', ' Electron Microscopy ', ' Fluorescence Light Microscopy ', ' Fluorescence Microscopy ', ' Patients ', ' Play ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Raman spectrometry ', ' Raman Spectroscopy ', ' IR/UV/Raman Spectroscopy ', ' Raman Spectrum Analysis ', ' Time ', ' Tissue Extracts ', ' Body Tissues ', ' Tissues ', ' Hydrogen Oxide ', ' Water ', ' Businesses ', ' Imagery ', ' Visualization ', ' base ', ' Label ', ' Microscope ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' Chemicals ', ' Bayesian Method ', ' Bayesian posterior distribution ', ' Bayesian classification procedure ', ' Bayesian classification method ', ' Bayesian approaches ', ' Bayesian Statistical Method ', ' Bayesian Methodology ', ' Collaborations ', ' Metabolic ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' instrument ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' millisecond ', ' Msec ', ' Side ', ' System ', ' vibration ', ' neoplastic cell ', ' Tumor Cell ', ' particle ', ' Speed ', ' novel ', ' Modality ', ' Pathogenesis ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' imaging method ', ' image-based method ', ' imaging modality ', ' small molecule ', ' Address ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Imaging Device ', ' Imaging Tool ', ' Imaging Instrument ', ' Molecular Analysis ', ' Resolution ', ' Cancer Biology ', ' Validation ', ' Monitor ', ' Molecular ', ' Cellular Metabolic Process ', ' cellular metabaolism ', ' cell metabolism ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' anticancer research ', ' cancer research ', ' anti-cancer research ', ' spectroscopic imaging ', ' imaging spectroscopy ', ' cancer imaging ', ' tumor imaging ', ' oncology imaging ', ' oncologic imaging ', ' cancer stem cell ', ' malignant stem cell ', ' Imaging technology ', ' imaging Segmentation ', ' commercialization ', ' endoplasmic reticulum stress ', ' ER stress ', ' tumor metabolism ', ' tumor cell metabolism ', ' cancer metabolism ', ' cancer cell metabolism ', ' Bayesian Modeling ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' imaging system ', ' targeted imaging ', ' cancer biomarkers ', ' cancer markers ', ' three dimensional cell culture ', ' 3D culture ', ' 3D cell culture ', ' high resolution imaging ', ' human imaging ', ' metabolic imaging ', ' ']",NCI,BOSTON UNIVERSITY (CHARLES RIVER CAMPUS),R33,2019,365154,0.051274442657896845
"Simulation of Proton Translocation in Biomolecules PROJECT SUMMARY  The transport of protons in biomolecular systems is a phenomenon of fundamental importance to processes such as ATP synthesis, enzyme catalysis, the maintenance of pH gradients, proton pumping, viral infection, and substrate/ion transport across membranes via protein transporters, symporters, and antiporters. Modeling biomolecular proton translocation in silico is a significant challenge due to the complex chemical reactions involved in Grotthuss proton shutting between water molecules and with protonatable amino acids, as well as the complexity of the target biomolecular systems. In most cases, it is not only important to understand the mechanism of proton binding and transport, but also its coupling to other mechanistically relevant biomolecular processes, such as protein conformational changes, substrate binding, other protonation events, and dynamic hydration.  In this project the continued development and application of a powerful multiscale computer simulation methodology is described for the study of proton transport in several key classes of proton translocating biomolecular systems, including channels (influenza A and B M2 channels), antiporters/symporters (ClC Cl-/H+ antiporter and phosphate transporter, respectively), and transporters (proton-coupled oligopeptide transporter and EmrE multidrug transporter). The overall research plan is made possible by a novel reactive molecular dynamics simulation approach integrated with quantum mechanics/molecular mechanics (QM/MM) methods that allows for the study of explicit long-length and -time scale proton transport through water molecules and ionizable molecular groups in hydrogen-bonded networks, as well as by new innovations in enhanced free energy sampling methodology, machine learning, kinetic network theory, and coarse-graining. A primary goal in the research with this methodology in hand is to reveal the mechanisms of proton transport, as well as its coupling to hydration and conformational changes, in the above mentioned biomolecular systems. All of these studies will be carried out in collaboration with leading experimentalists, while continuing to add a new dimension to the field of biomolecular computer simulation as a whole. 1 PROJECT NARRATIVE  In this project, computer simulations will be used to study proton transport in several important biomolecular systems. Proton translocation is of fundamental significance throughout biology, as demonstrated by the pH-dependence of biomolecular structure and function and the central role of transmembrane proton gradients in bioenergy conversion. Moreover, understanding proton transport is of fundamental importance and direct relevance to numerous aspects of human health, including metabolism, aging, diabetes, neurodegeneration, retinal degeneration, antivral and anti-bacterial therapeutics, and homeostasis. 1",Simulation of Proton Translocation in Biomolecules,9965046,R01GM053148,"['Achievement ', ' Achievement Attainment ', ' Aging ', ' Amino Acids ', ' aminoacid ', ' Anions ', ' Behavior ', ' Sampling Biases ', ' Biology ', ' Transporter Protein ', ' Transport Proteins ', ' Transport Protein Gene ', ' Carrier Proteins ', ' Catalysis ', ' Charge ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' diabetes ', ' Diabetes Mellitus ', ' Diffusion ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Enzyme Gene ', ' Enzymes ', ' Future ', ' Goals ', ' H+ Pump ', ' H(+) Pump ', ' Proton Pump ', ' Hand ', ' Health ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Modern Man ', ' Human ', ' H-bond ', ' Hydrogen Bonding ', ' influenza infection ', ' flu infection ', ' Grippe ', ' Influenza ', ' Kinetics ', ' Maintenance ', ' Medicine ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Motion ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' neuronal degeneration ', ' neurological degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Oligopeptides ', ' Phosphates ', ' inorganic phosphate ', ' Protein Conformation ', ' Proteins ', ' Hydrogen Ions ', ' H+ element ', ' Protons ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Support ', ' retinal degenerative diseases ', ' retinal degenerative ', ' retina degeneration ', ' degenerative retina diseases ', ' Retinal Degeneration ', ' social role ', ' Role ', ' Software ', ' Computer software ', ' Specificity ', ' Time ', ' Travel ', ' virus-induced disease ', ' virus infection ', ' viral infection ', ' Viral Diseases ', ' Virus Diseases ', ' Hydrogen Oxide ', ' Water ', ' Wisconsin ', ' antiporter ', ' Ion Transport ', ' protonation ', ' Area ', ' Medical ', ' insight ', ' Progress Reports ', ' Funding ', ' Anti-Bacterial Agents ', ' antibacterial ', ' anti-bacterial ', ' Antibacterial Agents ', ' Collaborations ', ' Letters ', ' Therapeutic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Entropy ', ' Mechanics ', ' mechanical ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Reaction ', ' System ', ' Consult ', ' chemical reaction ', ' Membrane ', ' membrane structure ', ' molecular dynamics ', ' Molecular Dynamics Simulation ', ' symporter ', ' Co-Transporters ', ' Free Energy ', ' Structure ', ' simulation ', ' novel ', ' Agreement ', ' Code ', ' Coding System ', ' chemical bond ', ' Modeling ', ' Sampling ', ' theories ', ' molecular mechanics ', ' Inorganic Phosphate Transporter ', ' Phosphate Transporters ', ' Phosphate Transport Proteins ', ' Influenza A virus ', ' Type A Influenza ', ' Orthomyxovirus Type A ', ' Influenzavirus A ', ' Influenza Viruses Type A ', ' Influenza A ', ' Influenza B Virus ', ' Orthomyxoviruses Type B ', ' Influenza Viruses Type B ', ' Influenza B ', ' pH gradient ', ' deltapH ', ' delta pH ', ' Molecular Interaction ', ' Binding ', ' Hydration ', ' Hydration status ', ' Length ', ' Defect ', ' ATP Synthesis Pathway ', ' ATP Synthesis ', ' Data ', ' Quantum Mechanics ', ' Transport Process ', ' Molecular Transport ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' anti-influenza drug ', ' antiflu drug ', ' anti-flu drug ', ' quantum ', ' Outcome ', ' migration ', ' Coupled ', ' Coupling ', ' innovation ', ' innovative ', ' innovate ', ' multi drug transporter ', ' multidrug transporter ', ' experimental study ', ' experimental research ', ' experiment ', ' Grain ', ' ']",NIGMS,UNIVERSITY OF CHICAGO,R01,2019,109700,0.0374765116784504
"Groundwork for a Synchrotron MicroCT Imaging Resource for Biology (SMIRB) Project Summary Each major human disease is associated with a specific range of morphological changes to cells and tissues in the micron scale. Normal and abnormal structure was discovered and is still characterized using histology - a microscopic technique that depends on physical tissue slices. Presently, histologys use in systems biology is limited by its largely descriptive and two-dimensional nature. Making histology quantitative and three-dimensional would be potentially transformational for research and diagnostics, but has been impractical. Accordingly, we have now created a 3D form of histology by customizing X-ray microtomography (micro-CT) of fixed and stained, millimeter-scale, whole organisms and tissue samples. We used fixed and metal-stained, whole zebrafish because they contain a full range of tissues within the size range currently studied histologically. The result is the first practical way to create virtual histology-like sections in any plane. Three-dimensional, complete histological phenotyping has potential use in genetic and chemical screens, and in clinical and toxicological tissue diagnostics. Here, we propose the next steps needed to enable high-throughput, quantitative, 3D histological phenotyping of whole, millimeter-scale animals. The proposed work applies the principles of chemistry, physics, and computer science to improve image resolution, throughput, and analytics, organized into three specific aims. Specific Aim 1 will build on our developments in this project and further improve imaging volume and resolution by upgrading imaging array, optics, and sub-pixel shifting, and to throughput by changes in sample embedding, loading geometry and mechanics, helical CT scanning, scintillator material, and to data sharing by improvements to the ViewTool infrastructure and user interface. Specific Aim 2 will yield reference images to define the range of normal phenotypic variation and to obtain samples related to a range of potential applications. Specific Aim 3 will apply the power of machine learning to segmentation, annotation, and analytics. Together, this work will establish a practical foundation for large-scale genetic and chemical screens involving mm-scale, whole organisms based on 3-dimensional, quantitative, histological phenotyping. The instrumentation and analytics will be state-of-the-art in its combination of resolution, field-of-view, pancellularity, image quality, analytical potential, throughput, sample stability, and reproducibility and largely usable with both tube and synchrotron X-ray sources. The voxel resolution will be at least 0.5 m across fields-of-view of up to 1 cm. Representation of every cell type make the images suitable for cross-referencing across imaging modalities. Potential applications will be explored, wild-type will begin to be defined, and training sets for automated segmentation generated. The potential impact will encompass the missions of most NIH Institutes and Centers. The whole-animal genetic and chemical screens enabled are expected to impact drug development, diagnostics, and our basic understanding of how genes and environment define phenotype. Project Narrative Our group has established the only three-dimensional form of histology that is suitable for histopathology and quantitative tissue phenotyping, tissue X-ray microtomography (micro-CT). We outline here a plan to establish mechanisms for increasing resolution and field-of-view, to add sample multiplexing, to simply sample preparation, and to explore machine learning mechanisms for defining normal and abnormal structure towards whole-organism complete tissue phenotyping. The resulting tools will allow the community to comprehensively and computationally determine the roles of genes and environment in defining phenotype, which has implications in drug development, biomedical research, and medicine.",Groundwork for a Synchrotron MicroCT Imaging Resource for Biology (SMIRB),9792960,R24OD018559,"['Age ', ' ages ', ' Animals ', ' Biology ', ' Biomedical Research ', ' bone ', ' Cell Body ', ' Cells ', ' Cs element ', ' Cesium ', ' Chemistry ', ' Communities ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Embryonic ', ' Embryo ', ' Environment ', ' Fishes ', ' Foundations ', ' Genes ', ' Goals ', ' Histology ', ' Institutes ', ' instrumentation ', ' Iodides ', ' Medicine ', ' Metals ', ' Mission ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Nerve ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' optical ', ' Optics ', ' Phenotype ', ' Physics ', ' Research ', ' Research Resources ', ' Resources ', ' Remote Operation (Robotics) ', ' Robotics ', ' social role ', ' Role ', ' Siblings ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Staining method ', ' Stains ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' Travel ', ' Work ', ' Writing ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Roentgen Rays ', ' Zebra Fish ', ' Zebra Danio ', ' Danio rerio ', ' Brachydanio rerio ', ' Zebrafish ', ' Measures ', ' Normal Values ', ' Normal Range ', ' Custom ', ' Caenorhabditis elegans ', ' C.elegans ', ' C. elegans ', ' C elegans ', ' Synchrotrons ', ' Tube ', ' base ', ' Organ ', ' detector ', ' improved ', ' Body measure procedure ', ' Body Measures ', ' Microscopic ', ' Variant ', ' Variation ', ' Biological ', ' Histologic ', ' Histologically ', ' Series ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Chemicals ', ' Training ', ' Cellular Structures ', ' Cell Structure ', ' Cell Components ', ' Genetic ', ' Morphology ', ' tool ', ' Diagnostic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Mechanics ', ' mechanical ', ' millimeter ', ' Dimensions ', ' Scanning ', ' Source ', ' cell type ', ' Texture ', ' Techniques ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' mutant ', ' computer science ', ' Histopathology ', ' Structure ', ' Spiral Computed Tomography ', ' spiral CT scan ', ' Spiral Volumetric Computed Tomography ', ' Spiral Volumetric CT ', ' Spiral CT ', ' Spiral Acquisition CT ', ' Helical Computed Tomography ', ' Helical CT ', ' Sampling ', ' drug development ', ' imaging method ', ' image-based method ', ' imaging modality ', ' Tissue Sample ', ' Systems Biology ', ' Animal Genetics ', ' Data ', ' Reproducibility ', ' Resolution ', ' Slice ', ' Whole Organism ', ' Preparation ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' Output ', ' disease phenotype ', ' virtual ', ' computerized tools ', ' computational tools ', ' two-dimensional ', ' 2-dimensional ', ' human disease ', ' clinical toxicology ', ' data sharing ', ' Geometry ', ' Structural defect ', ' structural anomalies ', ' structural abnormalities ', ' Structural malformation ', ' microCT ', ' micro CT ', ' crowdsourcing ', ' crowdsource ', ' crowd-sourcing ', ' crowd source ', ' Tissue imaging ', ' histological studies ', ' histologic studies ', ' unsupervised learning ', ' unsupervised machine learning ', ' Infrastructure ', ' supervised learning ', ' supervised machine learning ', ' feature detection ', ' feature recognition ', ' ']",OD,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,R24,2019,667280,0.0705625339996395
"Identification of Neurochemical Antecedents and Consequences of Distinct Learning Processes Relevant to Addiction Liability ABSTRACT Cues or stimuli in the environment can guide behavior in adaptive ways, bringing one in close proximity to valuable resources (i.e. food, water, mates); but they can also elicit maladaptive behavior. For example, in addicts, exposure to cues (e.g. places, paraphernalia) previously associated with drug-taking often leads to relapse, despite the desire to remain abstinent. The ability of such cues to elicit complex emotional and motivational states and gain control over one's behavior occurs via Pavlovian learning mechanisms. Using an animal model that captures individual differences in response to reward cues, we can now study the neural processes underlying aberrant forms of cue-reward learning, bringing us closer to identifying novel targets for the treatment of addiction. When rats are exposed to a Pavlovian conditioning paradigm wherein a discrete cue is repeatedly paired with presentation of a reward, some are sign-trackersthose that attribute incentive salience to the cue, and others goal-trackersthose that assign only predictive value to the cue. Thus, there is individual variation in the extent to which food cues are attributed with Pavlovian incentive motivational value (incentive salience), and this variation predicts the degree to which drug cues will attain control over behavior and the propensity to relapse. Furthermore, this animal model allows us to parse the incentive from the predictive properties of reward cues, and we have used it to demonstrate that distinct neural circuits regulate these different forms of cue-reward learning. In addition, we have shown that dopamine is critical for incentive learning (i.e. sign-tracking), but not predictive learning (i.e. goal-tracking). Most studies to-date, however, have been hampered by the inability to measure neural correlates of these phenotypes prior to learning. That is, rats must first undergo Pavlovian conditioning in order to be characterized as sign- or goal-trackers. Thus, the first Aim of the current proposal is to determine whether there are pre-existing basal differences in neurotransmitter signaling in the nucleus accumbens core that predict those individuals prone to attribute incentive salience to reward cues prior to behavioral testing. To do this, we will use a novel chemical analytical approach (stable-isotope labeling) that will allow us, for the first time, to assess true basal levels of dopamine, norepinephrine, acetylcholine, serotonin, glutamate and GABA in sign- and goal-trackers. The second Aim will use another novel, but different, chemical analytical approach to simultaneously assess up to 50 neurochemicals in the nucleus accumbens core in sign- and goal-trackers. The focus of the second Aim will be on the neurochemical profiles that emerge as a consequence of an individual's associative learning style. Advanced statistical analyses will be applied in order to identify neurochemical profiles that best predict the behavioral phenotypes and to examine the relationship between neurochemicals over the course of learning. This work will highlight specific neural systems that may render an individual more susceptible to control by reward cues and lay the foundation for future studies to identify novel neuromolecular targets for the treatment of addiction. PROJECT NARRATIVE The way an individual responds to cues associated with rewards may be a key determinant of vulnerability to addiction and relapse. We will employ novel analytical approaches to uncover neurochemical signatures associated with individual variation in response to reward cues. These studies will identify pre-existing and experience-dependent neural mechanisms that allow cues in the environment to gain inordinate control over behavior, and could lead to novel targets for the treatment of addiction.",Identification of Neurochemical Antecedents and Consequences of Distinct Learning Processes Relevant to Addiction Liability,9716629,R21DA045146,"['L-Glutamate ', ' Glutamates ', ' Goals ', ' Grant ', ' Incentives ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Methods ', ' Modernization ', ' Motivation ', ' neurochemical ', ' neurochemistry ', ' Nerve Transmitter Substances ', ' Neurotransmitters ', ' Noradrenaline ', ' Levonorepinephrine ', ' Levarterenol ', ' Norepinephrine ', ' Nucleus Accumbens ', ' Phenotype ', ' abnormal psychology ', ' Psychopathology ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Relapse ', ' Research Resources ', ' Resources ', ' Rewards ', ' Hippophaine ', ' Enteramine ', ' 5HT ', ' 5-Hydroxytryptamine ', ' 5-HT ', ' Serotonin ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' thoughts ', ' Thinking ', ' Time ', ' Hydrogen Oxide ', ' Water ', ' Work ', ' Measures ', ' Outcome Measure ', ' Dataset ', ' Data Set ', ' reinforcer ', ' improved ', ' Procedures ', ' sample collection ', ' specimen collection ', ' Variant ', ' Variation ', ' Microdialysis ', ' Chemicals ', ' Stimulus ', ' Conditioned Stimulus ', ' Individual ', ' Exposure to ', ' Knowledge ', ' Complex ', ' Techniques ', ' System ', ' Location ', ' experience ', ' tandem mass spectrometry ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' relating to nervous system ', ' neural ', ' novel ', ' Partner in relationship ', ' mate ', ' behavior test ', ' behavioral test ', ' drug seeking behavior ', ' Drug Exposure ', ' neural circuit ', ' synaptic circuitry ', ' synaptic circuit ', ' neural circuitry ', ' Impulsivity ', ' Emotional ', ' Modeling ', ' Sampling ', ' Property ', ' response ', ' executive function ', ' executive control ', ' Stable Isotope Labeling ', ' Address ', ' Predictive Value ', ' Pathologic ', ' Process ', ' Development ', ' developmental ', ' Behavioral ', ' motivated behavior ', ' Individual Differences ', ' neuromechanism ', ' neural mechanism ', ' Heritability ', ' addiction ', ' addictive disorder ', ' neurobiological mechanism ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' Algorithm Design ', ' algorithmic composition ', ' algorithm engineering ', ' Algorithmic Engineering ', ' Algorithmic Design ', ' neural correlate ', ' incentive salience ', ' learning strategy ', ' learning method ', ' learning activity ', ' high dimensionality ', ' individual variation ', ' individual variability ', ' individual heterogeneity ', ' machine learning algorithm ', ' Acetylcholine ', ' Behavior ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Chlorides ', ' High Speed Liquid Chromatography ', ' High Performance Liquid Chromatography ', ' HPLC ', ' High Pressure Liquid Chromatography ', ' associative conditioning ', ' Pavlovian conditioning ', ' Associative Learning ', ' classical conditioning ', ' Cues ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Disorder ', ' Disease ', ' Hydroxytyramine ', ' Dopamine ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Exhibits ', ' Food or Food Product ', ' Food ', ' Foundations ', ' Future ', ' -Aminobutyric Acid ', ' GABA ', ' Aminalone ', ' Aminalon ', ' 4-amino-butanoic acid ', ' 4-Aminobutyric Acid ', ' 4-Aminobutanoic Acid ', ' gamma-Aminobutyric Acid ', ' glutamatergic ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R21,2019,233699,0.041881690743943795
"Machine Learning for Drug Response Prediction PROJECT SUMMARY/ABSTRACT  Finding new drugs in the seas of small molecules is a difficult task if no prior information is available. Our broad research goal is to develop innovative and accurate machine learning algorithms to predict the drug responses related to complex human diseases. Specifically, we pursue questions of how a cell line responds to a single drug and combinatorial therapies, from the perspective of biological networks and small-molecule chemoinformatics. One research goal is to understand and predict the cell line-specific responses through integrating a wide range of methods, including the propagation of drug effects via biological networks, matrix factorization of molecular profiles and chemoinformatic analysis of small molecules. We will deploy our algorithms to softwares and web servers, which will inform the downstream experimental design to identify the single and combinatorial drug candidates against human diseases. Our research program will contribute to accelerate the drug discovery process by in silico screening through large amount of potent chemicals. PROJECT NARRATIVE  Molecular targeted therapy is one of the most successful weapons against many complex human diseases. However, identifying effective small-molecule drugs is like looking for a needle in a haystack. The proposed research, by bridging the gaps between existing methods and creating novel machine learning algorithms, will provide valuable guidance to drug development.",Machine Learning for Drug Response Prediction,9794189,R35GM133346,"['Algorithms ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Experimental Designs ', ' Goals ', ' Methods ', ' Research ', ' Sea ', ' Software ', ' Computer software ', ' Biological ', ' Chemicals ', ' weapons ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Complex ', ' novel ', ' response ', ' drug development ', ' drug discovery ', ' small molecule ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Process ', ' innovation ', ' innovative ', ' innovate ', ' combinatorial ', ' human disease ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' drug candidate ', ' screening ', ' molecular targeted therapies ', ' molecular targeted treatment ', ' molecular targeted therapeutics ', ' drug response prediction ', ' Predict drug response ', ' machine learning algorithm ', ' web server ', ' ']",NIGMS,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R35,2019,331020,0.07348222027510437
"Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization Project Summary  The proposed work will accelerate the pace of drug discovery by developing, validating, and testing new methods, tools, and resources for structure-based drug design. Two fundamental challenges of structure-based drug design are the accurate scoring and ranking of protein-ligand structures, which identies active com- pounds, and the ability to efciently search a large number of ligands, which ensures that active compounds are sampled. This proposal will address these challenges by developing a novel approach for protein-ligand scoring and expanding the size of the chemical space that can be efciently searched during lead optimiza- tion. The methods will be validated by their prospective application toward the discovery of new anti-cancer molecules and will be made readily accessible through online resources and open-source tools.  The proposal leverages recent and signicant advances in deep learning and image recognition to develop scoring functions that accurately recognize high-afnity protein-ligand interactions. This is achieved by design- ing and training convolutional neural nets on three-dimensional representations of protein-ligand structures to discriminate between binders and non-binders. Convolutional neural net training will exploit large datasets of afnity and structural data to automatically extract the relevant features necessary to accurately prioritize compounds. Additionally, the proposal develops the rst means of fully integrating a convolutional neural net scoring function directly into an energy minimization and docking workow.  Interactive virtual screening enables the search of millions of compounds in a few seconds so that queries can be interactively optimized. Interactivity enables the synergistic unication of human expert knowledge and efcient computational algorithms. The proposed work will dramatically expand the size of chemical space ac- cessible through interactive virtual screening. Algorithms for efciently searching the chemical space of billions or trillions of compounds implicitly dened by a set of reaction schemas and fragments will be created as part of a lead optimization workow. Fragment-oriented search will be accelerated by a new data structure that combines pharmacophore and molecular shape information into a single sub-linear time index.  The scoring and lead optimization methods developed in this proposal will be released as open-source soft- ware and made immediately available through open-access online resources. As part of the prospective valida- tion of the proposed methods, these resources will be used to identify hit compounds and optimize leads for two targets related to cancer metabolism: serine hydroxymethyltransferase and kidney glutaminase isoform C. Successful completion of the objectives of this proposal will positively impact public health by reducing the cost and time-to-market of developing new drugs, particularly with respect to novel protein targets. Project Narrative  Researchers will be able to more quickly and accurately identify potential drug candidates using the new methods, tools, and resources for structure-based drug discovery created by this project. These tools will be readily accessible through open-access web sites and open-source software. As part of the project these tools will be used to identify new molecules that are relevant to the treatment of cancer.","Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization",9634985,R01GM108340,"['Algorithms ', ' Award ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cellular Growth ', ' Cellular Expansion ', ' cell growth ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Drug Design ', ' Environment ', ' Feedback ', ' Liver Glutaminase ', ' L glutamine amidohydrolase ', ' GA Protein ', ' EC 3.5.1.2 ', ' Breast Cell Glutaminase ', ' Glutaminase ', ' Q. Levoglutamide ', ' Q Levoglutamide ', ' L-Glutamine ', ' Gln ', ' Glutamine ', ' Modern Man ', ' Human ', ' In Vitro ', ' indexing ', ' Intelligence ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' Ligands ', ' Methods ', ' Modernization ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Play ', ' Proteins ', ' Public Health ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Threonine Aldolase ', ' Serine Transhydroxymethylase ', ' Serine Hydroxymethyltransferase ', ' Serine Hydroxymethylase ', ' Serine Aldolase ', ' Allothreonine Aldolase ', ' Glycine Hydroxymethyltransferase ', ' Software ', ' Computer software ', ' Testing ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' Imagery ', ' Visualization ', ' base ', ' improved ', ' Biochemical ', ' Ensure ', ' Chemicals ', ' Training ', ' Databases ', ' data base ', ' Data Bases ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' cancer cell ', ' Malignant Cell ', ' tool ', ' Knowledge ', ' Dimensions ', ' Dependence ', ' Reaction ', ' Cell Proliferation ', ' Cellular Proliferation ', ' Cell Multiplication ', ' Cell Growth in Number ', ' molecular shape ', ' neoplastic cell ', ' Tumor Cell ', ' Performance ', ' Protein Isoforms ', ' Isoforms ', ' success ', ' pharmacophore ', ' resource guides ', ' Structure ', ' novel ', ' Sampling ', ' Neural Network Simulation ', ' Perceptrons ', ' Neural Network Models ', ' Connectionist Models ', ' cancer therapy ', ' anticancer therapy ', ' anti-cancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' drug discovery ', ' RANK protein ', ' receptor activator of NF-kappaB ', ' TNFRSF11A gene product ', ' Effectiveness ', ' chemical informatics ', ' cheminformatics ', ' Address ', ' Affinity ', ' Data ', ' in vivo ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' Modification ', ' Image ', ' imaging ', ' web site ', ' website ', ' cost ', ' virtual ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' tumor xenograft ', ' blind ', ' prospective ', ' combinatorial ', ' user-friendly ', ' Computational algorithm ', ' computer algorithm ', ' data structure ', ' web interface ', ' open source ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' overexpression ', ' overexpress ', ' drug candidate ', ' tumor metabolism ', ' tumor cell metabolism ', ' cancer metabolism ', ' cancer cell metabolism ', ' screening ', ' Algorithmic Software ', ' Software Algorithm ', ' Algorithmic Tools ', ' online resource ', ' web-based resource ', ' web resource ', ' online compendium ', ' on-line resource ', ' on-line compendium ', ' internet resource ', ' lead optimization ', ' anti-cancer ', ' anticancer ', ' deep learning ', ' Infrastructure ', ' convolutional neural network ', ' convolutional neural nets ', ' ConvNet ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2019,313000,0.12914649675204226
"High Accuracy Computational Methods for Biomolecular Nuclear Magnetic Resonance Spectroscopy High accuracy computational methods for biomolecular nuclear magnetic resonance spectroscopy Nuclear magnetic resonance (NMR) spectroscopy is one of the most important condensed phase probes of composition, structure and dynamics of biomolecules and bio-organic species. NMR observables such as chemical shifts and spin-spin splittings can be measured to very high accuracy, and are sensitive both to the functional groups that are present and to their detailed geometries and chemical environment. As such these NMR measurements could be used to develop protein structures with a quality equivalent to high resolution X-ray crystallography but in their native aqueous environments. The connection to structure, while true in principle, is nevertheless sometimes difficult to reveal in practice through direct assignment of the spectrum. Simulation methods that accurately predict spectral observables from structure are a key goal for spectral assignment. Such methods are even more crucial for the inverse problem of realizing high quality NMR structures of folded proteins from spectra, and as powerful restraints for determining the structural ensembles of intrinsically disordered proteins (IDPs). Existing approaches to this problem typically rely on semi-empirical heuristics, and while they have achieved considerable success, they also reveal limitations that significantly degrade the quality of structural prediction. In this proposal, we will develop a new, first principles quantum mechanical (QM) based approach to simulation of NMR spectral observables for condensed phase biomolecules and bio-organics. Rapid prototyping of new QM methods will be enabled by the development of a distinctive in-silico NMR laboratory that applies finite magnetic fields and nuclear spins. From this capability, new methods for chemical shifts and spin-spin splittings will emerge that offer improved accuracy versus cost tradeoffs, and will be employed to populate databases that reflect protein relevant and energetically accessible environments. With such data, both artificial neural networks and Bayesian supervised learning approaches will determine a quantitative relationship between structure and computed NMR observable, and the resulting eQMCalculator will be tested on the refinement of folded proteins and creation of structural ensembles for IDPs. Project Title: High Accuracy Computational Methods for Biomolecular Nuclear Magnetic Resonance Spectroscopy NMR shifts and splitting measurements for organic materials containing 1H, 2H, 13C, and 15N nuclei can provide detailed descriptions of the structure of drug molecules, folded proteins and their complexes, as well as the structural ensembles of intrinsically disordered proteins (IDPs). However there are currently limitations of turning accurate NMR measurements into accurate structures that clearly hampers advances that could be made on connecting structure to function of proteins in their native aqueous environments. This proposal aims to significantly improve the ability to predict the chemical shifts and indirect spin-spin couplings to yield the spectrum associated with a given folded structure or IDP ensemble of structures, with very high accuracy, and with good computational efficiency.",High Accuracy Computational Methods for Biomolecular Nuclear Magnetic Resonance Spectroscopy,9633923,U01GM121667,"['Nucleus ', ' Cell Nucleus ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Environment ', ' Intelligent systems ', ' Expert Systems ', ' Goals ', ' Laboratories ', ' Methods ', ' Methodology ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Nuclear Magnetic Resonance ', ' Proteins ', ' Quantum Theory ', ' Solvents ', ' Testing ', ' Work ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Roentgen Rays ', ' Measures ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' protein folding ', ' base ', ' improved ', ' Residual state ', ' Residual ', ' Phase ', ' Biological ', ' X-Ray Crystallography ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' Chemicals ', ' Evaluation ', ' Training ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Collaborations ', ' Letters ', ' tool ', ' restraint ', ' Mechanics ', ' mechanical ', ' Adopted ', ' Complex ', ' System ', ' vibration ', ' Nuclear ', ' Biomolecular Nuclear Magnetic Resonance ', ' Biomolecular NMR ', ' Equation ', ' Magnetism ', ' magnetic ', ' magnetic field ', ' success ', ' heuristics ', ' functional group ', ' aqueous ', ' Structure ', ' simulation ', ' Modeling ', ' Sampling ', ' Property ', ' response ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' drug structure ', ' protein structure ', ' Data ', ' Resolution ', ' Characteristics ', ' protein function ', ' Development ', ' developmental ', ' cost ', ' quantum ', ' Coupling ', ' prototype ', ' database structure ', ' data base structure ', ' Geometry ', ' learning strategy ', ' learning method ', ' learning activity ', ' personalized approach ', ' tailored approach ', ' precision approach ', ' individualized approach ', ' Personalized medical approach ', ' Structural Protein ', ' experimental study ', ' experimental research ', ' experiment ', ' artificial neural network ', ' synthetic neural network ', ' computational neural network ', ' artificial neural net ', ' supervised learning ', ' supervised machine learning ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,U01,2019,294912,0.08405505269761487
"Computational Techniques for Advancing Untargeted Metabolomics Analysis PROJECT SUMMARY/ABSTRACT Detecting and quantifying products of cellular metabolism using mass spectrometry (MS) has already shown great promise in biomarker discovery, nutritional analysis and other biomedical research fields. Despite recent advances in analysis techniques, our ability to interpret MS measurements remains limited. The biggest challenge in metabolomics is annotation, where measured compounds are assigned chemical identities. The annotation rates of current computational tools are low. For several surveyed metabolomics studies, less than 20% of all compounds are annotated. Another contributing factor to low annotation rates is the lack of systematic ways of designing a candidate set, a listing of putative chemical identities that can be used during annotation. Relying on exiting databases is problematic as considering the large combinatorial space of molecular arrangements, there are many biologically relevant compounds not catalogued in databases or documented in the literature. A secondary yet important challenge is interpreting the measurements to understand the metabolic activity of the sample under study. Current techniques are limited in utilizing complex information about the sample to elucidate metabolic activity. The goal of this project is to develop computational techniques to advance the interpretation of large-scale metabolomics measurements. To address current challenges, we propose to pursue three Aims: (1) Engineering candidate sets that enhance biological discovery. (2) Developing new techniques for annotation including using deep learning and incremental build out methods to recommend novel chemical structures that best explain the measurements. (3) Constructing probabilistic models to analyze metabolic activity. Each technique will be rigorously validated computationally and experimentally using chemical standards. Two detailed case studies on the intestinal microbiota will allow us to further validate our tools. Microbiota-derived metabolites have been detected in circulation and shown to engage host cellular pathways in organs and tissues beyond the digestive system. Identifying these metabolites is thus critical for understanding the metabolic function of the microbiota and elucidating their mechanisms. The complex test cases will challenge our techniques, provide feedback during development, and allow us to further disseminate our techniques. We will work closely with early adopters of our tools, as proposed in supporting letters, to further validate our tools and encourage wide adoption. All proposed tools will be open source and made accessible through the web. Our tools promise to change current practices in interpreting metabolomics data beyond what is currently possible with databases, current annotation tools, statistical and overrepresentation analysis, or combinations thereof. The use of machine learning and large data sets as proposed herein defines the most promising research direction in metabolomics analysis. PROJECT NARRATIVE  Untargeted Metabolomics is a recently developed technique that allows the measurement of thousands of molecules in a biological sample. This work proposes several novel computational techniques that address limitations of current metabolomics analysis tools. We anticipate that this work will advance discoveries in biomedical research and have direct benefits to human health.",Computational Techniques for Advancing Untargeted Metabolomics Analysis,9886611,R01GM132391,"['Adoption ', ' Biomedical Research ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Gastrointestinal Organ System ', ' Gastrointestinal Body System ', ' Digestive System ', ' Alimentary System ', ' Ailmentary System ', ' gastrointestinal system ', ' Disorder ', ' Disease ', ' Engineering ', ' Feedback ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' bowel ', ' Intestinal ', ' Intestines ', ' Literature ', ' Maps ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Macromolecular Structure ', ' Molecular Structure ', ' nutrition ', ' Play ', ' Probability ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Running ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Subject Headings ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Work ', ' Measures ', ' case report ', ' Case Study ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' Public Domains ', ' base ', ' Organ ', ' Label ', ' Biological ', ' Medical ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Letters ', ' Metabolic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Techniques ', ' interest ', ' Performance ', ' physical property ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' Property ', ' drug development ', ' drug discovery ', ' PubMed ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' small molecule ', ' chemical standard ', ' Address ', ' Data ', ' Computational Technique ', ' Validation ', ' Nutritional ', ' nutritious ', ' Molecular ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' PubChem ', ' cost ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' Consumption ', ' combinatorial ', ' open source ', ' gut microbiota ', ' intestinal tract microflora ', ' intestinal microflora ', ' intestinal microbiota ', ' intestinal microbes ', ' intestinal flora ', ' gut microflora ', ' gut microbiotic ', ' gut microbial consortia ', ' gut microbial composition ', ' gut microbial community ', ' gut microbe community ', ' gut flora ', ' gut community ', ' gut commensal ', ' gastrointestinal microbial flora ', ' enteric microbiota ', ' enteric microbial community ', ' Gastrointestinal microbiota ', ' GI microbiota ', ' dark matter ', ' biomarker discovery ', ' metabolome ', ' metabonome ', ' microbiota ', ' multispecies consortia ', ' microflora ', ' microbial flora ', ' microbial consortia ', ' experimental study ', ' experimental research ', ' experiment ', ' annotation  system ', ' annotation tool ', ' annotation framework ', ' microbiota metabolites ', ' microbiota derived metabolites ', ' deep learning ', ' neural network ', ' ']",NIGMS,TUFTS UNIVERSITY MEDFORD,R01,2019,379614,0.07325056639699973
"Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling Project Summary/Abstract With the global rise in obesity-related diseases and increasing recognition of the role of fat in diseases such as fatty liver, there is growing need for a noninvasive chemical assay of in vivo lipid depots. But the rich chemistry of these molecules is often ignored in MRI, which typically treats fat as a homogeneous proton species because differences in chemical shift and relaxation are difficult to distinguish in a clinical setting. Innovation: This proposal will be the first to use nonuniform echo spacing to generate J-coupling based contrast between chemically different fats. While fat spins often give monotonically decaying signal under a uniformly spaced spin echo train, J-coupling causes nonuniformly spaced spin echo trains to generate complex fingerprints, which distinguish and even quantify fats with otherwise similar MR properties. Significance: The immediate clinical impact will be to demonstrate a novel J-coupling based contrast mechanism in vivo which will contribute to a multiparametric MRI protocol to distinguish the 25% of the population with benign steatosis from the 2-3% with nonalcoholic steatohepatitis (NASH). The broader significance of this work is that this novel contrast mechanism could revolutionize the study and clinical management of many diseases associated with bioactive lipid subtypes. Approach: The aims are designed to test the hypothesis that nonuniform echo trains (1) can create contrast between different fats, which (2) will contribute to a multiparametric noninvasive protocol to distinguish benign steatosis and NASH. Aim 1 will identify the echo spacing best suited for distinguishing benign steatosis and NASH, first using density matrix simulations based on high resolution spectra of liver fat from animals with each disease, and then using experiments on whole rat livers. In Aim 2, the sequence developed in Aim 1 will be tested in humans with biopsy proven benign steatosis or NASH, along with a suite of standard methods of liver and fat characterization. This metric, and also metrics derived from conventional images, will be tested for the ability to separate these patient groups. In addition, machine learning algorithms will be used to find a metric that combines multiecho intensities with standard MR metrics. This proposal will prove the usefulness of nonuniform echo trains as a new contrast mechanism and yield a multiparametric MRI protocol to distinguish simple steatosis and NASH. Moreover, this general approach to distinguish fats could ultimately find a broad range of biomedical applications, such as imaging lipid based therapeutics, distinguishing the 4 fatty acids that make up 90% of the adipose stores, or detecting other lipotoxic subtypes. The results of this work will justify a larger scale study to properly validate the sensitivity to different fat species in humans. Project Narrative This proposal will prove the usefulness of nonuniform echo trains both as a new J-coupling based contrast mechanism and as part of a multiparametric MRI protocol to distinguish simple steatosis (~25% of the population) from patients on the NASHfibrosiscirrhosis trajectory of metabolically induced liver disease (2- 3% of the population). Moreover, this general approach to distinguish fats could ultimately find a broad range of biomedical applications, such as imaging lipid based therapeutics, distinguishing the 4 fatty acids that make up 90% of the adipose stores, or detecting other lipotoxic subtypes. The results of this work will justify a larger scale study to properly validate the sensitivity to different fat species in humans.",Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling,9782953,R21EB023414,"['Adipose tissue ', ' yellow adipose tissue ', ' white adipose tissue ', ' adipose ', ' Fatty Tissue ', ' Animals ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Chemistry ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Fats ', ' Fatty acid glycerol esters ', ' Fatty Acids ', ' hepatic steatosis ', ' Liver Steatosis ', ' Fatty Liver ', ' Fibrosis ', ' Fingerprint ', ' Modern Man ', ' Human ', ' Lipids ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Liver diseases ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Matched Group ', ' Methods ', ' Oils ', ' Patients ', ' Hydrogen Ions ', ' H+ element ', ' Protons ', ' Rats Mammals ', ' Rat ', ' Common Rat Strains ', ' Rattus ', ' Relaxation ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Spectrum Analyses ', ' Spectroscopy ', ' Spectrum Analysis ', ' Testing ', ' Work ', ' base ', ' density ', ' liver imaging ', ' liver scanning ', ' Benign ', ' Clinical ', ' Chemicals ', ' Predisposition ', ' Susceptibility ', ' Training ', ' analog ', ' Therapeutic ', ' Metabolic ', ' Complex ', ' Protocols documentation ', ' Protocol ', ' age group ', ' simulation ', ' novel ', ' Code ', ' Coding System ', ' Property ', ' Data ', ' Resolution ', ' in vivo ', ' Clinical Management ', ' trend ', ' sex ', ' Cirrhosis ', ' cirrhotic ', ' Image ', ' imaging ', ' design ', ' designing ', ' Obesity associated disease ', ' Obesity related disease ', ' Population ', ' Coupling ', ' innovation ', ' innovative ', ' innovate ', ' nonalcoholic steatohepatitis ', ' nonalcoholic steato-hepatitis ', ' non-alcoholic steatohepatitis ', ' non-alcoholic steato-hepatitis ', ' non-alcohol induced steatohepatitis ', ' NASH ', ' experimental study ', ' experimental research ', ' experiment ', ' machine learning algorithm ', ' ']",NIBIB,YALE UNIVERSITY,R21,2019,209375,0.024074188450169107
"DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY     DESCRIPTION (provided by applicant):         Adverse drug reactions (ADRs) are dangerous and expensive, afflicting about 1.5% of hospitalized patients with profound health and financial consequences. In Medicare patients alone, adverse drug reactions account for 19% of total spending ($339 billion), more than 1,900 deaths, and more than 77,000 extra hospital days per year. Idiosyncratic ADRs, especially rare and severe hypersensitivity-driven ADRs, are the leading cause of medicine withdrawal and termination of clinical development. At the same time, a large proportion of drugs are not associated with hypersensitivity driven ADRs, offering hope that new medicines could avoid them entirely with reliable predictors of risk. Hypersensitivity driven ADRs are caused by the formation of chemically reactive metabolites by metabolic enzymes. These reactive metabolites covalently attach to proteins to become immunogenic and provoke an ADR. Unfortunately, current computational and experimental approaches do not reliably identify drug candidates that form reactive metabolites. These approaches are limited because they inadequately model metabolism, which can both render toxic molecules safe and safe molecules toxic. To overcome this limitation, the proposed study aims to curate a public database of metabolism and reactivity and use this database to build accurate and validated mathematical models of metabolism and reactivity. The models will be constructed using machine-learning algorithms that quantitatively summarize the knowledge from thousands of published studies. The Aims are to (1) curate a database of metabolism and build models that identify rules governing the structure of reaction products during drug metabolism in the liver, (2) curate a database of reactivity and build improved reactivity models that mechanistically predict which metabolites are reactive with biological molecules, and (3) curate a database of reactive metabolites and combine these models to predict when molecules form reactive metabolites that covalently bind proteins. The computational models generated by these Aims will be validated through statistical approaches and against bench-top experiments. Taken together, this approach will substantially improve on existing approaches by more accurately modeling the properties determining whether metabolism renders drugs toxic or safe. The predictive models will make new medicines safer by helping researchers avoid molecules prone to ADRs without harming patients. PROJECT NARRATIVE Adverse drug reactions, especially rare but severe hypersensitivity-driven reactions, have profound financial and health implications and are caused by reactive drug metabolites. As an extension of tools and data developed by our groups, we will build and test mathematical models and datasets that more accurately predict when molecules form clinically important reactive metabolites than current methodologies, such as structural alerts. We will use these models to build a tool that will better predict when drug candidates form reactive metabolites, which will make new medicines safer by enabling researchers to avoid drug candidates prone to causing adverse reactions.",DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY,9742516,R01LM012222,"['necrocytosis ', ' Cell Death ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Dangerousness ', ' Death ', ' Cessation of life ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Skin Rash ', ' Rash ', ' Exanthem ', ' Exanthema ', ' Foundations ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' Allergy ', ' Hypersensitivity ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Literature ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Medicine ', ' Metabolic Activation ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' Methods ', ' Methodology ', ' Chemical Models ', ' Macromolecular Structure ', ' Molecular Structure ', ' Patients ', ' Proteins ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' Erythema Multiforme Major ', ' Stevens-Johnson Syndrome ', ' Testing ', ' Time ', ' Mediating ', ' Dataset ', ' Data Set ', ' drug withdrawal ', ' macromolecule ', ' improved ', ' Clinical ', ' Biological ', ' Physiological ', ' Physiologic ', ' Series ', ' Chemicals ', ' Hepatotoxicity ', ' hepatoxicity ', ' hepatic toxicity ', ' Toxic effect on liver cells ', ' Liver Toxicity ', ' Hepatotoxic effect ', ' Withdrawal ', ' Binding Proteins ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Databases ', ' data base ', ' Data Bases ', ' Relative Risks ', ' Biological Process ', ' Biological Function ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Metabolic ', ' gene function ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Immune ', ' Immunes ', ' Event ', ' Reaction ', ' Pattern ', ' Adverse reactions ', ' adduct ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' drug metabolism ', ' Modeling ', ' Property ', ' drug development ', ' immunogenic ', ' repository ', ' mathematical model ', ' mathematical modeling ', ' mathematic model ', ' Math Models ', ' liver metabolism ', ' hepatic metabolism ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' in vitro Assay ', ' Validation ', ' Molecular ', ' Process ', ' protein function ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' immunogenicity ', ' quantum ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' drug candidate ', ' screening ', ' model building ', ' Assessment tool ', ' Assessment instrument ', ' online repository ', ' web-based repository ', ' web repository ', ' online archive ', ' on-line repository ', ' on-line archive ', ' experimental study ', ' experimental research ', ' experiment ', ' clinical development ', ' machine learning algorithm ', ' adverse drug reaction ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2019,374026,0.07188929896491424
"Pacific Northwest Advanced Compound Identification Core OVERALL SUMMARY The capability to chemically identify thousands of metabolites and other chemicals in clinical samples will revolutionize the search for environmental, dietary, and metabolic determinants of disease. By comparison to near-comprehensive genetic information, comparatively little is understood of the totality of the human metabolome, largely due to insufficiencies in molecular identification methods. Through innovations in computational chemistry and advanced ion mobility separations coupled with mass spectrometry, we propose to overcome a significant, long standing obstacle in the field of metabolomics: the absence of methods for accurate and comprehensive identification of metabolites without relying on data from analysis of authentic chemical standards. A paradigm shift in metabolomics, we will use gas-phase molecular properties that can be both accurately predicted computationally and consistently measured experimentally, and which can thus be used for comprehensive identification of the metabolome without the need for authentic chemical standards. The outcomes of this proposal directly advance the mission and goals of the NIH Common Fund by: (i) transforming metabolomics science by enabling consideration of the totality of the human metabolome through optimized identification of currently unidentifiable molecules, eventually reaching hundreds of thousands of molecules, and (ii) developing standardized computational tools and analytical methods to increase the national capacity for biomedical researchers to identify metabolites quickly and accurately. This work is significant because it enables comprehensive and confident chemical measurement of the metabolome. This work is innovative because it utilizes an integrated quantum-chemistry and machine learning computational pipeline to accurately predict physical-chemical properties of metabolites coupled to measurements. OVERALL NARRATIVE This project will utilize integrated quantum-chemistry and machine learning computational computational approaches coupled with advanced instrumentation to characterize the human metabolome, and identify currently unidentifiable molecules without the use of authentic chemical standards. Results from these studies will contribute to the goal of understanding diseases, and the tools and resources will be made publically available for biomedical researchers.",Pacific Northwest Advanced Compound Identification Core,9769745,U2CES030170,"['Adoption ', ' Algorithms ', ' Biomedical Research ', ' Analytic Chemistry ', ' Analytical Chemistry ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' Engineering ', ' Gases ', ' Goals ', ' Modern Man ', ' Human ', ' instrumentation ', ' Isotopes ', ' Libraries ', ' Methods ', ' Methodology ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pacific Northwest ', ' Probability ', ' Reference Standards ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Science ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Toxin ', ' Urine Urinary System ', ' Urine ', ' Work ', ' Measures ', ' doubt ', ' Uncertainty ', ' analytical method ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Phase ', ' Biological ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Serum ', ' Blood Serum ', ' Educational workshop ', ' Workshop ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Funding ', ' chemical property ', ' Liquid substance ', ' liquid ', ' fluid ', ' Metabolic ', ' Genetic ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Dependence ', ' Source ', ' Techniques ', ' experience ', ' quantum chemistry ', ' small molecule libraries ', ' chemical library ', ' High Performance Computing ', ' high-end computing ', ' stereochemistry ', ' Structure ', ' novel ', ' Sampling ', ' Property ', ' computational chemistry ', ' drug discovery ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' chemical standard ', ' Data ', ' Resolution ', ' Supercomputing ', ' super computing ', ' Attributes of Chemicals ', ' Computers and Advanced Instrumentation ', ' Computer Instrumentation ', ' Advanced Instrumentation ', ' Molecular ', ' ion mobility ', ' computerized tools ', ' computational tools ', ' Outcome ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' human disease ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' comparative ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' non-genetic ', ' nongenetic ', ' drug candidate ', ' genetic information ', ' dark matter ', ' Predictive Analytics ', ' metabolome ', ' metabonome ', ' ']",NIEHS,BATTELLE PACIFIC NORTHWEST LABORATORIES,U2C,2019,1074150,0.16409630656627852
"Digital representation of chemical mixtures to aid drug discovery and formulation PROJECT SUMMARY Collaborative Drug Discovery, Inc. (CDD) proposes to develop a suite of software modules to enable scientists to unambiguously represent chemical mixtures in standard machine-readable formats, filling an urgent and widely-recognized need. Chemicals are typically formulated as mixtures. Recording and communicating information about chemical mixtures is essential for scientists and support staff in the pharmaceutical industry, in academia, in non-profit research organizations, in government, at specialty chemical vendors, and at commercial manufacturers to:  discover, develop, formulate, manufacture and regulate drugs;  manage reagent inventories; comply with laboratory safety requirements; inform first responders;  describe and reproduce biomedical experiments; and  assess and disseminate information about toxicity risks of chemical reagents and consumer products.  A working committee of the International Union of Pure and Applied Chemistry (IUPAC) is close to formalizing Mixtures InChI (or MInChI), which will extend the International Chemical Identifier (InChI) to become the first standard to encompass mixtures. MInChI will effectively index mixtures in the same way that InChI indexes individual compounds.  CDD will first develop the data structures and software necessary to enable adoption and utilization of MInChI and create the first general-purpose system for recording information about chemical mixtures that is computable and interoperable. The most innovative part of the project and the bulk of the effort will be to develop a sophisticated automated translation tool that will accurately convert legacy catalogs of chemical mixtures from plaintext descriptions or ad hoc formats so that they are properly represented in a machine readable format that can in turn be easily rendered into MInChI identifiers. The broad vision is to help industry to overcome the barriers to adoption so that MInChI can quickly deliver benefits for drug discovery, chemical safety, and toxicology. PROJECT NARRATIVE The proposed project will create novel computational tools that will help researchers to efficiently and accurately document the composition of chemical mixtures in a format that computers can easily interpret, process, and exchange. This innovative capability will help to accelerate the discovery and development of novel and improved drugs against a wide range of diseases. It will also help to advance our understanding of the toxicology of mixtures (which often differs from the toxicology of individual components) and improve laboratory safety both in industry and in educational settings. !",Digital representation of chemical mixtures to aid drug discovery and formulation,9826639,R43TR002528,"['Adoption ', ' Chemistry ', ' Computers ', ' Disorder ', ' Disease ', ' Pharmaceutical Industry ', ' Pharmaceutic Industry ', ' Drug Industry ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Government ', ' Modern Man ', ' Human ', ' indexing ', ' Industry ', ' Intelligence ', ' Inventory ', ' Equipment and supply inventories ', ' Laboratories ', ' Methods ', ' Names ', ' Reagent ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Safety ', ' Shorthand ', ' Software ', ' Computer software ', ' Solvents ', ' Specialty ', ' medical specialties ', ' Technology ', ' Toxicology ', ' Traction ', ' Translations ', ' Vendor ', ' visual function ', ' Sight ', ' Vision ', ' cofactor ', ' improved ', ' Specific qualifier value ', ' Specified ', ' Phase ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Visual ', ' Individual ', ' Databases ', ' data base ', ' Data Bases ', ' Collaborations ', ' Letters ', ' tool ', ' English Language ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Catalogs ', ' Scientist ', ' System ', ' Drug Formulations ', ' Services ', ' consumer product ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' novel ', ' member ', ' Code ', ' Coding System ', ' Modeling ', ' Readability ', ' drug discovery ', ' Manufacturer Name ', ' Manufacturer ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Pharmacological Substance ', ' Pharmaceuticals ', ' Pharmaceutical Agent ', ' Pharmacologic Substance ', ' Address ', ' Academia ', ' Data ', ' International ', ' Process ', ' Text ', ' Development ', ' developmental ', ' digital ', ' computerized tools ', ' computational tools ', ' innovation ', ' innovative ', ' innovate ', ' interoperability ', ' data structure ', ' open source ', ' natural language ', ' experimental study ', ' experimental research ', ' experiment ', ' Infrastructure ', ' first responder ', ' ']",NCATS,"COLLABORATIVE DRUG DISCOVERY, INC.",R43,2019,54833,0.19074195678426362
"Integrating cheminformatics and molecular simulations for virtual drug screening     DESCRIPTION (provided by applicant): The development of highly efficient and accurate approaches to structure-based virtual screening (VS) continues to represent a formidable challenge in the field of computational drug discovery. Outstanding and widely recognized research problems in the field include the relative computational inefficiency of most approaches, which limits the size of molecular libraries used for virtual screening; the low hit rate; and the inaccurate prediction of ligand binding affinity and pose. The proposed studies address these challenges by using innovative and computationally efficient approaches to VS that fully integrate concepts from the complementary fields of cheminformatics and molecular simulation to devise an integrated two-step VS methodology. Building upon our experience in cheminformatics and QSAR modeling, we aim to develop novel, computationally efficient cheminformatics approaches to pre-process very large (on the order of 107 compounds) chemical libraries available for biological screening, and eliminate up to 99% of improbable ligands. Only the remaining 1% of probable ligands will be evaluated by slower but accurate ensemble flexible docking approaches relying on molecular simulation techniques. The cheminformatics step will also produce important information on privileged protein-ligand interactions that will be used in a live-processing step to guide the structure-based virtual screening and avoid oversampling of ligand poses. Moreover, post- processing cheminformatics methods will be implemented to filter out decoy poses from docking calculations. The ultimate goal of our hybrid methodology is to arrive at a small set of high-affinity computational hits in receptor-bound conformations that can be validated experimentally. We will pursue this goal following three specific aims: 1) Develop novel cheminformatics-based virtual screening approaches to eliminate both improbable ligands and improbable poses, as well as generate information on preferred protein-ligand interactions; 2) Develop new, efficient flexible ensemble docking methods guided by the preferred protein- ligand interactions to select the most probable ligands and predict their binding poses; 3) Apply the developed hierarchical virtual screening workflow to several therapeutic targets and test high-confidence computational hits in experimental assays. All computational tools resulting from this project will be made publicly available. This proposal is innovative because the proposed VS platform will result from a unique marriage of disparate approaches for VS, combining their corresponding strengths. This proposal is significant because the implementation of this project will enable substantial improvement in the efficiency, accuracy, and experimentally-confirmed impact of structure-based drug discovery tools. PUBLIC HEALTH RELEVANCE: Advances in drug discovery rely on the development of novel effective computational methodologies. This proposal advances an efficient and robust computational workflow for structure-based virtual screening of very large chemical libraries. The ultimate goal of this project is to arrive at a small number of candidate molecules with high predicted binding affinity to their biological targets, which will be tested in confirmatory experiments.",Integrating cheminformatics and molecular simulations for virtual drug screening,9694695,R01GM114015,"['Affect ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Enzyme Gene ', ' Enzymes ', ' Goals ', ' Hybrids ', ' Libraries ', ' Ligands ', ' Marriage ', ' Methods ', ' Methodology ', ' Mining ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' Pharmacology ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Phosphotransferases ', ' Proteins ', ' Research ', ' zoosperm ', ' Spermatozoa ', ' Sperm ', ' sperm cell ', ' backbone ', ' Spine ', ' Spinal Column ', ' Vertebral column ', ' Testing ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Biological ', ' Series ', ' Active Sites ', ' Chemicals ', ' Orphan ', ' Descriptor ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Side ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Benchmarking ', ' Best Practice Analysis ', ' experience ', ' molecular size ', ' Performance ', ' receptor binding ', ' receptor bound ', ' small molecule libraries ', ' chemical library ', ' user friendly software ', ' user friendly computer software ', ' Structure ', ' simulation ', ' novel ', ' G-Protein-Coupled Receptors ', ' GPCR ', ' G Protein-Coupled Receptor Genes ', ' G Protein-Complex Receptor ', ' Modeling ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' therapeutic testing ', ' therapeutic evaluation ', ' chemical informatics ', ' cheminformatics ', ' small molecule ', ' Address ', ' Affinity ', ' Molecular Bank ', ' molecular library ', ' Ligand Binding ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' Development ', ' developmental ', ' virtual ', ' computerized tools ', ' computational tools ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' innovation ', ' innovative ', ' innovate ', ' therapeutic target ', ' public health relevance ', ' flexibility ', ' flexible ', ' screening ', ' Computational Geometry ', ' improved outcome ', ' experimental study ', ' experimental research ', ' experiment ', ' Drug Screening ', ' virtual technology ', ' ']",NIGMS,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,R01,2019,235391,0.05662815169959435
"Pacific Northwest Advanced Compound Identification Core OVERALL SUMMARY The capability to chemically identify thousands of metabolites and other chemicals in clinical samples will revolutionize the search for environmental, dietary, and metabolic determinants of disease. By comparison to near-comprehensive genetic information, comparatively little is understood of the totality of the human metabolome, largely due to insufficiencies in molecular identification methods. Through innovations in computational chemistry and advanced ion mobility separations coupled with mass spectrometry, we propose to overcome a significant, long standing obstacle in the field of metabolomics: the absence of methods for accurate and comprehensive identification of metabolites without relying on data from analysis of authentic chemical standards. A paradigm shift in metabolomics, we will use gas-phase molecular properties that can be both accurately predicted computationally and consistently measured experimentally, and which can thus be used for comprehensive identification of the metabolome without the need for authentic chemical standards. The outcomes of this proposal directly advance the mission and goals of the NIH Common Fund by: (i) transforming metabolomics science by enabling consideration of the totality of the human metabolome through optimized identification of currently unidentifiable molecules, eventually reaching hundreds of thousands of molecules, and (ii) developing standardized computational tools and analytical methods to increase the national capacity for biomedical researchers to identify metabolites quickly and accurately. This work is significant because it enables comprehensive and confident chemical measurement of the metabolome. This work is innovative because it utilizes an integrated quantum-chemistry and machine learning computational pipeline to accurately predict physical-chemical properties of metabolites coupled to measurements. OVERALL NARRATIVE This project will utilize integrated quantum-chemistry and machine learning computational computational approaches coupled with advanced instrumentation to characterize the human metabolome, and identify currently unidentifiable molecules without the use of authentic chemical standards. Results from these studies will contribute to the goal of understanding diseases, and the tools and resources will be made publically available for biomedical researchers.",Pacific Northwest Advanced Compound Identification Core,10012251,U2CES030170,"['Adoption ', ' Algorithms ', ' Biomedical Research ', ' Analytic Chemistry ', ' Analytical Chemistry ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' Engineering ', ' Gases ', ' Goals ', ' Modern Man ', ' Human ', ' instrumentation ', ' Isotopes ', ' Libraries ', ' Methods ', ' Methodology ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Pacific Northwest ', ' Probability ', ' Reference Standards ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Science ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Toxin ', ' Urine Urinary System ', ' Urine ', ' Work ', ' Measures ', ' doubt ', ' Uncertainty ', ' analytical method ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Phase ', ' Biological ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Serum ', ' Blood Serum ', ' Educational workshop ', ' Workshop ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Funding ', ' chemical property ', ' Liquid substance ', ' liquid ', ' fluid ', ' Metabolic ', ' Genetic ', ' Exposure to ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Dependence ', ' Source ', ' Techniques ', ' experience ', ' quantum chemistry ', ' small molecule libraries ', ' chemical library ', ' High Performance Computing ', ' high-end computing ', ' stereochemistry ', ' Structure ', ' novel ', ' Sampling ', ' Property ', ' computational chemistry ', ' drug discovery ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' chemical standard ', ' Data ', ' Resolution ', ' Supercomputing ', ' super computing ', ' Attributes of Chemicals ', ' Computers and Advanced Instrumentation ', ' Computer Instrumentation ', ' Advanced Instrumentation ', ' Molecular ', ' ion mobility ', ' computerized tools ', ' computational tools ', ' Outcome ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' human disease ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' comparative ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' non-genetic ', ' nongenetic ', ' drug candidate ', ' genetic information ', ' dark matter ', ' Predictive Analytics ', ' metabolome ', ' metabonome ', ' ']",NIEHS,BATTELLE PACIFIC NORTHWEST LABORATORIES,U2C,2019,141763,0.16409630656627852
"Image-guided robot for high-throughput microinjection of Drosophila embryos PROJECT SUMMARY This proposal is submitted in response to the NIH Development of Animal Models and Related Biological Materials for Research (R21) program. The proposal develops an image-guided robotic platform that performs the automated delivery of molecular genetic tools and non-genetically encoded reagents such as chemical libraries, fluorescent dyes to monitor cellular processes, functionalized magnetic beads, or nanoparticles into thousands of Drosophila embryos in a single experimental session. The proposed work builds on recent engineering innovations in our collaborative group which has developed image-guided robotic systems that can precisely interface with single cells in intact tissue. The two Specific Aims provide for a systematic development of the proposed technologies. AIM 1 first engineers a robotic platform (Autoinjector) that can scan and image Drosophila embryos in arrays of egg laying plates. We will utilize machine learning algorithms for automated detection of embryos, followed by thresholding and morphology analysis to detect embryo centroids and annotate injection sites. In AIM 2, we will utilize microprocessor-controlled fluidic circuits for programmatic delivery of femtoliter to nanoliter volumes of reagents into individual embryos. We will quantify the efficacy of the Autoinjector by comparing the survival, fertility, and transformation rates of transposon or PhiC31-mediated transgenesis to manual microinjection datasets. Finally, we will demonstrate the efficient delivery of sgRNAs and mutagenesis in the presence of Cas9. This project fits very well within the goals of the program by engineering a novel tool for producing and improving animal models. The Autoinjector will accelerate Drosophila research and empower scientists to perform novel experiments and genome-scale functional genomics screens that are currently too inefficient or labor intensive to be conducted on a large scale and may additionally enable other novel future applications. PROJECT NARRATIVE This proposal develops a technology platform that will enable automated microinjection of molecular genetic tools and non-genetically encoded tools such as chemical libraries, fluorescent dyes, functionalized magnetic beads, or nanoparticles, into thousands of Drosophila embryos in a single experimental session. The successful development of this technology will empower Drosophila biologists to perform screens and develop new applications that are currently too inefficient or labor intensive to contemplate and will accelerate research into the function of the nervous system and the molecular and genetic underpinnings of numerous diseases in this important animal model.",Image-guided robot for high-throughput microinjection of Drosophila embryos,9806367,R21OD028214,"['Biocompatible Materials ', ' biological material ', ' Biomaterials ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Nucleus ', ' Cell Nucleus ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cell Body ', ' Cells ', ' computer vision ', ' Computer Vision Systems ', ' cold storage ', ' cold preservation ', ' Cryofixation ', ' Cryopreservation ', ' Disorder ', ' Disease ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Drosophila melanogaster ', ' Embryonic ', ' Embryo ', ' Engineering ', ' Expenditure ', ' Fecundity ', ' Fecundability ', ' Fertility ', ' fluorescent dye/probe ', ' Fluorescent Agents ', ' Fluorescence Agents ', ' Fluorescent Dyes ', ' Future ', ' Goals ', ' Laboratories ', ' Manuals ', ' Methods ', ' Microinjections ', ' Microprocessor ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Motivation ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' nervous system function ', ' Neurological function ', ' Neurologic function ', ' Nervous System Physiology ', ' Reagent ', ' Research ', ' Research Resources ', ' Resources ', ' Remote Operation (Robotics) ', ' Robotics ', ' spatial perception ', ' spatial orientation ', ' perceptual spatial orientation ', ' Spatial Discrimination ', ' Space Perception ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Work ', ' Mutagenesis Molecular Biology ', ' Genetics-Mutagenesis ', ' Mutagenesis ', ' gRNA ', ' Guide RNA ', ' Molecular Genetics ', ' Mediating ', ' Dataset ', ' Data Set ', ' base ', ' genetic manipulation ', ' Microscope ', ' improved ', ' Site ', ' Individual ', ' Transgenes ', ' Liquid substance ', ' liquid ', ' fluid ', ' Genetic ', ' Morphology ', ' Robot ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' Investigation ', ' Scanning ', ' System ', ' Location ', ' nanolitre ', ' nanoliter ', ' nano litre ', ' experience ', ' mutant ', ' Performance ', ' small molecule libraries ', ' chemical library ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' technology development ', ' tech development ', ' Transgenic Organisms ', ' transgenic ', ' novel ', ' response ', ' functional genomics ', ' Gene Transfer Techniques ', ' Transgenesis ', ' Diameter ', ' Caliber ', ' magnetic beads ', ' Detection ', ' Collection ', ' Exploratory/Developmental Grant ', ' exploratory developmental study ', ' R21 Program ', ' R21 Mechanism ', ' Signaling Molecule ', ' Monitor ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' cost ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' nanoparticle ', ' nanosized particle ', ' nano-sized particle ', ' nano particle ', ' innovation ', ' innovative ', ' innovate ', ' egg ', ' biological research ', ' stem ', ' genome-wide ', ' genomewide ', ' genome scale ', ' animal model development ', ' screening ', ' image guided ', ' image guidance ', ' mutation screening ', ' mutation scanning ', ' gene product ', ' experimental study ', ' experimental research ', ' experiment ', ' Injections ', ' machine learning algorithm ', ' robotic system ', ' ']",OD,UNIVERSITY OF MINNESOTA,R21,2019,184118,0.055429370847045197
"Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence Project Summary The lack of accurate and reliable techniques for visualizing and quantifying the delivery and uptake (pharmacokinetics) of small molecules into the skin has been a major challenge in the development of both new and generic topical drugs. This is particularly true in the measurement of bioequivalence, where a generic drug candidate must be compared against a reference brand-label drug. Current methods, which rely on expensive, destructive, and bulk measurements do not provide the spatial or temporal resolution necessary to extract pharmacokinetic profiles to determine equivalence of drugs at the cellular level over time in human skin. New tools, which allow for direct, real-time quantification of pharmacokinetics non-invasively in humans are needed to drive innovation in the topical drug space. Pharmacokinetic Tomography (PKT) is a method of generated three-dimensional, real-time maps of various molecular species such as lipids, water, proteins and drugs in tissue using spectroscopic imaging techniques. These imaging techniques make use of the intrinsic molecular vibrations of drug molecules to track their uptake quantitatively without the need for labels or alterations to molecular structure. This proposal will develop new coherent Raman imaging tools to create a platform for quantifying the behavior of drugs in ex vivo human skin. This PKT-based platform will be able to measure the uptake of drugs such as antibiotics, kinase inhibitors, steroids, retinoids and NSAIDs in the skin with sub-cellular and sub-second time resolution to glean critical pharmacokinetic parameters needed for drug development and bioequivalence measurements. To compare PKT to an FDA-recognized standard, these PKT imaging will be carried out alongside dermal open flow microperfusion (dOFM), a skin fluid sampling technique that measures the concentration of drugs over time. The multimodal PKT platform, when completed, will be able to measure the bioequivalence of various drugs in situ in human subjects. This research program will specifically develop new imaging toolkits that combine advanced microscopy with state-of-the-art computer vision and machine learning analysis techniques to collect and extract pharmacokinetic data. Using a new type of versatile laser, we will create a coherent Raman technique ideal for detection of drug molecules which contain unique chemical structures. In order to broaden the applicability of the platform to a far wider range of potential drug molecules, we will develop a sparse sampling coherent Raman imaging approach that will quantify molecules by their unique combinations of molecular structures. The development and approval of topical generic drugs for treating dermatological conditions has been slow due to the difficulty and cost in establishing bioequivalence of potential drugs using existing pharmacokinetic profiling methods. For this reason, there is a major need for techniques that can enable the direct visualization and quantification of drugs as they flow and accumulate within tissue. This proposal seeks to develop Pharmacokinetic Tomography imaging tools that make use of the intrinsic molecular vibrational properties of drugs to create a platform translatable to human studies for the measurement of drug bioequivalence.",Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence,9913677,U01FD006698,[''],FDA,MASSACHUSETTS GENERAL HOSPITAL,U01,2019,499369,0.08229532541366606
"Computer Simulations of Enzymes Computer simulations using molecular dynamics (MD) and the combined quantum  mechanical/molecular mechanical (QM/MM) approach are capable of describing structures and dynamics  of proteins and chemical reactions catalyzed by enzymes. An accurate and  computationally efficient energy function is necessary. However, challenges remain: the  accuracy of QM method, the compatibility between the electron density of the QM subsystem and  classical force fields for the MM subsystem, and the cost of ab initio QM/MM methods capitalizing  on the accuracy and reliability of the associated QM approaches. To address these challenges, we  have developed a series of ab initio QM/MM approaches on reaction path optimizations and free  energy calculations, the QM/MM minimum free-energy path (QM/MM-MFEP) and the QM/MM neural  network (QM/MM-NN) methods. This proposal aims to develop further the ab initio QM/MM methodology  and its applications to the studies of redox processes in important enzymes, and the construction  of ab initio force fields combined with neural network representations. Our long-term goals are to develop and establish accurate first-principles based and density  functional theory (DFT) based MD and QM/MM simulation as an equal partner with experiments for the  study of enzymes and proteins and to provide insight into chemical and redox processes in  biological systems. Our aims are as follows: (1) We aim to make ab initio QM/MM models for much  more accurate QM/MM energies, for the QM description and for the electrostatic and vdW interactions   between the QM and MM subsystems. (2) We aim to develop a combined computational  model to explore the key molecular determinants of the reduction potential variability in  metalloproteins. We will provide detailed insight into chemical and redox reaction mechanisms in  biological systems, in particular laccases. (3) We aim at the development of accurate  force fields of water, and proteins for simulations in biological applications, going beyond the  traditional force field forms and limitation in accuracy. The proposed developments will capitalize on the theoretical developments in quantum  electronic theory, such as the linear response theory and accurate many-electron approach for  non-covalent interactions, and leverage machine-learning methods in data science for biological  system simulations. The proposed work will lead to the major advancement of the ab initio QM/MM  method and force fields, and insights into the structure-function paradigm for proteins  and important redox process and reaction mechanisms in enzymes. In addition, it will also lead to  methodology development for design of new drugs and enzyme inhibitors. Understanding chemical reactions and redox processes in solution and in enzymes is of critical  importance, because the structure-function relationship and the catalytic role of enzymes  are fundamental insights in biochemical research, and they are essential for the development of  new or better inhibitors and enzymes. Quantitative tools such as simulations make key contributions  to the investigation of the structure-function relationship, complementing experimental studies.  This proposal aims at developing methods for simulating structures and dynamics in proteins, and  chemical and redox processes catalyzed by enzymes, and investigating the mechanisms of  important enzymes-copper protein laccases, leading to significant advances in research tools for  studying enzymes and contributing to the understanding of life processes, as well as aiding in the  design of inhibitors and drugs.",Computer Simulations of Enzymes,9818963,R01GM061870,"['inhibitor/antagonist ', ' inhibitor ', ' Chemistry ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Cu element ', ' Copper ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Negatrons ', ' Negative Beta Particle ', ' Electrons ', ' Enzyme Gene ', ' Enzymes ', ' balance function ', ' balance ', ' Equilibrium ', ' Goals ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Metalloproteins ', ' Methods ', ' Methodology ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Molecular Conformation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' oxidation reduction reaction ', ' Redox ', ' Oxidation-Reduction ', ' protein design ', ' genetic protein engineering ', ' Protein Engineering ', ' Proteins ', ' Research ', ' social role ', ' Role ', ' structure function relationship ', ' chemical structure function ', ' Structure-Activity Relationship ', ' Hydrogen Oxide ', ' Water ', ' Work ', ' Xrays ', ' X-Rays Radiation ', ' X-Rays ', ' X-Radiation ', ' Roentgen Rays ', ' p-Diphenol Oxidase ', ' Urishiol Oxidase ', ' Laccase ', ' base ', ' density ', ' improved ', ' Site ', ' Variant ', ' Variation ', ' Biological ', ' Biochemical ', ' Series ', ' Chemicals ', ' insight ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Electrostatics ', ' Life ', ' Mechanics ', ' mechanical ', ' Adopted ', ' Investigation ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Reaction ', ' chemical reaction ', ' electron density ', ' intermolecular interaction ', ' molecular dynamics ', ' Molecular Dynamics Simulation ', ' Performance ', ' Potential Energy ', ' Free Energy ', ' Structure ', ' simulation ', ' Modeling ', ' Neural Network Simulation ', ' Perceptrons ', ' Neural Network Models ', ' Connectionist Models ', ' Property ', ' response ', ' theories ', ' molecular mechanics ', ' Enzyme Inhibitor Drugs ', ' Enzyme Inhibitor Agent ', ' Enzyme Inhibitor ', ' Enzyme Antagonist ', ' Address ', ' Biochemical Process ', ' Biophysical Process ', ' biophysical mechanism ', ' Protein Dynamics ', ' Scheme ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' cost ', ' design ', ' designing ', ' quantum ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' biological systems ', ' perturbation theory ', ' learning strategy ', ' learning method ', ' learning activity ', ' Data Science ', ' experimental study ', ' experimental research ', ' experiment ', ' neural network ', ' ']",NIGMS,DUKE UNIVERSITY,R01,2019,341716,0.11849891556966882
"Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC PROJECT SUMMARY The Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC (CMP-GA) is a cross-cutting team with advanced high-throughput chemical analytics and big data capabilities to develop a comprehensive map of molecular transducers of physical activity. The investigative team excels in ultrasensitive, precise and spatially resolved analyses of small molecules, lipids, and proteins. The team members have strong academic records as innovative, independent scientists, core laboratory directors and effective collaborators in complex research initiatives. Instrumentation includes state-of-the-art ultra-high resolution accurate mass high-field Orbitrap tandem mass spectrometry (MS) and ultraperformance liquid chromatography (UPLC); three- dimensional (3-D) molecular imaging via high throughput multi-modal MS at 5 m resolution; unique ion mobility-mass spectrometry machine-learning approaches for chemical identifications; and other such as GC- Orbitrap, 1D and 2D high field (800 MHz) NMR spectroscopy, ICP-MS, immunoassays, chemical and enzymatic assays, etc. The analytical laboratories are integrated through the NIH-supported Atlanta Clinical and Translational Sciences Institute, and operate within the outstanding research environment of Emory University and the Georgia Institute of Technology (GA Tech). CMP-GA has six elements organized to provide 1) leadership in the design and implementation of MoTrPAC goals; 2) bioinformatics, computational support and data delivery to the MoTrPAC Data Coordinating Center; 3) global, targeted and spatially resolved metabolomics; 4) metabolite forensics for unequivocal chemical identification of novel molecular transducers; 5) innovative proteomic and chemoproteomic technologies to define transducers within the redox proteome, ubiquitinome, acetylome, kinome and nuclear proteome; and 6) identification and quantification of lipid transducers. Through the successful completion of these aims and collaboration with the MoTrPAC consortium, investigators of CMP-GA will deliver a publically-available data resource and molecular transducer map that will enhance and accelerate mechanistic research on diseases and conditions affected by physical activity. PROJECT NARRATIVE This is a comprehensive metabolomics and proteomics chemical analysis site to support the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Advanced analytical methods, including mass spectrometry, bioinformatics and chemical forensics are used to provide targeted and global analysis of small molecules, lipids, proteins to develop a molecular transducer map for physical activity.",Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC,9648148,U24DK112341,"['Affect ', ' Aging ', ' Animal Experimentation ', ' Animal Research ', ' Animal Experimental Use ', ' Animals ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Liquid Chromatography ', ' Clinical Study ', ' Clinical Research ', ' Communication ', ' Complement Proteins ', ' Complement ', ' Disorder ', ' Disease ', ' Elements ', ' Environment ', ' Exercise ', ' Forensics ', ' Forensic Medicine ', ' Goals ', ' Health ', ' Immunoassay ', ' Institutes ', ' instrumentation ', ' Isotopes ', ' Laboratories ', ' Leadership ', ' Lipids ', ' Maps ', ' Methods ', ' Macromolecular Structure ', ' Molecular Structure ', ' muscular ', ' Muscle Tissue ', ' Muscle ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' oxidation reduction reaction ', ' Redox ', ' Oxidation-Reduction ', ' Particle Size ', ' Peptide Fingerprinting ', ' Peptide Mapping ', ' Transphosphorylases ', ' Phosphotransferase Gene ', ' Kinases ', ' Phosphotransferases ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' Proteins ', ' Scientific Publication ', ' Publications ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Technology ', ' Time ', ' Transducers ', ' Universities ', ' cytokine ', ' Measures ', ' Health Benefit ', ' Mediating ', ' Custom ', ' analytical method ', ' Label ', ' Procedures ', ' Site ', ' Clinical ', ' Adipocytes ', ' Mature fat cell ', ' Mature Lipocyte ', ' Lipocytes ', ' Fat Cells ', ' Adipose Cell ', ' Link ', ' Chemicals ', ' Training ', ' Physical activity ', ' Educational workshop ', ' Workshop ', ' Measurement ', ' Oxidative Stress ', ' Collaborations ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' lectures ', ' Scientist ', ' Dimensions ', ' Complex ', ' Oral ', ' Protocols documentation ', ' Protocol ', ' Reaction ', ' System ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' Nuclear ', ' Neurodegenerative Disorders ', ' neurodegenerative illness ', ' degenerative neurological diseases ', ' degenerative diseases of motor and sensory neurons ', ' Neurologic Degenerative Conditions ', ' Neurodegenerative Diseases ', ' Neural degenerative Disorders ', ' Neural Degenerative Diseases ', ' Nervous System Degenerative Diseases ', ' Degenerative Neurologic Disorders ', ' Degenerative Neurologic Diseases ', ' oxidized lipid ', ' tandem mass spectrometry ', ' novel ', ' member ', ' Proteome ', ' Sampling ', ' response ', ' Proteomics ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Bioinformatics ', ' Bio-Informatics ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' small molecule ', ' Systems Biology ', ' Data ', ' Molecular Target ', ' Resolution ', ' Clinical Sciences ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Validation ', ' Monitor ', ' Molecular ', ' Process ', ' Development ', ' developmental ', ' molecular imaging ', ' molecule imaging ', ' ion mobility ', ' Data Coordinating Center ', ' Data Coordination Center ', ' design ', ' designing ', ' innovation ', ' innovative ', ' innovate ', ' advanced system ', ' ultra high resolution ', ' multimodality ', ' multi-modality ', ' Big Data ', ' BigData ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' phenotypic biomarker ', ' phenotypic marker ', ' chemoproteomics ', ' data resource ', ' ']",NIDDK,EMORY UNIVERSITY,U24,2019,2734947,0.07436405813847966
"Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria PROJECT SUMMARY Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria. Antibiotic-resistant Gram-negative bacterial infections are increasing in incidence and novel antibiotics are urgently needed to combat this growing threat to public health. A major roadblock to the development of novel antibiotics is our poor understanding of the structural features of small molecules that correlate with bacterial penetration and efflux. As a result, while potent biochemical inhibitors can often be identified for new targets, developing them into compounds with whole-cell antibacterial activity has proven challenging. To address this critical problem, we propose herein a comprehensive, multidisciplinary approach to develop quantitative models to predict small-molecule penetration and efflux in Gram-negative bacteria. We have pioneered a general platform for systematic, quantitative evaluation of small-molecule accumulation in bacteria, using label-free LC-MS/MS detection and multivariate cheminformatic analysis. We have also developed unique isogenic strain sets of wild-type, hyperporinated, efflux-knockout, and doubly-compromised E. coli, P. aeruginosa, and A. baumannii that allow us to dissect the individual contributions of outer/inner membrane penetration and active efflux to net accumulation, using a kinetic model that accurately recapitulates available experimental data. Moreover, we have developed machine learning and neural network approaches to QSAR (quantitative structureactivity relationship) modeling of pharmacological properties that will now be used to develop predictive cheminformatic models for Gram-negative accumulation, penetration, and efflux. This project will be carried out by a multidisciplinary SPEAR-GN Project Team (Small-molecule Penetration & Efflux in Antibiotic-Resistant Gram-Negatives, speargun) involving the labs of Derek Tan (MSK, PI), Helen Zgurskaya (OU, PI), Bradley Sherborne (Merck, Lead Collaborator), Valentin Rybenkov (OU, Co-I), Adam Duerfeldt (OU, Co-I), Carl Balibar (Merck, Collaborator), and David McLaren (Merck, Collaborator), comprising extensive combined expertise in organic and diversity-oriented synthesis, biochemistry, microbiology, high- throughput screening, mass spectrometry, biophysical modeling, cheminformatics, and medicinal chemistry. Herein, we will design and synthesize chemical libraries with diverse structural and physicochemical properties; analyze their accumulation in the isogenic strain sets in both high-throughput and high-density assay formats; extract kinetic parameters for penetration and efflux from the resulting experimental datasets; develop and validate robust QSAR models for accumulation, penetration, and efflux; and demonstrate the utility of these models in medicinal chemistry campaigns to develop novel Gram-negative antibiotics against three targets. This project will provide a major advance in the field of antibacterial drug discovery, providing powerful enabling tools to the scientific community to address this major threat to public health. PUBLIC HEALTH RELEVANCE Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria. Antibiotic-resistant Gram-negative bacteria pose a growing threat to public health in the U.S. and globally. A major obstacle to the development of new antibiotics to combat such infections is our poor understanding of the chemical requirements for small molecules to enter Gram-negative cells and to avoid ejection by efflux pumps. The proposed comprehensive, multidisciplinary research program aims to develop predictive computational tools to identify such molecules by carrying out large-scale, quantitative analyses of the accumulation of diverse small molecules in Gram-negative bacteria. These tools will then enable medicinal chemistry campaigns to develop novel antibiotics.",Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria,9761970,R01AI136795,"['inhibitor/antagonist ', ' inhibitor ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Architecture ', ' Engineering / Architecture ', ' Bacteria ', ' Biochemistry ', ' Biological Chemistry ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Availability ', ' Physiologic Availability ', ' Biologic Availability ', ' Bioavailability ', ' Cell Body ', ' Cells ', ' Pharmaceutic Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutical Chemistry ', ' Communities ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' E. coli ', ' E coli ', ' Escherichia coli ', ' Gram-Negative Bacteria ', ' Modern Man ', ' Human ', ' Incidence ', ' Infection ', ' Kinetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Libraries ', ' Microbiology ', ' Pharmacology ', ' Pseudomonas pyocyanea ', ' P.aeruginosa ', ' P. aeruginosa ', ' P aeruginosa ', ' Pseudomonas aeruginosa ', ' Public Health ', ' Quantitative Evaluations ', ' social role ', ' Role ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Testing ', ' Measures ', ' Gram-Negative Bacterial Infections ', ' antibiotic resistant ', ' antibiotic drug resistance ', ' Resistant to antibiotics ', ' Resistance to antibiotics ', ' Antibiotic Resistance ', ' Dataset ', ' Data Set ', ' base ', ' density ', ' improved ', ' Penetration ', ' Variant ', ' Variation ', ' Biochemical ', ' Chemicals ', ' Individual ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Measurement ', ' analog ', ' Anti-Bacterial Agents ', ' antibacterial ', ' anti-bacterial ', ' Antibacterial Agents ', ' Acinetobacter baumannii ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Oral ', ' Membrane ', ' membrane structure ', ' success ', ' cell envelope ', ' small molecule libraries ', ' chemical library ', ' Structure ', ' novel ', ' Partner in relationship ', ' mate ', ' Modeling ', ' Property ', ' high throughput screening ', ' High Throughput Assay ', ' Quantitative Structure-Activity Relationship ', ' Quantitiative Structure Activity Relationship ', ' QSAR ', ' drug discovery ', ' Effectiveness ', ' chemical informatics ', ' cheminformatics ', ' small molecule ', ' Address ', ' Data ', ' Detection ', ' Mammalian Cell ', ' Knock-out ', ' Knockout ', ' Development ', ' developmental ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' computerized tools ', ' computational tools ', ' design ', ' designing ', ' prospective ', ' multidisciplinary ', ' efflux pump ', ' interdisciplinary approach ', ' multidisciplinary approach ', ' combat ', ' public health relevance ', ' screening ', ' Algorithmic Software ', ' Software Algorithm ', ' Algorithmic Tools ', ' biophysical model ', ' biophysical modeling ', ' learning network ', ' lead optimization ', ' neural network ', ' off-label use ', ' off-label prescribing ', ' off-label application ', ' ']",NIAID,SLOAN-KETTERING INST CAN RESEARCH,R01,2019,1212566,0.0889977291708514
"Using machine learning to predict odor characteristics from molecular structure PROJECT SUMMARY/ABSTRACT We cannot yet look at a chemical structure and predict if the molecule will have an odor, much less what character it will have. The goal of the proposed research is to apply machine learning to predict perceptual characteristics from chemical features of molecules. The specific aims of the proposal will determine (1) which molecules are odorous , and (2) what data are needed to model odor character. Building a highly predictive model requires two key ingredients: high-quality data and a sound modeling approach. High-quality data must be accurate (ratings are consistent and describe true odor properties) and detailed (ratings describe even small differences in odor properties). We have collected human psychophysical data on a diverse set of molecules and have trained a model to predict if a molecule has an odor, but pilot data identified odorous contaminants that limit model training and measurement of model accuracy. In Aim 1, I will apply my background in analytical chemistry to evaluate the accuracy of the data, using gas chromatography to identify and correct errors caused by chemical contaminants. In Aim 2, I will apply my experience in human sensory evaluation to measure and compare the consistency and the degree of detail in ratings that can be achieved with different sensory methods and subject training procedures. By executing my training plan, I will develop the skills in statistical programming and machine learning needed to employ a sound modeling approach to these problems. The model constructed in Aim 1 will enable prediction of odor classification (odor/odorless) for any molecule and thus define which molecules are perceptually relevant. Predicting odor character is a far more complex challenge  while a molecule can have only one of two odor classifications (odor or odorless) it may elicit any number of diverse odor character attributes (fruity, floral, musky, sweet, etc.). Descriptive Analysis (DA) is the gold standard method for generating accurate and detailed sensory profiles, but this method is time-consuming. We estimate that an odor character dataset will be large enough (model-ready) to predict odor character with approximately 10,000 molecules and that it would require more than 30,000 hours of human subject evaluation, or approximately 6 years for the typical trained panel, to produce this dataset using DA. Before we invest the time and resources, it is responsible to evaluate the relative data quality of more rapid sensory methods. The results of Aim 2 are expected to determine the best approach for generating a model-ready dataset by quantifying trade-offs in degree of detail (data resolution), rating consistency, and method speed of five candidate sensory methods. Together, these aims represent a significant step forward in linking chemical recipe to human odor perception, an advancement that supports the NIDCD goal of understanding normal olfactory function (how stimulus relates to percept) and has many potential applications in foods (what composition of molecules should be present to produce a target aroma percept). PROJECT NARRATIVE Currently, scientists cannot predict whether a molecule will have an odor and, if so, what odor characteristics it will have based on its chemical structure. The goal of this project is to develop predictive models linking chemical composition to odor characteristics. These models will advance our understanding of the human olfactory system and help design strategies for improving the aroma and palatability of healthy foods.",Using machine learning to predict odor characteristics from molecular structure,10142097,F32DC019030,"['Measures ', ' Programmed Learning ', ' Dataset ', ' Data Set ', ' base ', ' human subject ', ' improved ', ' Procedures ', ' Link ', ' Chemicals ', ' Chemical Structure ', ' Evaluation ', ' Training ', ' Stimulus ', ' data quality ', ' Measurement ', ' Descriptor ', ' healthy food ', ' Health Food ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Hour ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Sensory ', ' experience ', ' Recipe ', ' Speed ', ' Structure ', ' skills ', ' Manpower ', ' personnel ', ' Human Resources ', ' Palate ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' Property ', ' rapid method ', ' rapid technique ', ' food science ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Resolution ', ' Collection ', ' Characteristics ', ' developmental ', ' Development ', ' NIDCD ', ' National Institute on Deafness and Other Communication Disorders ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Consumption ', ' model building ', ' machine learned algorithm ', ' machine learning algorithm ', ' Chemistry ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Gas Chromatography ', ' vapor phase chromatography ', ' Classification ', ' Systematics ', ' Food ', ' Food or Food Product ', ' Fruit ', ' dietary fruit ', ' Goals ', ' Gold ', ' Human ', ' Modern Man ', ' Learning ', ' Mass Fragmentography ', ' GC MS ', ' GCMS ', ' Gas-Liquid-Mass Spectrometry Chromatography ', ' Mass Fragmentographies ', ' Mass-Gas Chromatography Spectrometry ', ' Mass-Gas Chromatography Spectrum Analysis ', ' ion trap mass spectrometry ', ' mass fragmentometry ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Odors ', ' Olfactory Pathways ', ' Olfactory system ', ' olfactory circuitry ', ' olfactory circuits ', ' Perception ', ' Psychophysics ', ' psychophysical ', ' Quality Control ', ' Research ', ' Research Technics ', ' Research Techniques ', ' Resources ', ' Research Resources ', ' Science ', ' Smell Perception ', ' Olfaction ', ' Smell ', ' odor perception ', ' olfactory perception ', ' sound ', ' Testing ', ' Time ', ' Work ', ' ']",NIDCD,MONELL CHEMICAL SENSES CENTER,F32,2020,67446,0.15596419319164895
"In-silico prediction of protein-peptide interactions. IN-SILICO PREDICTION OF PROTEIN-PEPTIDE INTERACTIONS Automated docking methods are used extensively for gaining a mechanistic understanding of the molecular interactions underpinning cellular processes. While these tools work well for small molecules they perform poorly for peptides and cannot handle Intrinsically Disordered Proteins (IDPs) which play very important roles in these processes. The goal of this project is the development of an efficient and practical peptide docking software, useful for designing therapeutic peptides and gaining insight into IDPs binding ordered proteins. The proposed software supports biomedical applications ranging from investigating chemical pathways to designing and optimizing therapeutic molecules for diseases such as cancer and metabolic disorders. Under the previous award we developed and released a new method for docking fully-flexible peptides with up to 20 standard amino acids: AutoDock CrankPep (ADCP). We showed that it outperforms current state-of-the-art docking methods. For the next award, we propose to: 1) further develop ADCP to support docking IPDs with up to 70 amino acids and improve support for therapeutic peptides containing modified amino acids and complex macrocycles; 2) develop peptide-specific scoring functions to increase docking success rates and methods for predicting the free energy of binding of peptides. This will be done by exploiting the latest advances in statistical potentials for docking, as well as applying machine-learning techniques; 3) test and validate the software on our datasets, community benchmarks, and through our collaborations with outstanding biologists working on biomedical applications spanning from designing drugs for thrombosis and influenza, to modeling IDPs interacting with globular proteins; and 4) document the software and release it under an open source license on a regular basis along with datasets we compile and update on regularly. The proposed research will occur in the context of collaborations with experimental biologists working on highly relevant biomedical projects and providing experimental feedback and validation. In addition, this project will benefit from various collaborations with experts in the fields of computational biology, applied mathematics and artificial intelligence. This docking software tool will be developed by applying best practices in software engineering and be implemented as a modular, extensible, component-based software framework for peptide docking. This docking engine will be part of the widely used AutoDock software suite. The ability to model complexes formed by proteins and fully-flexible peptides or IDPs is in high demand and will greatly extend the range of peptide-based therapeutic approaches for which automated docking can be successfully applied. It will also support gaining insights into interactions of IDPs with proteins. As such, it will impact the research of many medicinal chemists and biologist and extend the use of computational tools to a wider community of scientists, thereby supporting the advancement of biomedical research. Automated docking is a workhorse for rational drug design, however, applying these methods to peptides has remained challenging, thus impeding the designing of therapeutic peptides and the study of Intrinsically Disordered Proteins (IDP) binding to their ordered partners. During the prior funding period, we made substantial progress toward peptide docking, resulting in a new docking engine: AutoDock CrankPep, which outperforms state-of-the-art docking methods for linear and cyclic peptides with up to 20 standard amino acids. We propose to further develop AutoDock CrankPep to support docking of therapeutic peptides with modified amino acids as well as IDPs with up to 70 amino acids, creating a practical docking tool for peptides that will impact the research of many computational and medicinal chemists and biologist, contribute to our understanding of biological processes, and significantly advance biomedical research.",In-silico prediction of protein-peptide interactions.,10116950,R01GM096888,"['Amino Acids ', ' aminoacid ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Automobile Driving ', ' driving ', ' Award ', ' Biological Availability ', ' Bioavailability ', ' Biologic Availability ', ' Physiologic Availability ', ' Biomedical Research ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Communities ', ' Disease ', ' Disorder ', ' Drug Design ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Feedback ', ' Goals ', ' Half-Life ', ' Influenza ', ' Grippe ', ' flu infection ', ' influenza infection ', ' Insulin ', ' Humulin R ', ' Novolin R ', ' Regular Insulin ', ' Libraries ', ' Ligands ', ' Mathematics ', ' Math ', ' Metabolic Diseases ', ' Metabolic Disorder ', ' Thesaurismosis ', ' metabolism disorder ', ' Methods ', ' Study models ', ' Modernization ', ' Peptides ', ' Cyclic Peptides ', ' Permeability ', ' Play ', ' Production ', ' Proteins ', ' Research ', ' Role ', ' social role ', ' Signal Pathway ', ' Computer software ', ' Software ', ' Software Engineering ', ' Computer Software Development ', ' Computer Software Engineering ', ' Software Tools ', ' Computer Software Tools ', ' Specificity ', ' Testing ', ' Thrombosis ', ' thrombotic disease ', ' thrombotic disorder ', ' Work ', ' Renaissance ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Mediating ', ' Dataset ', ' Data Set ', ' base ', ' globular protein ', ' improved ', ' Peripheral ', ' Area ', ' Biological ', ' Chemicals ', ' Training ', ' insight ', ' Ligand Binding Protein ', ' Ligand Binding Protein Gene ', ' Protein Binding ', ' bound protein ', ' Binding Proteins ', ' Workshop ', ' Educational workshop ', ' Licensing ', ' Funding ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' Therapeutic ', ' tool ', ' machine learned ', ' Machine Learning ', ' computer biology ', ' Computational Biology ', ' programs ', ' Scientist ', ' Complex ', ' Techniques ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' Performance ', ' Receptor Protein ', ' receptor ', ' success ', ' Toxicities ', ' Toxic effect ', ' Free Energy ', ' Structure ', ' novel ', ' Modeling ', ' Property ', ' protein protein interaction ', ' Documentation ', ' Molecular Interaction ', ' Binding ', ' small molecule ', ' Mutate ', ' Update ', ' Validation ', ' Process ', ' Docking ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' improved functioning ', ' computational resources ', ' computing resources ', ' combinatorial ', ' interoperability ', ' translational study ', ' open source ', ' Graphical interface ', ' graphic user interface ', ' software user interface ', ' graphical user interface ', ' therapeutic target ', ' flexible ', ' flexibility ', ' screening ', ' Software Framework ', ' therapeutic peptide ', ' peptide drug ', ' predictive tools ', ' in silico ', ' virtual screenings ', ' virtual screening ', ' ']",NIGMS,SCRIPPS RESEARCH INSTITUTE,R01,2020,399375,0.013766091560086674
"Groundwork for a Synchrotron MicroCT Imaging Resource for Biology (SMIRB) Project Summary Each major human disease is associated with a specific range of morphological changes to cells and tissues in the micron scale. Normal and abnormal structure was discovered and is still characterized using histology - a microscopic technique that depends on physical tissue slices. Presently, histologys use in systems biology is limited by its largely descriptive and two-dimensional nature. Making histology quantitative and three-dimensional would be potentially transformational for research and diagnostics, but has been impractical. Accordingly, we have now created a 3D form of histology by customizing X-ray microtomography (micro-CT) of fixed and stained, millimeter-scale, whole organisms and tissue samples. We used fixed and metal-stained, whole zebrafish because they contain a full range of tissues within the size range currently studied histologically. The result is the first practical way to create virtual histology-like sections in any plane. Three-dimensional, complete histological phenotyping has potential use in genetic and chemical screens, and in clinical and toxicological tissue diagnostics. Here, we propose the next steps needed to enable high-throughput, quantitative, 3D histological phenotyping of whole, millimeter-scale animals. The proposed work applies the principles of chemistry, physics, and computer science to improve image resolution, throughput, and analytics, organized into three specific aims. Specific Aim 1 will build on our developments in this project and further improve imaging volume and resolution by upgrading imaging array, optics, and sub-pixel shifting, and to throughput by changes in sample embedding, loading geometry and mechanics, helical CT scanning, scintillator material, and to data sharing by improvements to the ViewTool infrastructure and user interface. Specific Aim 2 will yield reference images to define the range of normal phenotypic variation and to obtain samples related to a range of potential applications. Specific Aim 3 will apply the power of machine learning to segmentation, annotation, and analytics. Together, this work will establish a practical foundation for large-scale genetic and chemical screens involving mm-scale, whole organisms based on 3-dimensional, quantitative, histological phenotyping. The instrumentation and analytics will be state-of-the-art in its combination of resolution, field-of-view, pancellularity, image quality, analytical potential, throughput, sample stability, and reproducibility and largely usable with both tube and synchrotron X-ray sources. The voxel resolution will be at least 0.5 m across fields-of-view of up to 1 cm. Representation of every cell type make the images suitable for cross-referencing across imaging modalities. Potential applications will be explored, wild-type will begin to be defined, and training sets for automated segmentation generated. The potential impact will encompass the missions of most NIH Institutes and Centers. The whole-animal genetic and chemical screens enabled are expected to impact drug development, diagnostics, and our basic understanding of how genes and environment define phenotype. Project Narrative Our group has established the only three-dimensional form of histology that is suitable for histopathology and quantitative tissue phenotyping, tissue X-ray microtomography (micro-CT). We outline here a plan to establish mechanisms for increasing resolution and field-of-view, to add sample multiplexing, to simply sample preparation, and to explore machine learning mechanisms for defining normal and abnormal structure towards whole-organism complete tissue phenotyping. The resulting tools will allow the community to comprehensively and computationally determine the roles of genes and environment in defining phenotype, which has implications in drug development, biomedical research, and medicine.",Groundwork for a Synchrotron MicroCT Imaging Resource for Biology (SMIRB),9991958,R24OD018559,"['Age ', ' ages ', ' Animals ', ' Biology ', ' Biomedical Research ', ' bone ', ' Cells ', ' Cell Body ', ' Cesium ', ' Cs element ', ' Chemistry ', ' Communities ', ' Drosophila genus ', ' Drosophila ', ' fruit fly ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Embryo ', ' Embryonic ', ' Environment ', ' Fishes ', ' Foundations ', ' Genes ', ' Goals ', ' Histology ', ' Institutes ', ' instrumentation ', ' Iodides ', ' Medicine ', ' Metals ', ' Mission ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nerve ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Optics ', ' optical ', ' Phenotype ', ' Physics ', ' Research ', ' Resources ', ' Research Resources ', ' Robotics ', ' Role ', ' social role ', ' Siblings ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Stains ', ' Staining method ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Travel ', ' Work ', ' Writing ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Zebrafish ', ' Brachydanio rerio ', ' Danio rerio ', ' Zebra Danio ', ' Zebra Fish ', ' Measures ', ' Normal Values ', ' Normal Range ', ' Custom ', ' C elegans ', ' C. elegans ', ' C.elegans ', ' Caenorhabditis elegans ', ' Synchrotrons ', ' Tube ', ' base ', ' Organ ', ' detector ', ' improved ', ' Body Measures ', ' Body measure procedure ', ' Microscopic ', ' Variation ', ' Variant ', ' Biological ', ' Histologically ', ' Histologic ', ' Series ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Chemicals ', ' Training ', ' Cell Components ', ' Cell Structure ', ' Cellular Structures ', ' Genetic ', ' Morphology ', ' tool ', ' Diagnostic ', ' Nature ', ' machine learned ', ' Machine Learning ', ' programs ', ' mechanical ', ' Mechanics ', ' millimeter ', ' Scanning ', ' Source ', ' cell type ', ' Texture ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' mutant ', ' computer science ', ' Histopathology ', ' Structure ', ' Helical CT ', ' Helical Computed Tomography ', ' Spiral Acquisition CT ', ' Spiral CT ', ' Spiral Volumetric CT ', ' Spiral Volumetric Computed Tomography ', ' spiral CT scan ', ' Spiral Computed Tomography ', ' Sampling ', ' drug development ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Tissue Sample ', ' Systems Biology ', ' Animal Genetics ', ' Data ', ' Reproducibility ', ' Resolution ', ' Slice ', ' Whole Organism ', ' Preparation ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' Output ', ' disease phenotype ', ' virtual ', ' computational tools ', ' computerized tools ', ' 2-dimensional ', ' two-dimensional ', ' human disease ', ' clinical toxicology ', ' data sharing ', ' Geometry ', ' Structural malformation ', ' structural abnormalities ', ' structural anomalies ', ' Structural defect ', ' X-ray microtomography ', ' Xray microtomography ', ' micro CT ', ' micro computed tomography ', ' microtomography ', ' microCT ', ' crowd source ', ' crowd-sourcing ', ' crowdsource ', ' crowdsourcing ', ' Tissue imaging ', ' histologic studies ', ' histological studies ', ' unsupervised machine learning ', ' unsupervised learning ', ' Infrastructure ', ' supervised machine learning ', ' supervised learning ', ' feature recognition ', ' feature detection ', ' data dissemination ', ' auto-segmentation ', ' automatic segmentation ', ' autosegmentation ', ' automated segmentation ', ' ']",OD,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,R24,2020,655482,0.0705625339996395
"Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC PROJECT SUMMARY The Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC (CMP-GA) is a cross-cutting team with advanced high-throughput chemical analytics and big data capabilities to develop a comprehensive map of molecular transducers of physical activity. The investigative team excels in ultrasensitive, precise and spatially resolved analyses of small molecules, lipids, and proteins. The team members have strong academic records as innovative, independent scientists, core laboratory directors and effective collaborators in complex research initiatives. Instrumentation includes state-of-the-art ultra-high resolution accurate mass high-field Orbitrap tandem mass spectrometry (MS) and ultraperformance liquid chromatography (UPLC); three- dimensional (3-D) molecular imaging via high throughput multi-modal MS at 5 m resolution; unique ion mobility-mass spectrometry machine-learning approaches for chemical identifications; and other such as GC- Orbitrap, 1D and 2D high field (800 MHz) NMR spectroscopy, ICP-MS, immunoassays, chemical and enzymatic assays, etc. The analytical laboratories are integrated through the NIH-supported Atlanta Clinical and Translational Sciences Institute, and operate within the outstanding research environment of Emory University and the Georgia Institute of Technology (GA Tech). CMP-GA has six elements organized to provide 1) leadership in the design and implementation of MoTrPAC goals; 2) bioinformatics, computational support and data delivery to the MoTrPAC Data Coordinating Center; 3) global, targeted and spatially resolved metabolomics; 4) metabolite forensics for unequivocal chemical identification of novel molecular transducers; 5) innovative proteomic and chemoproteomic technologies to define transducers within the redox proteome, ubiquitinome, acetylome, kinome and nuclear proteome; and 6) identification and quantification of lipid transducers. Through the successful completion of these aims and collaboration with the MoTrPAC consortium, investigators of CMP-GA will deliver a publically-available data resource and molecular transducer map that will enhance and accelerate mechanistic research on diseases and conditions affected by physical activity. PROJECT NARRATIVE This is a comprehensive metabolomics and proteomics chemical analysis site to support the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Advanced analytical methods, including mass spectrometry, bioinformatics and chemical forensics are used to provide targeted and global analysis of small molecules, lipids, proteins to develop a molecular transducer map for physical activity.",Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC,9869890,U24DK112341,"['Affect ', ' Aging ', ' Animal Experimentation ', ' Animal Experimental Use ', ' Animal Research ', ' Animals ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Liquid Chromatography ', ' Clinical Research ', ' Clinical Study ', ' Communication ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Elements ', ' Environment ', ' Exercise ', ' Forensic Medicine ', ' Forensics ', ' Goals ', ' Health ', ' Immunoassay ', ' Institutes ', ' instrumentation ', ' Isotopes ', ' Laboratories ', ' Leadership ', ' Lipids ', ' Maps ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Muscle ', ' Muscle Tissue ', ' muscular ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Oxidation-Reduction ', ' Redox ', ' oxidation reduction reaction ', ' Particle Size ', ' Peptide Mapping ', ' Peptide Fingerprinting ', ' Phosphotransferases ', ' Kinases ', ' Phosphotransferase Gene ', ' Transphosphorylases ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Post-Translational Protein Processing ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Modifications ', ' Post-Translational Protein Modification ', ' Posttranslational Modifications ', ' Posttranslational Protein Processing ', ' Protein Modification ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Records ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Technology ', ' Time ', ' Transducers ', ' Universities ', ' cytokine ', ' Measures ', ' Health Benefit ', ' Mediating ', ' Custom ', ' analytical method ', ' Label ', ' Procedures ', ' Site ', ' Clinical ', ' Adipose Cell ', ' Fat Cells ', ' Lipocytes ', ' Mature Lipocyte ', ' Mature fat cell ', ' Adipocytes ', ' Link ', ' Chemicals ', ' Training ', ' Physical activity ', ' Workshop ', ' Educational workshop ', ' Measurement ', ' Oxidative Stress ', ' Collaborations ', ' tool ', ' machine learned ', ' Machine Learning ', ' lectures ', ' Scientist ', ' Complex ', ' Oral ', ' Protocol ', ' Protocols documentation ', ' Reaction ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Nuclear ', ' Degenerative Neurologic Diseases ', ' Degenerative Neurologic Disorders ', ' Nervous System Degenerative Diseases ', ' Neural Degenerative Diseases ', ' Neural degenerative Disorders ', ' Neurodegenerative Diseases ', ' Neurologic Degenerative Conditions ', ' degenerative diseases of motor and sensory neurons ', ' degenerative neurological diseases ', ' neurodegenerative illness ', ' Neurodegenerative Disorders ', ' oxidized lipid ', ' tandem mass spectrometry ', ' novel ', ' member ', ' Proteome ', ' Sampling ', ' response ', ' Proteomics ', ' NMR Spectrometer ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Bio-Informatics ', ' Bioinformatics ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' Systems Biology ', ' Data ', ' Molecular Target ', ' Resolution ', ' Clinical Sciences ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Validation ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' ion mobility ', ' Data Coordination Center ', ' Data Coordinating Center ', ' designing ', ' design ', ' innovate ', ' innovative ', ' innovation ', ' advanced system ', ' ultra high resolution ', ' multi-modality ', ' multimodality ', ' BigData ', ' Big Data ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' phenotypic marker ', ' phenotypic biomarker ', ' chemoproteomics ', ' data resource ', ' advanced analytics ', ' ']",NIDDK,EMORY UNIVERSITY,U24,2020,3299001,0.07436405813847966
"Pacific Northwest Advanced Compound Identification Core OVERALL SUMMARY The capability to chemically identify thousands of metabolites and other chemicals in clinical samples will revolutionize the search for environmental, dietary, and metabolic determinants of disease. By comparison to near-comprehensive genetic information, comparatively little is understood of the totality of the human metabolome, largely due to insufficiencies in molecular identification methods. Through innovations in computational chemistry and advanced ion mobility separations coupled with mass spectrometry, we propose to overcome a significant, long standing obstacle in the field of metabolomics: the absence of methods for accurate and comprehensive identification of metabolites without relying on data from analysis of authentic chemical standards. A paradigm shift in metabolomics, we will use gas-phase molecular properties that can be both accurately predicted computationally and consistently measured experimentally, and which can thus be used for comprehensive identification of the metabolome without the need for authentic chemical standards. The outcomes of this proposal directly advance the mission and goals of the NIH Common Fund by: (i) transforming metabolomics science by enabling consideration of the totality of the human metabolome through optimized identification of currently unidentifiable molecules, eventually reaching hundreds of thousands of molecules, and (ii) developing standardized computational tools and analytical methods to increase the national capacity for biomedical researchers to identify metabolites quickly and accurately. This work is significant because it enables comprehensive and confident chemical measurement of the metabolome. This work is innovative because it utilizes an integrated quantum-chemistry and machine learning computational pipeline to accurately predict physical-chemical properties of metabolites coupled to measurements. OVERALL NARRATIVE This project will utilize integrated quantum-chemistry and machine learning computational computational approaches coupled with advanced instrumentation to characterize the human metabolome, and identify currently unidentifiable molecules without the use of authentic chemical standards. Results from these studies will contribute to the goal of understanding diseases, and the tools and resources will be made publically available for biomedical researchers.",Pacific Northwest Advanced Compound Identification Core,9968331,U2CES030170,"['Adoption ', ' Algorithms ', ' Biomedical Research ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Engineering ', ' Gases ', ' Goals ', ' Human ', ' Modern Man ', ' instrumentation ', ' Isotopes ', ' Libraries ', ' Methods ', ' Methodology ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Pacific Northwest ', ' Probability ', ' Reference Standards ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Science ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Toxin ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Measures ', ' doubt ', ' Uncertainty ', ' analytical method ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Phase ', ' Biological ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Blood Serum ', ' Serum ', ' Workshop ', ' Educational workshop ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' chemical property ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Genetic ', ' Exposure to ', ' tool ', ' machine learned ', ' Machine Learning ', ' programs ', ' Dependence ', ' Source ', ' Techniques ', ' experience ', ' computational quantum chemistry ', ' quantum chemistry ', ' chemical library ', ' small molecule libraries ', ' high-end computing ', ' High Performance Computing ', ' stereochemistry ', ' Structure ', ' novel ', ' Sampling ', ' Property ', ' computational chemistry ', ' drug discovery ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' chemical standard ', ' Data ', ' Resolution ', ' super computing ', ' Supercomputing ', ' Attributes of Chemicals ', ' Advanced Instrumentation ', ' Computer Instrumentation ', ' Computers and Advanced Instrumentation ', ' Molecular ', ' ion mobility ', ' computational tools ', ' computerized tools ', ' Outcome ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' human disease ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' comparative ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' nongenetic ', ' non-genetic ', ' drug candidate ', ' genetic information ', ' dark matter ', ' Predictive Analytics ', ' metabonome ', ' metabolome ', ' in silico ', ' computational pipelines ', ' ']",NIEHS,BATTELLE PACIFIC NORTHWEST LABORATORIES,U2C,2020,1125746,0.16409630656627852
"Systematic Discovery of Bioactivation-Associated Structural Alerts Modified Project Summary/Abstract Section Adverse drug reactions (ADRs) are dangerous and expensive. ADRS driven by immune-mediated hypersensitivity (including rashes, hepatotoxicity, and Steven-Johnson syndrome) are the most difficult to predict and occasionally can be severe as well as fatal. Hypersensitivity-driven ADRs are the leading cause of drug withdrawal and termination of clinical development. Yet a large proportion of drugs are not associated with hypersensitivity-driven ADRs, offering hope that new medicines could avoid these ADRs entirely if reliable models of bioactivation existed. Accurate prediction and identification of molecules prone to ADRs would revolutionize drug development by screening out ADR-prone candidates early, before exposure to patients, and guiding drug modifications to reduce ADR risk. Small molecules are not intrinsically immunogenic and instead, involve bioactivation into reactive metabolite is that then covalently modify proteins to create immunogenic antigens. Structural alerts are molecular substructures prone to bioactivation, and they are often used to identify small molecules prone to bioactivation, and at risk of bioactivation-mediated ADRs. Currently, bioactivation relevant alerts are defined by experts, and they have important limitations that this study overcomes. It is now possible to predict metabolism and reactivity and toxicity using machine learning approaches. Building on this foundation, this proposal systematically discovers new structural alerts by explicitly modeling the impact of metabolism on reactivity and hence the potential to form ADR-relevant adducts. We hypothesize that (1) known bioactivation reactions, (2) molecule citation data, and (3) new substructure mining algorithms can be used to identify emerging structural alerts. Aim 1. We will test this hypothesis by using a computational approach to systematically mine structural alerts from databases of known metabolism and reactivity reactions. Aim 2. We will computationally and experimentally validate structural alerts and assess their structural contingencies. Structural alerts are only conditionally bioactivated, depending on the precise molecule they appear. Newly proposed structural alerts, moreover, are most useful when there is experimental evidence that they in fact can be bioactivated.  PubHlthRel: Structural alerts discovered in this study will help scientists avoid toxic molecules in drug development, and better understand why medicines on the market become toxic. Overcoming a fundamental limitation with structural alerts, machine learning models of bioactivation will clarify in which molecules alerts are and are not bioactivated. This knowledge will help scientists make safer medicines in the future, modify existing medicines to make them safer, and reduce ADRs by using existing medicines more safely. Modified Public Health Relevance Section  Some medicines cause dangerous and expensive Adverse Drug Reactions (ADRs), and many of these ADRs are caused by bioactivation. Structural alerts are substructures prone to bioactivation, and scientists use them to identify molecules prone to bioactivation mediated ADRs. Using a combined data-mining and experimental approach, this proposal systematically discovers emerging structural alerts of increased importance in recently studied molecules. Knowledge gained from these studies could foster improved dosing regimens for marketed drugs and enable scientists to design safer medicines.",Systematic Discovery of Bioactivation-Associated Structural Alerts,10143838,R01GM140635,"['drug market ', ' Modeling ', ' drug development ', ' immunogenic ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' small molecule ', ' datamining ', ' data mining ', ' Dose ', ' Data ', ' in vitro Assay ', ' Molecular ', ' Process ', ' protein function ', ' immunogenicity ', ' designing ', ' design ', ' clinical relevance ', ' clinically relevant ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' public health relevance ', ' Regimen ', ' screening ', ' Injury to Liver ', ' hepatic damage ', ' hepatic injury ', ' liver damage ', ' liver injury ', ' Algorithmic Design ', ' Algorithmic Engineering ', ' algorithm engineering ', ' algorithmic composition ', ' Algorithm Design ', ' experiment ', ' experimental research ', ' experimental study ', ' clinical development ', ' deep learning ', ' adverse drug reaction ', ' Algorithms ', ' Antigens ', ' immunogen ', ' Cell Death ', ' necrocytosis ', ' Dangerousness ', ' Cessation of life ', ' Death ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Exanthema ', ' Exanthem ', ' Rash ', ' Skin Rash ', ' Foundations ', ' Future ', ' Health ', ' Medicare ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Title 18 ', ' health insurance for disabled ', ' Hospitalization ', ' Hospital Admission ', ' Hypersensitivity ', ' Allergy ', ' Length of Stay ', ' Number of Days in Hospital ', ' hospital days ', ' hospital length of stay ', ' hospital stay ', ' Manuals ', ' Medicine ', ' Metabolic Activation ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Mining ', ' Chemical Models ', ' Patients ', ' Proteins ', ' Risk ', ' Role ', ' social role ', ' Stevens-Johnson Syndrome ', ' Erythema Multiforme Major ', ' Testing ', ' United States ', ' Mediating ', ' drug withdrawal ', ' Acute Hepatic Failure ', ' Fulminant Liver Failure ', ' Fulminating Hepatic Failure ', ' Fulminating Liver Failure ', ' fulminant hepatic failure ', ' Acute Liver Failure ', ' improved ', ' Physiologic ', ' Physiological ', ' Chemicals ', ' Hepatotoxic effect ', ' Liver Toxicity ', ' Toxic effect on liver cells ', ' hepatic toxicity ', ' hepatoxicity ', ' Hepatotoxicity ', ' Ligand Binding Protein ', ' Ligand Binding Protein Gene ', ' Protein Binding ', ' bound protein ', ' Binding Proteins ', ' Fostering ', ' Data Bases ', ' data base ', ' Databases ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Metabolic ', ' gene function ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Immunes ', ' Immune ', ' Reaction ', ' Pattern ', ' Techniques ', ' adduct ', ' drug modification ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' ']",NIGMS,WASHINGTON UNIVERSITY,R01,2020,395313,0.07709884571405157
"Spatiotemporal control of concentration gradients with electrochemistry in extracelluar space Project Summary  The natural environment is intrinsically spatiotemporally heterogenous at both macroscopic and microscopic levels. What shapes such a heterogeneity includes the concentration gradients of biologically relevant chemical species in the extracellular medium including dioxygen (O2), reactive oxygen species (ROS), as well as essential redox-active transition metals. While a significant amount of effort has been devoted to spectroscopically image these chemical moieties, our capability to spatiotemporally control their concentration distributions in the extracellular medium remains limited. This is especially the case for biofilms and microbiota, in which the microorganisms small length scales pose significant challenges for concentration modulation. The inadequate control of concentration heterogeneity limits our capability of mimicking the natural environments in vitro and investigating how local concentration gradients affect microbial functionality. Therefore, there is a need for an advanced method of controlling chemical concentrations at microscopic level.  Our proposed research aims to use electrochemical nano-/micro-electrodes to spatiotemporally control the concentration gradients in the extracellular medium. When an electrochemical reaction occurs on an electrodes surface, a concentration gradient is established near the electrode. Taking advantages of this phenomena with the assistance of numerical simulation, we will employ an array of nano-/micro-electrodes with individually addressable electrochemical potentials to program any arbitrary spatiotemporal concentration profiles. We will fine-tune the surface chemistry and the electrochemical properties of these electrodes to ensure biocompatibility and reaction specificity. The developed system will be applied to biofilms and we aim to investigate how the microbial social behavior will be affected by a perturbation of local O2 concentration. Moreover, we will use this device to mimic the heterogenous environment in the gut and culture gut microbiota in vitro. An algorithm based on machine learning will be employed to actively adjust electrode potentials, maintaining a stable concentration profile despite the accumulation of gut microorganisms.  Ultimately, our work will expand our capability of controlling the concentration heterogeneity in nature. The developed electrochemical system will serve an in vitro platform to culture microorganisms in their native environment, or as a tool to perturb the concentration profiles. Combining electrochemistry, inorganic chemistry, and nanomaterials the research will enable a deeper understanding of the spatial distribution and temporal response of microbial systems. Project Narrative The natural environment is intrinsically heterogenous yet our control of concentrations for chemical species is limited at microscopic level. The proposed research is relevant to the mission of the NIH because it describes the development of technology that will expand our capability of controlling chemical concentration profiles in a variety of microbial systems relevant to the public health. The research described here will enable a deeper understanding of disease-related microbial systems and help to formulate strategies to combat diseases.",Spatiotemporal control of concentration gradients with electrochemistry in extracelluar space,10029526,R35GM138241,"['Affect ', ' Algorithms ', ' Chemistry ', ' Inorganic Chemistry ', ' Disease ', ' Disorder ', ' Electrochemistry ', ' Electrodes ', ' Environment ', ' Heterogeneity ', ' In Vitro ', ' Methods ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Oxidation-Reduction ', ' Redox ', ' oxidation reduction reaction ', ' Public Health ', ' Research ', ' Social Behavior ', ' sociobehavior ', ' sociobehavioral ', ' Spatial Distribution ', ' Specificity ', ' Work ', ' Dioxygen ', ' Microbial Biofilms ', ' biofilm ', ' Active Oxygen ', ' Oxygen Radicals ', ' Pro-Oxidants ', ' Reactive Oxygen Species ', ' base ', ' Surface ', ' Microscopic ', ' Biological ', ' Ensure ', ' Chemicals ', ' Individual ', ' Shapes ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' programs ', ' Reaction ', ' microorganism ', ' System ', ' extracellular ', ' biocompatibility ', ' biomaterial compatibility ', ' microorganism culture ', ' tech development ', ' technology development ', ' microbial ', ' simulation ', ' transition metal ', ' Transition Elements ', ' Devices ', ' Property ', ' response ', ' Length ', ' nano array ', ' nano array Analytical Device ', ' nanoarray ', ' Nanoarray Analytical Device ', ' nano ', ' nano materials ', ' nanomaterials ', ' imaging spectroscopy ', ' spectroscopic imaging ', ' spatiotemporal ', ' combat ', ' GI microbiota ', ' Gastrointestinal microbiota ', ' enteric microbial community ', ' enteric microbiota ', ' gastrointestinal microbial flora ', ' gut commensal ', ' gut community ', ' gut flora ', ' gut microbe community ', ' gut microbial community ', ' gut microbial composition ', ' gut microbial consortia ', ' gut microbiotic ', ' gut microflora ', ' intestinal flora ', ' intestinal microbes ', ' intestinal microbiota ', ' intestinal microflora ', ' intestinal tract microflora ', ' gut microbiota ', ' microbial consortia ', ' microbial flora ', ' microflora ', ' multispecies consortia ', ' microbiota ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R35,2020,371084,0.10407412150012103
"Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts PROJECT SUMMARY Collaborative Drug Discovery, Inc. (CDD) proposes to continue development of a novel approach based on deep learning neural networks to encode molecules into chemically rich vectors. In Phase 1 we demonstrated that this representation enables computational models that more accurately predict the chemical properties of molecules than state-of-the-art models, yet are also far simpler to build because they do not require any expert decisions or optimization to achieve high performance. In Phase 2 we will exploit this unprecedented simplicity to develop an intuitive software package that will for the first time enable any chemist or biologist working in drug discovery to create and run their own predictive models  without relying on specialized cheminformatics expertise  yet still achieve or exceed the accuracy of the best currently available techniques. Scientists engaged in drug discovery research from academic laboratories to large pharmaceutical companies rely on computational QSAR models to predict pharmacologically relevant properties and obviate the need to perform expensive, time-consuming assays (many of which require animal studies) for every molecule of interest. Improved models will enable researchers to select lead candidate series more effectively, explore chemical space around leads to generate novel IP more efficiently, reduce failure rates for compounds advancing through the drug discovery pipeline, and accelerate the entire drug discovery process. These benefits will be realized broadly across most therapeutic areas.  We also plan to take the technology one step further, leveraging our chemically rich vector representation to enable the software to creatively suggest novel compounds (which do not appear in the training libraries, screening libraries, or lead series) that outperform the lead candidates simultaneously on bioactivity, ADME/Tox and PK assays . Solving this inverse problem is the Holy Grail of computational medicinal chemistry and has the potential to revolutionize drug discovery. ! PROJECT NARRATIVE The proposed project will create novel computational tools that will help researchers to understand whether potential new drugs are likely to be both safe and effective, and identify similar compounds that are likely to be safer and more effective against the same target. This innovative capability will help to accelerate the discovery and development of novel and improved drugs against a wide range of diseases. !",Novel deep learning strategy to better predict pharmacological properties of candidate drugs and focus discovery efforts,10004481,R44TR002527,"['absorption ', ' Animals ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Pharmaceutical Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutic Chemistry ', ' Classification ', ' Systematics ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Goals ', ' Laboratories ', ' Language ', ' Libraries ', ' Methodology ', ' Molecular Structure ', ' Macromolecular Structure ', ' Permeability ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Pharmacology ', ' Play ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Running ', ' Computer software ', ' Software ', ' Solubility ', ' Technology ', ' Time ', ' Translations ', ' base ', ' improved ', ' Area ', ' Phase ', ' Variation ', ' Variant ', ' Series ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Failure ', ' Intuition ', ' chemical property ', ' Descriptor ', ' Therapeutic ', ' Scientist ', ' Techniques ', ' Best Practice Analysis ', ' Benchmarking ', ' interest ', ' experience ', ' Performance ', ' melting ', ' Structure ', ' novel ', ' Modeling ', ' Property ', ' computational chemistry ', ' QSAR ', ' Quantitiative Structure Activity Relationship ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' voice recognition ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' chemical informatics ', ' cheminformatics ', ' Data ', ' Validation ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' Output ', ' vector ', ' feeding ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Consumption ', ' innovate ', ' innovative ', ' innovation ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' lead series ', ' drug candidate ', ' screening ', ' model building ', ' learning activity ', ' learning method ', ' learning strategy ', ' lead candidate ', ' deep learning based neural network ', ' deep learning neural network ', ' deep neural net ', ' deep neural network ', ' deep learning ', ' neural network ', ' autoencoding neural network ', ' autoencoder ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' ']",NCATS,"COLLABORATIVE DRUG DISCOVERY, INC.",R44,2020,749928,0.11551184872000905
"Using machine learning techniques to characterize the Metabolomics Workbench Dataset PROJECT SUMMARY/ABSTRACT  Mass spectrometry in combination with chromatography provides a powerful approach to characterize small molecules produced in cells, tissues and other biological systems. In essence, measured metabolites provide a functional readout of cellular state, allowing novel biological studies that advance our understanding of health and disease. Currently, the main bottleneck in metabolomics is determining the chemical identities associated with the spectral signatures of measured masses. Despite the growth of spectral databases and advances in annotation tools that recommend the chemical structure that best explains each signature, the large majority of measured masses cannot be assigned a chemical identity. There is now consensus that gleaning partial information regarding the measured spectra in terms of chemical substructure or chemical classification can inform biological studies. This consensus is reflected in the newly updated reporting standards for metabolite annotation as proposed by the Metabolite Identification Task Group of the Metabolomics Society. As we show in our Preliminary Results, spectral characterization results in features that can enhance performance in machine-learning tasks such as annotation.  This work aims to enhance the use and value of the metabolomics dataset in Metabolomics Workbench by: (1) developing machine-learning tools trained on this dataset to characterize unknown spectra, and (2) adding characterization information to the Metabolomics Workbench dataset. In Aim 1, we identify spectral patterns (motifs) that can represent chemically meaningful groupings of peaks within the spectra (e.g., peaks associated with aromatic substructures, loss of a substructure fragment, etc.). We utilize neural topic models that use variational inference to identify such motifs. We expect such models to offer computational speedups and to identify more chemically coherent motifs when compared to earlier implementations of topic modeling. We generate motifs across all spectra in the Metabolomics Workbench and provide annotations for each spectrum.  In Aim 2, we map spectral signatures to chemical ontology classes. As ontologies are hierarchical and as a molecule can be associated with multiple classes at different hierarchical levels of an ontology, we cast this mapping problem as a hierarchical multi-label classification problem and use neural networks to implement such a classifier. The classifier will be trained using the Metabolomics Workbench dataset. Learned motifs from Aim 1 will be used as additional input features to improve classification. We expect that the developed classifier can be used by others to elucidate measurements of unidentified molecules with chemical ontology classes, or to generate ontology terms that can be used as features in downstream machine-learning tasks. Relevance to Public Health The project proposes to investigate machine learning techniques to enhance the utility of a Common Fund data set hosted through the Metabolomics Workbench. This data set consists of biologically relevant molecules and information about their structural composition and their mass spectrometry signatures. We anticipate that our techniques will result in annotating and adding information to the data set, which in turn will advance discoveries in biomedical research and have direct benefits to human health.",Using machine learning techniques to characterize the Metabolomics Workbench Dataset,10111982,R03OD030601,"['Biomedical Research ', ' Cells ', ' Cell Body ', ' Chromatography ', ' Gas Chromatography ', ' vapor phase chromatography ', ' Liquid Chromatography ', ' Classification ', ' Systematics ', ' Complement ', ' Complement Proteins ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Gene Expression ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health ', ' Histidine ', ' Human ', ' Modern Man ', ' Ions ', ' Maps ', ' Molecular Structure ', ' Macromolecular Structure ', ' Phenotype ', ' Public Health ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Societies ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Time ', ' Tissues ', ' Body Tissues ', ' Vocabulary ', ' Vocabulary Words ', ' Work ', ' Measures ', ' General Taxonomy ', ' Taxonomy ', ' Glean ', ' Dataset ', ' Data Set ', ' Label ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Biochemical ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' Metabolic ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' Catalogs ', ' Pattern ', ' Techniques ', ' Performance ', ' neural ', ' relating to nervous system ', ' Structure ', ' novel ', ' Reporting ', ' Modeling ', ' Sampling ', ' response ', ' protein expression ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' Data ', ' Computational Technique ', ' Ontology ', ' Update ', ' Validation ', ' Molecular ', ' groupings ', ' Grouping ', ' cost ', ' functional outcomes ', ' Consumption ', ' Coupled ', ' biological systems ', ' biomarker discovery ', ' annotation framework ', ' annotation tool ', ' annotation  system ', ' neural network ', ' ']",OD,TUFTS UNIVERSITY MEDFORD,R03,2020,263120,-0.002487992776462518
"Computational Techniques for Advancing Untargeted Metabolomics Analysis PROJECT SUMMARY/ABSTRACT Detecting and quantifying products of cellular metabolism using mass spectrometry (MS) has already shown great promise in biomarker discovery, nutritional analysis and other biomedical research fields. Despite recent advances in analysis techniques, our ability to interpret MS measurements remains limited. The biggest challenge in metabolomics is annotation, where measured compounds are assigned chemical identities. The annotation rates of current computational tools are low. For several surveyed metabolomics studies, less than 20% of all compounds are annotated. Another contributing factor to low annotation rates is the lack of systematic ways of designing a candidate set, a listing of putative chemical identities that can be used during annotation. Relying on exiting databases is problematic as considering the large combinatorial space of molecular arrangements, there are many biologically relevant compounds not catalogued in databases or documented in the literature. A secondary yet important challenge is interpreting the measurements to understand the metabolic activity of the sample under study. Current techniques are limited in utilizing complex information about the sample to elucidate metabolic activity. The goal of this project is to develop computational techniques to advance the interpretation of large-scale metabolomics measurements. To address current challenges, we propose to pursue three Aims: (1) Engineering candidate sets that enhance biological discovery. (2) Developing new techniques for annotation including using deep learning and incremental build out methods to recommend novel chemical structures that best explain the measurements. (3) Constructing probabilistic models to analyze metabolic activity. Each technique will be rigorously validated computationally and experimentally using chemical standards. Two detailed case studies on the intestinal microbiota will allow us to further validate our tools. Microbiota-derived metabolites have been detected in circulation and shown to engage host cellular pathways in organs and tissues beyond the digestive system. Identifying these metabolites is thus critical for understanding the metabolic function of the microbiota and elucidating their mechanisms. The complex test cases will challenge our techniques, provide feedback during development, and allow us to further disseminate our techniques. We will work closely with early adopters of our tools, as proposed in supporting letters, to further validate our tools and encourage wide adoption. All proposed tools will be open source and made accessible through the web. Our tools promise to change current practices in interpreting metabolomics data beyond what is currently possible with databases, current annotation tools, statistical and overrepresentation analysis, or combinations thereof. The use of machine learning and large data sets as proposed herein defines the most promising research direction in metabolomics analysis. PROJECT NARRATIVE  Untargeted Metabolomics is a recently developed technique that allows the measurement of thousands of molecules in a biological sample. This work proposes several novel computational techniques that address limitations of current metabolomics analysis tools. We anticipate that this work will advance discoveries in biomedical research and have direct benefits to human health.",Computational Techniques for Advancing Untargeted Metabolomics Analysis,10022125,R01GM132391,"['Adoption ', ' Biomedical Research ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' gastrointestinal system ', ' Ailmentary System ', ' Alimentary System ', ' Digestive System ', ' Gastrointestinal Body System ', ' Gastrointestinal Organ System ', ' Disease ', ' Disorder ', ' Engineering ', ' Feedback ', ' Goals ', ' Health ', ' Human ', ' Modern Man ', ' Intestines ', ' Intestinal ', ' bowel ', ' Literature ', ' Maps ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Molecular Structure ', ' Macromolecular Structure ', ' nutrition ', ' Play ', ' Probability ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Running ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Work ', ' Measures ', ' case report ', ' Case Study ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' Public Domains ', ' base ', ' Organ ', ' Label ', ' Biological ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Letters ', ' Metabolic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Techniques ', ' interest ', ' Performance ', ' physical property ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' Property ', ' drug development ', ' drug discovery ', ' MeSH ', ' Medical Subject Headings ', ' MeSH Thesaurus ', ' PubMed ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' chemical standard ', ' Address ', ' Data ', ' Computational Technique ', ' Validation ', ' nutritious ', ' Nutritional ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' PubChem ', ' cost ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' Consumption ', ' combinatorial ', ' open source ', ' GI microbiota ', ' Gastrointestinal microbiota ', ' enteric microbial community ', ' enteric microbiota ', ' gastrointestinal microbial flora ', ' gut commensal ', ' gut community ', ' gut flora ', ' gut microbe community ', ' gut microbial community ', ' gut microbial composition ', ' gut microbial consortia ', ' gut microbiotic ', ' gut microflora ', ' intestinal flora ', ' intestinal microbes ', ' intestinal microbiota ', ' intestinal microflora ', ' intestinal tract microflora ', ' gut microbiota ', ' dark matter ', ' biomarker discovery ', ' metabonome ', ' metabolome ', ' microbial consortia ', ' microbial flora ', ' microflora ', ' multispecies consortia ', ' microbiota ', ' experiment ', ' experimental research ', ' experimental study ', ' annotation framework ', ' annotation tool ', ' annotation  system ', ' microbiota derived metabolites ', ' microbiota metabolites ', ' deep learning ', ' neural network ', ' large data sets ', ' large datasets ', ' ']",NIGMS,TUFTS UNIVERSITY MEDFORD,R01,2020,378983,0.07325056639699973
"High Accuracy Computational Methods for Biomolecular Nuclear Magnetic Resonance Spectroscopy High accuracy computational methods for biomolecular nuclear magnetic resonance spectroscopy Nuclear magnetic resonance (NMR) spectroscopy is one of the most important condensed phase probes of composition, structure and dynamics of biomolecules and bio-organic species. NMR observables such as chemical shifts and spin-spin splittings can be measured to very high accuracy, and are sensitive both to the functional groups that are present and to their detailed geometries and chemical environment. As such these NMR measurements could be used to develop protein structures with a quality equivalent to high resolution X-ray crystallography but in their native aqueous environments. The connection to structure, while true in principle, is nevertheless sometimes difficult to reveal in practice through direct assignment of the spectrum. Simulation methods that accurately predict spectral observables from structure are a key goal for spectral assignment. Such methods are even more crucial for the inverse problem of realizing high quality NMR structures of folded proteins from spectra, and as powerful restraints for determining the structural ensembles of intrinsically disordered proteins (IDPs). Existing approaches to this problem typically rely on semi-empirical heuristics, and while they have achieved considerable success, they also reveal limitations that significantly degrade the quality of structural prediction. In this proposal, we will develop a new, first principles quantum mechanical (QM) based approach to simulation of NMR spectral observables for condensed phase biomolecules and bio-organics. Rapid prototyping of new QM methods will be enabled by the development of a distinctive in-silico NMR laboratory that applies finite magnetic fields and nuclear spins. From this capability, new methods for chemical shifts and spin-spin splittings will emerge that offer improved accuracy versus cost tradeoffs, and will be employed to populate databases that reflect protein relevant and energetically accessible environments. With such data, both artificial neural networks and Bayesian supervised learning approaches will determine a quantitative relationship between structure and computed NMR observable, and the resulting eQMCalculator will be tested on the refinement of folded proteins and creation of structural ensembles for IDPs. Project Title: High Accuracy Computational Methods for Biomolecular Nuclear Magnetic Resonance Spectroscopy NMR shifts and splitting measurements for organic materials containing 1H, 2H, 13C, and 15N nuclei can provide detailed descriptions of the structure of drug molecules, folded proteins and their complexes, as well as the structural ensembles of intrinsically disordered proteins (IDPs). However there are currently limitations of turning accurate NMR measurements into accurate structures that clearly hampers advances that could be made on connecting structure to function of proteins in their native aqueous environments. This proposal aims to significantly improve the ability to predict the chemical shifts and indirect spin-spin couplings to yield the spectrum associated with a given folded structure or IDP ensemble of structures, with very high accuracy, and with good computational efficiency.",High Accuracy Computational Methods for Biomolecular Nuclear Magnetic Resonance Spectroscopy,9875487,U01GM121667,"['Cell Nucleus ', ' Nucleus ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease ', ' Disorder ', ' Environment ', ' Expert Systems ', ' Intelligent systems ', ' Goals ', ' Laboratories ', ' Methods ', ' Methodology ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Nuclear Magnetic Resonance ', ' Proteins ', ' Quantum Theory ', ' Solvents ', ' Testing ', ' Work ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Measures ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' protein folding ', ' base ', ' improved ', ' Residual ', ' Residual state ', ' Phase ', ' Biological ', ' Single Crystal Diffraction ', ' X Ray Crystallographies ', ' X-Ray Diffraction Crystallography ', ' X-Ray/Neutron Crystallography ', ' Xray Crystallography ', ' X-Ray Crystallography ', ' Chemicals ', ' Evaluation ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Collaborations ', ' Letters ', ' tool ', ' restraint ', ' mechanical ', ' Mechanics ', ' Adopted ', ' Complex ', ' System ', ' vibration ', ' Nuclear ', ' Biomolecular NMR ', ' Biomolecular Nuclear Magnetic Resonance ', ' Equation ', ' magnetic ', ' Magnetism ', ' magnetic field ', ' success ', ' heuristics ', ' functional group ', ' aqueous ', ' Structure ', ' simulation ', ' Modeling ', ' Sampling ', ' Property ', ' response ', ' NMR Spectrometer ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' drug structure ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Data ', ' Resolution ', ' Characteristics ', ' protein function ', ' developmental ', ' Development ', ' cost ', ' quantum ', ' Coupling ', ' prototype ', ' data base structure ', ' database structure ', ' Geometry ', ' learning activity ', ' learning method ', ' learning strategy ', ' Personalized medical approach ', ' individualized approach ', ' precision approach ', ' tailored approach ', ' personalized approach ', ' experiment ', ' experimental research ', ' experimental study ', ' artificial neural net ', ' computational neural network ', ' synthetic neural network ', ' artificial neural network ', ' supervised machine learning ', ' supervised learning ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' in silico ', ' structured data ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,U01,2020,297077,0.08405505269761487
"Simulation of Proton Translocation in Biomolecules PROJECT SUMMARY  The transport of protons in biomolecular systems is a phenomenon of fundamental importance to processes such as ATP synthesis, enzyme catalysis, the maintenance of pH gradients, proton pumping, viral infection, and substrate/ion transport across membranes via protein transporters, symporters, and antiporters. Modeling biomolecular proton translocation in silico is a significant challenge due to the complex chemical reactions involved in Grotthuss proton shutting between water molecules and with protonatable amino acids, as well as the complexity of the target biomolecular systems. In most cases, it is not only important to understand the mechanism of proton binding and transport, but also its coupling to other mechanistically relevant biomolecular processes, such as protein conformational changes, substrate binding, other protonation events, and dynamic hydration.  In this project the continued development and application of a powerful multiscale computer simulation methodology is described for the study of proton transport in several key classes of proton translocating biomolecular systems, including channels (influenza A and B M2 channels), antiporters/symporters (ClC Cl-/H+ antiporter and phosphate transporter, respectively), and transporters (proton-coupled oligopeptide transporter and EmrE multidrug transporter). The overall research plan is made possible by a novel reactive molecular dynamics simulation approach integrated with quantum mechanics/molecular mechanics (QM/MM) methods that allows for the study of explicit long-length and -time scale proton transport through water molecules and ionizable molecular groups in hydrogen-bonded networks, as well as by new innovations in enhanced free energy sampling methodology, machine learning, kinetic network theory, and coarse-graining. A primary goal in the research with this methodology in hand is to reveal the mechanisms of proton transport, as well as its coupling to hydration and conformational changes, in the above mentioned biomolecular systems. All of these studies will be carried out in collaboration with leading experimentalists, while continuing to add a new dimension to the field of biomolecular computer simulation as a whole. 1 PROJECT NARRATIVE  In this project, computer simulations will be used to study proton transport in several important biomolecular systems. Proton translocation is of fundamental significance throughout biology, as demonstrated by the pH-dependence of biomolecular structure and function and the central role of transmembrane proton gradients in bioenergy conversion. Moreover, understanding proton transport is of fundamental importance and direct relevance to numerous aspects of human health, including metabolism, aging, diabetes, neurodegeneration, retinal degeneration, antivral and anti-bacterial therapeutics, and homeostasis. 1",Simulation of Proton Translocation in Biomolecules,9934213,R01GM053148,"['Achievement ', ' Achievement Attainment ', ' Aging ', ' Amino Acids ', ' aminoacid ', ' Anions ', ' Behavior ', ' Sampling Biases ', ' Biology ', ' Carrier Proteins ', ' Transport Protein Gene ', ' Transport Proteins ', ' Transporter Protein ', ' Catalysis ', ' Charge ', ' Communities ', ' Computer Simulation ', ' Computer based Simulation ', ' computational simulation ', ' computerized simulation ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Diabetes Mellitus ', ' diabetes ', ' Diffusion ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Elements ', ' Enzymes ', ' Enzyme Gene ', ' Future ', ' Goals ', ' Proton Pump ', ' H(+) Pump ', ' H+ Pump ', ' Hand ', ' Health ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Human ', ' Modern Man ', ' Hydrogen Bonding ', ' H-bond ', ' Influenza ', ' Grippe ', ' flu infection ', ' influenza infection ', ' Kinetics ', ' Maintenance ', ' Medicine ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Methods ', ' Methodology ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Motion ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Oligopeptides ', ' inorganic phosphate ', ' Phosphates ', ' Protein Conformation ', ' Proteins ', ' Protons ', ' H+ element ', ' Hydrogen Ions ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Research Support ', ' Retinal Degeneration ', ' degenerative retina diseases ', ' retina degeneration ', ' retinal degenerative ', ' retinal degenerative diseases ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' Specificity ', ' Time ', ' Travel ', ' Virus Diseases ', ' Viral Diseases ', ' viral infection ', ' virus infection ', ' virus-induced disease ', ' Water ', ' Hydrogen Oxide ', ' Wisconsin ', ' antiporter ', ' Ion Transport ', ' protonation ', ' Area ', ' Medical ', ' insight ', ' Progress Reports ', ' Funding ', ' Antibacterial Agents ', ' anti-bacterial ', ' antibacterial ', ' Anti-Bacterial Agents ', ' Collaborations ', ' Letters ', ' Therapeutic ', ' machine learned ', ' Machine Learning ', ' Entropy ', ' mechanical ', ' Mechanics ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Reaction ', ' System ', ' Consult ', ' chemical reaction ', ' membrane structure ', ' Membrane ', ' Molecular Dynamics Simulation ', ' molecular dynamics ', ' Co-Transporters ', ' symporter ', ' Free Energy ', ' Structure ', ' simulation ', ' novel ', ' Agreement ', ' Coding System ', ' Code ', ' chemical bond ', ' Modeling ', ' Sampling ', ' theories ', ' molecular mechanics ', ' Phosphate Transport Proteins ', ' Phosphate Transporters ', ' Inorganic Phosphate Transporter ', ' Influenza A ', ' Influenza Viruses Type A ', ' Influenzavirus A ', ' Orthomyxovirus Type A ', ' Type A Influenza ', ' Influenza A virus ', ' Influenza B ', ' Influenza Viruses Type B ', ' Orthomyxoviruses Type B ', ' Influenza B Virus ', ' delta pH ', ' deltapH ', ' pH gradient ', ' Molecular Interaction ', ' Binding ', ' Hydration ', ' Hydration status ', ' Length ', ' Defect ', ' ATP Synthesis ', ' ATP Synthesis Pathway ', ' Data ', ' Quantum Mechanics ', ' Molecular Transport ', ' Transport Process ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' anti-flu drug ', ' antiflu drug ', ' anti-influenza drug ', ' quantum ', ' Outcome ', ' migration ', ' Coupled ', ' Coupling ', ' innovate ', ' innovative ', ' innovation ', ' multidrug transporter ', ' multi drug transporter ', ' experiment ', ' experimental research ', ' experimental study ', ' Grain ', ' in silico ', ' kinetic model ', ' ']",NIGMS,UNIVERSITY OF CHICAGO,R01,2020,310328,0.0374765116784504
"Integrative chemical-biological profiling to determine primary drivers of wildfire smoke-induced toxicity PROJECT SUMMARY  Wildfire occurrence, duration, and intensity have heightened in recent decades and continue to impact the health of millions of individuals worldwide. Smoke that is emitted from wildfires consists of a complex mixture of particulate matter and toxic gases. The chemical composition of wildfire smoke is dependent upon the type of biomass burn conditions and fuel type, which are heavily influenced by geographical region. The chemical mixtures within wildfire smoke that humans are exposed to can consequently cause variable health outcomes through potentially different biological mechanisms. Human exposure to wildfire smoke represents a growing concern in public health, and adequately characterizing health risks associated with biomass smoke across varying burn conditions and geographic areas is not possible with the data currently available.  The variabilities in toxicological responses across wildfire smoke exposure conditions have yet to be fully established and evaluated in the context of chemical composition. The growing threat of wildfires necessitates the elucidation of individual and/or co-occurring components of wildfire smoke that act as the primary drivers of toxicity. To address this important research issue, we expand upon a foundational study that has previously characterized the chemical constituents in various biomass burn scenarios and evaluated, in part, toxicological responses to these exposures in the mouse lung. Here, we leverage this extensive database and banked samples to: 1. characterize in vivo transcriptomic responses and pathway alterations associated with biomass smoke in the mouse lung; 2. integrate chemical-toxicity profiles using computational approaches to prioritize chemicals that are likely driving toxicity responses; and 3. further evaluate chemical drivers of biomass smoke toxicity responses using in vitro approaches.  This research will be carried out through a collaboration with laboratories at the University of North Carolina at Chapel Hill and the U.S. Environmental Protection Agency, allowing for a unique combination of expertise for studying the primary drivers of wildfire smoke-induced toxicity. This expertise includes skills in computational toxicology, exposure science, and molecular biology, coupled with experience studying adverse health effects and immune responses induced by exposure to air pollutants. PROJECT NARRATIVE Exposure to wildfire smoke continues to be a growing threat to public health, yet the primary drivers of toxicity and disease are not completely understood. This proposal represents an innovative approach to increase understanding on the health effects of wildfires by leveraging a robust dataset of chemical-biological profiles from mice exposed to biomass smoke condensate samples derived from variable conditions. New data will also be generated alongside additional in vitro testing to more comprehensively examine mechanisms of toxicity and identify the primary drivers of wildfire smoke-induced toxicity, resulting in improved abilities to predict region- specific health risks attributable to wildfires.",Integrative chemical-biological profiling to determine primary drivers of wildfire smoke-induced toxicity,9956440,R21ES031740,"['Affect ', ' Air ', ' Air Pollutants ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biomass ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cells ', ' Cell Body ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Cessation of life ', ' Death ', ' Disease ', ' Disorder ', ' DNA Damage ', ' DNA Injury ', ' Female ', ' Foundations ', ' Gases ', ' Gene Expression ', ' Genes ', ' Geographic Locations ', ' Geographic Area ', ' Geographic Region ', ' Geographical Location ', ' geographic site ', ' Health ', ' Human ', ' Modern Man ', ' In Vitro ', ' Inflammation ', ' Laboratories ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' male ', ' Methods ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' North Carolina ', ' Phenotype ', ' Proteins ', ' Public Health ', ' Research ', ' Risk ', ' Science ', ' Smoke ', ' Tissues ', ' Body Tissues ', ' Toxicology ', ' United States Environmental Protection Agency ', ' Environmental Protection Agency ', ' Universities ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' smoke inhalation ', ' Lung damage ', ' lung injury ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Critical Paths ', ' Critical Pathways ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' Immunes ', ' Immune ', ' Complex ', ' System ', ' respiratory ', ' Inhalation Exposure ', ' experience ', ' genotoxicity ', ' toxicant ', ' Toxicities ', ' Toxic effect ', ' skills ', ' novel ', ' Position ', ' Positioning Attribute ', ' Lung Parenchyma ', ' Lung Tissue ', ' Structure of parenchyma of lung ', ' Sampling ', ' response ', ' Toxicogenomics ', ' Complex Mixtures ', ' Address ', ' Data ', ' in vivo ', ' Chemically Induced Toxicity ', ' pathway ', ' Pathway interactions ', ' Particulate Matter ', ' data integration ', ' Outcome ', ' Population ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' transcriptomics ', ' Wildfire ', ' human exposure ', ' exposed human population ', ' public health relevance ', ' in vitro testing ', ' data reduction ', ' biomass smoke ', ' biomass fuel ', ' protein markers ', ' protein biomarkers ', ' computational toxicology ', ' Inhaling ', ' Inhalation ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' asthma attack ', ' exacerbation in asthma ', ' exacerbation prone asthma ', ' exacerbation prone asthmatic ', ' asthma exacerbation ', ' ']",NIEHS,UNIV OF NORTH CAROLINA CHAPEL HILL,R21,2020,227277,0.015060239396602327
"Reconstruction of heterogeneous and small macromolecules by cyro-EM PROJECT SUMMARY Single-particle electron cryomicroscopy (cryo-EM) has recently joined X-ray crystallography and NMR spectroscopy as a high-resolution structural method for biological macromolecules. In addition, cryo-EM produces images of individual molecules, and therefore has the potential to resolve conformational changes. The proposal aims to develop new algorithms and software for extending the application of cryo-EM to molecules that are either too small or too flexible to be mapped by existing computational tools for cryo-EM. This extension requires solving two of the most challenging computational problems posed by cryo-EM. First, mapping the structural variability of macromolecules is widely recognized as the main computational challenge in cryo-EM. Structural variations are of great significance to biologists, as they provide insight into the functioning of molecular machines. Existing computational tools are limited to a small number of distinct conformations, and therefore are incapable of tackling highly mobile biomolecules with multiple, continuous spectra of conformational changes. The first area of investigation in this project is the development of a computational framework to analyze continuous variability. The proposed approach is based on a new mathematical representation of continuously changing structures and its efficient estimation using Markov chain Monte Carlo (MCMC) algorithms. MCMC algorithms have found great success in many other scientific disciplines, yet they have been mostly overlooked for cryo-EM single particle analysis. Second, a major limiting factor for present cryo-EM studies is the molecule size. Images of small molecules (below ~50kDa) have too little signal to allow existing methods to provide valid 3-D reconstructions. It is commonly believed that cryo-EM cannot be used for molecules that are too small to be reliably detected and picked from micrographs. Challenging that widespread belief, the second area of investigation focuses on developing a groundbreaking approach for reconstructing small molecules directly from micrographs without particle picking. The new approach is based on autocorrelation analysis and completely bypasses particle picking and orientation assignment and requires just one pass over the data. The single-pass approach opens new possibilities for real-time processing during data acquisition. PROJECT NARRATIVE Determining structures of proteins and other large molecules is an essential step in the basic understanding of biological processes, and a first step in rational drug design. We propose to develop new, faster and more reliable computer algorithms to significantly increase the power of structure-determination using electron cryomicroscopy (cryo-EM). Importantly, our methods will broaden the application of cryo-EM to molecules that are either too small or too flexible to be mapped by existing techniques.",Reconstruction of heterogeneous and small macromolecules by cyro-EM,9943364,R01GM136780,"['Algorithms ', ' Belief ', ' Crystallization ', ' Diffusion ', ' Drug Design ', ' Human Genome ', ' human whole genome ', ' Heterogeneity ', ' Ion Channel ', ' Ionic Channels ', ' Membrane Channels ', ' Maps ', ' Markov Chains ', ' Markov Process ', ' Mathematics ', ' Math ', ' Methods ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Molecular Weight ', ' Motion ', ' Names ', ' Noise ', ' Particle Size ', ' Proteins ', ' Research ', ' Ribosomes ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' statistics ', ' Time ', ' Work ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Ion Pumps ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' Spliceosomes ', ' base ', ' macromolecule ', ' improved ', ' Area ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Pythons ', ' Single Crystal Diffraction ', ' X Ray Crystallographies ', ' X-Ray Diffraction Crystallography ', ' X-Ray/Neutron Crystallography ', ' Xray Crystallography ', ' X-Ray Crystallography ', ' insight ', ' Discipline ', ' Individual ', ' Fostering ', ' Biological Function ', ' Biological Process ', ' Collaborations ', ' machine learned ', ' Machine Learning ', ' programs ', ' Investigation ', ' Dimensions ', ' Complex ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' interest ', ' particle ', ' Receptor Protein ', ' receptor ', ' success ', ' Cryo-electron Microscopy ', ' Electron Cryomicroscopy ', ' cryo-EM ', ' cryoEM ', ' Cryoelectron Microscopy ', ' molecular mass ', ' Molecular Motors ', ' Structure ', ' expectation ', ' G Protein-Complex Receptor ', ' G Protein-Coupled Receptor Genes ', ' GPCR ', ' G-Protein-Coupled Receptors ', ' Bypass ', ' Modeling ', ' Sampling ', ' theories ', ' Markov chain Monte Carlo algorithms ', ' Markov chain Monte Carlo computational algorithm ', ' Markov chain Monte Carlo method ', ' Markov chain Monte Carlo procedure ', ' Markov chain Monte Carlo sampling ', ' Markov chain Monte Carlo simulation ', ' Markov chain Monte Carlo technique ', ' Markov chain Monte Carlo methodology ', ' NMR Spectrometer ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' data processing ', ' computerized data processing ', ' protein complex ', ' Institution ', ' small molecule ', ' Polymerase ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Data ', ' Detection ', ' Resolution ', ' Update ', ' Preparation ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' reconstruction ', ' computational framework ', ' computer framework ', ' computational tools ', ' computerized tools ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' 3-D structure ', ' 3-dimensional structure ', ' 3D structure ', ' three dimensional structure ', ' data acquisition ', ' Molecular Machines ', ' computer algorithm ', ' Computational algorithm ', ' open source ', ' flexible ', ' flexibility ', ' Algorithmic Tools ', ' Software Algorithm ', ' Algorithmic Software ', ' Structural Protein ', ' high dimensionality ', ' ']",NIGMS,PRINCETON UNIVERSITY,R01,2020,328440,0.0648613075505383
"Computer Simulations of Enzymes Computer simulations using molecular dynamics (MD) and the combined quantum  mechanical/molecular mechanical (QM/MM) approach are capable of describing structures and dynamics  of proteins and chemical reactions catalyzed by enzymes. An accurate and  computationally efficient energy function is necessary. However, challenges remain: the  accuracy of QM method, the compatibility between the electron density of the QM subsystem and  classical force fields for the MM subsystem, and the cost of ab initio QM/MM methods capitalizing  on the accuracy and reliability of the associated QM approaches. To address these challenges, we  have developed a series of ab initio QM/MM approaches on reaction path optimizations and free  energy calculations, the QM/MM minimum free-energy path (QM/MM-MFEP) and the QM/MM neural  network (QM/MM-NN) methods. This proposal aims to develop further the ab initio QM/MM methodology  and its applications to the studies of redox processes in important enzymes, and the construction  of ab initio force fields combined with neural network representations. Our long-term goals are to develop and establish accurate first-principles based and density  functional theory (DFT) based MD and QM/MM simulation as an equal partner with experiments for the  study of enzymes and proteins and to provide insight into chemical and redox processes in  biological systems. Our aims are as follows: (1) We aim to make ab initio QM/MM models for much  more accurate QM/MM energies, for the QM description and for the electrostatic and vdW interactions   between the QM and MM subsystems. (2) We aim to develop a combined computational  model to explore the key molecular determinants of the reduction potential variability in  metalloproteins. We will provide detailed insight into chemical and redox reaction mechanisms in  biological systems, in particular laccases. (3) We aim at the development of accurate  force fields of water, and proteins for simulations in biological applications, going beyond the  traditional force field forms and limitation in accuracy. The proposed developments will capitalize on the theoretical developments in quantum  electronic theory, such as the linear response theory and accurate many-electron approach for  non-covalent interactions, and leverage machine-learning methods in data science for biological  system simulations. The proposed work will lead to the major advancement of the ab initio QM/MM  method and force fields, and insights into the structure-function paradigm for proteins  and important redox process and reaction mechanisms in enzymes. In addition, it will also lead to  methodology development for design of new drugs and enzyme inhibitors. Understanding chemical reactions and redox processes in solution and in enzymes is of critical  importance, because the structure-function relationship and the catalytic role of enzymes  are fundamental insights in biochemical research, and they are essential for the development of  new or better inhibitors and enzymes. Quantitative tools such as simulations make key contributions  to the investigation of the structure-function relationship, complementing experimental studies.  This proposal aims at developing methods for simulating structures and dynamics in proteins, and  chemical and redox processes catalyzed by enzymes, and investigating the mechanisms of  important enzymes-copper protein laccases, leading to significant advances in research tools for  studying enzymes and contributing to the understanding of life processes, as well as aiding in the  design of inhibitors and drugs.",Computer Simulations of Enzymes,10001530,R01GM061870,"['inhibitor/antagonist ', ' inhibitor ', ' Chemistry ', ' Complement ', ' Complement Proteins ', ' Computer Simulation ', ' Computer based Simulation ', ' computational simulation ', ' computerized simulation ', ' Copper ', ' Cu element ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Electrons ', ' Negative Beta Particle ', ' Negatrons ', ' Enzymes ', ' Enzyme Gene ', ' Equilibrium ', ' balance ', ' balance function ', ' Goals ', ' Laboratories ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Metalloproteins ', ' Methods ', ' Methodology ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Oxidation-Reduction ', ' Redox ', ' oxidation reduction reaction ', ' Protein Engineering ', ' genetic protein engineering ', ' protein design ', ' Proteins ', ' Research ', ' Role ', ' social role ', ' Structure-Activity Relationship ', ' chemical structure function ', ' structure function relationship ', ' Water ', ' Hydrogen Oxide ', ' Work ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Laccase ', ' Urishiol Oxidase ', ' p-Diphenol Oxidase ', ' base ', ' density ', ' improved ', ' Site ', ' Variation ', ' Variant ', ' Biological ', ' Biochemical ', ' Series ', ' Chemicals ', ' insight ', ' Collaborations ', ' tool ', ' Electrostatics ', ' Life ', ' mechanical ', ' Mechanics ', ' Adopted ', ' Investigation ', ' Scanning ', ' Protocol ', ' Protocols documentation ', ' Reaction ', ' chemical reaction ', ' electron density ', ' intermolecular interaction ', ' Molecular Dynamics Simulation ', ' molecular dynamics ', ' Performance ', ' Potential Energy ', ' Free Energy ', ' Structure ', ' simulation ', ' Modeling ', ' Connectionist Models ', ' Neural Network Models ', ' Perceptrons ', ' Neural Network Simulation ', ' Property ', ' response ', ' theories ', ' molecular mechanics ', ' Enzyme Antagonist ', ' Enzyme Inhibitor ', ' Enzyme Inhibitor Agent ', ' Enzyme Inhibitor Drugs ', ' Address ', ' Biochemical Process ', ' biophysical mechanism ', ' Biophysical Process ', ' Protein Dynamics ', ' Scheme ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' cost ', ' designing ', ' design ', ' quantum ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' biological systems ', ' perturbation theory ', ' Data Science ', ' experiment ', ' experimental research ', ' experimental study ', ' neural network ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' machine learning method ', ' ']",NIGMS,DUKE UNIVERSITY,R01,2020,360797,0.11849891556966882
"Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence Project Summary The lack of accurate and reliable techniques for visualizing and quantifying the delivery and uptake (pharmacokinetics) of small molecules into the skin has been a major challenge in the development of both new and generic topical drugs. This is particularly true in the measurement of bioequivalence, where a generic drug candidate must be compared against a reference brand-label drug. Current methods, which rely on expensive, destructive, and bulk measurements do not provide the spatial or temporal resolution necessary to extract pharmacokinetic profiles to determine equivalence of drugs at the cellular level over time in human skin. New tools, which allow for direct, real-time quantification of pharmacokinetics non-invasively in humans are needed to drive innovation in the topical drug space. Pharmacokinetic Tomography (PKT) is a method of generated three-dimensional, real-time maps of various molecular species such as lipids, water, proteins and drugs in tissue using spectroscopic imaging techniques. These imaging techniques make use of the intrinsic molecular vibrations of drug molecules to track their uptake quantitatively without the need for labels or alterations to molecular structure. This proposal will develop new coherent Raman imaging tools to create a platform for quantifying the behavior of drugs in ex vivo human skin. This PKT-based platform will be able to measure the uptake of drugs such as antibiotics, kinase inhibitors, steroids, retinoids and NSAIDs in the skin with sub-cellular and sub-second time resolution to glean critical pharmacokinetic parameters needed for drug development and bioequivalence measurements. To compare PKT to an FDA-recognized standard, these PKT imaging will be carried out alongside dermal open flow microperfusion (dOFM), a skin fluid sampling technique that measures the concentration of drugs over time. The multimodal PKT platform, when completed, will be able to measure the bioequivalence of various drugs in situ in human subjects. This research program will specifically develop new imaging toolkits that combine advanced microscopy with state-of-the-art computer vision and machine learning analysis techniques to collect and extract pharmacokinetic data. Using a new type of versatile laser, we will create a coherent Raman technique ideal for detection of drug molecules which contain unique chemical structures. In order to broaden the applicability of the platform to a far wider range of potential drug molecules, we will develop a sparse sampling coherent Raman imaging approach that will quantify molecules by their unique combinations of molecular structures. The development and approval of topical generic drugs for treating dermatological conditions has been slow due to the difficulty and cost in establishing bioequivalence of potential drugs using existing pharmacokinetic profiling methods. For this reason, there is a major need for techniques that can enable the direct visualization and quantification of drugs as they flow and accumulate within tissue. This proposal seeks to develop Pharmacokinetic Tomography imaging tools that make use of the intrinsic molecular vibrational properties of drugs to create a platform translatable to human studies for the measurement of drug bioequivalence.",Pharmacokinetic Tomography for the Measurement of Topical Drug Product Bioequivalence,9999520,U01FD006698,[''],FDA,MASSACHUSETTS GENERAL HOSPITAL,U01,2020,253172,0.08229532541366606
"MegaTox for analyzing and visualizing data across different screening systems Project Summary Computational toxicology aims to use rules, models and algorithms based on prior data for specific endpoints, to enable the prediction of whether a new molecule will possess similar liabilities or not. Our recent efforts have used sources like PubChem and ChEMBL to build predictive models for different toxicity-related and drug discovery endpoints. Our Phase I SBIR proposal called MegaTox will provide toxicity machine learning models developed with different algorithms for 40-50 in vitro and in vivo toxicity datasets. We propose using this technology to generate machine learning models for predicting potential compounds against either TGF- a target for countering chlorine induced lung inflammation as well as the adenosine A1 receptor to identify agonists as potential anticonvulsants. In addition, we can also compile molecules that can reactivate acetylcholinesterase which would enable the potential to discover medical countermeasures to address nerve agent and pesticide poisoning. We will access multiple machine learning approaches and validate these Bayesian or other machine learning models (including Linear Logistic Regression, AdaBoost Decision Tree, Random Forest, Support Vector Machine and deep neural networks (DNN) of varying depth) with our own in-house technology for these selected targets. We will aim for ROC values greater than 0.75 and MCC and F1 scores that are acceptable (>0.3). These models will be used to virtually screen FDA approved drugs, clinical candidates, commercially available drugs or other molecules. We will select up to 50 molecules to be tested using in vitro assays alongside controls for each target. These combined efforts should in the first instance provide commercially viable treatments which will be used to experimentally validate our computational models that can be shared with the medical countermeasures scientific community. In summary, we are proposing to build and validate models for targets based on public databases, select compounds for testing, create proprietary data and use this as a starting point for further optimization of compounds if needed. Our goal is to identify at least one promising compound for each target that we then pursue and protect our IP. We will pursue additional grant funding to take these medical countermeasures through additional in vitro and in vivo preclinical studies. Ultimately, we will license our products to larger companies for development prior to clinical trials. Project Narrative There is an urgent need to develop medical countermeasures (MCM) to address pulmonary agents, nerve agents and organophosphorus pesticides. Our approach leverages public and private data to build machine learning models for different targets involved in the physiological effects of the aforementioned agents. We then use these computational models to select new molecules to test in vitro. Our approach builds on our MegaTox approach focused on modeling toxicology targets to specifically focus on identifying compounds for TGF- and Adenosine A1 as well as potential AChE reactivators. This computational approach will be validated using in vitro testing and offers several advantages to identify potential novel or repurposed molecules as MCM including speed and cost-effectiveness.",MegaTox for analyzing and visualizing data across different screening systems,10094026,R43ES031038,"['Acetylcholinesterase ', ' Acetylcholine Hydrolase ', ' acetylcholine acetylhydrolase ', ' choline esterase I ', ' Adenosine ', ' Adenosine A1 Receptor ', ' Algorithms ', ' Anticonvulsants ', ' Anticonvulsant Agent ', ' Anticonvulsant Drugs ', ' Anticonvulsive Agents ', ' Anticonvulsive Drugs ', ' Chlorine ', ' Cl element ', ' Clinical Trials ', ' Communities ', ' cost effectiveness ', ' Decision Trees ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Goals ', ' Grant ', ' In Vitro ', ' Pesticides ', ' Privatization ', ' Technology ', ' Testing ', ' Toxicology ', ' Transforming Growth Factor alpha ', ' Epidermal Growth Factor-Related Transforming Growth Factor ', ' TGF A ', ' TGF-alpha ', ' TGF- ', ' TGFalpha ', ' TGF ', ' Transforming Growth Factor beta ', ' Bone-Derived Transforming Growth Factor ', ' Milk Growth Factor ', ' Platelet Transforming Growth Factor ', ' TGF B ', ' TGF-beta ', ' TGF- ', ' TGFbeta ', ' TGF ', ' Transforming Growth Factor-Beta Family Gene ', ' Dataset ', ' Data Set ', ' base ', ' Phase ', ' Physiologic ', ' Physiological ', ' Logistic Regressions ', ' Ache ', ' Data Bases ', ' data base ', ' Databases ', ' Licensing ', ' Funding ', ' Agonist ', ' pesticide toxicity ', ' pesticide poisoning ', ' machine learned ', ' Machine Learning ', ' Source ', ' System ', ' Toxicities ', ' Toxic effect ', ' Speed ', ' novel ', ' Modeling ', ' drug discovery ', ' nerve agent ', ' Address ', ' Data ', ' in vitro Assay ', ' in vivo ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' developmental ', ' Development ', ' pre-clinical study ', ' preclinical study ', ' PubChem ', ' virtual ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Lung Inflammation ', ' choking agent ', ' pulmonary agents ', ' FDA approved ', ' in vitro testing ', ' screening ', ' computational toxicology ', ' clinical candidate ', ' deep learning based neural network ', ' deep learning neural network ', ' deep neural net ', ' deep neural network ', ' random forest ', ' medical countermeasure ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' support vector machine ', ' ']",NIEHS,"COLLABORATIONS PHARMACEUTICALS, INC.",R43,2020,124915,0.07265266149007603
"A Multiwell Plate Format Microfluidic Immobilization Chip for High-Content Imaging of Whole Animals for in vivoNeurotoxicology Testing Project Summary: Neurotoxicological evaluation of new compounds intended for human use or of potential human exposure is mandated by international regulatory bodies and largely relies on lethality testing in higher-order vertebrate animals. High screening costs, long experimental times, and legislative requirements to reduce dependence on animal testing have led many industries to search for alternative technologies. In vitro toxicology testing uses isolated cells or monotypic cell culture and can only provide limited insight since these models lack biologically relevant intact multi-typic cellular network structures. While both technologies have been augmented by in silico technologies, there is still a non-trivial gap between what can be learned and translated from simple, fast, inexpensive in vitro methods versus longer, complex, and costly in vivo studies in higher order animals. Newormics approach to filling this gap is to enable in vivo neurotoxicological assessment in Caenorhabditis elegans, an accepted alternative invertebrate model organism, by developing neuron-specific toxicity assays, delivered via a proprietary high-density, large-scale microfluidic immobilization device for high-content, high throughput analysis. Building on advances made during Phase I and important market learnings from participation in the NIH I-Corps program, Phase II proposes several new elements of innovation to achieve our goals in 3 specific aims. In Aim 1, we will convert our first-generation microfluidic device to a high-density (384- well) vivoChip with improved microfabrication technologies, incorporate on-chip culture for transfer-less exposure and testing, and integrate automation for chip loading, imaging, and analysis. These measures will significantly increase test scale (from 80 compounds per chip to 280) and lower the consumable and labor costs per test. In Aim 2, building on our dopaminergic neurotox assay from Phase I, we will develop four neurotox assays with brightly fluorescently labeled dopaminergic, serotonergic, GABAergic, and cholinergic neurons providing the unprecedented ability to assess subtle phenotypic effects of chemicals on individual intact, functional neurons. To achieve real-time image processing, multi-parameter phenotyping, and managing the terabytes of image data generated per test, we will build a computational platform empowered by a graphic user interface. This platform will be used for image compilation, user-annotated phenotype definition and scoring, and automated report generation with appropriate statistical analysis. In Aim 3, with our industry partners, we will validate our platform and assays using reference chemicals. As more chemicals are tested, we will build a database which can be further mined. The outcome of this work will enable many industries to reduce lethal animal testing and get safer industrial and personal consumer products to market faster for economic benefit, reaching regulatory compliance for reduced animal use, and improved healthcare for neurological diseases. Narrative: The proposed work will enable the use of a small invertebrate model organism, C. elegans, for neuron-specific analysis of neurodegeneration phenotypes from high-resolution fluorescence images of individual neurons at high throughputs. The proposed imaging system and the neuron-specific assays will provide an unprecedented ability to assess developmental neurotoxicity in an intact, live, whole organism, down to a neuronal mechanism- of-action level. This project will fill the gap between in vitro and in vivo toxicology testing with an effective invertebrate model organism as alternate to vertebrate animal testing.",A Multiwell Plate Format Microfluidic Immobilization Chip for High-Content Imaging of Whole Animals for in vivoNeurotoxicology Testing,10082215,R44MH118841,"['Animals ', ' Automation ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Cell Culture Techniques ', ' cell culture ', ' Cells ', ' Cell Body ', ' Complement ', ' Complement Proteins ', ' Statistical Data Interpretation ', ' Statistical Data Analyses ', ' Statistical Data Analysis ', ' statistical analysis ', ' Dendrites ', ' Dopamine ', ' Hydroxytyramine ', ' Eating ', ' Food Intake ', ' Economics ', ' Elements ', ' Feedback ', ' Future ', ' gamma-Aminobutyric Acid ', ' 4-Aminobutanoic Acid ', ' 4-Aminobutyric Acid ', ' 4-amino-butanoic acid ', ' Aminalon ', ' Aminalone ', ' GABA ', ' -Aminobutyric Acid ', ' Gel ', ' Goals ', ' Human ', ' Modern Man ', ' Immobilization ', ' orthopedic freezing ', ' In Vitro ', ' Industrialization ', ' Industry ', ' Invertebrates ', ' Invertebrata ', ' Learning ', ' Manuals ', ' Market Research ', ' Methods ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nerve Degeneration ', ' Neuron Degeneration ', ' neural degeneration ', ' neurodegeneration ', ' neurodegenerative ', ' neurological degeneration ', ' neuronal degeneration ', ' Nervous system structure ', ' Nervous System ', ' Neurologic Body System ', ' Neurologic Organ System ', ' nervous system disorder ', ' Nervous System Diseases ', ' Neurologic Disorders ', ' Neurological Disorders ', ' neurological disease ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Neurotransmitters ', ' Nerve Transmitter Substances ', ' Organoids ', ' Phenotype ', ' Robotics ', ' Serotonin ', ' 5-HT ', ' 5-Hydroxytryptamine ', ' 5HT ', ' Enteramine ', ' Hippophaine ', ' Computer software ', ' Software ', ' Specificity ', ' Technology ', ' Testing ', ' Time ', ' Toxicology ', ' Translating ', ' Vertebrates ', ' Vertebrate Animals ', ' vertebrata ', ' Work ', ' Generations ', ' Measures ', ' health care ', ' Healthcare ', ' C elegans ', ' C. elegans ', ' C.elegans ', ' Caenorhabditis elegans ', ' base ', ' density ', ' image processing ', ' Label ', ' improved ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Evaluation ', ' insight ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' Data Bases ', ' data base ', ' Databases ', ' Research Activity ', ' Toxicity Testing ', ' Toxicity Tests ', ' fluid ', ' liquid ', ' Liquid substance ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' programs ', ' Hour ', ' Complex ', ' Dependence ', ' Protocol ', ' Protocols documentation ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Protocol Compliance ', ' interest ', ' Services ', ' empowered ', ' consumer product ', ' neurotoxicology ', ' success ', ' chemical library ', ' small molecule libraries ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Toxicities ', ' Toxic effect ', ' Speed ', ' Structure ', ' Devices ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' high throughput analysis ', ' fluidic ', ' Microfluidics ', ' Address ', ' Microfluidic Device ', ' Microfluidic Lab-On-A-Chip ', ' microfluidic chip ', ' Microfluidic Microchips ', ' Animal Testing ', ' Data ', ' International ', ' Microfabrication ', ' Resolution ', ' in vitro Model ', ' in vivo ', ' in vivo Model ', ' Validation ', ' Whole Organism ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cholinergic neuron ', ' cost ', ' designing ', ' design ', ' Outcome ', ' cost effective ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' developmental neurotoxicity ', ' neuron toxicity ', ' neuronal toxicity ', ' neurotoxicity ', ' Graphical interface ', ' graphic user interface ', ' software user interface ', ' graphical user interface ', ' human exposure ', ' exposed human population ', ' fluorescent imaging ', ' fluorescence imaging ', ' industrial partnership ', ' industry partnership ', ' industry partner ', ' screening ', ' developmental toxicity ', ' imaging platform ', ' imaging system ', ' Industry Standard ', ' I-Corps ', ' Innovation Corps ', ' reproductive toxicity ', ' connectome ', ' terabyte ', ' high resolution imaging ', ' experiment ', ' experimental research ', ' experimental study ', ' testing services ', ' computing platform ', ' computational platform ', ' realtime image ', ' real-time images ', ' in silico ', ' ']",NIMH,"NEWORMICS, LLC",R44,2020,700867,0.04789053126630145
"Imaging Molecular Level Details of Collagen Fibers by VSFG Microscopy In this proposed project, we plan to fill the knowledge gap of the relationships between microscopic self-assembled structures, collagen-molecule interactions and macroscopic fiber morphologies of type-I collagen, the primary component of most human tissues and a commonly used biomaterial for tissue engineering. By investigating collagen-water and collagen-protein interactions in in vitro systems that mimic basic aspects of physiologically relevant three- dimensional fibrillar tissue architectures, we aim to fill knowledge gaps in fundamental collagen research. We will achieve this goal by developing a hyperspectral imaging technique  vibrational sum frequency generation (VSFG) microscopy  at high repetition rates (400 kHz) and apply it to collagen. The long-term vision is to develop new biophysics methods to reveal molecular-level structures and interactions for pericellular space research and other complex biological environments, and eventually applying it to study various pericellular environment related diseases. In order to correlate spectral features to microscopic and macroscopic structures of type I collagen, we plan to apply machine-learning techniques to analyze our data and extract spectral signatures of collagens micro/macrostructures. We will two major scientific focuses: (A) understanding molecular signatures of microscopic self-assembly fibrils structures and its relationship to the macroscopic morphology (plan 1 and 2); and (B) investigating molecular level collagen-molecule interactions (plan 3 and 4). Specific plans include:  1. Obtaining hyperspectral VSFG images of collagen tissues to study their morphology in a  label free and non-invasive manner  2. Establishing molecular spectral signatures of self-assembled collagen fibril structures  3. Understanding collagen-water interaction in first solvation layer of collagen fibers.  4. Imaging spatial locations of chemicals and peptides that interact with collagens. If successful, the significance is that a label free, vibrational mode specific imaging technique specific for pericellular space will be available, which can reveal molecular level insights of collagen structures and its interactions with surrounding molecules, pertinent to fibrosis and cell pericellular space interaction related diseases. This proposed project contributes to the scope of NIGMS by developing new technology to reveal fundamental molecular-level principle, mechanism and signatures related to morphology of collagen I at both micro- and macroscopic scales, and collagen-molecule interactions, laying foundations for biophysical/biochemical principles for future biomedical applications related to collagens. This proposed development of vibrational sum frequency generation microscopy, in the short term, will spatially resolve collagen tissues with chemical structure and molecular interaction information in a complicated environment. Machine learning and simulation approaches will be employed to build a data base to convert hyperspectral images of collagen into a spatial map with microscopic structures and molecular interaction information. In the long term, the fundamental biochemical knowledge learned from this development will lay foundations for rationally design biomedical approaches to monitor and control pericellular spaces and its interaction with cells, and further advance treatment to diseases related to it.",Imaging Molecular Level Details of Collagen Fibers by VSFG Microscopy,10028946,R35GM138092,"['Architecture ', ' Engineering / Architecture ', ' Biocompatible Materials ', ' Biomaterials ', ' biological material ', ' Biophysics ', ' biophysical foundation ', ' biophysical principles ', ' biophysical sciences ', ' Cells ', ' Cell Body ', ' Collagen ', ' Disease ', ' Disorder ', ' Environment ', ' Fibrosis ', ' Foundations ', ' Future ', ' Goals ', ' image reconstruction ', ' image construction ', ' image generation ', ' In Vitro ', ' Maps ', ' Microscopy ', ' Peptides ', ' Proteins ', ' Research ', ' Tissues ', ' Body Tissues ', ' Collagen Type I ', ' Type 1 Collagen ', ' Vision ', ' Sight ', ' visual function ', ' Water ', ' Hydrogen Oxide ', ' Generations ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Label ', ' Microscopic ', ' Biological ', ' Physiologic ', ' Physiological ', ' Biochemical ', ' Chemicals ', ' Chemical Structure ', ' Collagen Fiber ', ' Fiber ', ' insight ', ' Data Bases ', ' data base ', ' Databases ', ' Morphology ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Frequencies ', ' Complex ', ' human tissue ', ' Techniques ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Location ', ' vibration ', ' bioengineered tissue ', ' engineered tissue ', ' Tissue Engineering ', ' Structure ', ' simulation ', ' novel technologies ', ' new technology ', ' Molecular Interaction ', ' Binding ', ' Collagen Fibril ', ' Data ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' NIGMS ', ' National Institute of General Medical Sciences ', ' Sum ', ' Monitor ', ' Molecular ', ' developmental ', ' Development ', ' molecule imaging ', ' molecular imaging ', ' imaging ', ' Image ', ' self assembly ', ' designing ', ' design ', ' biophysical approaches ', ' biophysical methodology ', ' biophysical methods ', ' biophysical techniques ', ' ']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R35,2020,393958,0.055271637810367785
"Image-guided robot for high-throughput microinjection of Drosophila embryos PROJECT SUMMARY This proposal is submitted in response to the NIH Development of Animal Models and Related Biological Materials for Research (R21) program. The proposal develops an image-guided robotic platform that performs the automated delivery of molecular genetic tools and non-genetically encoded reagents such as chemical libraries, fluorescent dyes to monitor cellular processes, functionalized magnetic beads, or nanoparticles into thousands of Drosophila embryos in a single experimental session. The proposed work builds on recent engineering innovations in our collaborative group which has developed image-guided robotic systems that can precisely interface with single cells in intact tissue. The two Specific Aims provide for a systematic development of the proposed technologies. AIM 1 first engineers a robotic platform (Autoinjector) that can scan and image Drosophila embryos in arrays of egg laying plates. We will utilize machine learning algorithms for automated detection of embryos, followed by thresholding and morphology analysis to detect embryo centroids and annotate injection sites. In AIM 2, we will utilize microprocessor-controlled fluidic circuits for programmatic delivery of femtoliter to nanoliter volumes of reagents into individual embryos. We will quantify the efficacy of the Autoinjector by comparing the survival, fertility, and transformation rates of transposon or PhiC31-mediated transgenesis to manual microinjection datasets. Finally, we will demonstrate the efficient delivery of sgRNAs and mutagenesis in the presence of Cas9. This project fits very well within the goals of the program by engineering a novel tool for producing and improving animal models. The Autoinjector will accelerate Drosophila research and empower scientists to perform novel experiments and genome-scale functional genomics screens that are currently too inefficient or labor intensive to be conducted on a large scale and may additionally enable other novel future applications. PROJECT NARRATIVE This proposal develops a technology platform that will enable automated microinjection of molecular genetic tools and non-genetically encoded tools such as chemical libraries, fluorescent dyes, functionalized magnetic beads, or nanoparticles, into thousands of Drosophila embryos in a single experimental session. The successful development of this technology will empower Drosophila biologists to perform screens and develop new applications that are currently too inefficient or labor intensive to contemplate and will accelerate research into the function of the nervous system and the molecular and genetic underpinnings of numerous diseases in this important animal model.",Image-guided robot for high-throughput microinjection of Drosophila embryos,9989196,R21OD028214,"['Biocompatible Materials ', ' Biomaterials ', ' biological material ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Cell Nucleus ', ' Nucleus ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Cells ', ' Cell Body ', ' Computer Vision Systems ', ' computer vision ', ' Cryopreservation ', ' Cryofixation ', ' cold preservation ', ' cold storage ', ' Disease ', ' Disorder ', ' Drosophila genus ', ' Drosophila ', ' fruit fly ', ' Drosophila melanogaster ', ' Embryo ', ' Embryonic ', ' Engineering ', ' Expenditure ', ' Fertility ', ' Fecundability ', ' Fecundity ', ' Fluorescent Dyes ', ' Fluorescence Agents ', ' Fluorescent Agents ', ' fluorescent dye/probe ', ' Future ', ' Goals ', ' Laboratories ', ' Manuals ', ' Methods ', ' Microinjections ', ' Microprocessor ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Motivation ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Needles ', ' Nervous System Physiology ', ' Neurologic function ', ' Neurological function ', ' nervous system function ', ' Reagent ', ' Research ', ' Resources ', ' Research Resources ', ' Robotics ', ' Space Perception ', ' Spatial Discrimination ', ' perceptual spatial orientation ', ' spatial orientation ', ' spatial perception ', ' Technology ', ' Tissues ', ' Body Tissues ', ' Work ', ' Mutagenesis ', ' Genetics-Mutagenesis ', ' Mutagenesis Molecular Biology ', ' Guide RNA ', ' gRNA ', ' Molecular Genetics ', ' Mediating ', ' Dataset ', ' Data Set ', ' base ', ' gene manipulation ', ' genetically manipulate ', ' genetically perturb ', ' genetic manipulation ', ' Microscope ', ' improved ', ' Site ', ' Individual ', ' Transgenes ', ' fluid ', ' liquid ', ' Liquid substance ', ' Genetic ', ' Morphology ', ' Robot ', ' tool ', ' machine learned ', ' Machine Learning ', ' programs ', ' Scientist ', ' Investigation ', ' Scanning ', ' System ', ' Location ', ' nano litre ', ' nanoliter ', ' nanolitre ', ' experience ', ' mutant ', ' Performance ', ' chemical library ', ' small molecule libraries ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' tech development ', ' technology development ', ' transgenic ', ' Transgenic Organisms ', ' novel ', ' response ', ' functional genomics ', ' Transgenesis ', ' Gene Transfer Techniques ', ' Diameter ', ' Caliber ', ' magnetic beads ', ' Detection ', ' Collection ', ' R21 Mechanism ', ' R21 Program ', ' exploratory developmental study ', ' Exploratory/Developmental Grant ', ' Signaling Molecule ', ' Monitor ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' cost ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' nano particle ', ' nano-sized particle ', ' nanosized particle ', ' nanoparticle ', ' innovate ', ' innovative ', ' innovation ', ' egg ', ' biological research ', ' stem ', ' genome scale ', ' genomewide ', ' genome-wide ', ' animal model development ', ' screening ', ' image guidance ', ' image guided ', ' mutation scanning ', ' mutation screening ', ' gene product ', ' experiment ', ' experimental research ', ' experimental study ', ' Injections ', ' machine learned algorithm ', ' machine learning algorithm ', ' robotic system ', ' automatic algorithm ', ' automated algorithm ', ' ']",OD,UNIVERSITY OF MINNESOTA,R21,2020,222618,0.055429370847045197
"Determination of structure, dynamics and energetics of enzyme reactions Project Summary  Understanding enzyme mechanisms is of paramount importance from both the basic biophysics perspective of understanding life processes and the role of enzymes in diseases. To achieve a detailed understanding of enzyme catalysis, the effects of protein structure and dynamics on the reaction energetics need to be elucidated. We propose a combined computational and experimental approach that combines the synthetic, computational and structural biology expertise of a team of investigators that has been working together for >15 years to create a molecular movie where the position, movement and energy of every atom in the system followed over the entire reaction pathway. The proposal exploits the emerging convergence of timescales accessible by molecular simulation using GPUs and time resolved structural biology. Specific Aim 1 describes the simulation of the complete reaction pathway of Pseudomonas mevalonii (Pm) HMGCoA Reductase (HMGR) and will use transition state force fields (TSFFs) generated by the quantum guided molecular mechanics method to allow the sec MD simulations of the chemical steps. TSFFs not only circumvent the well-known boundary problem of QM/MM, but are also 102-104 times faster. This allows a realistic modeling of the coupling of sec dynamics and catalysis that was demonstrated in the last grant period to be essential for understanding the reaction. Together with accelerated MD simulations of the conformational changes involved in the reaction using standard force fields, these computational studies cover the fsec to sec timescale. In Specific Aim 2, the computational results will be merged with the results of a three-tiered approach to obtain structural snapshots with progressively increasing time resolution: (i) Frozen intermediates that map out the overall pathway on long timescales, (ii) time resolved Laue crystallography using pH jump initiation on the msec timescale and (iii) use of photocaged substrates to allow time resolved Laue experiments on the sec timescale. This approach will be applied to the study of HMGR, an enzyme of high biophysical and biomedical significance that has a complex reaction mechanism involving three chemical steps, six large-scale conformational changes and two cofactor exchange steps. The project is highly innovative because it (i) uses a combination of MD simulations using TSFFs and time resolved crystallography to span timescales of at least 12 orders of magnitude, (ii) iteratively couples the Markov State analysis of long timescale trajectories to the Singular Value Decomposition used to analyze time resolved crystallography data, thus providing new tools to generate and experimentally validate trial structures (iii) applies global optimization and machine learning techniques to allow the automated fitting of TSFFs for proteins, which will enhance the application of this powerful method to other proteins and (iv) provides new photocaged substrates for the study of enzyme mechanisms to the chemical biology community. All tool compounds, methods and codes developed in this project will be made available to the scientific community. Public Health Statement  The detailed study of enzyme mechanisms is a cornerstone of biophysical chemistry that, while basic in nature, has had a major impact on human health including the development of new mechanism-based drugs for a range of diseases and an understanding of the mechanism of action for existing drugs that allows the design of combination therapies. The combination of Laue crystallography and long-scale MD simulations will allow simultaneous studies of structure, dynamics and energetic studies with unprecedented detail. The application to HMG CoA Reductase, arguably the single most important drug target in western industrialized countries, will demonstrate the applicability of the methodology to an enzyme of high mechanistic complexity. 1","Determination of structure, dynamics and energetics of enzyme reactions",9897100,R01GM111645,"['Biochemistry ', ' Biological Chemistry ', ' Biology ', ' Biophysics ', ' biophysical foundation ', ' biophysical principles ', ' biophysical sciences ', ' Catalysis ', ' Cholesterol ', ' Combined Modality Therapy ', ' Multimodal Therapy ', ' Multimodal Treatment ', ' combination therapy ', ' combined modality treatment ', ' combined treatment ', ' multi-modal therapy ', ' multi-modal treatment ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Couples ', ' Crystallization ', ' Crystallography ', ' Crystallographies ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Enzymes ', ' Enzyme Gene ', ' Equilibrium ', ' balance ', ' balance function ', ' Freezing ', ' Goals ', ' Grant ', ' Health ', ' Human ', ' Modern Man ', ' Hydroxymethylglutaryl-CoA reductase ', ' 3-Hydroxy-3-methylglutaryl CoA Reductase ', ' HMG CoA Reductases ', ' Maps ', ' Methods ', ' Methodology ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Movement ', ' body movement ', ' Oxidoreductase ', ' Dehydrogenases ', ' Oxidoreductase Gene ', ' Reductases ', ' Proteins ', ' Pseudomonas ', ' Chrysemonas ', ' Flavimonas ', ' Public Health ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Running ', ' Science ', ' Time ', ' Work ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Mutagenesis ', ' Genetics-Mutagenesis ', ' Mutagenesis Molecular Biology ', ' base ', ' cofactor ', ' improved ', ' Biological ', ' Active Sites ', ' Link ', ' Chemicals ', ' Antibacterial Agents ', ' anti-bacterial ', ' antibacterial ', ' Anti-Bacterial Agents ', ' Collaborations ', ' Industrialized Countries ', ' Industrialized Nations ', ' developed country ', ' developed nation ', ' developed nations ', ' Developed Countries ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' computer biology ', ' Computational Biology ', ' Knowledge ', ' Life ', ' Msec ', ' millisecond ', ' Complex ', ' Reaction ', ' Techniques ', ' System ', ' electron density ', ' enzyme mechanism ', ' experience ', ' Molecular Dynamics Simulation ', ' molecular dynamics ', ' particle ', ' structural biology ', ' biophysical chemistry ', ' Free Energy ', ' Structure ', ' simulation ', ' movie ', ' Position ', ' Positioning Attribute ', ' Coding System ', ' Code ', ' Modeling ', ' theories ', ' molecular mechanics ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Data ', ' Protein Dynamics ', ' Resolution ', ' Validation ', ' Enzymology ', ' Enzymatic Biochemistry ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' computational studies ', ' computer studies ', ' designing ', ' design ', ' molecular scale ', ' quantum ', ' Coupling ', ' innovate ', ' innovative ', ' innovation ', ' synthetic biology ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' Drug Targeting ', ' experiment ', ' experimental research ', ' experimental study ', ' machine learning method ', ' ']",NIGMS,UNIVERSITY OF NOTRE DAME,R01,2020,335664,0.06919366949567468
"Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization Project Summary  The proposed work will accelerate the pace of drug discovery by developing, validating, and testing new methods, tools, and resources for structure-based drug design. Two fundamental challenges of structure-based drug design are the accurate scoring and ranking of protein-ligand structures, which identies active com- pounds, and the ability to efciently search a large number of ligands, which ensures that active compounds are sampled. This proposal will address these challenges by developing a novel approach for protein-ligand scoring and expanding the size of the chemical space that can be efciently searched during lead optimiza- tion. The methods will be validated by their prospective application toward the discovery of new anti-cancer molecules and will be made readily accessible through online resources and open-source tools.  The proposal leverages recent and signicant advances in deep learning and image recognition to develop scoring functions that accurately recognize high-afnity protein-ligand interactions. This is achieved by design- ing and training convolutional neural nets on three-dimensional representations of protein-ligand structures to discriminate between binders and non-binders. Convolutional neural net training will exploit large datasets of afnity and structural data to automatically extract the relevant features necessary to accurately prioritize compounds. Additionally, the proposal develops the rst means of fully integrating a convolutional neural net scoring function directly into an energy minimization and docking workow.  Interactive virtual screening enables the search of millions of compounds in a few seconds so that queries can be interactively optimized. Interactivity enables the synergistic unication of human expert knowledge and efcient computational algorithms. The proposed work will dramatically expand the size of chemical space ac- cessible through interactive virtual screening. Algorithms for efciently searching the chemical space of billions or trillions of compounds implicitly dened by a set of reaction schemas and fragments will be created as part of a lead optimization workow. Fragment-oriented search will be accelerated by a new data structure that combines pharmacophore and molecular shape information into a single sub-linear time index.  The scoring and lead optimization methods developed in this proposal will be released as open-source soft- ware and made immediately available through open-access online resources. As part of the prospective valida- tion of the proposed methods, these resources will be used to identify hit compounds and optimize leads for two targets related to cancer metabolism: serine hydroxymethyltransferase and kidney glutaminase isoform C. Successful completion of the objectives of this proposal will positively impact public health by reducing the cost and time-to-market of developing new drugs, particularly with respect to novel protein targets. Project Narrative  Researchers will be able to more quickly and accurately identify potential drug candidates using the new methods, tools, and resources for structure-based drug discovery created by this project. These tools will be readily accessible through open-access web sites and open-source software. As part of the project these tools will be used to identify new molecules that are relevant to the treatment of cancer.","Methods, Tools and Resources for Interactive Online Virtual Screening and Lead Optimization",9857604,R01GM108340,"['tumor cell metabolism ', ' tumor metabolism ', ' screening ', ' Algorithmic Tools ', ' Software Algorithm ', ' Algorithmic Software ', ' internet resource ', ' on-line compendium ', ' on-line resource ', ' online compendium ', ' web resource ', ' web-based resource ', ' online resource ', ' lead optimization ', ' anticancer ', ' anti-cancer ', ' deep learning ', ' Infrastructure ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' in silico ', ' Visualization ', ' virtual screenings ', ' virtual screening ', ' structured data ', ' large data sets ', ' large datasets ', ' Algorithms ', ' Award ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' cell growth ', ' Cellular Expansion ', ' Cellular Growth ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Drug Design ', ' Environment ', ' Feedback ', ' Glutaminase ', ' Breast Cell Glutaminase ', ' EC 3.5.1.2 ', ' GA Protein ', ' L glutamine amidohydrolase ', ' Liver Glutaminase ', ' Glutamine ', ' Gln ', ' L-Glutamine ', ' Q Levoglutamide ', ' Q. Levoglutamide ', ' Human ', ' Modern Man ', ' In Vitro ', ' indexing ', ' Intelligence ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Libraries ', ' Ligands ', ' Methods ', ' Modernization ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Play ', ' Proteins ', ' Public Health ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Glycine Hydroxymethyltransferase ', ' Allothreonine Aldolase ', ' Serine Aldolase ', ' Serine Hydroxymethylase ', ' Serine Hydroxymethyltransferase ', ' Serine Transhydroxymethylase ', ' Threonine Aldolase ', ' Computer software ', ' Software ', ' Testing ', ' Time ', ' Work ', ' base ', ' improved ', ' Biochemical ', ' Ensure ', ' Chemicals ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Malignant Cell ', ' cancer cell ', ' tool ', ' Knowledge ', ' Dependence ', ' Reaction ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Cell Growth in Number ', ' Cell Multiplication ', ' Cellular Proliferation ', ' Cell Proliferation ', ' molecular shape ', ' Tumor Cell ', ' neoplastic cell ', ' Performance ', ' Isoforms ', ' Protein Isoforms ', ' success ', ' pharmacophore ', ' resource guides ', ' Structure ', ' novel ', ' Sampling ', ' Connectionist Models ', ' Neural Network Models ', ' Perceptrons ', ' Neural Network Simulation ', ' Cancer Treatment ', ' Malignant Neoplasm Therapy ', ' Malignant Neoplasm Treatment ', ' anti-cancer therapy ', ' anticancer therapy ', ' cancer therapy ', ' drug discovery ', ' TNFRSF11A gene product ', ' receptor activator of NF-kappaB ', ' RANK protein ', ' Effectiveness ', ' chemical informatics ', ' cheminformatics ', ' Address ', ' Affinity ', ' Data ', ' in vivo ', ' Validation ', ' Molecular ', ' Process ', ' Docking ', ' Modification ', ' imaging ', ' Image ', ' website ', ' web site ', ' cost ', ' virtual ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' tumor xenograft ', ' blind ', ' prospective ', ' combinatorial ', ' user-friendly ', ' computer algorithm ', ' Computational algorithm ', ' data structure ', ' web interface ', ' open source ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' overexpress ', ' overexpression ', ' drug candidate ', ' cancer cell metabolism ', ' cancer metabolism ', ' ']",NIGMS,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2020,313000,0.12914649675204226
"Computational Techniques for Advancing Untargeted Metabolomics Analysis PROJECT SUMMARY/ABSTRACT Detecting and quantifying products of cellular metabolism using mass spectrometry (MS) has already shown great promise in biomarker discovery, nutritional analysis and other biomedical research fields. Despite recent advances in analysis techniques, our ability to interpret MS measurements remains limited. The biggest challenge in metabolomics is annotation, where measured compounds are assigned chemical identities. The annotation rates of current computational tools are low. For several surveyed metabolomics studies, less than 20% of all compounds are annotated. Another contributing factor to low annotation rates is the lack of systematic ways of designing a candidate set, a listing of putative chemical identities that can be used during annotation. Relying on exiting databases is problematic as considering the large combinatorial space of molecular arrangements, there are many biologically relevant compounds not catalogued in databases or documented in the literature. A secondary yet important challenge is interpreting the measurements to understand the metabolic activity of the sample under study. Current techniques are limited in utilizing complex information about the sample to elucidate metabolic activity. The goal of this project is to develop computational techniques to advance the interpretation of large-scale metabolomics measurements. To address current challenges, we propose to pursue three Aims: (1) Engineering candidate sets that enhance biological discovery. (2) Developing new techniques for annotation including using deep learning and incremental build out methods to recommend novel chemical structures that best explain the measurements. (3) Constructing probabilistic models to analyze metabolic activity. Each technique will be rigorously validated computationally and experimentally using chemical standards. Two detailed case studies on the intestinal microbiota will allow us to further validate our tools. Microbiota-derived metabolites have been detected in circulation and shown to engage host cellular pathways in organs and tissues beyond the digestive system. Identifying these metabolites is thus critical for understanding the metabolic function of the microbiota and elucidating their mechanisms. The complex test cases will challenge our techniques, provide feedback during development, and allow us to further disseminate our techniques. We will work closely with early adopters of our tools, as proposed in supporting letters, to further validate our tools and encourage wide adoption. All proposed tools will be open source and made accessible through the web. Our tools promise to change current practices in interpreting metabolomics data beyond what is currently possible with databases, current annotation tools, statistical and overrepresentation analysis, or combinations thereof. The use of machine learning and large data sets as proposed herein defines the most promising research direction in metabolomics analysis. PROJECT NARRATIVE  Untargeted Metabolomics is a recently developed technique that allows the measurement of thousands of molecules in a biological sample. This work proposes several novel computational techniques that address limitations of current metabolomics analysis tools. We anticipate that this work will advance discoveries in biomedical research and have direct benefits to human health.",Computational Techniques for Advancing Untargeted Metabolomics Analysis,10145183,R01GM132391,"['Adoption ', ' Biomedical Research ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' gastrointestinal system ', ' Ailmentary System ', ' Alimentary System ', ' Digestive System ', ' Gastrointestinal Body System ', ' Gastrointestinal Organ System ', ' Disease ', ' Disorder ', ' Engineering ', ' Feedback ', ' Goals ', ' Health ', ' Human ', ' Modern Man ', ' Intestines ', ' Intestinal ', ' bowel ', ' Literature ', ' Maps ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Molecular Structure ', ' Macromolecular Structure ', ' nutrition ', ' Play ', ' Probability ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Running ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Work ', ' Measures ', ' case report ', ' Case Study ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' Public Domains ', ' base ', ' Organ ', ' Label ', ' Biological ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Letters ', ' Metabolic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Techniques ', ' interest ', ' Performance ', ' physical property ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' Property ', ' drug development ', ' drug discovery ', ' MeSH ', ' Medical Subject Headings ', ' MeSH Thesaurus ', ' PubMed ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' small molecule ', ' chemical standard ', ' Address ', ' Data ', ' Computational Technique ', ' Validation ', ' nutritious ', ' Nutritional ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' PubChem ', ' cost ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' Consumption ', ' combinatorial ', ' open source ', ' GI microbiota ', ' Gastrointestinal microbiota ', ' enteric microbial community ', ' enteric microbiota ', ' gastrointestinal microbial flora ', ' gut commensal ', ' gut community ', ' gut flora ', ' gut microbe community ', ' gut microbial community ', ' gut microbial composition ', ' gut microbial consortia ', ' gut microbiotic ', ' gut microflora ', ' intestinal flora ', ' intestinal microbes ', ' intestinal microbiota ', ' intestinal microflora ', ' intestinal tract microflora ', ' gut microbiota ', ' dark matter ', ' biomarker discovery ', ' metabonome ', ' metabolome ', ' microbial consortia ', ' microbial flora ', ' microflora ', ' multispecies consortia ', ' microbiota ', ' experiment ', ' experimental research ', ' experimental study ', ' annotation framework ', ' annotation tool ', ' annotation  system ', ' microbiota derived metabolites ', ' microbiota metabolites ', ' deep learning ', ' neural network ', ' large data sets ', ' large datasets ', ' ']",NIGMS,TUFTS UNIVERSITY MEDFORD,R01,2020,10920,0.07325056639699973
"Developing an in vitro to in vivo pipeline of mammary gland exposure-response relationships to per- and poly-fluoroalkyl substances (PFAS) Project Abstract  Per- and polyfluoroalkyl substances (PFAS) are a family of over 5000 man-made chemicals that are ubiquitous in the environment, due to their chemical stability and bioaccumulative properties. Many of these forever chemicals have been linked with health concerns, including strong evidence of developmental health and harm to hormone-sensitive tissues. Manufacturers continue to substitute new PFAS for which exposure- based health risks are unknown. There is an urgent public health need to determine the effects of PFAS in use on both mammary gland development and increased breast cancer incidence. Current exposure studies use rodent models that require cumbersome end-point analyses as well as large monetary and time investments.  Our proposal is aimed at developing an in vitro to in vivo extrapolation (IVIVE) pipeline of mammary gland development and maintenance to identify and prioritize potentially toxic PFAS, to ultimately mitigate number of animals needed for environmental exposure studies. Our approach is to develop in vitro models of the mammary gland of increasing complexity but decreasing throughput, identifying links between high-throughput and high- complexity model endpoint readouts to best prioritize large chemical libraries. A key technology to establish links across multiple in vitro culture platforms is optical coherence tomography-based structural-functional imaging (OCT-SFI), developed by MPI Oldenburg, which non-invasively visualizes label-free cells, their intracellular motility, and morphology of formed spheroids, within optically turbid tissue models.  Our first specific aim advances a high-throughput paper-based culture system, developed by MPI Lockett, to study mammary epithelial cell invasion in physiologically relevant tissue microenvironments. The platform will evaluate 96 different exposure conditions in parallel. Our second specific aim employs 3D co-culture models that include fibroblasts to model stromal signaling known to affect mammary gland development. OCT-SFI will provide cellular motility and morphology of the organotypic spheroids that form in these cultures. Finally, our third aim will screen a library of 40 PFAS, with a particular focus on the perfluoroethercarboxylic acids (PFECAs) currently used in industrial coatings. In addition, 12 PFAS will be screened for which there is existing in vivo rodent model data available, and comparisons between in vitro assay outputs and in vivo gland remodeling will be used to refine the assay models and establish initial thresholds for screening.  The models developed as part of this proposal will thus be predictive of biology, enabling the high-throughput capability needed for future screening of all PFAS as well as other emerging endocrine disruptors. The projects risk is balanced by the known imaging capabilities of OCT-SFI to probe responses in 3D spheroid and paper- based co-cultures. The high-throughput nature of this IVIVE pipeline makes it ideal for screening libraries of potential toxicants, providing information-rich datasets of spatially and temporally resolved morphological and molecular changes across the tissue-like structures. Project Narrative This proposal aims to develop a pipeline to screen and prioritize libraries of potentially toxic man-made chemicals found in the environment for further analyses, with particular emphasis on per- and poly-fluoroalkyl substances (PFAS) of which there are over 5000 currently known. Current environmental exposure testing methods evaluate mammary gland development in live mice because the mammary gland is highly susceptible to chemical exposure; yet, such methods are slow and expensive. Our proposal uses mammary cell culture models in increasingly complex, tissue-like environments, in combination with high-speed 3D optical imaging techniques, and ultimately compare the platform with a few candidate PFAS against existing data in live mice, setting the stage for future high-throughput screening of potential environmental toxicants.",Developing an in vitro to in vivo pipeline of mammary gland exposure-response relationships to per- and poly-fluoroalkyl substances (PFAS),10152786,R01ES032730,"['Acids ', ' Affect ', ' Animals ', ' Architecture ', ' Engineering / Architecture ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biology ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cell Culture Techniques ', ' cell culture ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' cell motility ', ' Cell Locomotion ', ' Cell Migration ', ' Cell Movement ', ' Cellular Migration ', ' Cellular Motility ', ' Motility ', ' Cells ', ' Cell Body ', ' Clinical Trials ', ' Environment ', ' Environmental Exposure ', ' Epithelium ', ' Epithelium Part ', ' Family ', ' Fibroblasts ', ' Future ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health ', ' Hormones ', ' Endocrine Gland Secretion ', ' Therapeutic Hormone ', ' In Vitro ', ' Incidence ', ' Industrialization ', ' Investments ', ' Libraries ', ' Maintenance ', ' Methods ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' North Carolina ', ' Odds Ratio ', ' Cross-Product Ratio ', ' Relative Odds ', ' Risk Ratio ', ' Optics ', ' optical ', ' Paper ', ' Pathology ', ' Public Health ', ' Rattus ', ' Common Rat Strains ', ' Rat ', ' Rats Mammals ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Rodent ', ' Rodentia ', ' Rodents Mammals ', ' Scoring Method ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Toxic Environmental Substances ', ' Environmental Toxin ', ' Toxic Environmental Agents ', ' environmental toxicant ', ' Up-Regulation ', ' Upregulation ', ' Work ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Dataset ', ' Data Set ', ' base ', ' Label ', ' Physiologic ', ' Physiological ', ' Link ', ' Chemicals ', ' Epithelial ', ' Fiber ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' ER Positive ', ' ER+ ', ' Estrogen receptor positive ', ' Co-culture ', ' Cocultivation ', ' Coculture ', ' Coculture Techniques ', ' Exposure to ', ' Morphology ', ' tool ', ' Nature ', ' Complex ', ' Scanning ', ' Techniques ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Cancer Induction ', ' carcinogenesis ', ' chemical stability ', ' breast epithelium ', ' mammary epithelium ', ' chemical library ', ' small molecule libraries ', ' toxicant ', ' Speed ', ' Structure ', ' Chemical Exposure ', ' novel ', ' Protein Gene Products ', ' Gene Proteins ', ' Cell Proliferative Activity ', ' Cellular Proliferation Rate ', ' Mitotic Index ', ' Proliferation Index ', ' S-Phase Fraction ', ' carcinogenicity ', ' Modeling ', ' Property ', ' response ', ' assay development ', ' High Throughput Assay ', ' high throughput screening ', ' Doppler OCT ', ' OCT Tomography ', ' optical Doppler tomography ', ' optical coherence Doppler tomography ', ' Optical Coherence Tomography ', ' model design ', ' mammary ', ' Mammary gland ', ' Manufacturer ', ' Manufacturer Name ', ' Cell to Cell Communication and Signaling ', ' Cell-Cell Signaling ', ' intercellular communication ', ' Gland ', ' mammary gland morphogenesis ', ' mammary morphogenesis ', ' mammary gland development ', ' Breast Cancer Epidemiology ', ' Data ', ' Mesenchymal ', ' precancerous ', ' premalignant ', ' in vitro Assay ', ' in vitro Model ', ' in vivo ', ' Physiologic Imaging ', ' physiological imaging ', ' Functional Imaging ', ' Rodent Model ', ' Tissue Model ', ' cell morphology ', ' Cellular Morphology ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' Output ', ' NIEHS ', ' National Institute of Environmental Health Sciences ', ' optic imaging ', ' optical imaging ', ' model of data ', ' model the data ', ' modeling of the data ', ' data modeling ', ' 3-D modeling ', ' 3D modeling ', ' three-dimensional modeling ', ' Endocrine Disrupter ', ' Endocrine Disrupting Chemicals ', ' Endocrine disrupting agent ', ' endocrine disrupting compound ', ' Endocrine Disruptors ', "" man's "", ' man ', ' malignant phenotype ', ' screening ', ' mammary epithelial cells ', ' Breast Epithelial Cells ', ' noninvasive imaging ', ' non-invasive imaging ', ' protein markers ', ' protein biomarkers ', ' 3D cell culture ', ' 3D culture ', ' three dimensional cell culture ', ' imaging capabilities ', ' perfluorinated alkyl substances ', ' perfluoroalkyl substances ', ' Poly-fluoroalkyl substances ', ' deep learning ', ' machine learned algorithm ', ' machine learning algorithm ', ' deep learning algorithm ', ' ']",NIEHS,UNIV OF NORTH CAROLINA CHAPEL HILL,R01,2020,559511,0.03301031845210689
"A Web Service for Fragment-based Selectivity Analysis of Drug Leads Abstract Significance: To date, no specific therapeutic drug or vaccine has been approved for the treatment of human coronavirus. Better, direct-acting anti-viral drugs and accelerated methods for identifying them are desperately needed. Having a large body of diverse fragment binding simulation data for each SARS-CoV-2 drug target represents a unique opportunity to accelerate preclinical drug discovery for SARS-CoV-2 protein inhibitors. In contrast to testing-based approaches, understanding fragment interaction patterns provides chemists specific mechanistic information to guide lead optimization. We propose to (1) create comprehensive fragment maps for the full suite of SARS-CoV-2 proteins; (2) build automated tools for enumeration and evaluation of compounds that address protease selectivity and inhibition at Spike protein ppi and allosteric sites; and (3) make these available worldwide through the BMaps Web application. As such, all anti-viral researchers can benefit. Innovation: Generating thousands of fragment binding patterns for each of the known SARS-CoV-2 protein structures is a novel scientific approach to the rational design of SARS-CoV-2 antivirals. This would be the largest data source of fragment data on SARS-CoV-2 drug targets available and the resource would be accessible by all scientists working to address the COVID-19 pandemic. The innovation proposed is to enable a new scientific approach to rational design for SARS-CoV-2 antivirals based on the analysis of fragment binding patterns using novel compound enumeration and evaluation methods. Aim 1: Generate fragment and water maps for the full suite of proteins involved in the coronavirus life cycle. Using hot spots for location bias, run ~1,000 fragment simulations on each consensus of 6 structures from molecular dynamics. Aim 2: Develop automated tools to accelerate the enumeration and evaluation of candidate inhibitor molecules. Two approaches are proposed: (1) adapt our test software to enumerate all available modifications with all fragments for a given starting point and (2) use a Conditional GAN (Generative Adversarial Network) deep learning network to enumerate inhibitors from fragments, using discriminator networks to bias towards synthesizable molecules with good properties. Aim 3. Build a repository of candidate inhibitors targeting coronavirus proteins through a variety of different mechanisms. Overall Impact: The SARS-CoV-2 protein-fragment maps lead chemists to often non-obvious ideas to progress their compounds toward clinical trials. The ability to automatically enumerate and evaluate compounds from a large fragment map repository enables broad access to target-relevant chemical diversity, without tedious manual searching. A repository of candidate inhibitors targeting coronavirus proteins enables drug researchers to get started quickly. Project Narrative Accessing diverse chemical fragment binding data (1,000s for each SARS-CoV-2 drug target) presents a unique opportunity to accelerate much needed preclinical drug discovery for SARS-CoV-2 inhibitors. The fragment-based drug design platform (BMaps, www.boltzmannmaps.com), built under NIH Phase I and II grants, will be extended with fragment maps for SARS-CoV-2 proteins and further automation of compound enumeration through fragment growing. This will empower antiviral drug researchers in attacking the difficult problems of SARS-CoV-2 protease selectivity and inhibitor binding at allosteric or protein-protein interaction sites on the SARS-CoV-2 S protein.",A Web Service for Fragment-based Selectivity Analysis of Drug Leads,10149527,R43GM133284,"['Algorithms ', ' Allosteric Site ', ' inhibitor ', ' inhibitor/antagonist ', ' Antiviral Drugs ', ' Antivirals ', ' anti-viral agents ', ' anti-viral drugs ', ' anti-virals ', ' Antiviral Agents ', ' Automation ', ' Biotech ', ' Biotechnology ', ' Capsid ', ' Clinical Trials ', ' Communities ', ' Data Sources ', ' Drug Design ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Pharmaceutical Preparations ', ' Grant ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' HIV ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lead ', ' Life Cycle ', ' life course ', ' Life Cycle Stages ', ' Manuals ', ' Maps ', ' Methods ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Molecular Conformation ', ' Macromolecular Structure ', ' Molecular Structure ', ' Monte Carlo algorithm ', ' Monte Carlo calculation ', ' Monte Carlo procedure ', ' Monte Carlo simulation ', ' Monte Carlo Method ', ' NIH ', ' National Institutes of Health ', ' United States National Institutes of Health ', ' Esteroproteases ', ' Peptidases ', ' Protease Gene ', ' Proteases ', ' Proteinases ', ' Proteolytic Enzymes ', ' Peptide Hydrolases ', ' Proteins ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Running ', ' Computer software ', ' Software ', ' Testing ', ' Vaccines ', ' Water ', ' Hydrogen Oxide ', ' Data Set ', ' Dataset ', ' base ', ' Site ', ' Phase ', ' Coronavirus ', ' Coronaviridae ', ' corona virus ', ' Chemicals ', ' Evaluation ', ' Antiviral Therapy ', ' anti-viral therapy ', ' viral infectious disease treatment ', ' Internet ', ' WWW ', ' web ', ' world wide web ', ' Therapeutic ', ' tool ', ' Consensus ', ' Scientist ', ' Pattern ', ' Location ', ' Viral ', ' Nucleocapsid Proteins ', ' experience ', ' molecular dynamics ', ' Molecular Dynamics Simulation ', ' Proteolysis ', ' Protein Cleavage ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' simulation ', ' novel ', ' Property ', ' protein protein interaction ', ' repository ', ' depository ', ' software development ', ' develop software ', ' developing computer software ', ' Emerging Communicable Diseases ', ' Emerging Infectious Diseases ', ' drug discovery ', ' Binding ', ' Molecular Interaction ', ' Polymerase ', ' Protein Fragment ', ' Address ', ' protein structure ', ' protein structures ', ' proteins structure ', ' Data ', ' Homology Modeling ', ' Collection ', ' Hot Spot ', ' Modification ', ' Development ', ' developmental ', ' pre-clinical ', ' preclinical ', ' web services ', ' web-based service ', ' web site ', ' website ', ' design ', ' designing ', ' innovation ', ' innovate ', ' innovative ', ' Drug Targeting ', ' learning network ', ' web app ', ' web application ', ' Hepatitis B Virus ', ' HBV ', ' Homologous Serum Hepatitis Virus ', ' lead optimization ', ' deep learning ', ' influenza M2 ', ' influenza virus M2 ', ' 2019-nCoV ', ' 2019 novel coronavirus ', ' COVID-19 virus ', ' COVID19 virus ', ' SARS-CoV-2 ', ' SARS-CoV2 ', ' SARS-associated coronavirus 2 ', ' SARS-coronavirus-2 ', ' SARS-related coronavirus 2 ', ' SARSCoV2 ', ' Severe Acute Respiratory Distress Syndrome CoV 2 ', ' Severe Acute Respiratory Distress Syndrome Corona Virus 2 ', ' Severe Acute Respiratory Distress Syndrome Coronavirus 2 ', ' Severe Acute Respiratory Syndrome CoV 2 ', ' Severe acute respiratory syndrome coronavirus 2 ', ' Wuhan coronavirus ', ' coronavirus disease 2019 virus ', ' nCoV2 ', ' human coronavirus ', ' HCoV ', ' human CoV ', ' human corona virus ', ' COVID-19 pandemic ', ' COVID-19 crisis ', ' COVID-19 epidemic ', ' COVID-19 health crisis ', ' COVID-19 public health crisis ', ' COVID19 crisis ', ' COVID19 epidemic ', ' COVID19 health crisis ', ' COVID19 pandemic ', ' COVID19 public health crisis ', ' SARS-CoV-2 epidemic ', ' SARS-CoV-2 pandemic ', ' SARS-CoV2 epidemic ', ' SARS-CoV2 pandemic ', ' SARS-coronavirus-2 epidemic ', ' SARS-coronavirus-2 pandemic ', ' Severe Acute Respiratory Syndrome CoV 2 epidemic ', ' Severe Acute Respiratory Syndrome CoV 2 pandemic ', ' Severe acute respiratory syndrome coronavirus 2 epidemic ', ' Severe acute respiratory syndrome coronavirus 2 pandemic ', ' corona virus disease 2019 epidemic ', ' corona virus disease 2019 pandemic ', ' coronavirus disease 2019 crisis ', ' coronavirus disease 2019 epidemic ', ' coronavirus disease 2019 health crisis ', ' coronavirus disease 2019 pandemic ', ' coronavirus disease 2019 public health crisis ', ' ']",NIGMS,"CONIFER POINT PHARMACEUTICALS, LLC",R43,2020,210280,0.0334119811745553
"Computational Explorations of Unconventional Approaches to Control Noncovalent Interactions PROJECT SUMMARY The research interests of my group are rooted in explorations of new and useful conceptual models to improve the control and prediction of noncovalent interactions. Our research involves the use of a variety of computational quantum chemical tools, applications of density functional theory (DFT), cheminformatics, and machine-learning methods. A premise of our research is that aromaticity may be used to modulate many types of noncovalent interactions (such as hydrogen bonding, -stacking, anion- interactions). The reciprocal relationship we find, between aromaticity in molecules and the strengths of noncovalent interactions, is surprising especially since they are typically considered as largely separate ideas in chemistry. The innovation of this research is that it will enable use of intuitive back-of-the-envelope electron-counting rules (such as the 4n+2e Hckel rule for aromaticity) to make predictions of experimental outcomes regarding the impact of noncovalent interactions. A five-year goal is to realize the use of our conceptual models in real synthetic examples prepared by our experimental collaborators. My research vision is to bridge discoveries of innovative concepts to their practical impacts for biomedical and biomolecular research. PROJECT NARRATIVE This research proposal includes four projects that are jointly motivated by the challenge to control and predict noncovalent interactions in organic and biomolecular systems. The proposed work involves applications of a variety of computational quantum chemical tools and synergistic investigations with experimental collaborators. We seek to identify new and useful concepts to guide experimental designs of novel non-natural molecular systems (e.g., receptors, biosensors, and hydrogels) that have potential biomedical applications.",Computational Explorations of Unconventional Approaches to Control Noncovalent Interactions,10016376,R35GM133548,"['Anions ', ' Back ', ' Dorsum ', ' Chemistry ', ' Electrons ', ' Negative Beta Particle ', ' Negatrons ', ' Experimental Designs ', ' Goals ', ' Hydrogen Bonding ', ' H-bond ', ' Research ', ' Research Proposals ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' density ', ' improved ', ' Chemicals ', ' Intuition ', ' root ', ' Plant Roots ', ' tool ', ' Investigation ', ' System ', ' interest ', ' Receptor Protein ', ' receptor ', ' biological sensor ', ' Biosensor ', ' Hydrogels ', ' novel ', ' Modeling ', ' theories ', ' chemical informatics ', ' cheminformatics ', ' Research Project Summaries ', ' Molecular ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' quantum coding ', ' quantum computation ', ' quantum error correcting codes ', ' quantum computing ', ' machine learning method ', ' ']",NIGMS,UNIVERSITY OF HOUSTON,R35,2020,377200,0.09612010576995965
"Machine Learning for Drug Response Prediction PROJECT SUMMARY/ABSTRACT  Finding new drugs in the seas of small molecules is a difficult task if no prior information is available. Our broad research goal is to develop innovative and accurate machine learning algorithms to predict the drug responses related to complex human diseases. Specifically, we pursue questions of how a cell line responds to a single drug and combinatorial therapies, from the perspective of biological networks and small-molecule chemoinformatics. One research goal is to understand and predict the cell line-specific responses through integrating a wide range of methods, including the propagation of drug effects via biological networks, matrix factorization of molecular profiles and chemoinformatic analysis of small molecules. We will deploy our algorithms to softwares and web servers, which will inform the downstream experimental design to identify the single and combinatorial drug candidates against human diseases. Our research program will contribute to accelerate the drug discovery process by in silico screening through large amount of potent chemicals. PROJECT NARRATIVE  Molecular targeted therapy is one of the most successful weapons against many complex human diseases. However, identifying effective small-molecule drugs is like looking for a needle in a haystack. The proposed research, by bridging the gaps between existing methods and creating novel machine learning algorithms, will provide valuable guidance to drug development.",Machine Learning for Drug Response Prediction,10005370,R35GM133346,"['Algorithms ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Experimental Designs ', ' Goals ', ' Methods ', ' Research ', ' Sea ', ' Computer software ', ' Software ', ' Biological ', ' Chemicals ', ' weapons ', ' machine learned ', ' Machine Learning ', ' programs ', ' Complex ', ' novel ', ' response ', ' drug development ', ' drug discovery ', ' small molecule ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' Process ', ' innovate ', ' innovative ', ' innovation ', ' combinatorial ', ' human disease ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' drug candidate ', ' screening ', ' molecular targeted therapeutics ', ' molecular targeted treatment ', ' molecular targeted therapies ', ' Predict drug response ', ' drug response prediction ', ' machine learned algorithm ', ' machine learning algorithm ', ' web server ', ' in silico ', ' ']",NIGMS,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R35,2020,331020,0.07348222027510437
"Pacific Northwest Advanced Compound Identification Core OVERALL SUMMARY The capability to chemically identify thousands of metabolites and other chemicals in clinical samples will revolutionize the search for environmental, dietary, and metabolic determinants of disease. By comparison to near-comprehensive genetic information, comparatively little is understood of the totality of the human metabolome, largely due to insufficiencies in molecular identification methods. Through innovations in computational chemistry and advanced ion mobility separations coupled with mass spectrometry, we propose to overcome a significant, long standing obstacle in the field of metabolomics: the absence of methods for accurate and comprehensive identification of metabolites without relying on data from analysis of authentic chemical standards. A paradigm shift in metabolomics, we will use gas-phase molecular properties that can be both accurately predicted computationally and consistently measured experimentally, and which can thus be used for comprehensive identification of the metabolome without the need for authentic chemical standards. The outcomes of this proposal directly advance the mission and goals of the NIH Common Fund by: (i) transforming metabolomics science by enabling consideration of the totality of the human metabolome through optimized identification of currently unidentifiable molecules, eventually reaching hundreds of thousands of molecules, and (ii) developing standardized computational tools and analytical methods to increase the national capacity for biomedical researchers to identify metabolites quickly and accurately. This work is significant because it enables comprehensive and confident chemical measurement of the metabolome. This work is innovative because it utilizes an integrated quantum-chemistry and machine learning computational pipeline to accurately predict physical-chemical properties of metabolites coupled to measurements. OVERALL NARRATIVE This project will utilize integrated quantum-chemistry and machine learning computational computational approaches coupled with advanced instrumentation to characterize the human metabolome, and identify currently unidentifiable molecules without the use of authentic chemical standards. Results from these studies will contribute to the goal of understanding diseases, and the tools and resources will be made publically available for biomedical researchers.",Pacific Northwest Advanced Compound Identification Core,10260964,U2CES030170,"['Adoption ', ' Algorithms ', ' Biomedical Research ', ' Analytical Chemistry ', ' Analytic Chemistry ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Engineering ', ' Gases ', ' Goals ', ' Human ', ' Modern Man ', ' instrumentation ', ' Isotopes ', ' Libraries ', ' Methods ', ' Methodology ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Pacific Northwest ', ' Probability ', ' Reference Standards ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Science ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Toxin ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Measures ', ' doubt ', ' Uncertainty ', ' analytical method ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Phase ', ' Biological ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Blood Serum ', ' Serum ', ' Workshop ', ' Educational workshop ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' chemical property ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Genetic ', ' Exposure to ', ' tool ', ' machine learned ', ' Machine Learning ', ' programs ', ' Dependence ', ' Source ', ' Techniques ', ' experience ', ' computational quantum chemistry ', ' quantum chemistry ', ' chemical library ', ' small molecule libraries ', ' high-end computing ', ' High Performance Computing ', ' stereochemistry ', ' Structure ', ' novel ', ' Sampling ', ' Property ', ' computational chemistry ', ' drug discovery ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' chemical standard ', ' Data ', ' Resolution ', ' super computing ', ' Supercomputing ', ' Attributes of Chemicals ', ' Advanced Instrumentation ', ' Computer Instrumentation ', ' Computers and Advanced Instrumentation ', ' Molecular ', ' ion mobility ', ' computational tools ', ' computerized tools ', ' Outcome ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' human disease ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' comparative ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' nongenetic ', ' non-genetic ', ' drug candidate ', ' genetic information ', ' dark matter ', ' Predictive Analytics ', ' metabonome ', ' metabolome ', ' in silico ', ' computational pipelines ', ' ']",NIEHS,BATTELLE PACIFIC NORTHWEST LABORATORIES,U2C,2020,152500,0.16409630656627852
"High accuracy computational methods for biomolecular nuclear magnetic resonance spectroscopy High accuracy computational methods for biomolecular nuclear magnetic resonance spectroscopy Nuclear magnetic resonance (NMR) spectroscopy is one of the most important condensed phase probes of composition, structure and dynamics of biomolecules and bio-organic species. NMR observables such as chemical shifts and spin-spin splittings can be measured to very high accuracy. Because they are sensitive to the biological functional groups, detailed geometries, and chemical environments, they allow for prediction of solution phase protein structures or to identify or verify the structure of chemical compounds in the crystalline phase. The connection to structure, while true in principle, is nevertheless sometimes difficult to reveal in practice through direct assignment of the spectrum. Simulation methods that accurately predict spectral observables from structure are a key goal for NMR spectral assignment. Such methods are even more crucial for the inverse problem of realizing high quality NMR structures of folded proteins from spectra, and as powerful restraints for determining the structural ensembles of intrinsically disordered proteins (IDPs). Existing approaches to this problem typically rely on semi-empirical heuristics, and while they have achieved considerable success, they also reveal limitations that significantly degrade the quality of structural prediction. In this equipment supplement we are proposing to acquire a dedicated compute cluster for high throughput calculations of wavefunction-based QM methods we have developed for chemical shifts that offer improved accuracy over DFT. This will be employed to populate databases that reflect protein and small molecule drug relevant for machine learning methods we have developed under NIH support. With such data, machine learning and deep networks will determine a quantitative relationship between structure and computed NMR observable, and the resulting data science driven methods will be tested on the refinement of folded proteins and small molecule drug prediction. NMR shifts and splitting measurements for organic materials containing 1H, 2H, 13C, and 15N nuclei can provide detailed descriptions of the structure of drug molecules, folded proteins and their complexes, as well as the structural ensembles of intrinsically disordered proteins (IDPs). However there are currently limitations of turning accurate NMR measurements into accurate structures that clearly hampers advances that could be made on connecting structure to function of proteins in their native aqueous environments. This supplemental equipment proposal aims to use machine learning on QM data through the purchase of a high-throughput GPU/CPU cluster, and will significantly improve the ability to predict the chemical shifts and indirect spin-spin couplings to yield the spectrum associated with a given folded structure or drug crystal, with very high accuracy, and with good computational efficiency.",High accuracy computational methods for biomolecular nuclear magnetic resonance spectroscopy,10145510,U01GM121667,"['Cell Nucleus ', ' Nucleus ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Crystallization ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Equipment ', ' Goals ', ' Methods ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nuclear Magnetic Resonance ', ' Proteins ', ' Testing ', ' Measures ', ' protein folding ', ' base ', ' improved ', ' Phase ', ' Biological ', ' Chemicals ', ' Chemical Structure ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' restraint ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Biomolecular NMR ', ' Biomolecular Nuclear Magnetic Resonance ', ' success ', ' heuristics ', ' functional group ', ' aqueous ', ' Structure ', ' simulation ', ' NMR Spectrometer ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' small molecule ', ' drug structure ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Data ', ' protein function ', ' data grid ', ' datagrid ', ' distributed computing ', ' cluster computing ', ' Geometry ', ' crystallinity ', ' Data Science ', ' machine learning method ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,U01,2020,150000,0.14026568442694362
"Altering Hepatitis B Virus assembly through pharmacological intervention Project Summary/Abstract Viruses are one of the leading causes of morbidity and mortality worldwide, with Hepatitis B Virus (HBV) being one of the most infectious and prevalent among them. Roughly 250 million people worldwide suffer from chronic HBV infection, including 1-2 million in the United States. Of those infected, approximately 15-25% will develop se- rious liver problems, including cirrhosis, cancer, and ultimately failure, leading to 600,000 deaths annually. While therapies exist to manage chronic HBV infection, all target viral genomic processes such as reverse transcription and DNA replication, and none provide a cure due to viral persistence and resistance. A promising orthogonal approach to eliminating infection is to target HBV's capsid, the protein shell that encapsulates the viral genome. The Finn laboratory has previously developed compounds that induce the misdirected assembly of non-functional HBV capsids, showing that small molecules have the power to affect the structures of these large multi-protein assemblies. While much is known about the structures of the intermolecular interactions with these compounds identied after the fact, little about the dynamics of such interactions has been explored, and a predictive under- standing of functional (antiviral) binding has yet to be developed. Both deciencies will begin to be addressed in this program. Using molecular dynamics (MD) simulations coupled with in vitro experiments on HepAD38 cells, the PIs have identied seven compounds based on motifs previously unknown to interact with HBV that target the capsid assembly process. These compounds bind in a known pocket at the interface of two capsid-protein (Cp) dimers, possess moderate antiviral activity, and low toxicity. In the rst aim, using docking, free-energy perturba- tion, and synthetic chemistry, the PIs will optimize the lead compound to improve its efcacy against HBV. In the second aim, using molecular dynamics simulations, advanced free-energy calculations, and experimental assays on different HBV protein oligomers, up to and including the whole virus capsid, the PIs will determine how small molecules interfere with capsid assembly. Both aims will benet from using a machine-learning-based classi- cation scheme as well as novel enhanced sampling methods. The lessons learned here concerning how small molecules can re-direct the assembly pathway into unproductive conformations can be generalized for application to other viruses. Project Narrative In spite of the dramatic increase in our understanding of the structure and properties of hepatitis B virus (HBV), this pathogen remains a major threat to human health. That knowledge also makes HBV an important test case for new antiviral strategies. This project aims to limit the impact of HBV by using computer simulations and synthetic chemistry to develop an improved understanding of the assembly process of HBV as well as new drugs that can eliminate HBV infection in ways that may be generalized to other pathogenic viruses.",Altering Hepatitis B Virus assembly through pharmacological intervention,10051923,R01AI148740,"['Affect ', ' Antiviral Agents ', ' Antiviral Drugs ', ' Antivirals ', ' anti-viral agents ', ' anti-viral drugs ', ' anti-virals ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Capsid ', ' Cations ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Computer Simulation ', ' Computer based Simulation ', ' computational simulation ', ' computerized simulation ', ' Cessation of life ', ' Death ', ' Equilibrium ', ' balance ', ' balance function ', ' Goals ', ' Health ', ' HIV-1 ', ' HIV-I ', ' HIV1 ', ' Human Immunodeficiency Virus Type 1 ', ' Human immunodeficiency virus 1 ', ' Human ', ' Modern Man ', ' In Vitro ', ' Infection ', ' Laboratories ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Liver ', ' hepatic body system ', ' hepatic organ system ', ' Methods ', ' Molecular Conformation ', ' Molecular Configuration ', ' Molecular Stereochemistry ', ' conformation ', ' conformational state ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Pharmacology ', ' Protein Conformation ', ' Reverse Transcription ', ' Testing ', ' United States ', ' Viral Genome ', ' virus genome ', ' Virus Diseases ', ' Viral Diseases ', ' viral infection ', ' virus infection ', ' virus-induced disease ', ' Virus ', ' base ', ' improved ', ' Procedures ', ' Encapsulated ', ' Failure ', ' viral assembly ', ' Virus Assembly ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Complex ', ' Viral ', ' chronic HBV infection ', ' chronic hepatitis B virus infection ', ' Chronic Hepatitis B ', ' dimer ', ' intermolecular interaction ', ' Molecular Dynamics Simulation ', ' molecular dynamics ', ' success ', ' Cryo-electron Microscopy ', ' Electron Cryomicroscopy ', ' cryo-EM ', ' cryoEM ', ' Cryoelectron Microscopy ', ' DNA Replication ', ' DNA Synthesis ', ' DNA biosynthesis ', ' protein oligomer ', ' Toxicities ', ' Toxic effect ', ' Free Energy ', ' Structure ', ' simulation ', ' novel ', ' Sampling ', ' Property ', ' protein protein interaction ', ' drug development ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Coat Proteins ', ' Viral Coat Proteins ', ' Viral Outer Coat Protein ', ' Capsid Proteins ', ' Molecular Interaction ', ' Binding ', ' small molecule ', ' Address ', ' protein structures ', ' proteins structure ', ' protein structure ', ' Protein Dynamics ', ' Synthetic Chemistry ', ' Synthesis Chemistry ', ' Classification Scheme ', ' Scheme ', ' Process ', ' Docking ', ' Modification ', ' developmental ', ' Development ', ' cirrhotic ', ' Cirrhosis ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' designing ', ' design ', ' Outcome ', ' pathogen ', ' Coupled ', ' resistant ', ' Resistance ', ' clinical relevance ', ' clinically relevant ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' experiment ', ' experimental research ', ' experimental study ', ' HBV ', ' Homologous Serum Hepatitis Virus ', ' Hepatitis B Virus ', ' lead optimization ', ' viral pathogen ', ' pathogenic virus ', ' virus genomics ', ' viral genomics ', ' ']",NIAID,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2020,407510,0.05823225706140418
"A Machine Learning Platform for Adaptive Chemical Screening Project Summary High-throughput screening remains the most common method to identify the primary chemical hits in chemical biology and drug discovery projects. However, large-scale screens are often financially out of reach for many academic labs. The resulting small screens of small chemical libraries often identify few confirmed hits, most of which are unsuitable for medicinal chemistry follow-up. There is a critical need for computational tools that can guide experimental screening at a reasonable cost while exploring far more chemicals. This proposal will develop a computational platform that can be applied to any target or phenotypic system to select compounds for experimental screening from virtual chemical libraries with a billion or more compounds. New machine learning and high-throughput computing methods will navigate this large chemical space strategically and efficiently, improving the quality of the identified compounds. The computationally guided screening can ultimately improve the chemical diversity, target specificity, and stability of the identified active compounds, accelerating and enabling drug discovery across NIH Institutes. The long-term goal of this research is to develop technologies that make chemical screening accessible to more research groups and enable drug discovery in any therapeutic area. Data science techniques can take advantage of existing public bioactivity data in PubChem to help prioritize chemical screening for a new target. In this technology development proposal, the researchers will 1) determine a general initial screening compound set, 2) develop a computationally-guided iterative screening system, and 3) create and experimentally validate an end-to-end high-throughput computing workflow that directs drug discovery for any new target. At each step, rigorous comparisons to experimental results and baseline models will ensure the methods are working as expected and offer capabilities that do not exist in the current state-of-the-art computational methods. The resulting computational platform will improve the efficiency of and reduce the barriers to chemical screening, ultimately making screening for new compounds available to academic research groups in ways and in places where it has previously been inaccessible. Project Narrative The proposed project is broadly relevant to public health as a critical advancement of technology to enable basic biomedical research across therapeutic areas. This effort creates a computational platform to reduce the overall cost and improve the quality of high-throughput screening in any chemical biology or drug discovery project, which will be rigorously compared to existing experimental techniques. Modern data science tools will reduce the barriers to high-throughput screening and make screening for new compounds available to academic research groups in ways and in places where it has previously been inaccessible.",A Machine Learning Platform for Adaptive Chemical Screening,10049862,R01GM135631,"['Algorithms ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biology ', ' Biomedical Research ', ' Budgets ', ' Pharmaceutical Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutic Chemistry ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Equilibrium ', ' balance ', ' balance function ', ' Goals ', ' Institutes ', ' Learning ', ' Libraries ', ' Methods ', ' Modernization ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Phenotype ', ' Public Health ', ' Psychological reinforcement ', ' Reinforcement ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Seeds ', ' Plant Embryos ', ' Plant Zygotes ', ' seed ', ' Computer software ', ' Software ', ' Specificity ', ' Technology ', ' Testing ', ' Time ', ' Protac ', ' proteolysis targeting chimera ', ' Dataset ', ' Data Set ', ' improved ', ' Area ', ' Biological ', ' Ensure ', ' Chemicals ', ' Cooperative Learning ', ' Experiential Learning ', ' Active Learning ', ' Funding ', ' Therapeutic ', ' tool ', ' scaffolding ', ' scaffold ', ' machine learned ', ' Machine Learning ', ' Techniques ', ' System ', ' Organ System ', ' body system ', ' Metabolic Protein Degradation ', ' Protein Turnover ', ' Regulatory Protein Degradation ', ' protein degradation ', ' chemical library ', ' small molecule libraries ', ' tech development ', ' technology development ', ' novel ', ' Modeling ', ' High Throughput Assay ', ' high throughput screening ', ' drug discovery ', ' preventing ', ' prevent ', ' virtual library ', ' Data ', ' Screening Result ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' PubChem ', ' cost ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' 3-D structure ', ' 3-dimensional structure ', ' 3D structure ', ' three dimensional structure ', ' cost effective ', ' innovate ', ' innovative ', ' innovation ', ' drug detection ', ' drug testing ', ' open source ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' therapeutic target ', ' prototype ', ' screening ', ' Algorithmic Design ', ' Algorithmic Engineering ', ' algorithm engineering ', ' algorithmic composition ', ' Algorithm Design ', ' Data Science ', ' lead optimization ', ' computing platform ', ' computational platform ', ' virtual screenings ', ' virtual screening ', ' ']",NIGMS,"MORGRIDGE INSTITUTE FOR RESEARCH, INC.",R01,2020,475021,0.15417726497158935
"Open data-driven infrastructure for building biomolecular force fields for predictive biophysics and drug design PROJECT SUMMARY/ABSTRACT The study of biomolecular interactions and design of new therapeutics requires accurate physical models of the atomistic interactions between small molecules and biological macromolecules. Over the least few decades, molecular mechanics force elds have demonstrated the potential that physical models hold for quantitative biophysical modeling and predictive molecular design. However, a signicant technology gap exists in our ability to build force elds that achieve high accuracy, can be systematically improved in a statistically robust manner, be extended to new areas of chemistry, can model post-translational and covalent modications, are able to quantify systematic errors in predictions, and can be broadly applied across a high-performance software packages. In this project, we aim to bridge this technology gap to enable new generations of accurate quantitative biomolec- ular modeling and (bio)molecular design for chemical biology and drug discovery. In Aim 1, we will produce a modern, open infrastructure to enable practitioners to rapidly and conveniently construct and employ accurate and statistically robust physical force elds via automated machine learning methods. In Aim 2, we will construct open, machine-readable experimental and quantum chemical datasets that will accelerate next-generation force eld development. In Aim 3, we will develop statistically robust Bayesian inference techniques to enable the auto- mated construction of type assignment schemes that avoid overtting and selection of physical functional forms statistically justed by the data. This approach will also provide an estimate of the systematic error in predicted properties arising from uncertainty in parameters or functional form choicesgenerally the dominant source of errorto be quantied with little added expense. In Aim 4, we will integrate and apply this infrastructure to produce open, transferable, self-consistent force elds that achieve high accuracy and broad coverage for modeling small molecule interactions with biomolecules (including unnatural amino or nucleic acids and covalent modications by organic molecules), with the ultimate goal of covering all major biomolecules. This research is signicant in that the technology developed in this project has the potential to radically transform the study of biomolecular phenomena by providing highly accurate force elds with exceptionally broad chemical coverage via fully consistent parameterization of organic (bio)molecules. In addition, we will produce new tools to automate force eld creation and tailoring to specic problem domains, quantify the systematic error in predictions, and identify new data for improving force eld accuracy. This will greatly improve our ability to study diverse biophysical processes at the molecular level, and to rationally design new small-molecule, protein, and nucleic acid therapeutics. This approach will bring statistical rigor to the eld of force eld construction and application by providing a means to make data-driven decisions, while enhancing reproducibility by enabling it to become a rigorous and reproducible science using a fully open infrastructure and datasets. PROJECT NARRATIVE Scientists use computer simulations of proteins, DNA, and RNA, at atomic detail, to learn how these molecules of life do their jobs. They also use simulations to help design new medications  compounds that can bind and inuence the behavior of these molecules of life, and thereby block diseases at the molecular level. We aim to greatly increase the utility of all of these simulations by improving the accuracy of the formulas they use to compute the forces acting between atoms.",Open data-driven infrastructure for building biomolecular force fields for predictive biophysics and drug design,9887804,R01GM132386,"['Automobile Driving ', ' driving ', ' Biology ', ' Biophysics ', ' biophysical foundation ', ' biophysical principles ', ' biophysical sciences ', ' Charge ', ' chemical synthesis ', ' Chemistry ', ' Computer Simulation ', ' Computer based Simulation ', ' computational simulation ', ' computerized simulation ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Drug Design ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Goals ', ' Heart ', ' Learning ', ' Methods ', ' Modernization ', ' Nucleic Acids ', ' Occupations ', ' Jobs ', ' Professional Positions ', ' Perception ', ' Proteins ', ' Research ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Science ', ' Computer software ', ' Software ', ' sound ', ' Technology ', ' Temperature ', ' Thermodynamics ', ' Thermodynamic ', ' Work ', ' Roentgen Rays ', ' X-Radiation ', ' X-Ray Radiation ', ' X-ray ', ' Xray ', ' Generations ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' base ', ' macromolecule ', ' improved ', ' Area ', ' Specified ', ' Specific qualifier value ', ' Biological ', ' Ensure ', ' Chemicals ', ' Training ', ' Individual ', ' Bayesian computation ', ' Bayesian inference ', ' Bayesian network analysis ', ' Bayesian spatial analysis ', ' Bayesian statistical analysis ', ' Bayesian statistical inference ', ' Bayesian statistics ', ' Bayesian Analysis ', ' Data Bases ', ' data base ', ' Databases ', ' Error Sources ', ' Measurement ', ' Therapeutic ', ' tool ', ' Electrostatics ', ' Life ', ' Scientist ', ' Investigation ', ' Complex ', ' Techniques ', ' System ', ' interest ', ' experience ', ' Performance ', ' physical property ', ' physical model ', ' Structure ', ' simulation ', ' model-based simulation ', ' models and simulation ', ' novel technologies ', ' new technology ', ' Modeling ', ' Property ', ' Readability ', ' molecular mechanics ', ' behavioral influence ', ' behavior influence ', ' drug discovery ', ' Molecular Interaction ', ' Binding ', ' chemical informatics ', ' cheminformatics ', ' small molecule ', ' Address ', ' biophysical mechanism ', ' Biophysical Process ', ' Data ', ' Reproducibility ', ' Scheme ', ' Validation ', ' Molecular ', ' Process ', ' Modification ', ' developmental ', ' Development ', ' designing ', ' design ', ' next generation ', ' quantum ', ' multidisciplinary ', ' open source ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' simulation software ', ' biophysical model ', ' open-source data ', ' open science ', ' open data ', ' non-natural amino acids ', ' non-proteinogenic amino acids ', ' nonproteinogenic amino acids ', ' unnatural amino acids ', ' experiment ', ' experimental research ', ' experimental study ', ' Infrastructure ', ' therapeutic nucleic acids ', ' nucleic acid-based therapeutics ', ' data infrastructure ', ' software infrastructure ', ' machine learning method ', ' ']",NIGMS,UNIVERSITY OF COLORADO,R01,2020,675565,0.08450829276412124
"Quantifying the role of adaptation in olfactory coding through the logic of navigation Project Summary This projects long-term goal is a fuller understanding of the neurobiological mechanisms of olfactory sensory adaptation that facilitate odor discrimination in the natural world. To confront the wide fluctuations in intensity and temporal variability that are characteristic of natural odor environments, animals have evolved refined neurosensory mechanisms for parsing behaviorally-relevant signals such as pheromones from background nuisance odors. This project seeks to elucidate how adaptive mechanisms in the olfactory periphery play a central role in this discrimination task. The project will utilize a novel behavioral assay that permits precise quantification of the logic used by insects in navigating complex, temporally dynamic odor environments. By combining this assay with data analytic methods and machine learning, a comprehensive lexicon of archetypal navigational strategies of insect odor navigation will be derived. Importantly, since both odors and insects can be simultaneously tracked in this assay, the project will uncover strategies employed by insects in not just static, but also fluctuating odor landscapes. By quantifying how these strategies modulate in time, the role of memory in shaping navigational strategies will also be determined. The project will then leverage this dictionary of navigational logic to quantify how various mechanisms of adaptation in Drosophila olfactory receptor neurons can shape odor discrimination. Importantly, this project will examine the role of olfactory sensory adaptation in an ethologically-relevant way, by connecting mechanisms that operate at the level of sensory input with neural computations that affect output behavior. Further, since the behavioral assay tracks complex odor environments simultaneous with freely-moving insects, the impact of behavior on future signal acquisition  behavioral feedback onto odor stimuli  is fully maintained. The behavioral experiments and data analysis in this project utilize the tractable, highly-characterized system of Drosophila melanogaster, in which a wealth of existing genetic tools will allow directed experimentation of specific adaptive mechanisms in olfaction. The results of this project will elucidate how insects effectively navigate complex odor environments, and how olfactory systems maintain sensitivity despite odor conflicts and temporal variability. Project Narrative This project will contribute to our understanding of how the olfactory sensory periphery and neural circuitry have evolved to effectively encode our vast and varied chemical environment. The project will help reveal how odor discrimination capability is maintained in natural odor landscapes, leading to practical interventional strategies for the control of disease vectors such as tsetse flies and mosquitos, who rely critically on their sense of smell to navigate. Chemical sensing is the only shared sensation among organisms as simple as bacteria and as complex as humans, and this project will enhance our fundamental knowledge of this universal sensory modality.",Quantifying the role of adaptation in olfactory coding through the logic of navigation,9868821,F32MH118700,"['Affect ', ' Algorithms ', ' Animals ', ' Bacteria ', ' Behavior ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Conflict (Psychology) ', ' Conflict ', ' Cues ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Dictionary ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease Vectors ', ' Drosophila genus ', ' Drosophila ', ' fruit fly ', ' Drosophila melanogaster ', ' Electrophysiology (science) ', ' Electrophysiology ', ' Neurophysiology / Electrophysiology ', ' electrophysiological ', ' Environment ', ' Exhibits ', ' Feedback ', ' Future ', ' Goals ', ' Human ', ' Modern Man ', ' Insecta ', ' Insects ', ' Insects Invertebrates ', ' Laws ', ' Logic ', ' Lymph ', ' Lymph Reticuloendothelial System ', ' lymphatic fluid ', ' Memory ', ' Theoretical model ', ' Theoretic Models ', ' Culicidae ', ' Mosquitoes ', ' Motion ', ' Odors ', ' Olfactory Pathways ', ' Olfactory system ', ' olfactory circuitry ', ' olfactory circuits ', ' Organism ', ' living system ', ' Pheromone ', ' Play ', ' Proteins ', ' Role ', ' social role ', ' Esthesia ', ' Sensation ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Smell Perception ', ' Olfaction ', ' Smell ', ' odor perception ', ' olfactory perception ', ' statistics ', ' Testing ', ' Time ', ' Tsetse Flies ', ' Glossina ', ' odorant-binding protein ', ' odor-binding protein ', ' Measures ', ' Walking ', ' Mediating ', ' analytical method ', ' Left ', ' Olfactory Receptor Neurons ', ' Chemicals ', ' Stimulus ', ' Genetic ', ' Shapes ', ' tool ', ' Photosensitiveness due to sun ', ' sun sensitivity ', ' Photosensitivity ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Frequencies ', ' Complex ', ' Sensory ', ' System ', ' experience ', ' light intensity ', ' mutant ', ' neural ', ' relating to nervous system ', ' novel ', ' Modality ', ' Coding System ', ' Code ', ' neural circuitry ', ' neurocircuitry ', ' synaptic circuit ', ' synaptic circuitry ', ' neural circuit ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disease control ', ' disorder control ', ' Molecular Interaction ', ' Binding ', ' Characteristics ', ' Behavioral ', ' Flies ', ' fly ', ' imaging ', ' Image ', ' Output ', ' environmental change ', ' Behavioral Assay ', ' Impairment ', ' neurobiological mechanism ', ' optogenetics ', ' sensory input ', ' Data Analytics ', ' neuro-sensory ', ' neurosensory ', ' experiment ', ' experimental research ', ' experimental study ', ' preservation ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NIMH,YALE UNIVERSITY,F32,2020,69554,0.03810939490106729
"Digital representation of chemical mixtures to aid drug discovery and formulation PROJECT SUMMARY Collaborative Drug Discovery, Inc. (CDD) proposes to develop a suite of software modules to enable scientists to unambiguously represent chemical mixtures in standard machine-readable formats, filling an urgent and widely-recognized need. Chemicals are typically formulated as mixtures. Recording and communicating infor- mation about chemical mixtures is essential for scientists and support staff in the pharmaceutical industry, in academia, in non-profit research organizations, in government, at specialty chemical vendors, and at commer- cial manufacturers to:  discover, develop, formulate, manufacture and regulate drugs;  manage reagent inventories; comply with laboratory safety requirements; inform first responders;  describe and reproduce biomedical experiments; and  assess and disseminate information about toxicity risks of chemical reagents and consumer products.  A working committee of the International Union of Pure and Applied Chemistry (IUPAC) is close to for- malizing Mixtures InChI (or MInChI), which will extend the International Chemical Identifier (InChI) to be- come the first standard to encompass mixtures. MInChI will effectively index mixtures in the same way that InChI indexes individual compounds.  In Phase 1 CDD developed the data structures and software necessary to enable adoption and utilization of MInChI and create the first general-purpose system for recording information about chemical mixtures that is computable and interoperable. In Phase 2 CDD will continue to develop a sophisticated automated transla- tion tool that will accurately convert legacy catalogs of chemical mixtures from plaintext descriptions or ad hoc formats so that they are properly represented in a machine readable format that can in turn be easily rendered into MInChI identifiers. The broad vision is to help industry to overcome the barriers to adoption so that ma- chine readable mixture descriptions can quickly deliver benefits for drug discovery, chemical safety, and toxi- cology. PROJECT NARRATIVE The proposed project will create novel computational tools that will help researchers to efficiently and accu- rately document the composition of chemical mixtures in a format that computers can easily interpret, process, and exchange. This innovative capability will help to accelerate the discovery and development of novel and improved drugs against a wide range of diseases. It will also help to advance our understanding of the toxicol- ogy of mixtures (which often differs from the toxicology of individual components) and improve laboratory safety both in industry and in educational settings. !",Digital representation of chemical mixtures to aid drug discovery and formulation,9902210,R44TR002528,"['Adoption ', ' Books ', ' Commercial Catalogs ', ' Chemistry ', ' Computers ', ' Disease ', ' Disorder ', ' Drug Industry ', ' Pharmaceutic Industry ', ' Pharmaceutical Industry ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Elements ', ' Goals ', ' Government ', ' Human ', ' Modern Man ', ' indexing ', ' Industry ', ' Intelligence ', ' Equipment and supply inventories ', ' Inventory ', ' Laboratories ', ' male ', ' Methods ', ' Molecular Structure ', ' Macromolecular Structure ', ' Names ', ' Polymers ', ' Reagent ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Safety ', ' Shorthand ', ' Computer software ', ' Software ', ' Solvents ', ' medical specialties ', ' Specialty ', ' Supervision ', ' Technology ', ' Time ', ' Toxicology ', ' Traction ', ' Translations ', ' Vendor ', ' Vision ', ' Sight ', ' visual function ', ' cofactor ', ' quality assurance ', ' improved ', ' Specified ', ' Specific qualifier value ', ' Phase ', ' Chemicals ', ' Chemical Structure ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' tool ', ' English Language ', ' Catalogs ', ' Scientist ', ' System ', ' Drug Formulations ', ' Services ', ' consumer product ', ' Toxicities ', ' Toxic effect ', ' Structure ', ' novel ', ' member ', ' Coding System ', ' Code ', ' Modeling ', ' Readability ', ' drug discovery ', ' Manufacturer ', ' Manufacturer Name ', ' Ally ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' Academia ', ' Data ', ' International ', ' Process ', ' Text ', ' developmental ', ' Development ', ' cost ', ' digital ', ' computational tools ', ' computerized tools ', ' innovate ', ' innovative ', ' innovation ', ' interoperability ', ' data structure ', ' open source ', ' natural language ', ' experiment ', ' experimental research ', ' experimental study ', ' deep learning ', ' Infrastructure ', ' first responder ', ' structured data ', ' ']",NCATS,"COLLABORATIVE DRUG DISCOVERY, INC.",R44,2020,748733,0.1900523441916366
"Integrated Instrument for non-natural aptamer generation Project Summary DNA and RNA aptamers are a useful class of synthetic affinity reagents. However, their performance can be greatly improved through the site-specific incorporation of chemically modified, non-natural nucleotides that provide a greater chemical repertoire to enable superior aptamer affinity and specificity. Because a broad spectrum of chemical functional groups can be incorporated, non-natural aptamers offer the exciting potential for targeting molecules for which the generation of monoclonal antibodies remains difficult, such as small- molecule drugs, metabolites and carbohydrates. Unfortunately, the access to non-natural aptamers is severely limited. This is because the process of generating non-natural aptamers is technically challenging and limited to a few specialized laboratories. The goal of this project is to develop an integrated instrument, the Non-Natural Aptamer Array (N2A2) that eliminates these bottlenecks and enable rapid and facile non-natural aptamer discovery at virtually any research laboratory. The N2A2 will be built on a modified version of a benchtop commercial sequencer (Illumina MiSeq), and will perform every stage of non-natural aptamer discovery including sequencing, screening and binding measurementsas part of a single work-flow. There are three main innovative aspects of our N2A2 system. First, our approach will entirely eliminate the need for polymerase engineering, and thus allows us to incorporate virtually any chemical functional group through click chemistry. Second, N2A2 will enable us to directly obtain the binding affinity (Kd) of ~10^7 aptamers directly in complex samples (e.g. cell lysate or serum), thereby resulting in aptamers with high-specificity. Finally, we will develop a machine-learning (ML) approach to identify key motifs (k-mers) and predict novel sequences with potentially higher affinity and specificity that can be tested using the N2A2 instrument. We believe this powerful combination of massively parallel, sequence-linked binding measurements with ML-based predictions will allow us to explore sequence space that is currently inaccessible to traditional in vitro selection methods, and enable us to discover aptamers with superior performance. The success of this project will produce an integrated instrument that greatly streamlines and accelerates the discovery of non-natural aptamers for a wide range of targets in complex media. The instrument is based on a commercially available sequencer and we will make all software available to the public. In this way, we believe the N2A2 instrument could broadly expand access to robust, high quality, custom affinity reagents for biomedical research and clinical diagnostics. Project Narrative We will develop an integrated instrument that simplifies the discovery of non-natural aptamer reagents for a wide range of molecules that are difficult to target using conventional antibody reagents. The access to these custom reagents will accelerate biomedical research and clinical diagnostics.",Integrated Instrument for non-natural aptamer generation,9872178,R01GM129313,"['Algorithms ', ' Antibodies ', ' Monoclonal Antibodies ', ' Clinical Treatment Moab ', ' mAbs ', ' Biomedical Research ', ' Carbohydrates ', ' Cells ', ' Cell Body ', ' Chemistry ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Engineering ', ' Goals ', ' In Vitro ', ' Laboratories ', ' Laboratory Research ', ' Methods ', ' Nucleotides ', ' Proteins ', ' Reagent ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Computer software ', ' Software ', ' Specificity ', ' Testing ', ' Tyrosine ', ' Work ', ' Generations ', ' Chinese Hamster Ovary Cell ', ' CHO Cells ', ' Custom ', ' base ', ' Label ', ' improved ', ' Site ', ' Link ', ' Chemicals ', ' Blood Serum ', ' Serum ', ' Opiates ', ' Opioid ', ' Measurement ', ' directed evolution ', ' Directed Molecular Evolution ', ' scaffolding ', ' scaffold ', ' instrument ', ' machine learned ', ' Machine Learning ', ' Complex ', ' System ', ' Performance ', ' success ', ' functional group ', ' aptamer ', ' novel ', ' Graph ', ' Modeling ', ' Sampling ', ' Molecular Interaction ', ' Binding ', ' small molecule ', ' Polymerase ', ' PD 1 ', ' PD-1 ', ' PD1 ', ' programmed cell death 1 ', ' programmed death 1 ', ' sle2 ', ' systemic lupus erythematosus susceptibility 2 ', ' programmed cell death protein 1 ', ' Affinity ', ' Data ', ' Reproducibility ', ' Process ', ' virtual ', ' innovate ', ' innovative ', ' innovation ', ' screening ', ' clinical diagnostics ', ' machine learned algorithm ', ' machine learning algorithm ', ' data processing pipeline ', ' data analysis pipeline ', ' ']",NIGMS,STANFORD UNIVERSITY,R01,2020,314000,0.04381482491261879
"Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity PROJECT SUMMARY/ABSTRACT  Experimental animal and clinical testing to evaluate hepatotoxicity demands extensive resources and long turnaround times. Utilization of computational models to directly predict the toxicity of new compounds is a promising strategy to reduce the cost of drug development and to screen the multitude of industrial chemicals and environmental contaminants currently lacking safety assessments. However, the current computational models for complex toxicity endpoints, such as hepatotoxicity, are not reliable for screening new compounds and face numerous challenges. Our recent studies have shown that traditional Quantitative Structure-Activity Relationship modeling is applicable for relatively simple properties or toxicity endpoints with a clear mechanism, but fails to address complex bioactivities such as hepatotoxicity. The primary objective of this proposal is to develop novel mechanism-driven Virtual Adverse Outcome Pathway (vAOP) models for the fast and accurate assessment of hepatotoxicity in a high-throughput manner The resulting vAOP models will be experimentally validated using a complement of in vitro and ex vivo testing. We have generated a preliminary vAOP model based on the antioxidant response element (ARE) pathway that has undergone initial validation and refinement using in vitro testing. To this end, our project will generate novel predictive models for hepatotoxicity by applying 1) a virtual cellular stress pathway model to mechanism profiling and assessment of new compounds; 2) computational predictions to fill in the missing data for specific targets within the pathway; 3) in vitro experimental validation with three complementary bioassays; and 4) ex vivo experimental validation with pooled primary human hepatocytes capable of biochemical transformation. The scientific approach of this study is to develop a universal modeling workflow that can take advantage of all available short-term testing information, obtained from both computational predictions using novel machine learning approaches and in vitro experiments, for target compounds of interest. We will validate and use our modeling workflow to directly evaluate the hepatotoxicity of new compounds and prioritize candidates for validation in pooled primary human hepatocytes. The resulting workflow will be disseminated via a web portal for public users around the world with internet access. Importantly, this study will pave the way for the next generation of chemical toxicity assessment by reconstructing the modeling process through a combination of big data, computational modeling, and low cost in vitro experiments. To the best of our knowledge, the implementation of this project will lead to the first publicly available mechanisms-driven modeling and web- based prediction framework for complex chemical toxicity based on publicly-accessible big data. These deliverables will have a significant public health impact by not only prioritizing compounds for safety testing or new chemical development, but also revealing toxicity mechanisms. PROJECT NARRATIVE Hepatotoxicity is a leading safety concern in the development of new chemicals. We will create virtual Adverse Outcome Pathway models that will directly evaluate the hepatotoxicity potentials of chemicals using massive public toxicity data. The primary deliverable of this project will be a publically-accessible, web-based search engine to evaluate new chemicals for risk of hepatotoxicity.",Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity,9864299,R01ES031080,"['Antioxidants ', ' anti-oxidant ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Complement ', ' Complement Proteins ', ' Computers ', ' Cryopreservation ', ' Cryofixation ', ' cold preservation ', ' cold storage ', ' Data Sources ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Environmental Pollution ', ' environmental contaminant ', ' environmental contamination ', ' Face ', ' faces ', ' facial ', ' Human ', ' Modern Man ', ' In Vitro ', ' Industrialization ', ' Statutes and Laws ', ' Legislation ', ' Libraries ', ' Liver ', ' hepatic body system ', ' hepatic organ system ', ' Luciferases ', ' Luciferase Immunologic ', ' Marketing ', ' Methods ', ' Methodology ', ' Mining ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Risk ', ' Safety ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Testing ', ' Time ', ' Toxicology ', ' Translating ', ' Vertebrates ', ' Vertebrate Animals ', ' vertebrata ', ' Generations ', ' Drug Costs ', ' Dataset ', ' Data Set ', ' Custom ', ' injuries ', ' Injury ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Biochemical ', ' Ensure ', ' Chemicals ', ' Chemical Structure ', ' Evaluation ', ' Hepatic Cells ', ' Hepatic Parenchymal Cell ', ' Liver Cells ', ' Hepatocyte ', ' Hepatotoxic effect ', ' Liver Toxicity ', ' Toxic effect on liver cells ', ' hepatic toxicity ', ' hepatoxicity ', ' Hepatotoxicity ', ' Data Bases ', ' data base ', ' Databases ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' tool ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Chemical Injury ', ' Source ', ' System ', ' Test Result ', ' interest ', ' Cellular injury ', ' cell damage ', ' cellular damage ', ' damage to cells ', ' injury to cells ', ' cell injury ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' toxicant ', ' knowledgebase ', ' knowledge base ', ' Response Elements ', ' Toxicities ', ' Toxic effect ', ' novel ', ' Modeling ', ' Property ', ' drug development ', ' Proteomics ', ' QSAR ', ' Quantitiative Structure Activity Relationship ', ' Quantitative Structure-Activity Relationship ', ' Pharmaceutical Agent ', ' Pharmaceuticals ', ' Pharmacological Substance ', ' Pharmacologic Substance ', ' datamining ', ' data mining ', ' Address ', ' Animal Testing ', ' Data ', ' in vitro Assay ', ' in vivo ', ' cell stress ', ' Cellular Stress ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' Nutraceutical ', ' Validation ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' preclinical ', ' pre-clinical ', ' PubChem ', ' cost ', ' computational framework ', ' computer framework ', ' virtual ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' next generation ', ' Population ', ' transcriptomics ', ' combat ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' in vitro testing ', ' safety testing ', ' candidate validation ', ' ER stress ', ' endoplasmic reticulum stress ', ' adverse consequence ', ' adverse outcome ', ' screening ', ' Injury to Liver ', ' hepatic damage ', ' hepatic injury ', ' liver damage ', ' liver injury ', ' BigData ', ' Big Data ', ' developmental toxicity ', ' internet portal ', ' on-line portal ', ' online portal ', ' web-based portal ', ' web portal ', ' reproductive toxicity ', ' search engine ', ' computational toxicology ', ' experiment ', ' experimental research ', ' experimental study ', ' deep learning based neural network ', ' deep learning neural network ', ' deep neural net ', ' deep neural network ', ' safety assessment ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' large data sets ', ' large datasets ', ' hepatocellular injury ', ' Data Pooling ', ' ']",NIEHS,RUTGERS THE STATE UNIV OF NJ CAMDEN,R01,2020,465692,0.14172202348534782
"Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level Project summary: Although altered cell metabolism is becoming an established hallmark of cancer, there remains a crucial need of new tools for quantitation of metabolites at single living cell level. In particular, due to lack of specific labels for metabolites, there is an unmet need for high-resolution imaging tools capable of mapping metabolites and small molecules (fatty acids, carbohydrates, amino acids) that play essential roles in pathogenesis of cancer. Supported by a R21 grant through the IMAT program, our team partially addressed this need via developing a multiplex stimulated Raman scattering (SRS) microscope, which enabled vibrational imaging of metabolites in live tumor cells and intact biopsies at the speed of 5 microseconds per spectrum. This R33 application aims to push the hyperspectral stimulated Raman imaging technology to the next level through (i) technical simplification and validation, (ii) developing a robust hyperspectral image segmentation framework, and (iii) integrating the SRS modality with a commercial spontaneous Raman microscope towards broad use by non-experts. We have assembled an inter-disciplinary team for the proposed development. The three specific aims are: (1) Developing an easy-to-operate, highly sensitive line-by-line hyperspectral SRS microscope and validate its capacity for cancer metabolic imaging at single cell level. (2) Establishing a feature analysis framework for segmentation of hyperspectral SRS images using the non-parametric Bayesian model. (3) Integrating and validating the stimulated Raman imaging modality on a spontaneous Raman microscope. By completing the proposed development and validation activities, we will have generated a highly novel spectroscopic imaging system broadly applicable to analysis of chemical contents of cells and tissues for discovery-driven research and marker- based precision diagnosis. Project Narrative: Altered cell metabolism is becoming an established hallmark of cancer. We propose a label-free stimulated Raman spectroscopic imaging system broadly applicable to analysis of chemical contents of cells and tissues for discovery-driven cancer research and marker-based precision diagnosis.",Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level,9990711,R33CA223581,"['Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' Imaging Instrument ', ' Imaging Tool ', ' Imaging Device ', ' Molecular Analysis ', ' Resolution ', ' Cancer Biology ', ' Validation ', ' Monitor ', ' Molecular ', ' cell metabolism ', ' cellular metabaolism ', ' Cellular Metabolic Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' anti-cancer research ', ' cancer research ', ' anticancer research ', ' imaging spectroscopy ', ' spectroscopic imaging ', ' oncologic imaging ', ' oncology imaging ', ' tumor imaging ', ' cancer imaging ', ' cancer progenitor cells ', ' malignant stem cell ', ' cancer stem cell ', ' Imaging technology ', ' imaging Segmentation ', ' commercialization ', ' ER stress ', ' endoplasmic reticulum stress ', ' cancer cell metabolism ', ' cancer metabolism ', ' tumor cell metabolism ', ' tumor metabolism ', ' Bayesian adaptive designs ', ' Bayesian adaptive models ', ' Bayesian belief network ', ' Bayesian belief updating model ', ' Bayesian framework ', ' Bayesian hierarchical model ', ' Bayesian network model ', ' Bayesian nonparametric models ', ' Bayesian spatial data model ', ' Bayesian spatial image models ', ' Bayesian spatial models ', ' Bayesian statistical models ', ' Bayesian tracking algorithms ', ' Bayesian Modeling ', ' imaging system ', ' targeted imaging ', ' cancer markers ', ' cancer biomarkers ', ' 3D cell culture ', ' 3D culture ', ' three dimensional cell culture ', ' high resolution imaging ', ' human imaging ', ' metabolic imaging ', ' Visualization ', ' Amino Acids ', ' aminoacid ', ' Amplifiers ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biopsy ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Carbohydrates ', ' Cells ', ' Cell Body ', ' Color ', ' Diagnosis ', ' Dimethyl Sulfoxide ', ' DMSO ', ' Demasorb ', ' Demeso ', ' Dimethylsulphinyl ', ' Dimethylsulphoxide ', ' Domoso ', ' Dromisol ', ' Endoplasmic Reticulum ', ' Ergastoplasm ', ' Fatty Acids ', ' Flow Cytometry ', ' Flow Cytofluorometries ', ' Flow Cytofluorometry ', ' Flow Microfluorimetry ', ' Flow Microfluorometry ', ' flow cytophotometry ', ' Grant ', ' Hybrids ', ' Industrialization ', ' Lipids ', ' Microscopy ', ' Electron Microscopy ', ' Fluorescence Microscopy ', ' Fluorescence Light Microscopy ', ' Patients ', ' Play ', ' Records ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Raman Spectrum Analysis ', ' IR/UV/Raman Spectroscopy ', ' Raman Spectroscopy ', ' Raman spectrometry ', ' Time ', ' Tissue Extracts ', ' Tissues ', ' Body Tissues ', ' Water ', ' Hydrogen Oxide ', ' Businesses ', ' base ', ' Label ', ' Microscope ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Chemicals ', ' Bayesian Methodology ', ' Bayesian Statistical Method ', ' Bayesian approaches ', ' Bayesian classification method ', ' Bayesian classification procedure ', ' Bayesian posterior distribution ', ' Bayesian Method ', ' Collaborations ', ' Metabolic ', ' Malignant Cell ', ' cancer cell ', ' tool ', ' instrument ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' programs ', ' Scientist ', ' Msec ', ' millisecond ', ' Side ', ' System ', ' vibration ', ' Tumor Cell ', ' neoplastic cell ', ' particle ', ' Speed ', ' novel ', ' Modality ', ' Pathogenesis ', ' NMR Spectrometer ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Malignant Ovarian Neoplasm ', ' Malignant Ovarian Tumor ', ' Malignant Tumor of the Ovary ', ' Ovary Cancer ', ' ovarian cancer ', ' Malignant neoplasm of ovary ', ' image-based method ', ' imaging method ', ' imaging modality ', ' small molecule ', ' Address ', ' Detection ', ' ']",NCI,BOSTON UNIVERSITY (CHARLES RIVER CAMPUS),R33,2020,375540,0.051274442657896845
"Automated Molecular Identity Disambiguator (AutoMID) PROJECT SUMMARY Small molecules are one of the most important classes of therapeutics alleviating suffering and in many cases death for hundreds of millions of people worldwide. Small molecules also serve as invaluable tools to study biology, often with the goal to validate novel targets for the development of future therapeutic drugs. Reproducibility of experimental results and the interoperability and reusability of resulting datasets depend on accurate descriptions of associated research objects, and most critically on correct representations of small molecules that are tested in biological assays. For example, it is not possible to develop predictive models of protein target - small molecule interactions if their chemical structure representations are not correct. Many factors contribute to errors in reported chemical structures in small molecule screening and omics reference databases, scientific publications, and many other web-based resources and documents. Because of the complexity of representing small molecules chemical structure graphs and the lack of thorough curation, errors are frequently introduced by non-experts and error propagation across different digital research assets is a pervasive problem. To address this challenging problem via a scalable approach, we propose the Automated Molecular Identity Disambiguator (AutoMID). AutoMID will be usable in batch mode at scale via an API, for example to assist chemical structure standardization and registration by maintainers of digital research assets, and also via interactive (UI) mode for everyday researchers to quickly and easily validate or correct their small molecule representations. AutoMID will leverage extensive highly standardized linked databases of chemical structures and associated information including names, synonyms, biological activity and physical properties and their sources / provenance and leverage expert rules and AI to enable reliable disambiguation of chemical structure identities at scale. PROJECT NARRATIVE Small molecules are one of the most important types of drugs. They also serve as invaluable tools to study biology. The complexity of representing chemical graphs and the lack of thorough curation leads to frequent small molecule structure errors, which propagate across digital research assets, impeding their interoperability and reusability. To address this challenging problem, we propose the Automated Molecular Identity Disambiguator (AutoMID). Built on expert knowledge and AI, AutoMID will enable researchers and maintainers of data repositories to reliably identify and resolve ambiguities in chemical structures at scale.",Automated Molecular Identity Disambiguator (AutoMID),9987129,R01LM013391,"['Adoption ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biology ', ' Pharmaceutical Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutic Chemistry ', ' Classification ', ' Systematics ', ' Data Sources ', ' Cessation of life ', ' Death ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Future ', ' Goals ', ' Hand ', ' Hybrids ', ' In Vitro ', ' Literature ', ' Manuals ', ' Molecular Structure ', ' Macromolecular Structure ', ' Names ', ' Legal patent ', ' Patents ', ' Privatization ', ' Proteins ', ' Publications ', ' Scientific Publication ', ' Records ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Semantics ', ' Standardization ', ' Testing ', ' Time ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Biological ', ' Link ', ' Chemicals ', ' Chemical Structure ', ' Training ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Therapeutic ', ' Deposit ', ' Deposition ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Source ', ' Postdoc ', ' Research Associate ', ' post-doc ', ' post-doctoral ', ' Postdoctoral Fellow ', ' physical property ', ' Structure ', ' novel ', ' Graph ', ' Categories ', ' Reporting ', ' Modeling ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' chemical informatics ', ' cheminformatics ', ' small molecule ', ' Address ', ' Data ', ' Data Element ', ' Detection ', ' Reproducibility ', ' in vivo ', ' Molecular ', ' developmental ', ' Development ', ' meta data ', ' Metadata ', ' model of data ', ' model the data ', ' modeling of the data ', ' data modeling ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' software systems ', ' designing ', ' design ', ' interoperability ', ' user-friendly ', ' relational database ', ' screening ', ' internet resource ', ' on-line compendium ', ' on-line resource ', ' online compendium ', ' web resource ', ' web-based resource ', ' online resource ', ' FAIR data ', ' Findable, Accessible, Interoperable, and Reusable ', ' FAIR principles ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' in silico ', ' harmonized data ', ' data harmonization ', ' knowledge curation ', ' ']",NLM,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,R01,2020,293345,0.17026252113524212
"Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria PROJECT SUMMARY Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria. Antibiotic-resistant Gram-negative bacterial infections are increasing in incidence and novel antibiotics are urgently needed to combat this growing threat to public health. A major roadblock to the development of novel antibiotics is our poor understanding of the structural features of small molecules that correlate with bacterial penetration and efflux. As a result, while potent biochemical inhibitors can often be identified for new targets, developing them into compounds with whole-cell antibacterial activity has proven challenging. To address this critical problem, we propose herein a comprehensive, multidisciplinary approach to develop quantitative models to predict small-molecule penetration and efflux in Gram-negative bacteria. We have pioneered a general platform for systematic, quantitative evaluation of small-molecule accumulation in bacteria, using label-free LC-MS/MS detection and multivariate cheminformatic analysis. We have also developed unique isogenic strain sets of wild-type, hyperporinated, efflux-knockout, and doubly-compromised E. coli, P. aeruginosa, and A. baumannii that allow us to dissect the individual contributions of outer/inner membrane penetration and active efflux to net accumulation, using a kinetic model that accurately recapitulates available experimental data. Moreover, we have developed machine learning and neural network approaches to QSAR (quantitative structureactivity relationship) modeling of pharmacological properties that will now be used to develop predictive cheminformatic models for Gram-negative accumulation, penetration, and efflux. This project will be carried out by a multidisciplinary SPEAR-GN Project Team (Small-molecule Penetration & Efflux in Antibiotic-Resistant Gram-Negatives, speargun) involving the labs of Derek Tan (MSK, PI), Helen Zgurskaya (OU, PI), Bradley Sherborne (Merck, Lead Collaborator), Valentin Rybenkov (OU, Co-I), Adam Duerfeldt (OU, Co-I), Carl Balibar (Merck, Collaborator), and David McLaren (Merck, Collaborator), comprising extensive combined expertise in organic and diversity-oriented synthesis, biochemistry, microbiology, high- throughput screening, mass spectrometry, biophysical modeling, cheminformatics, and medicinal chemistry. Herein, we will design and synthesize chemical libraries with diverse structural and physicochemical properties; analyze their accumulation in the isogenic strain sets in both high-throughput and high-density assay formats; extract kinetic parameters for penetration and efflux from the resulting experimental datasets; develop and validate robust QSAR models for accumulation, penetration, and efflux; and demonstrate the utility of these models in medicinal chemistry campaigns to develop novel Gram-negative antibiotics against three targets. This project will provide a major advance in the field of antibacterial drug discovery, providing powerful enabling tools to the scientific community to address this major threat to public health. PUBLIC HEALTH RELEVANCE Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria. Antibiotic-resistant Gram-negative bacteria pose a growing threat to public health in the U.S. and globally. A major obstacle to the development of new antibiotics to combat such infections is our poor understanding of the chemical requirements for small molecules to enter Gram-negative cells and to avoid ejection by efflux pumps. The proposed comprehensive, multidisciplinary research program aims to develop predictive computational tools to identify such molecules by carrying out large-scale, quantitative analyses of the accumulation of diverse small molecules in Gram-negative bacteria. These tools will then enable medicinal chemistry campaigns to develop novel antibiotics.",Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria,9982190,R01AI136795,"['inhibitor/antagonist ', ' inhibitor ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Architecture ', ' Engineering / Architecture ', ' Bacteria ', ' Biochemistry ', ' Biological Chemistry ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biological Availability ', ' Bioavailability ', ' Biologic Availability ', ' Physiologic Availability ', ' Cells ', ' Cell Body ', ' Pharmaceutical Chemistry ', ' Medicinal Chemistry ', ' Pharmaceutic Chemistry ', ' Communities ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Escherichia coli ', ' E coli ', ' E. coli ', ' Gram-Negative Bacteria ', ' Human ', ' Modern Man ', ' Incidence ', ' Infection ', ' Kinetics ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Libraries ', ' Microbiology ', ' Pharmacology ', ' Pseudomonas aeruginosa ', ' P aeruginosa ', ' P. aeruginosa ', ' Pseudomonas pyocyanea ', ' Public Health ', ' Quantitative Evaluations ', ' Role ', ' social role ', ' Mass Spectrum Analysis ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrometry ', ' Mass Spectroscopy ', ' Mass Spectrum ', ' Mass Spectrum Analyses ', ' Testing ', ' Measures ', ' Gram-Negative Bacterial Infections ', ' Resistance to antibiotics ', ' Resistant to antibiotics ', ' antibiotic drug resistance ', ' antibiotic resistant ', ' Antibiotic Resistance ', ' Dataset ', ' Data Set ', ' base ', ' density ', ' Label ', ' improved ', ' Penetration ', ' Variation ', ' Variant ', ' Biochemical ', ' Chemicals ', ' Individual ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' analog ', ' Antibacterial Agents ', ' anti-bacterial ', ' antibacterial ', ' Anti-Bacterial Agents ', ' A baumanni ', ' A baumannii ', ' A. baumanni ', ' A. baumannii ', ' A.baumannii ', ' Acinetobacter baumanni ', ' Acinetobacter baumannii ', ' tool ', ' machine learned ', ' Machine Learning ', ' programs ', ' Oral ', ' membrane structure ', ' Membrane ', ' success ', ' cell envelope ', ' chemical library ', ' small molecule libraries ', ' Structure ', ' novel ', ' mate ', ' Partner in relationship ', ' Modeling ', ' Property ', ' High Throughput Assay ', ' high throughput screening ', ' QSAR ', ' Quantitiative Structure Activity Relationship ', ' Quantitative Structure-Activity Relationship ', ' drug discovery ', ' Effectiveness ', ' chemical informatics ', ' cheminformatics ', ' small molecule ', ' Address ', ' Data ', ' Detection ', ' Mammalian Cell ', ' Knockout ', ' Knock-out ', ' developmental ', ' Development ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' designing ', ' design ', ' prospective ', ' multidisciplinary ', ' efflux pump ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' combat ', ' public health relevance ', ' screening ', ' Algorithmic Tools ', ' Software Algorithm ', ' Algorithmic Software ', ' biophysical model ', ' learning network ', ' lead optimization ', ' neural network ', ' kinetic model ', ' ']",NIAID,SLOAN-KETTERING INST CAN RESEARCH,R01,2020,1239304,0.0889977291708514
